Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005013	p-psa-v	ug/l (ug/l)	37895	98921	0.01%
3005013	p-psa-v	— (—)	21760	51558	100.00%	Distribution not available
3005013	s-psa-v	— (—)	17042	27050	100.00%	Distribution not available
3005013	s-psa-v	ug/l (ug/l)	8497	17871	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	436	523	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	— (—)	218	285	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	214	251	0.00%
3005013	p-prostataspesifinenantigeeni,vapaa	ug/l (ug/l)	87	114	0.00%
3005013	s-prostataspesifinenantigeeni,vapaa	— (—)	69	78	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(p-psa-v)	ug/l (ug/l)	65	113	0.00%
3005013	prostataspesifinenantigeeni,vapaa	— (—)	59	82	100.00%	Distribution not available
3005013	prostataspesifinenantigeeni,vapaa(psa-v)	ug/l (ug/l)	54	83	0.00%
3005013	prostataspesifinenantigeeni,vapaa(4900p-psa-v)	ug/l (ug/l)	41	64	0.00%
3005013	s-fpsa	ug/l (ug/l)	28	29	0.00%
3005013	s-psa-v(pi)	ug/l (ug/l)	16	21	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal spermatozoa

3205

18604

3.19

308.93

5.5

3.1

0.95

0.77

ug/l

19.04

2879

13041

Any death

3838

49336

0.49

307.65

2.7

3.1

0.96

0.74

ug/l

8.04

2688

33944

Abnormal serum enzyme levels

6702

41550

2.11

307.65

4.4

3.0

1.15

0.73

ug/l

59.63

5479

28726

Hyperplasia of prostate

10237

33729

2.54

307.65

3.9

2.5

0.81

0.75

ug/l

5.31

8176

20545

Malignant neoplasm of prostate, including Hilmo

8203

30781

2.31

307.65

4.8

2.7

1.05

0.69

ug/l

49.79

6591

20524

Hernia

10723

48440

1.59

307.65

2.9

2.8

0.72

0.77

ug/l

3.27

6906

30105

Malignant neoplasm of prostate

7840

29824

2.27

307.65

4.8

2.7

1.07

0.70

ug/l

47.16

6232

20097

Diseases of male genital organs

11795

38998

1.85

307.65

3.3

2.4

0.75

0.73

ug/l

1.29

8161

22122

Abnormal findings on examination of blood, without diagnosis

8098

48514

1.81

307.65

4.1

2.9

1.08

0.72

ug/l

55.65

6403

32669

Symptoms and signs involving the urinary system

10984

49030

1.94

307.65

3.5

2.8

0.81

0.75

ug/l

5.03

8288

31137

malignant neoplasm of male genital organs

7947

30649

2.25

307.65

4.7

2.7

1.06

0.69

ug/l

46.94

6289

20398

Unspecified haematuria

7079

38553

1.77

300.53

3.5

3.0

0.88

0.77

ug/l

8.08

5376

26042

Sleep apnoea

11190

51277

1.52

284.15

3.1

2.9

0.68

0.78

ug/l

19.78

7137

32934

Inguinal hernia

10075

48211

1.56

261.56

3.0

2.8

0.75

0.77

ug/l

0.94

6643

30052

Genitourinary diseases

8847

30397

1.58

256.71

3.1

2.3

0.73

0.70

ug/l

1.99

5877

16468

Sleep apnoea, including avohilmo

11240

50543

1.46

241.97

3.1

2.9

0.69

0.78

ug/l

19.63

7156

32530

Coxibs

3620

10938

1.92

214.97

3.2

2.9

0.75

0.89

ug/l

7.29

2349

7491

Retention of urine

5834

33398

1.65

187.81

3.5

3.1

0.95

0.78

ug/l

11.70

4595

23191

Pain in throat and chest

9271

41029

1.43

178.07

3.0

2.8

0.69

0.79

ug/l

15.81

6105

25542

Other diseases of hard tissues of teeth

7629

28320

1.49

172.43

3.3

2.9

0.77

0.81

ug/l

1.61

5269

17864

All kidney diseases

10204

52621

1.39

171.38

3.0

2.9

0.84

0.73

ug/l

9.53

7295

32926

296

10467

0.22

157.56

2.1

3.0

0.70

0.79

ug/l

0.96

194

7086

Acetic acid derivatives and related substances

3392

10928

1.75

150.14

3.2

2.9

0.77

0.89

ug/l

5.56

2226

7488

Artrosis, including avohilmo

10067

42209

1.38

149.61

3.0

2.8

0.71

0.79

ug/l

9.28

6429

26426

Inflammatory diseases of prostate (prostatitis)

2639

17014

2.04

144.00

3.6

2.5

0.73

0.75

ug/l

0.33

1853

10451

Diseases of oral cavity, salivary glands and jaws

7539

28703

1.43

139.73

3.1

2.9

0.79

0.82

ug/l

0.69

5151

18104

Chronic periodontitis, including avohilmo

10539

55330

1.34

136.53

3.1

2.9

0.74

0.76

ug/l

0.62

7249

34991

Periodontitis

10537

55348

1.33

133.51

3.1

2.9

0.74

0.76

ug/l

0.63

7253

34994

Oter anti-inflammatory and antirheumatic agents, non-steroids

3029

10554

1.76

131.80

3.4

2.9

0.71

0.90

ug/l

17.33

2076

7362

Hypothyreosis and Thyroxine purchase for inclusion criteria

5086

46708

0.69

131.22

3.1

3.0

0.71

0.78

ug/l

6.11

3435

31438

Oxicams

2985

10760

1.72

125.67

3.1

2.9

0.72

0.90

ug/l

9.52

1951

7432

Hypothyroidism, other/unspecified

5068

46256

0.69

124.35

3.1

3.0

0.71

0.78

ug/l

5.86

3424

31103

Exposure to unspecified factor

10122

57501

1.32

122.01

2.9

0.71

0.77

ug/l

5.25

6610

36682

Polyuria

3132

21126

1.69

119.47

3.6

3.1

0.62

0.78

ug/l

15.09

2340

14592

Injuries to the head

11360

55977

1.29

116.94

2.9

0.73

0.77

ug/l

2.37

7425

35659

Other diseases of intestines

10868

49224

1.30

116.50

3.0

2.8

0.71

0.77

ug/l

6.17

7208

30489

Hypothyroidism, strict autoimmune

4204

39014

0.68

114.03

3.1

0.72

0.79

ug/l

5.33

2817

26309

Chronic apical periodontitis

11478

52559

1.29

113.82

3.1

2.9

0.76

0.77

ug/l

0.26

7830

33107

Statin medication

6134

25434

1.41

113.56

2.7

2.6

0.71

0.77

ug/l

4.64

3700

14709

Basal cell carcinoma, including avohilmo

5091

25520

1.48

113.45

3.5

2.7

0.80

0.70

ug/l

8.18

3731

17464

Dental operations

7888

31211

1.37

112.06

3.1

2.9

0.79

0.81

ug/l

0.68

5369

19631

Benign neoplasms

11192

49582

1.29

111.74

3.0

2.8

0.75

0.77

ug/l

0.72

7434

30793

Codeine or tramadol medication

11837

52393

1.28

110.40

2.9

0.71

0.78

ug/l

8.84

7613

33497

Other disorders of ear

9917

51911

1.30

107.66

3.2

2.9

0.75

0.77

ug/l

1.05

6737

33523

Sleep disorders (combined)

11348

48052

1.28

106.94

3.1

2.9

0.69

0.79

ug/l

18.15

7340

30948

Tramadol

8614

41557

1.33

106.87

2.9

0.70

0.77

ug/l

6.00

5692

26374

Mood [affective] disorders

6467

54874

0.74

106.77

2.7

2.8

0.63

0.76

ug/l

12.92

4366

34182

Persons encountering health services in other circumstances, wide

12590

52912

1.27

106.76

3.1

2.8

0.73

0.77

ug/l

2.83

8301

33475

Disease of hard tissues of teeth, NOS

6801

27079

1.39

105.99

3.2

2.9

0.70

0.80

ug/l

10.60

4649

16989

Mood disorders

6502

54948

0.74

105.39

2.7

2.8

0.64

0.76

ug/l

12.89

4392

34240

Diseases of pulp and periapical tissues and dental caries

7835

31093

1.35

105.06

3.1

2.9

0.80

ug/l

0.06

5422

19579

Artificial joint operation, meniscal resection

10576

55626

1.29

104.06

3.0

2.9

0.69

0.78

ug/l

17.02

6913

35977

Codeine

9676

41832

1.30

103.84

2.9

2.8

0.70

0.77

ug/l

7.63

6176

26408

Malignant neoplasm, wide definition for exclusion

8861

41019

1.32

103.80

3.4

2.4

0.82

0.67

ug/l

18.58

6369

24227

Dental caries, including avohilmo

8642

34738

1.33

103.77

3.1

2.9

0.79

0.80

ug/l

0.31

5968

21931

Persons encountering health services for other counselling and medical advice, not elsewhere classified

11876

52603

1.27

103.59

3.1

2.8

0.74

0.77

ug/l

1.50

7704

33277

Depression

5735

51413

0.73

102.35

2.7

2.8

0.63

0.75

ug/l

9.88

3869

31604

Basal cell carcinoma

4836

24581

1.46

101.80

3.5

2.8

0.81

0.71

ug/l

7.81

3558

16949

Neoplasms

7745

31804

1.34

101.45

3.0

2.3

0.75

0.66

ug/l

7.07

4962

17665

Mood disorders, excluding more controls

6429

49901

0.74

100.65

2.7

2.9

0.64

0.78

ug/l

16.41

4362

31228

Malignant neoplasm of skin

5500

28279

1.42

100.40

3.5

2.7

0.81

0.70

ug/l

9.32

4023

18989

Disorders of lipoprotein metabolism and other lipidaemias

9789

48917

1.30

99.27

3.0

2.9

0.77

0.76

ug/l

0.25

6768

30694

Injuries to the shoulder and upper arm

9048

58470

1.30

98.68

2.9

0.71

0.77

ug/l

4.47

5839

37373

Diverticular disease of intestine

8650

44084

1.32

97.62

3.2

2.9

0.74

0.79

ug/l

2.92

6242

28876

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5334

27156

1.42

97.12

3.4

2.7

0.80

0.70

ug/l

8.03

3854

18416

Paracetamol or NSAID medication

1907

5691

1.80

97.08

2.9

2.8

0.77

0.88

ug/l

3.23

1212

3758

Solid cancers, helper endpoint

8543

39990

1.31

97.03

3.5

2.5

0.84

0.67

ug/l

20.43

6175

23915

Hypothyroidism, strict autoimmune, 3 medication purchases required

4151

38675

0.70

96.93

3.0

3.1

0.72

0.79

ug/l

4.38

2778

26157

Renal tubulo-interstitial diseases

8673

51519

1.30

96.88

3.1

3.0

0.90

0.75

ug/l

13.83

6474

33762

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5002

25558

1.43

95.77

3.5

2.7

0.81

0.70

ug/l

8.24

3660

17519

Caries of dentine, including avohilmo

8907

36306

1.30

93.85

3.1

2.9

0.78

0.80

ug/l

0.54

6143

22908

Disorders of the thyroid gland

6335

53138

0.75

93.16

3.1

3.0

0.73

0.78

ug/l

3.58

4323

35413

Injuries to the wrist and hand

9988

56218

1.27

93.09

2.9

0.71

0.76

ug/l

3.34

6298

36155

COPD, hospital admissions 1, only main diagnosis

2723

33270

0.64

91.41

2.9

3.3

0.77

0.82

ug/l

1.29

1874

23877

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4076

54214

0.70

91.23

2.6

2.9

0.65

0.76

ug/l

9.24

2825

34305

Propionic acid derivatives

3189

10948

1.55

90.49

3.0

2.9

0.75

0.89

ug/l

8.49

2074

7496

Malignant neoplasm

8538

40385

1.30

90.21

3.5

2.5

0.84

0.67

ug/l

19.55

6148

24052

Metabolic disorders

10007

49808

1.27

88.93

2.9

2.8

0.76

ug/l

0.10

6798

30943

Pure hypercholesterolaemia

8982

47545

1.29

88.75

3.1

2.9

0.78

0.76

ug/l

0.83

6346

30270

Any event in cancer register

8990

42614

1.29

88.73

3.5

2.5

0.84

0.68

ug/l

17.38

6458

25722

Intracranial trauma

5636

30197

1.37

88.01

2.8

0.70

0.79

ug/l

7.95

3657

18631

Mycoses

8301

58083

1.29

87.54

3.0

2.9

0.69

0.76

ug/l

6.18

5420

37006

Abnormalities of breathing

8785

41040

1.28

86.49

2.9

2.8

0.70

0.79

ug/l

8.62

5576

25552

L02BB Anti-androgens

1918

13053

1.95

85.98

5.3

3.3

1.65

0.80

ug/l

20.50

1492

9552

Mental and behavioural disorders due to alcohol

4681

58533

0.72

84.24

2.7

2.9

0.67

0.77

ug/l

6.51

3240

36991

Alcohol use disorder, ICD-based

3719

49669

0.70

82.72

2.6

2.9

0.65

0.76

ug/l

7.75

2561

31446

Gingivitis and periodontal diseases

10953

46752

1.25

81.96

3.1

2.8

0.73

0.78

ug/l

3.63

7349

29545

COPD, hospital admission 2, with asthma infections

2580

31212

0.65

81.53

2.8

3.3

0.76

0.82

ug/l

1.69

1777

22225

L02BX Other hormone antagonists and related agents

1198

7659

2.49

79.87

5.1

3.3

1.99

0.76

ug/l

21.79

987

5611

COPD related to multimorbidity

3407

38614

0.69

78.73

2.9

3.3

0.75

0.81

ug/l

2.25

2384

27773

Anti-inflammatory and antirheumatic products, non-steroids

3118

10948

1.51

78.70

3.1

2.9

0.76

0.89

ug/l

7.07

2033

7496

Arthrosis

8393

37352

1.29

78.67

3.0

2.8

0.70

0.80

ug/l

12.80

5489

23550

COPD, hospital admissions 3, with asthma pneumonia sepsis

2142

26481

0.63

78.51

2.8

3.3

0.77

0.83

ug/l

1.37

1483

19170

Anxiety disorders, excluding more controls

5065

42498

0.75

74.35

2.7

2.8

0.61

0.76

ug/l

25.87

3259

25637

Meniscus derangement

6694

36111

1.31

74.32

3.0

2.8

0.70

0.79

ug/l

10.55

4338

22947

Sub-endpoint used in defining T1D endpoints

1488

22953

0.60

74.10

2.4

2.9

0.74

0.77

ug/l

0.32

967

14475

Myocardial infarction, unclassifiable

1585

21520

0.60

73.77

2.8

3.3

0.88

0.84

ug/l

0.58

1132

15446

Substance abuse

5053

60309

0.75

73.26

2.6

2.9

0.65

0.77

ug/l

11.71

3494

38098

Finngen Rheumatological endpoints

9840

46379

1.24

73.02

2.9

2.8

0.71

0.78

ug/l

7.63

6424

28723

Alcohol dependence

2364

33029

0.65

72.73

2.6

2.9

0.62

0.75

ug/l

6.05

1635

20968

Benign neoplasm of colon, rectum, anus and anal canal

7202

50873

1.29

72.55

3.3

3.0

0.76

0.79

ug/l

0.92

5309

34501

Lung cancer and mesothelioma

1423

18796

0.59

71.87

2.9

3.3

0.81

0.83

ug/l

0.20

1006

13670

Other joint disorders

8850

38284

1.26

71.34

2.9

2.8

0.70

0.79

ug/l

10.70

5603

23795

Acute alcohol intoxication

2045

29340

0.64

71.33

2.7

2.9

0.67

0.77

ug/l

2.31

1426

18847

Shoulder lesions

8597

42958

1.26

69.77

3.0

2.9

0.68

0.79

ug/l

13.99

5704

27436

COPD, early/later onset

4017

43714

0.72

69.23

2.9

3.2

0.75

0.81

ug/l

2.42

2805

31097

Other soft tissue disorders, not elsewhere classified

9141

44358

1.24

68.67

3.1

2.8

0.71

0.79

ug/l

8.66

6188

27942

COPD, hospital admissions

3985

43413

0.73

67.60

2.9

3.2

0.75

0.81

ug/l

2.47

2788

30880

Testicular dysfunction

748

4252

2.59

67.48

3.0

2.5

0.63

0.67

ug/l

0.60

412

2358

Spondylopathies

8848

43912

1.25

66.38

3.0

2.9

0.70

0.80

ug/l

11.66

6048

28081

Dermatophytosis

6434

52126

1.29

66.16

3.0

2.9

0.69

0.76

ug/l

4.64

4135

33383

In situ neoplasms

2982

21775

1.44

65.72

3.5

3.3

0.77

0.82

ug/l

1.73

2201

15781

Gonarthrosis

7725

36140

1.27

65.49

3.0

2.9

0.71

0.81

ug/l

12.32

5167

23194

Other symptoms and signs involving the urinary system

1445

9472

1.77

64.42

4.3

3.0

0.79

0.77

ug/l

0.31

1155

6377

Malignant neoplasm of bronchus and lung

1093

14582

0.57

63.97

2.8

2.9

0.80

0.74

ug/l

0.79

759

10401

Mental and behavioural disorders due to psychoactive substance use

5255

60606

0.77

63.57

2.7

2.9

0.66

0.77

ug/l

9.68

3633

38339

Testicular hypofunction

668

3754

2.66

62.79

3.0

2.5

0.63

0.67

ug/l

0.50

367

2097

Bacterial pneumonia (organism specified)

3190

38268

0.72

62.05

2.7

3.1

0.78

0.80

ug/l

0.31

2179

25991

Rotator cuff syndrome

7047

41543

1.27

62.00

3.0

2.9

0.67

0.79

ug/l

18.08

4770

26841

Dislocation, sprain and strain of joints and ligaments of knee

5630

41641

1.29

61.35

2.7

0.66

0.73

ug/l

7.32

3320

25357

Soft tissue disorders

10288

44692

1.22

61.29

3.0

2.8

0.70

0.79

ug/l

11.97

6622

28102

5533

61453

0.78

60.54

2.7

2.9

0.67

0.77

ug/l

8.50

3827

39162

Early onset COPD

1629

23567

0.63

60.26

2.7

3.0

0.68

0.76

ug/l

1.87

1093

15914

Parasetamol

8227

34531

1.24

60.03

2.8

0.74

0.77

ug/l

1.21

5273

20993

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3342

19749

1.38

59.27

5.4

3.1

0.94

0.77

ug/l

18.13

2965

13740

Bacterial pneumonia, not elsewhere classified

2773

32714

0.71

59.09

2.7

3.1

0.77

0.78

ug/l

0.12

1903

22203

Anxiety disorders

5123

44657

0.78

58.06

2.7

0.61

0.73

ug/l

18.99

3284

26677

Diseases of pulp and periapical tissues, including avohilmo

10413

45809

1.21

57.70

3.1

2.9

0.77

0.78

ug/l

0.11

7107

28946

Actinic keratosis

4019

29132

1.36

57.69

3.6

3.3

0.79

0.83

ug/l

1.20

3008

21377

Bacterial pneumoniae

2976

34667

0.72

57.53

2.7

3.1

0.78

ug/l

0.03

2037

23418

Conductive and sensorineural hearing loss

8592

48791

1.23

57.44

3.3

2.9

0.77

0.78

ug/l

0.45

5964

32351

Disorders of choroid and retina

8793

52751

1.23

57.36

3.2

3.0

0.78

0.77

ug/l

0.30

6248

34744

Alcohol use disorder, Swedish definition

5385

60426

0.78

57.26

2.7

2.9

0.66

0.77

ug/l

12.41

3713

38455

Early onset COPD, excluding more controls

1629

23324

0.64

57.00

2.7

3.0

0.68

0.78

ug/l

2.74

1093

15671

Skin changes due to chronic exposure to nonionizing radiation

4071

29498

1.35

56.58

3.6

3.3

0.79

0.83

ug/l

1.10

3045

21636

Status post-ami

2630

26467

0.69

56.22

3.0

3.3

0.85

0.81

ug/l

0.68

1930

18993

Malignant neoplasm of respiratory system and intrathoracic organs

1379

17052

0.62

56.22

2.9

2.8

0.80

0.73

ug/l

1.33

971

12132

Chronic rhinitis, nasopharyngitis and pharyngitis

2521

18373

1.44

55.99

3.1

2.8

0.66

0.75

ug/l

2.96

1640

11555

Other heart diseases, wide

8340

42697

1.23

55.72

2.7

2.8

0.70

0.75

ug/l

3.33

5207

25943

Gonarthrosis [arthrosis of knee](FG)

8896

43728

1.23

55.52

3.1

2.9

0.71

0.79

ug/l

10.45

5995

27976

Neurotic, stress-related and somatoform disorders

5036

43937

0.78

55.48

2.7

0.61

0.73

ug/l

19.58

3218

26168

Malignant neoplasm of bronchus and lung, including Hilmo

1378

17102

0.62

55.34

2.9

0.81

0.73

ug/l

1.19

967

12190

Varicose veins

3651

35556

0.75

55.34

3.1

0.79

0.80

ug/l

0.24

2555

24607

Other arrhythmias

6111

37750

1.26

54.04

3.1

2.9

0.72

0.76

ug/l

1.84

4091

24133

Non-invasive ventilation

1191

16373

0.61

53.93

2.4

2.9

0.76

0.77

ug/l

0.18

631

10111

Sensorineural hearing loss

8285

47495

1.23

53.66

3.3

3.0

0.78

ug/l

0.24

5809

31796

Persons encountering health services for specific procedures and health care

10259

52593

1.20

53.58

3.0

2.8

0.81

0.74

ug/l

4.92

6959

32825

Cardiac arrhythmias

4997

25908

1.29

53.40

2.7

0.67

0.73

ug/l

3.13

2993

14960

Presbycusis

1457

9705

1.63

53.16

3.6

3.3

0.87

0.88

ug/l

0.18

974

7220

Other diseases of upper respiratory tract

11261

50580

1.19

52.35

3.1

2.9

0.70

0.79

ug/l

14.31

7301

32858

Fall on same level

11315

53272

1.19

52.31

2.9

0.72

0.77

ug/l

3.31

7349

33768

Schizophrenia or delusion, excluding more controls

1430

20903

0.65

52.27

2.3

2.6

0.55

0.73

ug/l

23.71

992

11695

Kela-code for severe mental illness

1780

25249

0.68

52.25

2.5

2.7

0.59

0.72

ug/l

11.75

1239

14874

Later onset COPD

2429

25652

0.70

51.98

3.1

3.5

0.79

0.85

ug/l

1.81

1737

19321

Polyarthropathies

6858

37198

1.24

51.70

3.0

2.8

0.76

0.80

ug/l

1.55

4719

23516

4242

31057

1.32

51.23

3.6

3.3

0.78

0.83

ug/l

1.28

3153

22624

Alcoholic liver disease

703

11581

0.53

51.16

2.5

3.0

0.70

0.75

ug/l

0.72

470

7675

Other bacterial diseases

9839

53545

1.20

50.30

2.8

2.9

0.77

0.75

ug/l

0.80

6647

33505

Schizophrenia

670

11547

0.54

50.08

2.0

2.6

0.51

0.69

ug/l

11.17

468

6541

Condition for Implicit Sepsis (Organ dysfunction codes)

8912

52417

1.20

49.65

2.9

0.75

0.76

ug/l

0.15

6142

32912

Type 1 diabetes

1357

19901

0.64

49.43

2.4

2.8

0.74

0.73

ug/l

0.02

878

12148

Symptoms and signs involving cognition, perception, emotional state and behaviour

9561

55930

1.20

49.31

3.1

2.9

0.73

0.77

ug/l

2.74

6623

35744

Diseases of the eye and adnexa

8111

34207

1.22

49.28

2.8

2.6

0.71

0.75

ug/l

2.19

5062

20277

Opioids

9472

41994

1.20

49.19

2.9

2.8

0.74

0.77

ug/l

0.97

5984

26497

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3661

14162

1.34

49.02

2.8

2.3

0.74

0.67

ug/l

2.30

2207

7373

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1046

15733

0.60

48.78

2.5

3.0

0.73

0.76

ug/l

0.46

705

10556

Exposure to other specified factors

7018

54115

1.23

48.57

2.8

0.70

0.75

ug/l

2.20

4379

34068

GASTRO-related operations

7110

29655

1.23

48.57

2.9

2.6

0.76

0.73

ug/l

1.09

4558

17093

Any gastric operation

7110

29655

1.23

48.57

2.9

2.6

0.76

0.73

ug/l

1.09

4558

17093

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

5462

43714

1.26

48.28

2.9

2.8

0.67

0.77

ug/l

8.67

3430

27934

Schizophrenia or delusion

1430

20798

0.66

48.19

2.3

2.6

0.55

0.71

ug/l

18.25

992

11947

Schizophrenia, schizotypal and delusional disorders

1443

20931

0.66

47.94

2.3

2.6

0.55

0.71

ug/l

16.85

1004

12059

Erysipelas

8133

52950

1.21

47.71

2.9

0.73

0.75

ug/l

0.87

5566

33521

Insulin, combination of fast acting with intermediate-acting or long-acting

5212

57633

0.80

47.53

2.7

3.0

0.80

0.77

ug/l

0.61

3548

37885

Unspecified mental disorder

1976

27119

0.70

47.24

2.5

2.7

0.59

0.72

ug/l

11.94

1368

15961

Episodal and paroxysmal disorders

10270

45033

1.19

46.99

2.9

2.8

0.71

0.79

ug/l

7.91

6553

28611

Sulfonylureas

2978

30312

0.74

46.64

3.0

3.3

0.83

0.81

ug/l

0.36

2105

21934

Diseases of oesophagus, stomach and duodenum

10537

54620

1.18

46.55

3.0

2.9

0.72

0.77

ug/l

4.00

7168

34439

Medical observation and evaluation for suspected diseases and conditions

7343

31581

1.22

46.28

2.9

2.8

0.73

0.79

ug/l

2.95

4873

19300

Other chronic obstructive pulmonary disease

3936

40094

0.77

46.13

2.9

3.2

0.74

0.81

ug/l

3.33

2755

28382

Diabetic retinopathy, strict definition

803

11292

0.58

45.08

2.5

2.9

0.78

0.76

ug/l

0.25

549

7584

5891

61514

0.81

43.72

2.7

2.9

0.67

0.77

ug/l

8.99

4054

39174

Fitting and adjustment of other devices

3967

28937

1.30

43.00

3.4

3.2

0.82

0.79

ug/l

1.23

2655

20758

Benign neoplasm: Colon

5975

48058

1.24

42.94

3.2

3.1

0.76

0.79

ug/l

0.91

4406

33123

Acute tubulo-interstitial nephritis

5450

39023

1.24

42.63

3.3

3.2

0.86

0.77

ug/l

4.27

4138

27001

Any prescribed medicine buy

8.97

42.13

3.0

1.5

0.91

0.54

ug/l

2.27

Substance abuse, excluding more controls

5053

51712

0.80

42.13

2.6

2.9

0.65

0.78

ug/l

14.30

3494

32601

Atherosclerosis, excluding cerebral and coronary sclerosis

3818

37084

0.77

41.79

2.9

3.3

0.80

0.81

ug/l

0.15

2708

26677

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

9073

51078

1.18

41.77

3.0

2.9

0.75

0.76

ug/l

0.45

6265

32351

Any operation in hilmo

515

1358

2.09

41.18

2.5

1.7

0.76

0.68

ug/l

0.52

266

489

Other dorsopathies, not elsewhere classified

9898

45010

1.18

41.05

2.9

0.70

0.79

ug/l

9.70

6403

28358

Adjustment and management of implanted device

2271

17377

1.42

40.90

3.3

0.80

ug/l

0.02

1702

12570

Acute alcohol intoxication, ICD10

1445

19988

0.67

40.07

2.6

2.8

0.65

0.73

ug/l

1.21

999

12402

Dorsalgia

9660

44994

1.18

39.84

2.9

0.69

0.79

ug/l

13.19

6316

28351

Other disorders of prostate

647

4056

2.11

39.82

3.6

2.6

0.90

0.80

ug/l

0.98

484

2612

Continuous positive airway pressure

2527

16510

1.39

39.81

3.2

2.9

0.79

0.78

ug/l

0.13

1620

10280

Other disorders of penis

1520

11162

1.57

39.70

3.1

2.5

0.66

0.75

ug/l

3.34

1006

6640

Type 1 diabetes, wide definition

1091

15984

0.65

39.23

2.3

2.8

0.75

0.73

ug/l

0.14

683

9611

Insulin, fast-acting or short human

2588

33051

0.75

39.15

2.6

3.0

0.80

0.76

ug/l

0.60

1737

21460

COPD

4159

41111

0.79

39.09

2.9

3.2

0.74

0.81

ug/l

3.81

2910

28982

Other hearing loss

2832

21814

1.34

38.56

3.4

3.2

0.84

ug/l

0.03

1973

15540

Redundant prepuce, phimosis and paraphimosis

3073

24467

1.34

38.35

2.8

2.3

0.70

ug/l

0.15

1820

13286

Peripheral artery disease

4078

39243

0.79

38.34

2.9

3.2

0.79

0.80

ug/l

0.13

2887

27955

Arthropathies

8731

38294

1.18

37.73

2.9

2.8

0.71

0.79

ug/l

7.37

5480

23804

ILD medications: prednisolone, methylprednisolone, prednisone

10773

53039

1.16

37.65

2.9

0.77

0.76

ug/l

0.32

7063

33576

Coxarthrosis

5926

33180

1.23

37.27

3.3

3.0

0.72

0.82

ug/l

9.10

4191

22076

Hypogonadotropic hypogonadism

493

2907

2.24

37.14

3.0

2.5

0.54

0.66

ug/l

4.37

272

1551

Spermatocele

1338

9823

1.62

36.90

3.2

2.6

0.68

0.78

ug/l

4.57

901

6210

Hydrocele

1902

14583

1.47

36.80

3.1

2.6

0.77

0.78

ug/l

0.12

1340

9244

Insulin, fast-acting

2575

32641

0.75

36.78

2.6

3.0

0.80

0.75

ug/l

0.75

1727

21142

Diseases of the ear and mastoid process

11094

49121

1.16

36.60

3.0

2.8

0.74

0.76

ug/l

1.02

7081

30741

Provisional assignment of new diseases of uncertain etiology

4636

38503

1.24

36.40

2.9

3.0

0.77

ug/l

0.02

3172

25385

Hypertension, essential

7397

36005

1.19

36.25

2.7

0.72

0.73

ug/l

0.30

4741

21423

Ill-defined and unknown causes of mortality

475

8039

0.53

36.24

2.7

3.2

0.91

0.83

ug/l

0.53

316

5647

Orchitis and epididymitis

1479

10969

1.54

36.19

3.3

2.5

0.78

0.76

ug/l

0.14

1018

6682

Covid-19 confirmed case

3587

29206

1.28

36.19

3.0

3.1

0.78

0.79

ug/l

0.22

2554

19883

Codes for special purposes

4638

38555

1.24

36.06

2.9

3.0

0.77

ug/l

0.02

3174

25422

Insulin, fast-acting (human)

548

9138

0.57

35.40

2.2

2.7

0.73

0.72

ug/l

0.04

340

5404

Dermatitis and eczema

8381

59468

0.86

35.03

2.9

0.71

0.77

ug/l

4.75

5477

37958

Concussion

4457

30155

1.24

34.74

2.8

0.69

0.79

ug/l

7.52

2827

18618

Pain (limb, back, neck, head abdominally)

8270

36016

1.18

34.48

2.9

0.72

0.80

ug/l

7.88

5379

22644

Follow-up examination after treatment for conditions other than malignant neoplasms

2559

21560

0.76

33.96

2.9

0.73

0.79

ug/l

1.32

1858

13839

Other disorders of veins

2763

21752

1.30

33.82

3.2

3.0

0.68

0.76

ug/l

5.57

1924

14483

Emergency coronary revascularization (for ACS)

9080

48554

1.17

33.76

2.8

2.9

0.73

0.77

ug/l

1.88

5957

30872

Use of hypnotics and sedatives

10908

55611

1.15

33.74

3.0

2.9

0.70

0.78

ug/l

9.97

7215

35450

Gonarthrosis,primary

9751

53161

1.16

33.26

3.2

3.0

0.72

0.79

ug/l

7.31

6790

35111

Spirochaetal infections, other/unspecified

2438

19135

1.33

33.23

3.2

3.0

0.71

0.75

ug/l

1.42

1606

12740

Excessive earwax

5601

46737

1.21

33.22

3.2

3.0

0.75

0.78

ug/l

0.95

3831

31575

Other spirochaetal diseases

2468

19400

1.33

33.20

3.2

3.0

0.71

0.75

ug/l

1.41

1623

12904

ILD medications

11030

53174

1.15

32.56

2.9

0.75

0.76

ug/l

0.33

7157

33609

Lyme disease

2417

19003

1.33

32.51

3.2

3.0

0.71

0.75

ug/l

1.40

1591

12656

Degeneration of macula and posterior pole

4888

32919

1.23

32.35

3.4

3.3

0.80

0.82

ug/l

0.56

3654

23800

Peripheral artery operations in Hilmo

937

13342

0.64

32.04

2.7

3.2

0.79

0.83

ug/l

0.40

640

9487

Hypertensive diseases

7375

36123

1.18

31.97

2.7

0.71

0.73

ug/l

0.60

4669

21452

Hypertension

7376

36122

1.18

31.97

2.7

0.71

0.73

ug/l

0.58

4670

21451

Progressive vascular leukoencephalopathy

393

2183

2.11

31.85

3.2

3.5

0.77

0.85

ug/l

0.78

313

1598

Other spirochaetal diseases

2431

19175

1.32

31.84

3.2

3.0

0.71

0.75

ug/l

1.47

1600

12773

Biguanides

9374

50474

1.16

31.81

2.8

2.9

0.76

ug/l

0.15

6116

32116

Other bacterial diseases

9364

55689

1.16

31.56

2.9

0.80

0.75

ug/l

2.38

6478

35047

Gout

3947

29173

1.27

31.52

3.1

0.82

0.83

ug/l

0.28

2887

20018

Non-small cell lung cancer, squamous, helper endpoint

245

4778

0.45

31.16

2.8

3.3

0.75

0.85

ug/l

1.40

165

3427

Symptoms and signs involving the circulatory and respiratory systems

9313

41114

1.16

31.08

2.9

2.8

0.71

0.79

ug/l

7.75

5856

25564

Diaphragmatic hernia

3010

24403

1.28

31.06

3.2

3.1

0.71

0.80

ug/l

3.35

2166

16590

Other heart diseases

3916

21104

1.24

30.93

2.6

0.65

0.71

ug/l

3.22

2306

11474

Diseases of the musculoskeletal system and connective tissue

5162

21826

1.21

30.81

2.9

2.7

0.73

0.83

ug/l

6.61

3203

13293

Exclusions for E4_PCOS_CONSORTIUM

1381

11953

0.71

30.81

2.9

2.6

0.66

0.72

ug/l

0.85

875

7010

Hypopituitarism

774

5159

1.68

30.76

3.1

2.6

0.57

0.70

ug/l

6.32

468

2955

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2406

18325

1.30

30.47

2.9

2.7

0.67

0.72

ug/l

0.99

1412

10771

Conduction disorders

3482

23357

1.27

30.30

3.3

3.2

0.79

0.80

ug/l

0.08

2498

16391

Other ill-defined and unspecified causes of mortality

435

7180

0.54

30.18

2.7

3.2

0.93

0.83

ug/l

0.66

289

5049

Type 1 diabetes, wide definition, subgroup 1

1066

14931

0.68

29.93

2.3

2.7

0.75

0.73

ug/l

0.19

667

8884

Deviated nasal septum

4346

36896

1.24

29.93

3.0

2.8

0.69

0.76

ug/l

3.81

2727

23542

Other special examinations and investigations of persons without complaint or reported diagnosis

7176

31589

1.18

29.92

2.9

2.8

0.72

0.79

ug/l

5.85

4619

19303

Disorders of lens

7562

41431

1.17

29.82

3.2

2.9

0.76

ug/l

0.01

5473

27372

Antihypertensive medication - note that there are other indications

4010

17536

1.23

29.70

2.6

2.5

0.69

0.71

ug/l

0.61

2347

9620

Non-small cell lung cancer, including Hilmo

1010

13295

0.67

29.65

3.0

2.8

0.83

0.74

ug/l

0.97

710

9472

Persons encountering health services for examination and investigation

7232

31589

1.17

29.31

2.9

2.8

0.74

0.79

ug/l

2.73

4684

19303

Certain infectious and parasitic diseases

7408

32371

1.17

28.97

2.9

0.75

0.79

ug/l

1.69

4859

20577

Other and unspecified tonsillitis

3034

20777

1.27

28.87

2.3

2.4

0.64

0.66

ug/l

0.66

1561

11118

COPD-related respiratory insufficiency

845

11985

0.65

28.63

2.7

3.3

0.77

0.83

ug/l

0.55

548

8614

Other intervertebral disc disorders

8369

44505

1.16

28.52

2.9

0.69

0.79

ug/l

12.85

5443

28172

Other external causes of accidental injury

7801

34250

1.16

28.37

2.9

0.76

0.79

ug/l

1.41

5095

21782

Allergic conjunctivitis

2505

19398

1.28

28.28

2.9

2.7

0.67

0.72

ug/l

1.03

1472

11438

Disorders of other endocrine glands

2853

22751

1.27

28.09

3.1

2.8

0.73

0.75

ug/l

0.51

1854

14395

Malignant melanoma, including Hilmo

1762

13657

1.38

28.06

3.5

2.8

0.79

0.72

ug/l

1.75

1310

9411

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1068

14807

0.70

27.46

2.5

2.7

0.62

0.74

ug/l

4.16

746

8379

Insulin, intermediate and long-acting

4905

55197

0.84

27.33

2.7

3.0

0.80

0.77

ug/l

0.80

3332

36400

Macular pucker

1629

12643

1.39

26.63

3.4

0.79

0.81

ug/l

0.24

1234

9333

Heart failure and coronary heart disease

4014

33340

0.82

26.53

2.9

3.2

0.78

0.80

ug/l

0.31

2873

23386

Accidents

7761

34250

1.16

26.16

2.9

0.76

0.79

ug/l

1.32

5072

21782

Other chronic obstructive pulmonary disease, including avohilmo

5082

48313

0.84

26.13

3.0

3.1

0.73

0.80

ug/l

4.43

3555

33671

Factors influencing health status and contact with health services

4269

18130

1.22

26.09

2.9

2.7

0.75

0.76

ug/l

0.20

2689

10663

Inflammatory bowel disease treatment related agents

10948

55177

1.13

25.82

2.9

0.75

0.76

ug/l

0.17

7150

34957

Voice disturbances

1820

14205

1.33

25.54

3.3

3.1

0.70

0.77

ug/l

2.29

1303

9778

Any mental disorder

9285

51927

0.88

25.48

2.8

2.9

0.69

0.78

ug/l

10.75

6319

32744

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1310

9887

1.43

25.25

3.3

2.9

0.84

0.76

ug/l

1.29

949

7192

Urolithiasis

4186

36027

1.22

25.02

3.1

0.77

0.78

ug/l

0.22

2903

24575

Chronic sinusitis

3324

27747

1.23

24.80

3.0

2.8

0.66

0.76

ug/l

11.61

2064

17602

Other cataract

4620

30100

1.20

24.66

3.3

3.1

0.81

0.78

ug/l

0.69

3386

20641

Chronic diseases of tonsils and adenoids

4908

35992

0.85

24.60

2.6

2.7

0.67

0.74

ug/l

3.89

2802

21968

Carcinoma in situ of skin of other and unspecified parts of face

812

5717

1.56

24.40

3.6

3.4

0.78

0.84

ug/l

0.71

625

4204

Anxiety (asthma-related co-morbidities)

3039

28316

0.81

24.08

2.6

0.57

0.71

ug/l

18.94

1938

15475

Cardiac arrest

532

6794

0.60

24.08

2.6

3.3

0.67

0.78

ug/l

3.14

363

4704

Dorsopathies

9855

45020

1.13

23.92

2.9

0.70

0.79

ug/l

11.36

6372

28361

Alcohol abuse, main dg, excluding more controls

1119

14849

0.71

23.81

2.6

2.8

0.63

0.75

ug/l

2.57

783

8921

Suicide or other Intentional self-harm

1067

14463

0.71

23.76

2.5

2.6

0.62

0.70

ug/l

2.34

746

8427

Carcinoma in situ of prostate

160

840

5.27

23.50

6.4

3.1

0.95

0.75

ug/l

3.01

147

581

Other antidepressants

10849

50322

1.12

23.37

3.0

2.9

0.68

0.79

ug/l

14.48

7230

32021

Memory loss

848

6065

1.52

23.14

3.3

0.80

0.81

ug/l

0.06

598

4297

Constipation

8397

52071

1.14

23.10

3.3

3.0

0.75

0.78

ug/l

1.25

5914

34654

Abdominal and pelvic pain

10759

48933

1.12

23.08

2.9

0.72

0.78

ug/l

4.33

7003

30868

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1068

14464

0.72

23.08

2.5

2.6

0.62

0.70

ug/l

2.34

746

8427

Other and unspecified disorders of vitreous body

3192

26428

1.23

23.05

3.5

3.2

0.75

0.77

ug/l

0.48

2338

18632

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6184

43794

1.17

23.05

3.0

3.1

0.83

0.78

ug/l

2.11

4402

29539

All chronic kidney diseases

5730

41171

1.17

23.02

3.0

3.1

0.96

0.76

ug/l

16.69

4233

27511

Haemorrhage from respiratory passages

3911

30212

1.21

22.98

3.2

3.0

0.77

0.82

ug/l

1.97

2730

20675

Senile cataract

6996

38113

1.16

22.74

3.3

3.0

0.77

ug/l

0.02

5125

25902

Percutaneous Coronary Intervention

8200

45054

1.14

22.62

2.8

2.9

0.72

0.76

ug/l

1.85

5325

28371

Heart failure,strict

5189

41658

0.85

22.49

2.9

3.2

0.78

ug/l

0.05

3753

28842

Amputation

723

10081

0.66

22.21

2.5

3.2

0.84

0.83

ug/l

0.04

503

7140

Implicit Sepsis

8153

53497

1.14

22.03

2.9

0.77

0.76

ug/l

0.07

5705

34377

Zoster [herpes zoster]

3984

33664

1.20

21.90

3.2

3.1

0.74

0.79

ug/l

2.26

2803

23182

Cardiovascular diseases (excluding rheumatic etc)

4375

21563

1.19

21.70

2.5

0.66

0.70

ug/l

1.43

2503

11591

All-cause Heart Failure

5568

44429

0.86

21.62

2.9

3.2

0.79

ug/l

0.10

4031

31079

Heart failure, strict

5663

45081

0.86

21.46

2.9

3.2

0.79

ug/l

0.07

4094

31469

Benzodiazepine use

7827

59997

0.88

21.31

3.0

2.9

0.70

0.77

ug/l

5.12

5237

38321

Diseases of liver

2482

29802

0.80

21.24

2.8

3.0

0.71

0.75

ug/l

1.06

1669

19527

Coxarthrosis [arthrosis of hip](FG)

6107

38100

1.16

21.11

3.3

3.0

0.73

0.81

ug/l

7.19

4336

25543

Need for other prophylactic measures

518

3422

1.66

21.08

3.2

2.9

0.78

0.73

ug/l

0.43

392

2148

Hypertensive diseases (excluding secondary)

4223

21096

1.19

20.70

2.5

2.6

0.68

0.71

ug/l

0.79

2507

11469

Diabetic maculopathy, excluding more controls

652

9220

0.66

20.62

2.5

3.0

0.75

0.76

ug/l

0.10

432

6004

Condition for Implicit Sepsis (Organ dysfunction codes)

8388

53428

1.13

20.39

2.9

0.76

ug/l

0.05

5852

33965

Influenza and pneumonia

9348

53847

1.12

20.26

2.7

2.9

0.75

ug/l

0.15

6097

33947

Non-small cell lung cancer, squamous

245

4233

0.52

20.18

2.8

0.75

0.77

ug/l

0.13

165

3008

Respiratory insufficiency

522

7599

0.63

20.18

2.6

3.3

0.70

0.85

ug/l

5.05

355

5462

First line medication for Crohn's disease

10583

52092

1.11

20.16

2.9

0.78

0.75

ug/l

1.04

6886

32803

Alcohol abuse, main dg

1119

14511

0.73

20.07

2.6

2.8

0.63

0.73

ug/l

2.00

783

8926

Pain in limb

7266

43523

1.14

19.93

3.1

2.8

0.70

0.79

ug/l

10.31

5005

27660

Alcohol withdrawal state with delirium

580

8128

0.64

19.92

2.7

2.9

0.59

0.74

ug/l

3.63

422

5172

Inguinal hernia, bilateral

1717

14117

1.35

19.85

3.1

0.75

0.80

ug/l

0.92

1201

9742

Carcinoma in situ of skin

787

5716

1.49

19.84

3.5

3.3

0.82

0.80

ug/l

0.11

564

4106

Small cell lung cancer, helper endpoint

2078

0.35

19.72

2.6

3.3

0.73

0.85

ug/l

0.55

1481

Excessive attrition of teeth

4293

37327

1.17

19.71

3.0

2.8

0.67

0.73

ug/l

3.52

2807

23286

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1934

15650

1.27

19.61

3.0

2.9

0.72

0.74

ug/l

0.21

1266

9947

Malaise and fatigue

4875

34421

1.17

19.56

3.0

3.1

0.82

0.79

ug/l

0.57

3400

23101

Malignant melanoma

1408

11121

1.34

19.53

3.5

2.8

0.79

0.71

ug/l

1.53

1041

7656

Melanocytic naevi

2073

16958

1.26

19.43

3.2

3.0

0.73

0.76

ug/l

0.90

1404

11166

Inguinal or femoral hernia, bilateral

1726

14222

1.34

19.41

3.1

0.75

0.80

ug/l

0.93

1209

9817

Type 2 diabetes, definitions combined, including avohilmo

8968

47320

1.12

19.40

2.8

2.9

0.75

0.76

ug/l

0.49

5826

29772

Malignant neoplasm of bladder, including Hilmo

1647

13301

1.33

19.38

3.1

2.9

0.78

0.74

ug/l

0.85

1218

9528

Squamous cell neoplasms and carcinomas of the skin

846

6257

1.46

19.06

3.2

2.9

0.86

0.77

ug/l

1.24

611

4531

AV-block

2271

16619

1.26

18.99

3.2

3.3

0.79

0.83

ug/l

0.61

1636

12063

Migraine, single triptan purchase ok & required. ICD-code if available is included

3281

26092

0.84

18.92

2.6

2.5

0.65

0.68

ug/l

1.76

1825

14479

Triptan medication for migraine, single purchase ok

3281

26092

0.84

18.92

2.6

2.5

0.65

0.68

ug/l

1.76

1825

14479

Unspecified privation

943

7076

1.42

18.74

2.9

0.70

0.76

ug/l

0.96

645

4579

Pneumonias (Asthma/COPD co-morbidities)

8998

54875

1.12

18.73

2.8

2.9

0.76

0.75

ug/l

0.23

5974

34573

Liquid cancers, helper endpoint

3636

27413

1.19

18.72

3.1

2.7

0.89

0.70

ug/l

10.44

2584

18195

Other retinal disorders

6424

44833

1.14

18.68

3.2

3.1

0.78

0.79

ug/l

0.12

4677

30429

Calculus of kidney and ureter

3737

32599

1.20

18.67

3.1

0.75

0.78

ug/l

0.73

2573

22133

All pneumoniae

9029

54838

1.12

18.61

2.7

2.9

0.76

0.75

ug/l

0.23

5992

34548

Non-small cell lung cancer

667

9129

0.68

18.51

3.0

2.8

0.77

0.75

ug/l

0.23

467

6513

Oral corticosteroids

10134

54949

1.11

18.36

3.0

2.9

0.77

0.76

ug/l

0.31

6739

34900

Other disorders of bladder

1512

12235

1.33

18.33

3.5

3.2

0.60

0.80

ug/l

21.29

1122

8567

Disturbances of skin sensation

1773

14345

1.27

18.25

3.0

2.8

0.63

0.73

ug/l

4.40

1165

8943

Peripheral arterial reconstruction

1452

17944

0.76

18.21

2.7

3.3

0.82

ug/l

0.03

1024

13092

Type 2 diabetes, definitions combined

8977

47935

1.12

18.09

2.8

2.9

0.75

0.76

ug/l

0.72

5873

30206

Type 2 diabetes, strict (exclude DM1)

9002

48079

1.12

18.09

2.8

2.9

0.74

0.76

ug/l

0.73

5889

30311

Other diseases of the respiratory system

1490

18456

0.77

18.01

2.8

3.2

0.75

0.82

ug/l

1.42

1015

13063

Other respiratory disorders and diseases

1490

18456

0.77

18.01

2.8

3.2

0.75

0.82

ug/l

1.42

1015

13063

Other diseases of urinary system

9743

49995

1.11

17.99

3.4

2.9

0.78

0.77

ug/l

0.09

7187

32934

Impotence

875

6744

1.51

17.96

3.2

2.5

0.71

0.75

ug/l

0.59

596

4106

Malignant melanoma of skin, including Hilmo

1438

11512

1.32

17.90

3.6

2.8

0.80

0.72

ug/l

1.93

1078

7934

Tinnitus

2008

16586

1.26

17.86

3.1

2.9

0.66

0.75

ug/l

3.07

1379

10990

Ptosis of eyelid

948

7180

1.40

17.83

3.4

3.2

0.73

0.79

ug/l

1.02

701

5081

Symptoms and signs involving the skin and subcutaneous tissue

5785

50517

1.14

17.76

3.1

3.0

0.71

0.77

ug/l

4.81

3981

33196

Bleeding

8512

55120

1.12

17.75

3.1

2.9

0.76

ug/l

0.12

5940

35671

Diabetic maculopathy

650

8439

0.68

17.64

2.5

2.9

0.75

0.76

ug/l

0.07

431

5625

Coronary revascularization (ANGIO or CABG)

8107

45064

1.12

17.63

2.7

2.9

0.72

0.76

ug/l

2.16

5256

28375

Diseases of the skin and subcutaneous tissue

10011

45920

1.11

17.42

2.9

2.8

0.72

0.78

ug/l

4.26

6521

28916

Pneumonia, organism unspecified

8419

53674

1.12

17.40

2.8

2.9

0.77

0.75

ug/l

0.60

5658

33900

Carcinoma in situ of skin of scalp and neck

347

2269

1.87

17.25

3.4

0.83

0.82

ug/l

0.05

242

1644

Contraceptive management

1994

16953

0.81

17.13

2.3

0.64

0.63

ug/l

0.26

927

8417

Abnormalities of heart beat

2758

22972

1.21

17.13

3.1

3.0

0.77

0.81

ug/l

0.81

1825

15454

Neurological diseases

7692

34904

1.12

17.05

2.8

0.70

0.80

ug/l

8.33

4858

21787

Special screening examination for neoplasms

737

5473

1.48

17.03

3.6

2.9

0.96

0.80

ug/l

3.20

525

3596

Diseases of external ear

3065

26375

1.20

17.02

3.3

3.0

0.76

0.77

ug/l

0.09

2050

17629

Other (not insulin) diabetes medications

9211

49920

1.11

17.00

2.8

2.9

0.75

0.76

ug/l

0.45

6006

31670

Retinal breaks without detachment

1484

11984

1.30

16.95

3.4

3.1

0.74

0.76

ug/l

0.42

1021

8232

Acute upper respiratory infections of multiple and unspecified sites

6163

40914

1.13

16.93

2.7

2.9

0.69

0.76

ug/l

5.61

3689

26104

Neurological diseases, wide definition

2271

9418

1.23

16.92

2.7

0.71

0.83

ug/l

4.54

1361

5382

Retinal detachments and breaks

3660

32013

1.18

16.77

3.2

3.1

0.76

0.78

ug/l

0.53

2551

22137

Fever of other and unknown origin

5254

41673

1.14

16.62

3.0

0.79

0.77

ug/l

0.24

3673

27051

Other diseases of anus and rectum

2684

22835

1.21

16.57

3.5

3.1

0.76

0.81

ug/l

1.68

1866

15417

Wet age-related macular degeneration

1470

11495

1.30

16.57

3.4

0.84

0.86

ug/l

0.39

1094

8510

Fentanyl

568

7923

0.68

16.33

3.2

3.1

1.31

0.81

ug/l

3.28

410

5533

Myocardial infarction, with ST-elevation

1708

20503

0.79

16.29

3.0

3.2

0.84

0.81

ug/l

0.39

1248

14374

All anxiety disorders

3039

27956

0.85

16.24

2.6

2.5

0.57

0.70

ug/l

15.20

1938

15465

Lumbar disc prolapse

6139

42361

1.13

16.21

2.8

2.9

0.68

0.78

ug/l

10.08

3942

26762

Myalgia

1401

11183

1.29

16.18

3.2

2.8

0.74

0.77

ug/l

0.29

909

7100

Headache

4130

37510

0.87

16.11

2.8

0.66

0.75

ug/l

7.63

2647

23113

Internal derangement of knee

3666

31925

1.17

16.02

2.9

2.8

0.70

0.79

ug/l

4.58

2323

20171

Cardiovascular diseases

3971

18570

1.16

16.02

2.5

0.67

0.70

ug/l

1.07

2219

9835

Cardiodefibrillation

4553

40596

1.16

16.00

3.2

0.76

0.79

ug/l

0.81

3216

28427

Type 1 diabetes, wide definition, subgroup 2

948

0.17

15.96

1.7

3.2

0.76

0.87

ug/l

0.43

648

Other disorders of eyelid

3662

30489

1.17

15.87

3.3

3.2

0.79

0.80

ug/l

0.27

2655

21603

Degeneration of nervous system due to alcohol

144

2578

0.46

15.79

2.5

3.1

0.65

0.74

ug/l

0.71

109

1750

Unknown and unspecified causes of morbidity

275

4420

0.59

15.72

3.3

3.0

0.72

0.79

ug/l

1.26

204

2863

Melanoma in situ

443

3048

1.63

15.70

3.6

3.3

0.79

0.78

ug/l

0.09

315

2154

Degeneration of the brain due to alcohol

144

2570

0.46

15.61

2.5

3.1

0.65

0.75

ug/l

0.80

109

1732

Migraine with aura

818

6076

1.37

15.56

2.8

2.6

0.64

0.72

ug/l

1.74

531

3593

Cholelithiasis

6181

47214

0.89

15.56

3.2

3.1

0.78

0.79

ug/l

0.20

4302

32052

Hallux valgus (acquired)

1148

10533

0.77

15.55

3.0

0.70

0.82

ug/l

2.29

810

7221

Hyperlipidaemia, other/unspecified

4520

37089

1.16

15.54

3.2

3.1

0.80

0.78

ug/l

0.38

3211

25282

Asthma/COPD (KELA code 203)

7380

55583

0.90

15.46

2.8

2.9

0.67

0.78

ug/l

15.22

4693

35483

Other disorders of male genital organs

522

3753

1.58

15.40

2.7

2.3

0.65

0.68

ug/l

0.47

310

2061

Recurrent or chronic depression

2271

18937

0.83

15.36

2.5

2.6

0.64

0.73

ug/l

2.00

1437

10487

Mouth breathing

4443

39579

1.16

15.20

3.0

2.8

0.66

0.73

ug/l

4.23

2771

25238

Presence of other devices

2348

19918

1.22

15.17

3.5

3.3

0.80

0.83

ug/l

0.87

1726

14456

Atrial fibrillation and flutter

3414

19312

1.18

15.13

2.7

0.68

0.72

ug/l

1.45

2137

11031

Irritable bowel syndrome

1432

11536

1.27

15.09

3.1

2.8

0.63

0.77

ug/l

8.37

938

7292

Symptoms and signs involving the digestive system and abdomen

10578

48933

1.10

14.99

2.9

0.72

0.78

ug/l

3.86

6888

30868

Persons encountering health services in circumstances related to reproduction

3407

26317

0.86

14.96

2.4

0.63

0.65

ug/l

0.67

1695

13755

Presence of other functional implants

5939

37188

1.13

14.91

3.4

3.1

0.76

0.80

ug/l

2.42

4312

25852

Dizziness and giddiness

6727

48396

1.12

14.90

3.2

3.0

0.73

0.79

ug/l

3.04

4734

32255

Small cell lung cancer, including Hilmo

1869

0.40

14.87

2.6

2.8

0.73

0.78

ug/l

0.21

1322

Small cell lung cancer

1869

0.40

14.87

2.6

2.8

0.73

0.78

ug/l

0.21

1322

Sequelae of cerebrovascular disease

3170

31229

0.85

14.83

3.0

3.2

0.82

0.80

ug/l

0.29

2253

21987

Injuries to the knee and lower leg

10759

55192

1.09

14.81

2.9

0.72

0.77

ug/l

4.10

6951

35504

Acute alcohol intoxication ICD-9

215

3485

0.55

14.75

2.8

3.0

0.58

0.76

ug/l

3.51

145

2284

Nontraumatic intracranial haemmorrhage

1413

17233

0.79

14.65

3.0

3.2

0.86

0.81

ug/l

0.67

1009

12060

Blepharochalasis

1960

16416

1.23

14.64

3.5

3.2

0.79

ug/l

0.05

1431

11715

Symptoms and signs involving speech and voice

2367

20165

1.20

14.52

3.3

3.1

0.72

0.79

ug/l

2.49

1708

13912

Other and unspecified nonorganic psychotic disorders

765

10112

0.74

14.41

2.2

2.4

0.51

0.67

ug/l

9.77

524

5292

Gastroduodenal ulcer

2204

25696

0.83

14.35

3.0

3.2

0.79

0.82

ug/l

0.79

1615

17958

Injury of muscle and tendon at shoulder and upper arm level

4450

39951

1.15

14.28

3.0

0.69

0.75

ug/l

3.62

2951

26386

Diabetic nephropathy

1074

13211

0.76

14.26

2.6

3.0

0.93

0.78

ug/l

1.82

793

9122

Urethral stricture

885

7015

1.42

14.25

3.5

3.1

0.63

0.80

ug/l

8.80

612

4852

Injury of muscle and tendon at lower leg level

1768

14874

1.26

14.18

2.9

2.8

0.73

0.74

ug/l

0.11

1113

9312

Substance use, excluding alcohol

1122

14033

0.77

14.14

2.5

2.6

0.53

0.71

ug/l

17.77

774

8024

Cholelithiasis, broad definition with cholecystitis

6604

48819

0.90

13.98

3.1

3.0

0.78

0.79

ug/l

0.21

4593

33005

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8802

55246

1.10

13.96

2.8

2.9

0.76

0.75

ug/l

0.35

5875

34846

Other disorders of fluid, electrolyte and acid-base balance

2152

24032

0.83

13.95

2.9

3.1

0.81

0.78

ug/l

0.43

1554

16442

Other predominantly sexually transmitted diseases, not elsewhere classified

723

5372

1.37

13.90

2.3

0.60

0.64

ug/l

0.39

387

2736

Asthma (only as main-diagnosis)

5557

35672

0.89

13.88

2.9

0.67

0.77

ug/l

10.40

3528

22473

Seborrhoeic keratosis

1865

15687

1.23

13.85

3.4

3.2

0.82

0.80

ug/l

0.20

1341

11070

Tonsillectomy and adenotomy

2395

19545

0.84

13.80

2.4

0.62

0.67

ug/l

2.41

1226

10402

Coronary artery bypass grafting

3272

27470

0.85

13.78

3.1

3.3

0.81

ug/l

0.04

2318

19856

Syncope and collapse

4617

35407

1.14

13.72

3.1

0.78

0.79

ug/l

0.30

3217

23779

Vasomotor and allergic rhinitis

2184

18161

1.20

13.71

2.8

2.6

0.67

0.73

ug/l

2.13

1259

10727

Special screening examination for infectious and parasitic diseases

2039

12646

1.21

13.60

2.6

2.4

0.61

0.70

ug/l

2.80

1198

6295

Ascites

371

5362

0.65

13.30

2.6

3.1

0.85

0.78

ug/l

0.28

250

3633

Diseases of middle ear and mastoid

3213

29972

0.86

13.23

2.8

0.79

0.74

ug/l

0.94

1939

18087

Diabetic neuropathy

731

9375

0.73

13.14

2.7

3.0

0.76

0.78

ug/l

0.13

525

6447

Insulin medication

5212

48405

0.89

13.07

2.7

2.9

0.80

0.77

ug/l

0.67

3548

31116

Carcinoma in situ of skin of trunk

366

2539

1.65

13.04

3.6

3.4

0.79

0.82

ug/l

0.28

287

1830

Erosion of teeth , including avohilmo

1582

13128

1.24

12.93

3.0

2.7

0.70

0.72

ug/l

0.31

1023

7966

Impacted cerumen

921

7281

1.34

12.92

3.7

3.2

0.84

0.80

ug/l

0.33

607

5125

Other diseases of lip and oral mucosa

2745

23885

1.17

12.72

3.1

2.9

0.69

0.74

ug/l

0.95

1865

15507

Subjective visual disturbances

1645

13743

1.23

12.62

3.1

3.0

0.67

0.76

ug/l

3.61

1166

9131

Other headache syndromes

2339

20052

1.18

12.60

2.9

2.8

0.62

0.76

ug/l

14.92

1497

12649

COPD (mode)

3067

27255

0.86

12.53

2.9

3.1

0.73

0.80

ug/l

2.80

2157

18957

Other superficial mycoses

689

5216

1.38

12.53

2.9

2.7

0.62

0.71

ug/l

1.72

431

3113

Gastrointestinal diseases

4836

21702

1.13

12.52

2.8

2.7

0.71

0.78

ug/l

2.83

2995

12787

Any dementia, excluding more controls

2927

22912

0.85

12.51

3.0

3.5

0.83

0.85

ug/l

0.31

2103

16967

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

724

9388

0.75

12.50

2.6

2.8

0.73

0.75

ug/l

0.10

462

5833

Hallux rigidus

1010

8051

1.30

12.48

3.0

0.62

0.80

ug/l

13.06

722

5512

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1199

14621

0.79

12.47

3.1

2.8

1.03

0.71

ug/l

5.53

841

10054

Abrasion of teeth

2091

17840

1.20

12.46

3.1

2.9

0.67

0.73

ug/l

3.43

1420

11466

Pain associated with micturition

739

5654

1.36

12.43

3.4

3.0

0.66

0.78

ug/l

3.28

512

3751

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

274

4103

0.61

12.42

2.6

2.7

0.75

0.74

ug/l

0.02

185

2852

Use of biperiden

226

3556

0.59

12.39

2.3

2.8

0.54

0.70

ug/l

4.37

167

2209

Thoracic aortic aneurysm

2074

18035

1.23

12.39

3.2

0.78

ug/l

0.03

1465

12651

742

5666

1.35

12.34

2.9

2.7

0.66

0.72

ug/l

0.92

542

3450

Enthesopathies of lower limb, excluding foot

1660

13931

1.22

12.28

3.1

2.8

0.67

0.75

ug/l

4.12

1035

8692

Melanocytic naevi of trunk

929

7367

1.32

12.21

3.4

3.0

0.76

ug/l

0.03

664

4885

Infections with a predominantly sexual mode of transmission

1250

10137

1.25

12.13

2.5

2.4

0.62

0.67

ug/l

1.09

737

5467

Carcinoma in situ of skin of ear and external auricular canal

230

1513

1.93

11.86

3.5

3.4

0.91

0.84

ug/l

0.18

174

1079

Oesophageal varices

252

3771

0.61

11.86

2.3

3.0

0.72

0.75

ug/l

0.11

173

2502

Degenerative diseases of the nervous system

2746

22956

0.86

11.81

3.0

3.4

0.86

0.85

ug/l

0.13

1978

16856

Benign neoplasm: Rectum, anus and anal canal

1994

17162

1.21

11.80

3.4

3.2

0.77

0.78

ug/l

0.10

1482

12023

Disorders of vitreous body

3976

34421

1.14

11.78

3.4

3.1

0.76

0.78

ug/l

0.38

2900

23999

Persons with potential health hazards related to communicable diseases

2026

17130

1.19

11.78

3.0

2.6

0.73

0.69

ug/l

0.78

1282

9746

Persons encountering health services for specific procedures, not carried out

669

5111

1.38

11.75

2.7

2.8

0.54

0.72

ug/l

10.44

490

3120

Autoimmune diseases related-to ILD

6394

59603

0.91

11.72

2.8

2.9

0.68

0.77

ug/l

10.08

4205

37924

Pneumonitis due to solids and liquids

573

7517

0.72

11.65

2.6

3.1

0.84

0.83

ug/l

0.01

398

5193

Other specific joint derangements/joint disorders

6206

36637

1.11

11.62

2.9

2.8

0.66

0.78

ug/l

13.28

3920

22717

Malignant neoplasm of pancreas

358

5064

0.66

11.58

2.9

2.7

0.78

0.73

ug/l

0.36

239

3517

Gout, idiopatic and unspecified

3438

30904

1.16

11.53

3.1

3.2

0.82

0.79

ug/l

0.65

2527

21646

Umbilical hernia

3230

28813

1.16

11.50

3.0

2.9

0.68

0.76

ug/l

4.14

2152

18455

Gastric ulcer

1313

15729

0.80

11.45

3.0

3.2

0.78

0.82

ug/l

0.70

950

11048

Diseases of appendix

6676

55334

1.10

11.44

2.8

0.74

0.75

ug/l

0.19

4127

34991

Anoxic brain damage

1238

0.37

11.43

3.0

3.1

0.66

0.81

ug/l

0.91

826

Spinal stenosis

5452

37784

1.12

11.43

3.1

0.71

0.81

ug/l

7.50

3889

25709

Diabetes medication

9190

50620

1.09

11.40

2.8

2.9

0.75

0.76

ug/l

0.32

5965

31838

Myocardial infarction, strict

4967

38753

0.89

11.39

2.9

3.1

0.79

0.78

ug/l

0.19

3526

26016

Appendicitis, broad definition

6635

55206

1.10

11.29

2.8

0.74

0.75

ug/l

0.19

4099

34894

Viral infections characterized by skin and mucous membrane lesions

7277

57413

1.10

11.20

3.0

2.9

0.70

0.76

ug/l

6.28

4716

36832

Undefined dementia

626

7524

0.74

11.19

2.8

3.3

0.92

0.89

ug/l

0.12

428

5450

Acute sinusitis

3629

29965

1.14

11.19

2.6

2.7

0.65

0.73

ug/l

5.03

2099

18108

Other medical care

4317

35067

1.13

11.17

3.5

3.1

1.09

0.77

ug/l

14.99

3050

24500

Nasal polyp

2184

19047

1.19

11.04

3.0

2.9

0.68

0.78

ug/l

5.83

1428

12557

Exclusions for E4_PCOS_BROAD

1182

9705

1.25

10.99

3.1

2.8

0.74

0.73

ug/l

0.09

760

5974

Focal epilepsy

1310

15670

0.81

10.93

2.7

3.0

0.74

0.77

ug/l

0.31

916

10353

Visual disturbances and blindness

3943

35474

1.13

10.72

3.0

0.74

0.77

ug/l

0.99

2731

23632

Hypothyroidism (congenital or acquired)

1785

8531

1.20

10.71

2.6

2.1

0.62

0.68

ug/l

2.15

1021

3833

Any event in hilmo or specialist outpatient

253

2.34

10.69

2.4

1.7

0.81

0.68

ug/l

0.85

Hypothyroidism, levothyroxine purchases

1778

8506

1.20

10.67

2.6

2.1

0.62

0.68

ug/l

2.34

1018

3831

Hypothyroidism and >3 levothyroxin purchases

1778

8506

1.20

10.67

2.6

2.1

0.62

0.68

ug/l

2.34

1018

3831

General examination and investigation of persons without complaint and reported diagnosis

6570

31511

1.10

10.64

2.9

2.8

0.71

0.79

ug/l

7.94

3999

19256

Acute appendicitis

6231

53589

1.10

10.62

2.8

0.74

ug/l

0.09

3831

33686

Other predominantly sexually transmitted diseases, not elsewhere classified

608

4597

1.35

10.58

2.4

0.60

0.65

ug/l

0.53

330

2386

Amputation of toe

541

7008

0.72

10.54

2.6

3.2

0.78

0.80

ug/l

0.16

377

4933

Smoking dependency

476

6341

0.71

10.46

2.7

2.9

0.61

0.74

ug/l

3.70

338

4059

Benign neoplasm: Rectum

1797

15507

1.21

10.46

3.4

3.1

0.77

0.78

ug/l

0.11

1345

10842

Mental and behavioural disorders due to tobacco

476

6338

0.71

10.43

2.7

2.9

0.61

0.74

ug/l

3.77

338

4061

Benign neoplasm: Colon, unspecified

2606

23078

1.17

10.37

3.2

0.78

0.79

ug/l

0.13

1876

16226

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7580

42476

1.09

10.37

2.8

3.0

0.76

0.77

ug/l

0.30

5102

27774

7580

42476

1.09

10.37

2.8

3.0

0.76

0.77

ug/l

0.30

5102

27774

Diabetes, varying definitions

8925

48730

1.09

10.36

2.8

2.9

0.74

0.76

ug/l

0.78

5803

30419

Dementia in Alzheimer disease

1115

11389

0.80

10.36

2.8

3.5

0.92

0.91

ug/l

0.05

748

8415

Gastro-oesophageal reflux disease

6317

50236

1.10

10.35

3.2

2.9

0.69

0.77

ug/l

9.23

4231

32584

Acute peritonitis

357

4945

0.68

10.35

2.5

3.0

0.72

0.77

ug/l

0.65

259

3289

Accidental poisoning by and exposure to alcohol

1072

0.36

10.35

2.5

2.8

0.61

0.75

ug/l

0.99

640

Unspecified dementia

627

7266

0.75

10.30

2.8

3.4

0.91

ug/l

0.00

429

5304

Gout, strict definition

2518

22416

1.18

10.29

3.1

3.2

0.84

0.79

ug/l

0.90

1865

15815

Complications of surgical and medical care, not elsewhere classified

8990

57434

1.08

10.27

3.1

2.9

0.74

0.77

ug/l

1.32

6199

36880

Epilepsy

2133

24388

0.85

10.26

2.7

2.9

0.72

0.79

ug/l

1.53

1448

15892

Restless leg syndrome

843

6733

1.30

10.25

3.4

3.0

0.67

0.77

ug/l

1.09

575

4473

Occupational exposure to risk-factors

218

3242

0.60

10.25

2.7

3.1

0.73

0.75

ug/l

0.12

135

2184

Disorders of vitreous body and globe

4088

35527

1.13

10.21

3.4

3.1

0.76

0.78

ug/l

0.37

2985

24747

Cough

3146

26515

1.14

10.18

3.2

3.0

0.69

0.81

ug/l

9.03

2132

17842

Other and unspecified glaucoma

549

4177

1.39

10.17

3.4

3.3

0.83

ug/l

0.02

407

2944

Calculus of lower urinary tract

740

5975

1.37

10.13

3.4

3.2

0.87

0.80

ug/l

1.04

542

4220

Hepatic failure, not elsewhere classified

179

2809

0.59

10.12

2.6

3.0

0.74

0.75

ug/l

0.05

124

1842

Status epilepticus

155

2532

0.57

10.12

2.7

3.0

0.64

0.77

ug/l

1.45

109

1676

Other extrapyramidal and movement disorders in other diseases

1803

15521

1.19

10.11

3.3

3.1

0.71

0.78

ug/l

1.43

1258

10649

Malignant neoplasm of pancreas, including Hilmo

493

6494

0.72

10.10

2.9

2.7

0.84

0.73

ug/l

0.62

340

4482

Other septicaemia

3213

34435

0.88

10.09

3.1

3.2

0.84

0.79

ug/l

0.95

2308

23876

Diabetic nephropathy, excluding more controls

1066

10562

0.79

10.06

2.6

3.0

0.92

0.75

ug/l

2.28

789

7123

Type 1 diabetes, strict (exclude DM2)

300

4327

0.67

10.06

2.1

2.3

0.62

0.65

ug/l

0.37

175

2144

Gout, unspecified

2803

25124

1.17

10.05

3.1

3.2

0.82

0.79

ug/l

0.51

2063

17637

Disorders of lacrimal system

2371

20693

1.16

10.00

3.2

3.0

0.73

0.77

ug/l

0.97

1678

13849

Malignant neoplasm of liver and intrahepatic bile ducts

168

2637

0.57

10.00

2.4

2.7

0.77

0.74

ug/l

0.18

106

1855

Viral warts

1396

11751

1.22

9.98

2.8

0.63

0.73

ug/l

5.87

854

7174

Malignant melanoma of skin

1023

8432

1.27

9.96

3.4

2.7

0.81

0.71

ug/l

1.63

767

5779

Heart failure and bmi 25plus

3233

24297

0.87

9.95

2.9

3.1

0.76

0.78

ug/l

0.57

2342

16471

Spirochaetal infections, other/unspecified

652

5091

1.35

9.94

3.4

3.0

0.70

0.76

ug/l

1.30

453

3431

Type 2 diabetes

8877

48378

1.08

9.92

2.8

2.9

0.74

0.76

ug/l

0.69

5780

30327

Non-ischemic cardiomyopathy

2642

23932

0.86

9.92

3.0

3.3

0.86

0.80

ug/l

1.16

1924

16742

Amputation of thigh

137

2276

0.55

9.90

2.4

3.4

1.02

0.83

ug/l

0.25

102

1602

Type 1 diabetes, definitions combined

306

4382

0.68

9.88

2.1

2.3

0.61

0.65

ug/l

0.40

178

2176

Anogenital herpesviral [herpes simplex] infection

391

2792

1.43

9.87

2.9

2.6

0.64

0.68

ug/l

0.22

245

1550

Asthma (only as main-diagnosis), excluding more controls

5403

33719

0.90

9.83

2.8

2.9

0.66

0.76

ug/l

9.15

3429

21092

Abnormalities of gait and mobility

1161

9713

1.25

9.81

3.0

3.2

0.73

0.81

ug/l

1.39

866

6947

Rheumatoid arthritis

1773

18464

0.85

9.81

3.0

0.74

0.82

ug/l

1.52

1228

12521

Benign neoplasm: Ascending colon

1323

11201

1.24

9.80

3.4

3.2

0.77

0.78

ug/l

0.04

1015

7920

Other inflammation of eyelid

883

7128

1.28

9.79

3.5

3.0

0.72

0.78

ug/l

1.04

639

4774

Carcinoma in situ of skin of lower limb, including hip

178

1109

1.80

9.79

3.7

3.3

0.79

0.80

ug/l

0.08

136

784

Dilated cardiomyopathy

1134

13420

0.80

9.73

2.7

3.1

0.80

0.78

ug/l

0.15

817

9165

Visual disturbances

3617

32593

1.13

9.70

3.0

0.74

0.77

ug/l

0.83

2499

21689

Cardiomyopathy (excluding other)

1259

14790

0.81

9.67

2.7

3.1

0.78

ug/l

0.06

898

10119

Carcinoma in situ of other and unspecified sites

502

3907

1.46

9.66

3.3

0.73

0.80

ug/l

1.19

379

2820

Personality disorders, excluding more controls

1215

14537

0.82

9.65

2.5

2.6

0.55

0.71

ug/l

11.69

836

7887

Falls/tendency to fall

10014

46972

1.08

9.62

2.9

0.71

0.77

ug/l

5.86

6462

29657

Amputation of foot

170

2606

0.58

9.60

2.1

3.3

0.72

0.78

ug/l

0.38

112

1814

Acute and transient psychotic disorders

494

6516

0.73

9.59

2.4

2.5

0.51

0.69

ug/l

10.15

359

3603

Abdominal aortic aneurysm (AAA)

1074

12653

0.80

9.57

3.0

3.4

0.83

0.87

ug/l

0.63

780

9285

Carcinoma in situ, bladder

475

3685

1.49

9.56

3.4

3.3

0.73

0.78

ug/l

0.78

361

2655

Temporomandibular joint disorders, including avohilmo

1591

13334

1.19

9.50

3.0

2.7

0.64

0.72

ug/l

2.75

963

8108

Diabetes mellitus

8923

48739

1.08

9.45

2.8

2.9

0.74

0.76

ug/l

0.74

5801

30425

Melanoma in situ of trunk

194

1277

1.82

9.44

3.6

3.2

0.76

0.78

ug/l

0.12

137

872

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1119

6583

1.25

9.43

3.0

0.70

0.88

ug/l

6.64

781

4396

Specific personality disorders

953

11640

0.80

9.35

2.5

2.6

0.54

0.69

ug/l

8.23

646

6588

Benign neoplasm: Sigmoid colon

1844

16074

1.19

9.33

3.3

3.1

0.75

0.78

ug/l

0.43

1403

11184

Lung diseases due to external agents

1090

12994

0.81

9.33

2.8

3.2

0.82

ug/l

0.02

771

9092

Mental retardation, excluding more controls

1683

0.51

9.32

2.2

2.6

0.73

0.74

ug/l

0.07

943

Any dementia

3123

24143

0.88

9.32

3.0

3.5

0.84

ug/l

0.02

2250

17940

Primary open-angle glaucoma, strict

2148

18820

1.17

9.26

3.3

0.79

0.82

ug/l

0.49

1541

13576

Examination and observation for other reasons

5841

31123

1.10

9.26

2.8

0.65

0.78

ug/l

16.42

4176

19049

Subarachnoid haemorrhage

576

7365

0.75

9.24

3.0

3.1

0.82

0.79

ug/l

0.19

405

5038

Fracture of femur

1756

18367

0.85

9.20

3.0

3.2

0.83

ug/l

0.03

1207

12889

Dissocial personality disorder

1370

0.46

9.08

2.1

2.4

0.61

0.68

ug/l

0.18

699

Benign neoplasm of other and unspecified endocrine glands

1014

8403

1.25

9.06

3.2

3.0

0.79

0.75

ug/l

0.33

716

5609

Atrial fibrillation and flutter with reimbursement

2967

16912

1.15

9.04

2.8

0.69

0.74

ug/l

1.34

2001

10278

Herpesviral [herpes simplex] infections

1153

9602

1.22

9.00

2.9

2.8

0.70

0.75

ug/l

0.77

744

6013

Overexertion and strenuous or repetitive movements

824

6698

1.28

9.00

2.8

2.7

0.61

0.71

ug/l

4.07

530

4030

Poisoning by drugs, medicaments and biological substances

1047

12614

0.81

8.99

2.4

2.6

0.57

0.69

ug/l

4.97

708

7152

Cystitis

5713

36842

0.91

8.94

3.4

3.1

0.80

ug/l

0.08

4247

25546

Myocardial infarction

5203

39599

0.90

8.93

2.9

3.0

0.78

ug/l

0.08

3691

26370

Intracerebral haemorrhage

911

10998

0.80

8.87

3.0

3.2

0.88

0.82

ug/l

0.56

661

7805

Amputation of ankle bones

120

1976

0.54

8.86

2.2

3.1

0.70

0.77

ug/l

0.49

1336

Diseases of peritoneum

514

6639

0.74

8.86

2.7

3.1

0.72

0.78

ug/l

1.14

371

4464

Acute appendicitis, no complications

4662

42536

1.11

8.85

2.7

0.73

0.72

ug/l

0.09

2812

25842

2652

20609

1.15

8.80

3.5

3.4

0.82

0.86

ug/l

0.85

1980

15246

L01XE Protein kinase inhibitors

267

3769

0.66

8.77

2.6

3.2

0.89

0.76

ug/l

0.98

192

2639

Hernia of abdominal wall, postoperative

1863

16296

1.18

8.76

3.0

2.8

0.71

0.74

ug/l

0.95

1293

10339

Type 1 diabetes, strict definition

184

2849

0.63

8.76

1.7

2.0

0.57

0.59

ug/l

0.10

1182

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

421

5525

0.72

8.75

2.7

0.73

ug/l

0.03

294

3817

Other benign neoplasms of skin

2844

25466

1.14

8.74

3.2

3.1

0.76

0.79

ug/l

0.70

1958

17435

Focal epilepsy, strict definition

1246

14662

0.83

8.73

2.7

3.0

0.74

0.77

ug/l

0.23

872

9724

Persistent delusional disorders

311

4317

0.69

8.69

2.3

2.8

0.58

0.73

ug/l

4.12

219

2607

Other and unspecified nerve root and plexus disorders, also in other diseases

1242

14616

0.83

8.64

2.9

2.8

0.66

0.73

ug/l

3.06

771

9148

204

3055

0.64

8.61

2.5

3.1

0.85

0.90

ug/l

0.18

126

2104

Depression medications

2012

8782

1.17

8.61

2.3

2.1

0.58

0.67

ug/l

2.56

1086

3882

Male infertility

479

3686

1.39

8.59

2.3

1.9

0.56

0.58

ug/l

0.26

221

1544

Disorders of vestibular function (Vertigo)

3332

29598

1.12

8.58

3.2

3.1

0.77

0.78

ug/l

0.11

2290

20222

Aneurysms, operations, SAH

935

11272

0.80

8.57

2.9

3.1

0.78

ug/l

0.00

632

7641

Enterocolitis due to Clostridium difficile

547

6982

0.76

8.54

2.9

3.1

0.93

0.80

ug/l

0.63

379

4848

Mental retardation, wide definition

103

1800

0.54

8.50

2.2

2.6

0.73

0.72

ug/l

0.04

1031

Valvular heart disease excluding rheumatic fever

5008

33332

1.11

8.49

3.1

3.0

0.78

0.77

ug/l

0.13

3545

22284

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8794

56925

1.08

8.49

3.0

2.9

0.82

0.76

ug/l

3.80

6067

36534

Infections with a predominantly sexual mode of transmission

1564

12489

1.18

8.47

2.5

2.4

0.61

0.67

ug/l

1.46

910

6656

Focal epilepsy, mode (most common among epilepsy diagnosis)

1159

13681

0.82

8.44

2.7

3.0

0.75

0.77

ug/l

0.21

811

9051

Ectropion of eyelid

425

3236

1.42

8.43

3.2

3.3

0.81

0.86

ug/l

0.37

314

2319

Soft tissue disorders related to use, overuse and pressure

2185

19315

1.16

8.42

3.0

2.9

0.65

0.78

ug/l

14.03

1459

12431

Asthma (diagnoses ohter than nonallergic)

6350

56631

0.92

8.40

2.9

0.67

0.78

ug/l

13.38

4183

36947

Benign paroxysmal vertigo

1804

15723

1.17

8.37

3.3

3.1

0.76

0.78

ug/l

0.36

1236

10845

Heart failure, not strict

6875

49980

0.92

8.37

2.9

3.0

0.78

0.76

ug/l

0.47

4961

33010

Adenocarcinoma and ductal carcinoma of pancreas

150

2346

0.59

8.34

2.5

2.7

0.64

0.74

ug/l

1.12

100

1622

Glomerular diseases

1404

16249

0.84

8.32

2.6

3.0

0.96

0.76

ug/l

3.15

1036

10846

Disorders of adult personality and behaviour

1275

14995

0.84

8.31

2.4

2.5

0.54

0.69

ug/l

9.91

869

8373

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

610

7698

0.78

8.20

2.4

2.5

0.55

0.68

ug/l

3.64

414

4198

Non-rheumatic valve diseases

4992

33254

1.10

8.18

3.1

3.0

0.78

0.77

ug/l

0.14

3535

22261

Trigger finger

965

8017

1.24

8.16

3.1

2.9

0.65

0.77

ug/l

5.74

654

5171

Other disorders of lacrimal gland

1872

16374

1.16

8.09

3.2

3.0

0.72

0.77

ug/l

1.68

1337

10899

Arterial embolism and thrombosis

364

4823

0.71

8.08

2.7

3.2

0.74

0.84

ug/l

1.16

259

3389

Fibroblastic disorders

2485

22270

1.15

8.08

3.3

3.1

0.74

0.82

ug/l

3.21

1722

15296

Personality disorders

1215

14307

0.83

8.07

2.5

0.55

0.69

ug/l

8.52

836

8047

Other diseases of intestine

1384

11939

1.20

8.07

3.2

3.0

0.77

0.79

ug/l

0.31

1018

8120

Obesity related asthma

2788

25073

1.13

8.05

3.0

2.9

0.60

0.75

ug/l

24.38

1828

16226

Nonorganic sleeping disorders

1182

9995

1.21

8.03

2.8

2.7

0.62

0.74

ug/l

3.42

762

6023

Cerebral cysts

229

3301

0.66

8.03

2.8

3.0

0.63

0.76

ug/l

2.05

150

2135

ILD medications: immunosuppressive drugs

4587

46277

0.91

8.03

2.7

2.8

0.70

0.74

ug/l

1.58

3085

29005

Schizoaffective disorder

270

3796

0.69

8.02

2.3

2.6

0.49

0.67

ug/l

9.73

198

2173

Other nutritional deficiencies

4161

42740

0.91

8.00

2.8

2.9

0.67

0.74

ug/l

3.82

2752

27140

Osteomyelitis

453

5802

0.73

7.98

2.8

3.1

0.75

0.76

ug/l

0.12

303

3919

Poisoning by medicine

927

11160

0.81

7.96

2.4

2.6

0.58

0.70

ug/l

3.72

628

6316

Testicular dysfunction, other/unspecified

446

2.55

7.94

2.8

2.6

0.67

0.68

ug/l

0.04

246

Other disorders of patella

1106

9317

1.21

7.93

2.8

2.6

0.66

0.74

ug/l

2.81

634

5435

Glaucoma-related operations

424

3232

1.39

7.92

3.6

3.3

0.78

0.79

ug/l

0.05

311

2285

Mental retardation

1638

0.54

7.92

2.2

2.6

0.73

0.72

ug/l

0.04

930

Type 1 diabetes, strict definition, subgroup 1

167

2582

0.63

7.92

1.7

2.0

0.57

0.59

ug/l

0.11

1051

Coxarthrosis, primary, with hip surgery

4420

38093

1.11

7.91

3.3

3.2

0.73

0.80

ug/l

6.19

3126

26879

Haemorrhoids and perianal venous thrombosis

2810

25252

1.13

7.91

3.3

3.1

0.78

0.80

ug/l

0.30

1997

17103

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2051

18119

1.15

7.85

2.6

2.7

0.69

0.71

ug/l

0.25

1240

10725

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

460

3574

1.38

7.85

3.1

2.7

0.83

0.74

ug/l

0.94

339

2471

Suppurative and necrotic conditions of lower respiratory tract

417

5364

0.73

7.83

2.7

3.1

0.72

0.77

ug/l

0.57

298

3603

Systemic atrophies primarily affecting the central nervous system

221

3151

0.65

7.83

2.7

3.1

0.80

0.77

ug/l

0.25

157

2139

1684

13850

1.17

7.68

3.5

3.4

0.84

0.85

ug/l

0.27

1263

10214

Cardiomyopathies, Primary/intrinsic

1232

14226

0.83

7.68

2.7

3.1

0.78

0.79

ug/l

0.02

882

9762

Injury, poisoning and certain other consequences of external causes

4648

21392

1.10

7.61

2.9

0.76

0.81

ug/l

1.78

2993

13676

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

998

8397

1.23

7.60

3.1

2.9

0.79

0.74

ug/l

0.40

657

5373

Chronic gastritis

2251

20081

1.15

7.58

3.4

3.2

0.77

0.82

ug/l

0.93

1657

14147

Cirrhosis of liver, NAS

364

4737

0.72

7.43

2.5

3.1

0.70

0.76

ug/l

0.65

249

3229

Paroxysmal tachycardia

1894

13981

1.16

7.43

3.0

2.9

0.74

0.75

ug/l

0.09

1300

8789

Macular hole

428

3301

1.37

7.42

3.2

3.3

0.80

0.79

ug/l

0.10

322

2380

Glomerular disorders in diseases classified elsewhere

889

10544

0.81

7.39

2.6

3.0

0.96

0.76

ug/l

2.38

659

7077

Bacterial infection, other or unspecified

5737

45206

1.09

7.38

3.0

3.1

0.86

0.77

ug/l

3.99

4187

30394

Organic, including symptomatic, mental disorders

4529

34838

0.91

7.36

3.1

3.3

0.78

0.82

ug/l

1.27

3278

25007

Primary open-angle glaucoma

2628

22910

1.13

7.31

3.4

3.3

0.79

0.82

ug/l

0.78

1899

16529

Benign lipomatous neoplasm

2362

21183

1.14

7.28

3.1

3.0

0.76

ug/l

0.05

1613

13925

Convulsions, not elsewhere classified

1739

19467

0.86

7.27

2.8

2.9

0.68

0.76

ug/l

1.78

1186

12184

Fibrosis and cirrhosis of liver

450

5723

0.75

7.23

2.5

3.1

0.71

0.77

ug/l

0.64

305

3906

Mild mental retardation

1133

0.47

7.21

2.1

2.6

0.69

0.70

ug/l

0.03

661

Asthma, hospital admissions , main diagnosis only

5685

53806

0.92

7.20

2.9

0.66

0.77

ug/l

12.22

3610

34572

Nonischemic cardiomyopathy

827

9814

0.80

7.19

2.8

3.1

0.86

0.79

ug/l

0.66

599

6636

Pyothorax

325

4257

0.71

7.19

2.7

3.1

0.75

0.76

ug/l

0.10

231

2856

Endocrine, nutritional and metabolic diseases

7187

34069

1.08

7.18

2.8

0.71

0.76

ug/l

2.37

4503

20393

Oxycodone

3391

33480

0.90

7.12

3.2

3.1

1.08

0.79

ug/l

8.39

2358

22949

Persons encountering health services in other circumstances

2923

26351

1.12

7.10

3.3

2.9

0.75

0.76

ug/l

0.23

2193

16920

Malignant neoplasm of oesophagus, including Hilmo

275

3674

0.69

7.08

2.8

2.6

0.70

0.71

ug/l

0.10

199

2466

Implicit bacterial Sepsis

3935

37787

0.91

7.07

2.8

3.2

0.83

0.79

ug/l

0.62

2834

26183

Cyst of kidney

713

5906

1.28

7.07

3.4

3.2

0.79

0.76

ug/l

0.17

488

4132

Anogenital herpesviral [herpes simplex] infection

261

1854

1.45

7.06

2.8

2.6

0.70

0.68

ug/l

0.05

164

1033

Tuberculosis

365

4758

0.73

7.06

3.0

3.2

0.85

ug/l

0.01

248

3337

Degenerative macular diseases

943

7962

1.23

7.04

3.3

3.2

0.79

0.82

ug/l

0.44

701

5663

Chronic ulcer of skin, not elsewhere classified

412

5274

0.74

7.02

2.6

3.1

0.68

0.80

ug/l

2.82

292

3599

Benign neoplasm: Caecum

952

8082

1.23

6.97

3.2

0.81

0.79

ug/l

0.11

737

5720

Caries of enamel

6188

47727

0.93

6.96

2.9

2.8

0.66

0.73

ug/l

6.52

3993

29286

Unstable angina pectoris

3873

33066

0.90

6.95

3.0

3.2

0.77

0.80

ug/l

0.74

2708

23244

Hepatocellular carcinoma

141

2103

0.60

6.94

2.4

2.7

0.86

0.75

ug/l

0.76

1469

Emphysema

614

7458

0.78

6.93

2.6

3.2

0.72

0.83

ug/l

1.96

424

5297

Diseases of salivary glands

2025

18021

1.14

6.88

3.0

2.9

0.70

0.75

ug/l

1.10

1331

11697

Later onset COPD, excluding more controls

2047

17614

0.87

6.83

3.1

3.5

0.75

0.84

ug/l

4.60

1490

13320

External causes of morbidity and mortality

5782

26962

1.08

6.83

2.9

0.77

0.80

ug/l

0.66

3770

17108

Injuries to the elbow and forearm

4129

39355

0.91

6.81

3.0

2.8

0.73

0.74

ug/l

0.18

2701

24700

Fissure and fistula of anal and rectal regions

2136

19136

1.14

6.79

3.2

2.9

0.69

0.77

ug/l

5.28

1376

12293

Coxarthrosis, primary

5779

45774

1.08

6.77

3.3

3.1

0.72

0.80

ug/l

9.44

4109

31857

Adenocarcinoma of pancreas

114

1805

0.59

6.75

2.6

2.8

0.59

0.75

ug/l

2.50

1268

Respiratory tuberculosis, confirmed and not-confirmed

315

4156

0.72

6.72

2.9

3.2

0.87

0.84

ug/l

0.15

211

2917

Respiratory tuberculosis

315

4156

0.72

6.72

2.9

3.2

0.87

0.84

ug/l

0.15

211

2917

Carpal tunnel syndrome

4092

39057

0.91

6.71

3.0

2.9

0.68

0.76

ug/l

5.16

2693

25279

Other specified/unspecified hearing loss

690

5690

1.26

6.71

3.2

3.1

0.84

0.82

ug/l

0.13

552

3965

Dysphagia

2178

19551

1.14

6.71

3.1

0.68

0.81

ug/l

8.69

1519

13497

Osteopathies and chondropathies

3466

35188

0.91

6.65

3.0

2.9

0.74

0.76

ug/l

0.38

2262

22755

Adenocarcinoma and papillary adenocarcinoma of stomach

147

2189

0.62

6.64

2.6

2.7

0.73

0.76

ug/l

0.19

110

1497

Retinal detachment with retinal break

1355

11879

1.19

6.64

3.1

0.80

0.78

ug/l

0.25

927

8141

Drug-induced neutropenia

281

3786

0.71

6.62

2.6

3.1

0.87

0.73

ug/l

0.91

194

2560

Benign neoplasm: Skin of eyelid, including canthus

1035

8834

1.20

6.62

3.4

3.1

0.77

0.79

ug/l

0.25

724

6129

Stroke, excluding SAH

5754

44814

0.92

6.62

3.0

3.1

0.83

0.78

ug/l

1.77

4127

30763

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

132

2034

0.62

6.58

1.9

2.2

0.60

0.61

ug/l

0.04

982

Left bundle-branch block

683

5654

1.27

6.58

3.3

3.2

0.81

ug/l

0.01

491

3949

Septicaemia

3733

37801

0.91

6.52

3.0

3.2

0.83

0.78

ug/l

0.97

2666

26045

Vocal cord dysfunction

1057

8104

1.20

6.50

3.0

2.9

0.67

0.77

ug/l

4.00

680

5085

Macular cyst

251

1838

1.48

6.47

3.1

3.2

0.76

0.80

ug/l

0.29

192

1288

Major coronary heart disease event excluding revascularizations

6145

43557

0.93

6.47

2.9

3.0

0.75

0.77

ug/l

0.66

4294

28630

Ischaemic Stroke, excluding all haemorrhages

5403

42943

0.92

6.45

3.0

3.1

0.84

0.79

ug/l

1.57

3862

29726

Non-small cell lung cancer, adenocarcinoma, helper endpoint

402

5088

0.75

6.44

3.1

3.3

0.79

0.82

ug/l

0.20

284

3663

Polypectomy (DHB20)

778

6578

1.26

6.43

3.0

2.9

0.71

0.74

ug/l

0.50

521

4278

Diabetes, insulin treatment (Kela reimbursement)

9246

52944

1.06

6.42

2.8

2.9

0.75

0.76

ug/l

0.46

6088

33351

Hypotension

1622

14392

1.16

6.36

3.3

0.81

0.83

ug/l

0.21

1180

10319

Malignant neoplasm of oesophagus

185

2579

0.65

6.34

2.8

2.7

0.68

0.74

ug/l

0.57

128

1732

Intentional self-harm by hanging, strangulation and suffocation

583

0.34

6.31

2.0

2.7

0.56

0.79

ug/l

1.74

330

Complications following myocardial infarction

723

0.40

6.27

2.9

3.3

1.11

0.78

ug/l

0.46

505

Unattended death

797

0.42

6.23

2.5

3.1

0.91

0.80

ug/l

0.19

529

Acquired absence of limb

864

0.44

6.22

3.2

2.9

0.77

0.75

ug/l

0.06

577

Adult respiratory distress syndrome

1054

0.49

6.22

2.9

3.1

0.60

0.81

ug/l

1.33

708

Agranulocytosis

490

6100

0.78

6.21

2.7

3.1

0.82

0.75

ug/l

0.69

337

4122

Stroke, including SAH

6007

46329

0.93

6.20

3.0

3.1

0.83

0.78

ug/l

1.91

4297

31473

Duodenal ulcer

953

11059

0.83

6.19

3.0

3.1

0.83

ug/l

0.02

712

7719

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8525

48636

1.07

6.17

2.8

2.9

0.75

0.76

ug/l

0.59

5596

30395

Explicit Sepsis

3770

37998

0.91

6.09

3.0

3.2

0.83

0.79

ug/l

0.76

2705

26257

Achilles tendinitis

905

7730

1.21

6.04

3.2

2.8

0.68

0.76

ug/l

2.34

592

4933

Other/unspecified seropositive rheumatoid arthritis

1170

13480

0.85

6.04

3.0

3.1

0.70

0.78

ug/l

1.22

792

9281

Crushed, pushed or stepped on by crowd or human stampede

444

3513

1.30

6.03

2.4

2.5

0.62

0.67

ug/l

0.61

253

1912

Nonorganic sleeping disorders, excluding more controls

1182

10247

1.17

6.02

2.8

0.62

0.76

ug/l

4.56

762

6062

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3413

19783

1.10

5.98

2.7

2.6

0.72

ug/l

0.05

2136

11142

Entropion and trichiasis of eyelid

773

6534

1.23

5.98

3.2

3.3

0.85

0.83

ug/l

0.15

576

4767

Unspecified jaundice

314

4067

0.73

5.98

2.7

3.1

0.79

0.80

ug/l

0.05

208

2761

Schizotypal disorder

1174

0.53

5.95

2.3

0.38

0.66

ug/l

7.06

589

Unspecified chronic bronchitis

185

2597

0.67

5.93

3.3

3.2

0.76

0.85

ug/l

0.79

131

1766

Tuberculosis, IBD comorbidity

420

5260

0.77

5.89

2.9

3.2

0.79

0.84

ug/l

0.28

285

3665

Toxic effect of ethanol

188

2634

0.68

5.89

2.2

2.7

0.59

0.72

ug/l

1.81

126

1554

Dental pulpitis, including avohilmo

6857

47167

0.94

5.88

2.7

2.8

0.66

0.73

ug/l

7.08

4230

28942

Seropositive rheumatoid arthritis, wide

1190

13664

0.86

5.87

3.0

3.1

0.70

0.78

ug/l

1.21

807

9401

Other disorders of glucose regulation and pancreatic internal secretion

437

5455

0.77

5.83

2.7

3.0

0.66

0.75

ug/l

1.42

297

3538

Hepatocellular carcinoma, including Hilmo

213

2863

0.68

5.79

2.6

2.7

0.82

0.74

ug/l

0.69

142

2001

Major coronary heart disease event

8252

47252

1.06

5.77

2.7

2.9

0.72

0.76

ug/l

1.95

5363

29900

Other neurological diseases

6839

50791

1.07

5.71

3.1

3.0

0.78

ug/l

0.14

4764

34292

General symptoms and signs

9933

47377

1.06

5.69

2.8

0.73

0.76

ug/l

1.46

6513

29465

Type1 diabetes, definitions combined, early onset

101

1614

0.61

5.66

1.7

1.8

0.53

0.51

ug/l

0.11

625

Tuberculosis, wide

429

5334

0.77

5.64

2.9

3.2

0.79

0.84

ug/l

0.29

291

3720

Non-selective monoamine reuptake inhibitors

2240

23809

0.89

5.64

2.9

3.0

0.63

0.78

ug/l

14.83

1487

15655

Polymyalgia rheumatica

985

8509

1.19

5.61

3.4

3.3

0.72

0.82

ug/l

2.53

705

6143

Oedema, not elsewhere classified

2706

24437

1.11

5.60

3.2

3.1

0.75

0.79

ug/l

0.95

1904

16564

Other specified and unspecified disorders of eye and adnexa

236

1735

1.43

5.59

3.1

3.0

0.63

0.75

ug/l

1.74

171

1108

Dyspnoea

8085

56706

1.06

5.58

3.0

2.9

0.71

0.78

ug/l

6.55

5539

37027

Striking against or struck by other objects

2978

27376

1.10

5.57

2.9

2.7

0.71

0.72

ug/l

0.05

1819

16483

Contact with and exposure to communicable diseases

1296

11293

1.15

5.57

3.0

2.4

0.68

0.67

ug/l

0.18

735

6093

Charcot foot

111

1660

0.60

5.56

2.5

3.1

0.65

0.70

ug/l

0.37

1099

Alzheimer’s disease (Early onset), excluding more controls

188

2468

0.69

5.55

2.7

3.2

0.98

0.92

ug/l

0.13

129

1746

Alzheimer’s disease (Early onset)

188

2617

0.69

5.52

2.7

3.3

0.98

0.85

ug/l

0.33

129

1823

Transient global amnesia

632

5269

1.24

5.50

3.4

3.2

0.71

0.79

ug/l

0.91

456

3719

Palmar fascial fibromatosis [Dupuytren]

2005

18238

1.14

5.49

3.4

3.1

0.77

0.83

ug/l

1.91

1405

12762

Other blood glucose lowering drugs, excl. Insulins

1205

13674

0.86

5.49

3.0

3.2

0.74

0.77

ug/l

0.55

824

9513

Allergic rhinitis

1369

11906

1.15

5.48

2.7

2.5

0.61

0.69

ug/l

2.97

758

6704

Decubitus ulcer and pressure area

389

4854

0.77

5.47

2.8

3.2

0.84

0.81

ug/l

0.13

273

3368

Infections, IBD-co-morbidities

1313

8239

1.16

5.46

2.9

2.8

0.80

0.85

ug/l

0.42

886

5081

Injury of muscle and tendon at hip and thigh level

856

7351

1.21

5.46

3.0

2.9

0.75

0.73

ug/l

0.19

525

4736

Localized swelling, mass and lump of skin and subcutaneous tissue

2454

22410

1.11

5.38

3.1

3.0

0.73

0.77

ug/l

0.88

1705

14854

Personality and behavioural disorders due to brain disease, damage and dysfunction

1150

0.54

5.38

2.3

2.9

0.63

0.79

ug/l

1.47

740

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1153

13181

0.86

5.38

2.9

3.1

0.71

0.78

ug/l

1.16

781

9068

GI-bleeding

2946

31890

0.91

5.36

3.0

3.2

0.82

0.80

ug/l

0.32

2041

22115

Other acute lower respiratory infections

4001

40901

0.92

5.34

2.8

2.9

0.72

0.78

ug/l

2.01

2565

26122

Arterial embolism and thrombosis of lower extremity artery

212

2843

0.70

5.34

2.6

3.3

0.78

0.81

ug/l

0.15

152

1996

Epileptic seizures related to alcohol

656

0.41

5.31

2.4

2.8

0.55

0.71

ug/l

1.22

411

Depression or dysthymia

6396

37360

0.94

5.29

2.9

0.67

0.80

ug/l

13.33

4230

23865

Migraine with aura and triptan purchases

295

2232

1.33

5.27

2.7

2.5

0.56

0.66

ug/l

1.80

185

1210

Use of antiglaucoma preparations and miotics

565

4681

1.25

5.25

3.6

3.3

0.80

0.84

ug/l

0.46

419

3328

Dementia

3760

27771

0.92

5.24

3.1

3.4

0.80

0.84

ug/l

1.17

2732

20632

Ulcer of oesophagus

555

6622

0.80

5.24

3.1

0.85

0.80

ug/l

0.29

399

4585

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2074

18672

1.12

5.24

2.6

2.5

0.62

0.69

ug/l

4.16

1160

10524

Schizoid personality disorder

1307

0.58

5.23

2.5

2.6

0.56

0.70

ug/l

1.41

758

Other and unspecified visual disturbances

637

5330

1.23

5.23

2.8

3.0

0.79

0.74

ug/l

0.28

430

3487

Heartburn

763

6487

1.21

5.22

3.1

2.9

0.64

0.76

ug/l

3.79

505

4212

Suppurative and unspecified otitis media

1610

15972

0.88

5.20

2.5

2.6

0.76

0.71

ug/l

0.54

930

9040

Respiratory tuberculosis, not confirmed

228

3024

0.72

5.18

2.7

3.3

0.92

0.84

ug/l

0.30

154

2130

Implicit Sepsis

7341

52570

1.06

5.17

2.9

3.0

0.78

0.76

ug/l

0.44

5206

34284

Gonarthrosis, primary, with knee surgery

4891

41409

0.93

5.14

3.2

3.1

0.70

0.80

ug/l

12.92

3487

29062

Primary coxarthrosis, bilateral

2447

22435

1.11

5.12

3.4

3.2

0.73

0.80

ug/l

3.24

1745

15820

Hypoglycaemia, other or unspecified

339

4285

0.76

5.12

2.6

2.9

0.67

0.75

ug/l

1.05

224

2760

Varicose veins of other sites

643

5439

1.24

5.11

2.9

2.7

0.81

0.72

ug/l

0.40

405

3273

Extreme obesity with alveolar hypoventilation

195

2641

0.70

5.07

2.6

3.0

0.59

0.75

ug/l

2.44

126

1712

Necrosis of pulp, including avohilmo

4613

43136

1.08

5.07

2.9

2.7

0.71

0.72

ug/l

0.25

2926

26111

Nontoxic goitre/thyroid nodule

975

8423

1.17

5.07

3.4

3.2

0.79

ug/l

0.06

717

5875

Infective dermatitis

717

8403

0.83

5.06

2.9

3.0

0.77

ug/l

0.00

473

5595

Tobacco use

288

3694

0.75

5.05

2.3

2.8

0.59

0.71

ug/l

3.04

192

2331

Exposure to excessive natural cold

890

0.50

5.05

2.1

3.0

0.87

0.79

ug/l

0.27

571

Alcohol-induced chronic pancreatitis

625

7314

0.81

5.05

2.6

2.8

0.61

0.72

ug/l

3.81

441

4564

Gout, FINNGEN

3947

36931

1.09

5.04

3.1

3.2

0.82

0.80

ug/l

0.29

2887

25914

Lung transplant status

560

1.85

5.01

1.5

2.8

0.48

0.73

ug/l

4.40

357

Benign neoplasm: Pituitary gland, craniopharyngeal duct

374

2986

1.31

5.01

3.2

3.0

0.79

0.74

ug/l

0.22

260

1896

Pain, not elsewhere classified

1964

17789

1.12

5.01

2.9

0.68

0.76

ug/l

2.31

1310

11382

Lung transplantation

560

1.85

5.00

1.5

2.8

0.48

0.73

ug/l

4.40

357

Hypo-osmolality and hyponatraemia

1053

11931

0.86

4.93

3.0

3.1

0.80

0.78

ug/l

0.12

748

8175

Pulmonary oedema

1244

0.58

4.92

2.3

3.2

1.07

0.83

ug/l

0.64

859

Disorders of sclera, cornea, iris and ciliary body

4347

40734

1.08

4.92

2.9

0.70

0.75

ug/l

4.04

2820

25660

Somnolence, stupor and coma

215

2859

0.72

4.89

2.8

3.0

0.90

0.77

ug/l

0.35

151

1872

Psychiatric diseases

9097

47700

0.95

4.86

2.8

2.9

0.70

0.79

ug/l

10.26

6064

30116

Benign neoplasm: Transverse colon

1037

9141

1.18

4.84

3.2

0.73

0.78

ug/l

0.70

787

6407

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

279

3595

0.75

4.78

2.2

0.41

0.65

ug/l

12.37

178

1713

Collagenous colitis

512

4233

1.24

4.77

3.0

0.72

0.75

ug/l

0.22

361

2778

Carcinoma in situ of skin of upper limb, including shoulder

235

1801

1.42

4.75

3.5

3.4

0.82

0.80

ug/l

0.05

176

1290

Focal brain injury

539

6401

0.81

4.75

3.1

3.0

0.67

0.81

ug/l

3.90

378

4140

Benign neoplasm of other and ill-defined parts of digestive system

1251

11111

1.15

4.74

3.2

3.1

0.76

0.78

ug/l

0.23

923

7709

Carcinoma in situ of other and unspecified digestive organs

347

2800

1.34

4.74

3.6

3.2

0.70

0.77

ug/l

0.85

250

1950

Malignant neoplasm of stomach

335

4171

0.77

4.72

2.8

2.7

0.79

0.74

ug/l

0.47

234

2882

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1303

0.60

4.71

2.3

2.7

0.67

0.75

ug/l

0.38

752

ILD-related respiratory insufficiency

219

2850

0.72

4.70

2.5

3.3

0.69

0.79

ug/l

0.55

142

2036

Melanoma in situ of other and unspecified parts of face

112

757

1.66

4.70

3.7

3.2

0.90

0.81

ug/l

0.24

538

137

1919

0.66

4.69

2.9

3.3

0.62

0.81

ug/l

2.42

1359

Laparoscopic right hemicolectomy

485

4032

1.26

4.69

3.4

3.2

0.75

0.77

ug/l

0.22

359

2849

Candidiasis

1424

12709

1.13

4.68

3.1

3.0

0.71

0.77

ug/l

0.93

1013

8427

Dialysis

252

3232

0.74

4.67

2.5

2.9

0.93

0.72

ug/l

3.64

211

2041

Other specified/unspecified arthritis

1992

18140

1.11

4.65

3.0

2.9

0.74

0.79

ug/l

1.03

1352

11882

Other specified disorders of external ear

462

3869

1.29

4.64

3.6

3.1

0.79

0.76

ug/l

0.18

312

2640

Chronic pancreatitis

1140

12783

0.86

4.64

2.8

2.9

0.66

0.75

ug/l

4.18

812

8319

Chronic periodontitis, complicated

5432

50963

1.07

4.64

3.1

2.9

0.74

0.76

ug/l

0.45

3904

33434

Use of pramipexole

1533

13790

1.13

4.63

3.1

0.68

0.78

ug/l

4.42

1060

9479

Obesity and other hyperalimentation

3978

40927

0.93

4.62

2.8

2.9

0.67

0.74

ug/l

3.71

2622

25966

Motor neuron disease

110

1597

0.64

4.61

2.5

3.2

0.83

0.84

ug/l

0.04

1103

Diseases of inner ear

4210

38197

1.08

4.61

3.2

3.0

0.77

ug/l

0.11

2832

25871

Melanocytic naevi of other and unspecified parts of face

302

2363

1.32

4.59

3.0

2.9

0.73

0.74

ug/l

0.10

193

1513

Benign neoplasm: Adrenal gland

596

5045

1.23

4.58

3.2

3.1

0.78

0.75

ug/l

0.21

431

3429

Nutritional anaemias

3402

35168

0.92

4.58

3.1

3.2

0.88

0.80

ug/l

1.81

2442

24593

Toxic effect of alcohol

123

1747

0.65

4.57

2.5

2.7

0.65

0.73

ug/l

0.79

1045

Diagnoses used for exclusion with ILD

2045

22328

0.90

4.55

2.8

3.1

0.80

0.79

ug/l

0.06

1371

15053

Otitis externa

1607

14505

1.13

4.54

3.2

2.9

0.74

0.76

ug/l

0.13

1082

9446

Obesity

3959

40770

0.93

4.54

2.8

2.9

0.67

0.74

ug/l

3.69

2609

25866

Motor neuron disease (with DMD)

111

1605

0.64

4.52

2.5

3.2

0.83

0.84

ug/l

0.07

1108

Chalazion

790

6825

1.19

4.51

3.1

2.9

0.69

0.74

ug/l

1.22

534

4334

Complications of procedures, not elsewhere classified

7016

55264

1.06

4.50

3.1

2.9

0.75

0.77

ug/l

0.81

4801

35972

Azathioprine

767

8887

0.85

4.50

2.6

2.7

0.72

ug/l

0.02

515

5382

Endovascular or surgical operations to intracerebral aneurysms

294

3715

0.76

4.49

2.4

3.0

0.84

0.74

ug/l

0.39

191

2444

Other other unspecified disorders of the circulatory system

161

2204

0.70

4.49

3.2

3.1

0.71

0.78

ug/l

0.61

114

1512

Other sexually transmitted chlamydial diseases

285

2205

1.31

4.47

2.3

2.0

0.59

0.60

ug/l

0.04

153

931

Acute upper respiratory infections

8167

52667

0.95

4.47

2.9

3.0

0.71

0.79

ug/l

8.93

5169

34972

Cardiomyopathy

1759

19253

0.89

4.44

2.7

3.1

0.79

ug/l

0.01

1251

13112

Spondylosis

5284

40752

1.07

4.43

3.1

3.0

0.68

0.80

ug/l

11.14

3657

26667

ILD medications: azathioprine

767

8873

0.85

4.41

2.6

2.7

0.72

ug/l

0.01

515

5378

Carcinoma in situ of rectum

133

956

1.60

4.37

3.6

3.1

0.69

0.73

ug/l

0.25

650

Dementia in other diseases classified elsewhere

262

3327

0.75

4.36

2.7

3.4

0.74

0.82

ug/l

0.43

181

2390

Other shoulder lesions

610

5174

1.21

4.35

2.8

2.7

0.67

0.75

ug/l

0.51

387

3150

Other disorders of the genitourinary system

393

3179

1.26

4.33

3.2

3.3

0.85

0.81

ug/l

0.13

265

2270

Hydrocephalus

425

5131

0.80

4.30

2.7

3.2

0.67

0.81

ug/l

3.58

299

3632

Problems related to social environment

1236

0.61

4.30

3.1

2.8

0.72

0.80

ug/l

0.28

798

Open wound of lower leg

1082

9587

1.15

4.29

2.8

2.9

0.72

0.76

ug/l

0.48

696

6074

Other congenital malformations

555

4656

1.21

4.28

2.8

0.72

0.71

ug/l

0.03

363

2891

Malignant neoplasm of stomach, including Hilmo

406

4902

0.80

4.27

2.8

2.7

0.76

0.74

ug/l

0.15

277

3376

Universal erythroderma, KELA reimbursement

1106

0.59

4.25

2.9

2.8

0.56

0.76

ug/l

2.50

707

Faecal incontinence

268

2076

1.31

4.23

3.6

3.1

0.90

0.78

ug/l

0.34

192

1428

Thyrotoxicosis

985

8644

1.15

4.23

3.0

0.75

0.77

ug/l

0.27

658

5759

Nontoxic single thyroid nodule

275

2144

1.31

4.22

3.5

3.1

0.83

0.77

ug/l

0.26

194

1469

Ischemic heart diseases

7896

45330

1.05

4.20

2.7

2.9

0.71

0.76

ug/l

3.20

5068

28432

Complications of medical and surgical care

6073

53074

1.06

4.19

3.1

3.0

0.74

0.78

ug/l

2.07

4180

35477

Nephropathy related operations

1026

11510

0.86

4.18

2.3

3.0

0.87

0.76

ug/l

2.85

794

7602

Morphin

108

1548

0.65

4.17

3.0

3.2

0.78

0.86

ug/l

0.37

1095

Other disorders of conjunctiva

1114

9925

1.15

4.17

3.3

3.1

0.71

0.79

ug/l

2.21

778

6899

Secondary malignant neoplasm of respiratory and digestive organs

1142

0.60

4.16

2.7

0.85

0.76

ug/l

0.47

791

Other diseases of the digestive system

2937

31461

0.92

4.14

3.1

3.2

0.82

0.80

ug/l

0.36

2042

21833

Undetermined asthma

910

7983

1.16

4.14

3.3

3.0

0.65

0.78

ug/l

5.38

605

5355

Other diseases of pleura

4618

42736

0.93

4.12

3.1

3.2

0.76

0.80

ug/l

1.47

3283

30127

Other infectious diseases

555

6516

0.83

4.11

2.8

3.1

0.79

0.81

ug/l

0.21

400

4418

Other postsurgical states

329

4057

0.78

4.11

2.6

3.0

0.63

0.74

ug/l

1.20

235

2702

Encephalopathy

775

0.52

4.10

2.4

2.9

0.47

0.76

ug/l

7.36

526

Dialysis, with operation codes

1100

12273

0.87

4.09

2.4

3.0

0.89

0.74

ug/l

4.51

859

8120

Bacterial Sepsis

4524

40860

0.93

4.09

2.8

3.1

0.82

0.79

ug/l

0.54

3247

28064

Other specified/unspecified diseases of inner ear

263

2.06

4.07

3.9

2.8

0.85

0.71

ug/l

0.51

172

Plantar fascial fibromatosis

495

4141

1.22

4.06

3.0

2.8

0.67

0.77

ug/l

1.99

333

2659

Bicipital tendinitis

447

3745

1.25

4.05

2.8

0.66

0.74

ug/l

1.15

295

2346

Other congenital malformations of skin

381

3108

1.25

4.04

2.9

0.69

0.72

ug/l

0.28

247

1923

Extrapyramidal and movement disorders

3159

29536

1.08

4.03

3.2

0.73

0.79

ug/l

2.52

2235

20573

Other anxiety disorders

2056

19434

0.91

4.03

2.6

2.5

0.56

0.70

ug/l

10.66

1343

10613

Diabetic retinopathy, excluding more controls

1847

11313

0.90

4.00

2.9

3.0

0.77

0.74

ug/l

0.46

1286

7525

Other systemic involvement of connective tissue (FG)

1317

11668

1.13

3.98

3.2

3.1

0.72

0.82

ug/l

3.56

922

8082

COPD/asthma related infections

8120

42476

0.95

3.95

2.9

3.0

0.74

0.77

ug/l

0.91

5288

27774

COPD/asthma/ILD related infections

8120

42476

0.95

3.95

2.9

3.0

0.74

0.77

ug/l

0.91

5288

27774

Sequelae of other accidents

1059

0.60

3.94

2.4

3.0

0.63

0.79

ug/l

1.48

685

Iron deficiency anaemia secondary to blood loss (chronic)

914

10347

0.87

3.94

3.0

3.2

0.88

0.81

ug/l

0.62

626

7185

Injuries to unspecified part of trunk, limb or body region

743

6472

1.18

3.91

2.8

3.0

0.70

0.76

ug/l

0.85

495

4247

Erectile dysfunction

1256

11473

1.16

3.91

3.8

3.2

0.73

0.80

ug/l

1.51

785

8229

Chronic laryngitis and laryngotracheitis

1002

8899

1.15

3.89

3.5

3.0

0.67

0.78

ug/l

5.07

685

6025

Diseases of the digestive system

3884

40979

0.93

3.88

3.0

3.1

0.80

0.79

ug/l

0.20

2665

28039

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2627

24449

1.09

3.88

2.9

2.8

0.66

0.73

ug/l

3.90

1621

15008

Seropositive rheumatoid arthritis

1190

13227

0.89

3.87

3.0

3.1

0.70

0.80

ug/l

1.64

807

9000

Normotensive glaucoma

535

4546

1.21

3.87

3.5

3.3

0.76

0.81

ug/l

0.46

387

3268

Other disorders of eye and adnexa

699

6043

1.18

3.86

3.1

2.9

0.64

0.73

ug/l

2.90

472

3835

Thyrotoxicosis, other and/or unspecified

819

7152

1.16

3.84

2.9

3.0

0.76

0.78

ug/l

0.20

539

4739

Generalized epilepsy

128

1785

0.70

3.84

2.6

2.7

0.69

0.75

ug/l

0.34

1033

Bronchitis

9234

55861

1.05

3.83

2.8

2.9

0.72

0.78

ug/l

4.00

5800

36430

Laparoscopic left hemicolectomy

171

1298

1.44

3.83

2.8

3.1

0.82

0.75

ug/l

0.49

120

879

Urticaria

1382

12462

1.12

3.82

2.8

0.74

0.73

ug/l

0.08

882

7763

Pollen allergy

600

5048

1.18

3.81

2.6

2.4

0.60

0.65

ug/l

0.43

315

2629

Secondary parkinsonism+Parkinsonism in other disease

149

1996

0.71

3.81

3.0

3.2

0.65

0.78

ug/l

1.71

105

1369

Adverse effects, not elsewhere classified

929

8194

1.15

3.80

2.9

0.68

0.74

ug/l

1.28

614

5200

Intestinal stricture

2396

25786

0.92

3.79

2.8

3.1

0.77

0.79

ug/l

0.27

1669

17807

Problems related to lifestyle

652

7515

0.85

3.76

2.5

2.7

0.60

0.73

ug/l

3.45

449

4512

Pneumonia due to Streptococcus pneumoniae

266

3306

0.77

3.75

2.5

3.0

0.78

0.76

ug/l

0.07

173

2120

Implicit bacterial Sepsis

4371

39816

0.94

3.75

2.9

3.2

0.81

0.79

ug/l

0.41

3154

27465

Trochanteric bursitis

464

3878

1.21

3.75

3.0

0.60

0.82

ug/l

7.51

328

2579

Recurrent dislocation and subluxation of joint

394

3257

1.24

3.74

2.4

2.3

0.61

0.70

ug/l

1.58

214

1667

Alzheimer disease

2414

19016

0.92

3.73

3.0

3.5

0.89

0.86

ug/l

0.35

1725

14161

Other infectious diseases

467

5509

0.82

3.73

2.8

3.1

0.79

0.80

ug/l

0.09

335

3717

Undetermined asthma, excluding more controls

910

8046

1.15

3.72

3.3

3.1

0.65

0.78

ug/l

5.26

605

5399

Total colectomy

211

2698

0.75

3.71

2.8

0.78

0.72

ug/l

0.39

140

1667

Total colectomy operation

211

2698

0.75

3.71

2.8

0.78

0.72

ug/l

0.39

140

1667

Phlebitis and thrombophlebitis (not including DVT)

1700

15572

1.11

3.67

3.0

0.80

0.77

ug/l

0.49

1179

10308

Other or ill-defined heart diseases

357

4299

0.80

3.66

2.7

2.9

0.78

ug/l

0.00

224

2746

Exposure to other and unspecified inanimate mechanical forces

572

4921

1.20

3.65

2.7

0.70

0.71

ug/l

0.04

366

2995

Vascular dementia (multiple infarctions)

865

0.58

3.65

2.9

3.3

0.87

0.95

ug/l

0.28

621

Alcoholic gastritis

118

1596

0.67

3.65

3.1

2.8

0.73

0.74

ug/l

0.03

1029

Ethmoidectomy

989

8823

1.15

3.65

3.2

2.8

0.69

0.73

ug/l

0.81

597

5516

Pain in thoracic spine

873

7703

1.15

3.64

2.8

0.68

0.76

ug/l

0.84

584

4733

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1237

11167

1.13

3.64

2.7

2.9

0.79

0.75

ug/l

0.36

876

7284

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

464

3908

1.21

3.62

2.4

0.61

0.70

ug/l

1.83

256

2066

Occlusion and stenosis of arteries, not leading to stroke

1024

0.61

3.61

2.4

3.3

0.89

0.85

ug/l

0.09

723

Brain glioblastoma and astrocytoma

1156

0.63

3.61

2.2

2.5

0.61

0.71

ug/l

1.06

715

Benign neoplasm of eye and adnexa

693

6047

1.17

3.60

3.4

3.1

0.76

0.78

ug/l

0.10

472

4134

Klinefelter syndrome, karyotype 47 XXY

111

2.67

3.59

2.0

2.2

0.40

0.64

ug/l

2.27

Other viral diseases

2216

20341

1.09

3.59

2.6

0.68

0.71

ug/l

0.55

1276

11672

Covid-19 suspected case

1169

10498

1.13

3.59

2.5

2.8

0.75

0.73

ug/l

0.15

710

6367

Kela-code for behavioural disturbances in mental retardation

535

0.48

3.57

2.2

2.9

0.62

0.73

ug/l

0.25

345

Ganglion

1136

10188

1.13

3.57

2.8

0.67

0.76

ug/l

2.75

695

6354

Other disorders of skin and subcutaneous tissue

5235

48840

0.94

3.57

3.1

0.76

0.78

ug/l

0.49

3667

32978

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

152

2015

0.72

3.57

2.8

3.3

0.93

0.84

ug/l

0.27

110

1420

Inhalation and ingestion of food causing obstruction of respiratory tract

638

0.52

3.55

2.9

3.1

0.67

0.79

ug/l

0.40

426

813

0.57

3.55

2.3

2.8

0.61

0.75

ug/l

0.70

495

Type 2 diabetes, wide definition

7610

46728

1.05

3.54

2.9

0.76

0.77

ug/l

0.18

5220

29663

Alcoholic cardiomyopathy

608

0.50

3.53

2.2

3.0

0.57

0.78

ug/l

1.40

406

Biological medication for rheuma

739

8434

0.86

3.53

2.4

2.5

0.63

0.68

ug/l

0.85

426

4714

Migraine without aura and triptan purchases

275

2185

1.27

3.53

2.5

2.4

0.58

0.66

ug/l

1.66

157

1145

Secondary parkinsonism

147

1946

0.71

3.50

3.1

3.2

0.65

0.76

ug/l

1.35

104

1324

Methotrexate

590

6836

0.85

3.50

2.8

3.0

0.64

0.76

ug/l

3.64

412

4513

Other abnormal findings of blood chemistry

337

2781

1.26

3.49

3.1

2.9

0.75

0.70

ug/l

0.46

183

1792

Blood alcohol or alcohol intoxication level

117

1608

0.69

3.49

2.5

2.6

0.75

0.70

ug/l

0.13

927

Thyrotoxicosis with toxic multinodular goitre

207

1599

1.32

3.48

3.6

3.2

0.65

0.79

ug/l

2.37

155

1091

Extracorporeal dialysis

466

5431

0.82

3.48

2.3

3.0

0.99

0.76

ug/l

4.97

378

3598

Other specified and unspecified personality disorders

384

4598

0.82

3.46

2.5

2.6

0.53

0.70

ug/l

6.68

281

2638

Other viral diseases, not elsewhere classified

1510

13696

1.11

3.44

2.6

0.69

0.72

ug/l

0.78

872

8046

Benign neoplasm of brain and other parts of central nervous system

450

3816

1.22

3.44

3.1

3.0

0.78

0.75

ug/l

0.18

303

2513

Disorders of acoustic nerve

204

1597

1.35

3.43

3.5

3.0

0.68

0.77

ug/l

0.83

135

1062

Malignant neoplasm, without specification of site, including Hilmo

245

3047

0.78

3.41

3.0

2.7

0.72

0.76

ug/l

0.25

180

2107

Gastrojejunal ulcer

969

0.61

3.41

2.1

2.9

0.63

0.80

ug/l

1.58

645

Cervicalgia

1346

12229

1.12

3.41

3.1

2.9

0.71

0.78

ug/l

0.80

922

7906

Chronic viral hepatitis

248

3086

0.78

3.39

2.2

2.3

0.47

0.65

ug/l

6.19

168

1557

Malignant neoplasm of bladder

787

6995

1.17

3.39

2.9

2.8

0.78

0.75

ug/l

0.24

552

5017

Open wound of head

5671

52246

1.06

3.38

2.9

0.74

0.77

ug/l

0.81

3743

33425

Abscess of lung

1324

0.66

3.34

2.7

2.9

0.61

0.78

ug/l

1.63

840

Emotionally unstable personality disorder

299

3672

0.80

3.34

2.4

0.47

0.65

ug/l

8.73

203

1906

Metatarsalgia

414

3474

1.21

3.33

3.0

2.9

0.64

0.77

ug/l

4.34

282

2230

Hyperaldosteronism

233

1867

1.32

3.32

3.4

3.0

0.77

0.74

ug/l

0.21

165

1211

Primary hyperparathyroidism

427

3594

1.21

3.32

3.4

3.1

0.77

0.76

ug/l

0.11

313

2431

Transport accidents

3808

30961

1.07

3.32

2.8

0.67

0.77

ug/l

12.07

2339

19312

1289

0.67

3.31

2.4

2.5

0.71

0.70

ug/l

0.04

721

Conjunctivitis (acute, non atopic)

1688

15454

1.10

3.30

2.9

2.8

0.73

0.74

ug/l

0.04

1099

9642

Adenocarcinoma and Papillary adenocarcinoma of kidney

142

1089

1.48

3.30

3.4

2.7

0.77

0.72

ug/l

0.36

113

728

Infectious mononucleosis

333

2736

1.24

3.30

2.2

2.3

0.65

0.64

ug/l

0.16

160

1366

Other pleural conditions

860

9602

0.87

3.30

3.0

3.3

0.81

0.83

ug/l

0.15

624

6852

Other disorders affecting eyelid function

597

0.52

3.30

1.8

2.8

0.65

0.78

ug/l

0.49

386

Arthropod-borne viral fevers and viral haemorrhagic fevers

1448

13255

1.11

3.27

2.7

2.9

0.77

0.75

ug/l

0.25

1005

8633

Migraine without aura

428

3593

1.20

3.26

2.5

0.58

0.67

ug/l

2.42

247

1961

Colonic or urogenital fistula

2218

20660

1.09

3.26

3.2

2.9

0.69

0.75

ug/l

3.75

1437

13541

Transient ischemic attack

5167

39920

1.06

3.26

3.1

3.2

0.80

0.79

ug/l

0.11

3651

27846

Other diseases of biliary tract

484

5630

0.84

3.25

2.9

3.1

0.72

0.80

ug/l

0.93

335

3846

Glaucoma, exfoliation

724

6382

1.16

3.23

3.5

3.3

0.78

0.86

ug/l

1.87

542

4647

Hard cardiovascular diseases

7671

43972

1.05

3.22

2.7

2.9

0.72

0.75

ug/l

1.10

4906

27310

Pacemaker

3411

30928

1.07

3.21

3.2

3.3

0.81

0.82

ug/l

0.19

2475

22302

Benign neoplasm: Appendix

656

1.55

3.18

3.4

3.0

0.75

0.80

ug/l

0.18

421

Brain glioblastoma

990

0.63

3.18

2.2

2.5

0.60

0.71

ug/l

1.25

635

Other arterial embolism and thrombosis

168

2152

0.74

3.17

2.9

3.3

0.68

0.81

ug/l

1.43

121

1482

Cardiomyopathies, Secondary/extrinsic

627

0.54

3.16

2.2

2.9

0.53

0.75

ug/l

1.68

413

Generalized anxiety disorder

573

4952

1.17

3.16

2.6

2.5

0.49

0.69

ug/l

12.29

360

2669

Functional dyspepsia

1542

14147

1.10

3.15

3.2

2.9

0.65

0.77

ug/l

5.54

990

9260

Other systemic involvement of connective tissue

1352

12328

1.11

3.12

3.2

0.72

0.80

ug/l

2.43

944

8584

Zoster [herpes zoster]

1265

11530

1.11

3.11

3.1

3.2

0.77

0.80

ug/l

0.42

889

8055

Asthma and allergy

461

3869

1.19

3.10

2.7

2.5

0.54

0.68

ug/l

5.16

259

2096

Tumor necrosis factor alpha inhibitors

635

7250

0.86

3.10

2.4

2.5

0.61

0.67

ug/l

1.66

360

4004

Other protozoal intestinal diseases

131

973

1.41

3.10

3.0

2.8

0.53

0.70

ug/l

4.01

608

Other/unspecified soft tissue disorders related to use, overuse and pressure

166

1275

1.35

3.10

2.9

2.7

0.63

0.76

ug/l

1.53

103

776

Senility

404

1.64

3.10

2.8

3.4

0.73

0.88

ug/l

0.86

281

Reimbursement for rheumatic diseases

3369

35511

0.94

3.09

2.8

2.9

0.69

0.76

ug/l

3.67

2255

23123

Exposure to excessive heat of man-made origin

595

0.53

3.09

2.9

3.0

0.63

0.76

ug/l

0.92

378

Other and unspecified intracranial injuries

170

2170

0.75

3.08

2.6

3.0

0.73

0.76

ug/l

0.19

117

1400

Non-small cell lung cancer, adenocarcinoma

402

4704

0.83

3.08

3.1

2.8

0.79

0.74

ug/l

0.61

284

3336

Other pulmonary heart/vessel disease

254

3103

0.79

3.07

2.9

3.2

0.93

0.81

ug/l

0.42

168

2178

Corns and callosities

355

4212

0.82

3.07

2.7

3.0

0.65

0.76

ug/l

2.54

244

2725

Other disorders of kidney and ureter

1161

10584

1.12

3.04

3.1

0.80

0.78

ug/l

0.29

827

7262

Sexual dysfunction

168

1318

1.38

3.04

2.6

2.8

0.68

0.74

ug/l

0.36

105

765

UC patients in KELA-register (code 208), prior to 1994

264

3202

0.79

3.04

3.0

0.72

0.73

ug/l

0.04

172

2087

Toxic effects of substances chiefly nonmedicinal as to source

647

7341

0.86

3.02

2.6

2.8

0.68

0.72

ug/l

0.71

433

4470

Benign neoplasm: Cranial nerves

212

1697

1.31

3.02

3.4

3.0

0.70

0.76

ug/l

0.36

140

1114

Malignant neoplasm of brain

173

2203

0.75

3.02

2.3

2.5

0.71

0.69

ug/l

0.10

101

1341

Other CVD

1773

16450

1.10

3.00

3.3

3.2

0.81

0.83

ug/l

0.24

1287

11750

Alcohol induced polyneuropathy

1138

0.65

2.99

2.6

3.1

0.63

0.76

ug/l

1.02

755

Dementia due to Parkinson's disease

153

1957

0.74

2.98

2.8

3.4

0.76

0.81

ug/l

0.25

102

1434

Vascular diseases of the intestine

219

2704

0.78

2.98

3.0

3.3

0.85

0.83

ug/l

0.09

148

1901

Complications of internal orthopaedic prosthetic devices, implants and grafts

1732

16049

1.10

2.96

3.2

0.68

0.80

ug/l

6.49

1229

11334

FESS (DNB20)

931

8389

1.13

2.96

3.2

2.8

0.68

0.72

ug/l

0.87

565

5211

Carbimazole or st.post thyroidectomy, condition for graves disease

770

6829

1.14

2.95

2.8

2.9

0.72

0.75

ug/l

0.34

519

4440

Disorders of refraction and accommodation

1423

12997

1.10

2.94

2.8

0.70

0.72

ug/l

0.25

873

7960

Dependence on enabling machines and devices, not elsewhere classified

712

0.59

2.93

1.8

3.0

0.75

0.74

ug/l

0.01

465

Certain infectious and parasitic diseases

8713

42094

1.04

2.93

2.8

2.9

0.74

0.77

ug/l

1.23

5679

26710

Asthma and allergy, excluding more controls

461

3891

1.18

2.92

2.7

2.4

0.54

0.68

ug/l

5.10

259

2109

Other and unspecified urticaria

887

7945

1.13

2.91

2.8

0.75

0.74

ug/l

0.08

574

4966

Melanocytic naevi of lower limb, including hip

229

1846

1.28

2.90

3.3

3.0

0.69

0.75

ug/l

0.61

159

1188

Diarrhoea and gastroenteritis of presumed infectious origin

5803

50110

1.05

2.90

2.6

2.8

0.72

0.76

ug/l

1.37

3495

31206

Superficial injury of wrist and hand

1174

10690

1.11

2.87

2.8

2.7

0.66

0.72

ug/l

1.69

720

6412

Injury of unspecified body region

528

4602

1.18

2.87

2.9

3.0

0.69

0.76

ug/l

0.77

346

3016

Fall on same level involving ice and snow

4161

39623

1.06

2.87

2.9

0.72

0.76

ug/l

1.24

2731

25521

Melanocytic naevi of upper limb, including shoulder

136

1032

1.37

2.83

3.2

3.0

0.62

0.74

ug/l

1.79

103

679

Open wound of wrist and hand

4642

43389

1.06

2.82

2.9

2.8

0.72

0.74

ug/l

0.48

2895

26806

Other respiratory diseases principally affecting the interstitium

1526

16460

0.91

2.80

3.0

3.2

0.74

0.82

ug/l

2.47

1095

11754

Rheumatoid arthritis, including avohilmo

1978

21220

0.92

2.80

3.0

3.1

0.73

0.78

ug/l

0.71

1353

14408

Asthma (mode)

6436

35861

0.96

2.80

2.9

0.67

0.77

ug/l

10.58

4140

22605

Malignant neoplasm of other and unspecified parts of biliary tract

967

0.65

2.80

2.8

2.7

0.61

0.78

ug/l

2.12

663

Chronic kidney disease

3305

30783

1.07

2.79

3.0

3.2

0.98

0.80

ug/l

9.44

2508

21584

Abnormal involuntary movements

975

8836

1.12

2.78

3.1

3.0

0.71

0.77

ug/l

1.16

715

5934

Secondary right heart disease

223

2729

0.79

2.78

2.8

3.2

0.91

0.80

ug/l

0.34

147

1909

Disorders of ocular muscles, binocular movement, accommodation and refraction

2883

26954

1.07

2.77

2.9

2.8

0.75

0.74

ug/l

0.09

1833

16881

Disorders of conjunctiva

5049

42350

0.95

2.77

3.0

2.8

0.70

0.74

ug/l

1.19

3180

26413

Alzheimer’s disease, strict definition

1797

15904

0.92

2.77

3.0

3.5

0.88

ug/l

0.06

1307

11778

Hydronephrosis

996

9053

1.12

2.77

3.5

3.2

1.18

0.78

ug/l

8.26

718

6261

Bacterial infection, other or unspecified

5253

43704

1.05

2.77

3.1

0.87

0.78

ug/l

3.84

3834

29640

Psychotic depression

263

3184

0.81

2.76

3.0

2.9

0.75

0.77

ug/l

0.13

172

1980

Colitis due to radiation

120

919

1.45

2.75

4.3

3.2

0.80

0.82

ug/l

0.06

627

Other sleep disorders

944

8556

1.13

2.75

2.9

0.75

0.77

ug/l

0.18

594

5634

Thiamine deficiency

505

0.52

2.75

3.3

2.8

0.70

0.73

ug/l

0.07

333

Otitis externa, unspecified

704

6266

1.14

2.74

3.2

2.9

0.82

0.74

ug/l

0.40

479

3986

Other arthritis (FG)

2306

21636

1.08

2.74

3.0

2.9

0.74

0.78

ug/l

0.98

1568

14106

Complications peculiar to reattachment and amputation

511

0.53

2.74

2.2

3.0

0.57

0.81

ug/l

0.78

331

Seropositive rheumatoid arthritis, strict definition

651

7345

0.87

2.73

2.9

3.1

0.76

0.78

ug/l

0.15

439

4985

Fracture of forearm

2575

25079

0.93

2.73

3.0

2.9

0.74

0.75

ug/l

0.14

1690

15931

Benign neoplasm: Anus and anal canal

213

1729

1.29

2.72

3.6

3.1

0.78

0.80

ug/l

0.12

152

1179

Olecranon bursitis

795

7201

1.15

2.72

3.0

2.9

0.65

0.78

ug/l

4.83

524

4662

Alzheimer’s disease (Atypical or mixed), excluding more controls

615

5524

0.87

2.72

2.8

3.5

0.96

0.93

ug/l

0.09

438

4164

Injuries to the abdomen, lower back, lumbar spine and pelvis

3084

28882

1.07

2.71

2.9

3.0

0.72

0.77

ug/l

1.81

2083

18946

Pneumonia due to other infectious organisms, not elsewhere classified

203

2494

0.78

2.71

2.5

3.1

0.74

0.76

ug/l

0.14

131

1634

Dementia, including avohilmo

4058

29227

0.94

2.70

3.1

3.4

0.80

0.84

ug/l

1.39

2955

21632

Oral lichen planus, including avohilmo , including avohilmo

260

2137

1.24

2.70

3.3

2.9

0.59

0.71

ug/l

2.89

164

1359

Secondary parkinsonism, excluding more controls

147

1873

0.75

2.69

3.1

3.2

0.65

0.85

ug/l

2.84

104

1281

Malignant neoplasm of colon, including Hilmo

1620

15037

1.09

2.69

3.1

2.8

0.85

0.73

ug/l

3.07

1157

10453

Disorders of gallbladder, biliary tract and pancreas

8607

56064

0.96

2.67

3.1

2.9

0.76

0.77

ug/l

0.74

5968

36523

Malignant neoplasm of eye, brain and central nervous system

231

2806

0.80

2.66

2.5

0.74

0.71

ug/l

0.25

145

1722

Systemic connective tissue disorders

1868

17400

1.08

2.66

3.1

0.69

0.79

ug/l

5.03

1318

12067

ILD, hospital admissions 3, with pneumonia sepsis

695

7743

0.87

2.66

2.9

3.3

0.75

0.80

ug/l

0.69

499

5556

Injuries to the hip and thigh

3881

36850

0.95

2.65

3.0

3.1

0.80

0.79

ug/l

0.06

2582

24893

Frostbite

812

0.63

2.65

2.3

2.8

0.65

0.77

ug/l

0.69

490

Other disorders of skin and subcutaneous tissue, not elsewhere classified

885

9773

0.89

2.64

3.1

0.70

0.78

ug/l

3.04

624

6657

Panic disorder

569

4992

1.15

2.63

2.5

0.55

0.69

ug/l

4.55

348

2696

Other and unspecified coagulation defects

251

2068

1.24

2.61

2.8

0.73

0.72

ug/l

0.08

163

1288

Open wound of thorax

1192

0.69

2.59

2.5

2.6

0.58

0.74

ug/l

1.68

687

Vascular syndromes of brain in cerebrovascular disorders

294

3469

0.82

2.58

2.7

3.3

0.87

0.82

ug/l

0.21

203

2442

Disorders of oesophagus in diseases classified elsewhere

114

1489

0.73

2.58

2.9

3.1

0.91

0.76

ug/l

0.38

1019

Rash and other nonspecific skin eruption

520

4557

1.16

2.57

2.9

3.0

0.72

0.76

ug/l

0.44

376

3000

conjunctival haemorrhage

560

4952

1.16

2.56

3.4

3.1

0.66

0.78

ug/l

3.39

381

3412

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6041

52058

1.05

2.56

3.1

3.0

0.76

0.78

ug/l

0.68

4205

35204

Anorexia (incl.atypical)

118

1561

0.74

2.55

2.5

2.7

0.72

0.78

ug/l

0.33

931

Medicines for HER+ breast cancer

113

790

1.36

2.55

3.2

2.5

1.10

0.75

ug/l

0.41

418

Benign neoplasm: Stomach

597

5292

1.15

2.54

3.2

0.80

0.79

ug/l

0.09

448

3661

Melanoma in situ of upper limb, including shoulder

399

1.61

2.54

3.6

3.1

0.78

0.77

ug/l

0.02

262

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

425

0.51

2.54

2.9

1.92

0.73

ug/l

0.42

276

Glucosamine medication

3147

26452

0.94

2.53

3.6

3.3

0.73

0.81

ug/l

3.33

2258

19013

Disorders of thyroid, IBD co-morbidities

1165

7485

1.10

2.53

3.0

2.9

0.73

0.86

ug/l

3.75

785

4752

Dementia due to Parkinsons disease, excluding more controls

153

1914

0.76

2.52

2.8

3.4

0.76

0.92

ug/l

0.96

102

1421

Diffuse brain injury

247

2957

0.81

2.52

2.7

2.8

0.66

0.77

ug/l

1.68

178

1851

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

632

5633

1.15

2.52

3.1

3.0

0.63

0.75

ug/l

3.38

421

3675

Hereditary ataxia

887

0.65

2.51

2.7

3.0

0.67

0.79

ug/l

0.64

586

Hernia of abdominal wall

4734

45454

1.05

2.51

3.0

0.70

0.76

ug/l

4.59

3200

29916

Exposure to smoke, fire and flames

155

1939

0.76

2.51

2.7

0.66

0.73

ug/l

0.72

1167

Other maltreatment syndromes

224

1842

1.26

2.51

2.0

2.3

0.56

0.66

ug/l

0.47

153

932

Use of disulfiram, acamprosate or naltrexone

745

8238

0.88

2.51

2.6

2.5

0.58

0.69

ug/l

3.16

525

4613

Other noninfective gastroenteritis and colitis

1524

14124

1.09

2.50

3.0

0.72

0.78

ug/l

1.24

1027

9247

Dissociative [conversion] disorders

825

0.66

2.49

2.4

2.7

0.58

0.72

ug/l

0.93

487

Alcohol-induced acute pancreatitis

342

3941

0.82

2.49

2.8

0.60

0.72

ug/l

3.01

229

2460

Complications of cardiac and vascular prosthetic devices, implants and grafts

144

1806

0.75

2.48

2.6

3.1

0.77

0.79

ug/l

0.15

1241

Panhypopituitarism

167

1343

1.32

2.48

3.7

2.9

0.59

0.74

ug/l

3.44

131

851

Isolated growth hormone deficiency

2.26

2.47

2.5

2.0

0.53

0.64

ug/l

0.59

Benign neoplasm: Descending colon

639

5729

1.15

2.47

3.3

3.1

0.80

0.77

ug/l

0.18

486

3964

Myocardial infarction, without ST-elevation

4427

42009

0.95

2.47

3.0

3.2

0.80

ug/l

0.04

3191

29585

Benign neoplasm: Conjunctiva

218

1791

1.26

2.47

3.2

3.0

0.86

0.77

ug/l

0.22

152

1185

Keratitis

2648

25045

1.07

2.46

2.9

2.8

0.71

0.75

ug/l

1.25

1704

15721

Nontoxic multinodular goitre

579

5108

1.14

2.46

3.4

3.2

0.78

ug/l

0.05

436

3614

Malignant neoplasm of brain, including Hilmo

267

3175

0.82

2.46

2.6

2.5

0.74

0.70

ug/l

0.43

176

1971

Other/unspecified dorsalgia

2588

24236

1.07

2.45

2.9

0.70

0.79

ug/l

2.60

1745

15412

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

488

4282

1.16

2.45

3.3

3.0

0.72

ug/l

0.04

329

2755

Other and unspecified dermatitis

3715

35437

1.06

2.45

2.9

3.0

0.70

0.77

ug/l

3.13

2542

23244

Acidosis

157

1942

0.76

2.44

2.5

3.0

0.81

0.74

ug/l

0.71

112

1319

Other enthesopathy of foot (+metatarsalgia)

438

3801

1.17

2.44

3.0

2.8

0.64

0.76

ug/l

4.34

299

2418

Acute bronchitis

2874

29700

0.94

2.43

2.9

3.0

0.74

0.80

ug/l

2.72

1897

19495

Malignant neoplasm of other and ill-defined sites, including Hilmo

853

0.66

2.43

2.9

2.7

0.68

0.80

ug/l

0.73

581

Use of anticholinesterases

2743

22808

0.94

2.42

3.1

3.5

0.81

0.86

ug/l

1.04

2000

16966

N06DA Anticholinesterases

2743

22808

0.94

2.42

3.1

3.5

0.81

0.86

ug/l

1.04

2000

16966

Pure hyperglyceridaemia

153

1903

0.76

2.41

2.8

3.0

1.08

0.74

ug/l

0.61

1236

Viral infections characterized by skin and mucous membrane lesions

3293

31325

1.06

2.40

2.8

0.70

0.74

ug/l

1.16

2061

19482

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

993

9113

1.12

2.40

3.3

2.7

0.87

0.71

ug/l

5.53

749

6241

Other/unspecified rheumatoid arthritis

501

5693

0.87

2.40

3.1

3.2

0.68

0.80

ug/l

3.43

351

3940

Other CVD (FINNGEN)

1167

8340

1.11

2.40

3.2

3.3

0.77

0.78

ug/l

0.06

841

5835

Eating disorders

169

2118

0.79

2.39

2.5

2.7

0.67

0.73

ug/l

0.55

109

1232

Disorders of skin appendages

3054

28967

1.06

2.39

2.9

2.8

0.71

0.74

ug/l

0.54

1949

18130

Sulfasalazine

1817

19409

0.93

2.38

2.8

2.9

0.71

0.74

ug/l

0.48

1195

12445

Idiopathic gout

1170

10860

1.11

2.37

3.1

3.2

0.82

0.78

ug/l

0.39

860

7615

Inflammatory bowel disease, strict (require KELA)

1461

15718

0.92

2.37

2.7

0.68

0.71

ug/l

1.01

910

9443

Malignant neoplasm, without specification of site

170

2101

0.78

2.37

2.8

2.7

0.67

0.77

ug/l

1.49

125

1447

Hypothermia

125

1585

0.74

2.37

2.4

3.1

0.77

ug/l

0.01

1050

Accidental poisoning by and exposure to other gases and vapours

329

0.47

2.36

1.9

2.8

0.84

0.78

ug/l

0.14

206

Intermittent heterotropia

216

1766

1.24

2.35

3.2

2.8

1.03

0.72

ug/l

0.72

129

1052

Malignant neoplasm of renal pelvis, including Hilmo

123

964

1.39

2.35

3.1

2.7

0.96

0.78

ug/l

0.59

651

Shock, not elsewhere classified

720

0.63

2.35

2.6

3.2

0.59

0.76

ug/l

1.57

484

Other infective otitis externa

418

3647

1.18

2.35

3.3

3.0

0.75

ug/l

0.02

306

2400

Other peripheral vascular diseases

360

4171

0.85

2.33

2.9

3.1

0.69

0.79

ug/l

2.00

254

2809

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2237

20873

1.07

2.33

4.0

2.8

1.51

0.71

ug/l

23.65

1735

14434

Presence of cardiac and vascular implants and grafts

5454

39091

1.05

2.33

3.0

3.1

0.81

0.79

ug/l

0.33

3870

26954

Brain meningioma

191

1548

1.26

2.32

3.2

2.6

0.82

0.74

ug/l

0.67

134

1039

Cervicocranial syndrome

554

4910

1.14

2.32

3.1

2.9

0.66

0.80

ug/l

3.12

375

3191

Other mycoses, not elsewhere classified/unspecified

123

956

1.36

2.31

3.1

3.0

0.74

0.73

ug/l

0.06

601

Ulcerative colitis, NAS

798

8795

0.89

2.30

2.7

2.8

0.68

0.73

ug/l

1.16

523

5410

Acne vulgaris

228

1877

1.23

2.30

2.3

2.1

0.54

0.62

ug/l

1.12

119

889

Infliximab

660

0.63

2.30

2.6

2.1

0.52

0.64

ug/l

0.94

307

Embedded and impacted teeth

741

6798

0.89

2.30

2.3

0.61

0.65

ug/l

0.34

389

3496

Second line medication for Crohn's disease

3704

38736

0.95

2.29

2.8

2.9

0.68

0.74

ug/l

2.54

2440

24571

Colitis, primary sclerosing, strict definition

556

0.59

2.29

2.3

2.5

0.82

0.69

ug/l

0.20

300

Evidence of alcohol involvement determined by blood alcohol level

1056

0.70

2.29

2.6

2.7

0.79

0.71

ug/l

0.12

622

Chromophobe cell carcinoma of kidney

416

1.62

2.29

3.0

2.7

0.69

0.77

ug/l

0.49

280

Brain meningioma, including Hilmo

203

1659

1.25

2.29

3.2

2.7

0.82

0.73

ug/l

0.75

143

1112

Other diseases of pericardium

325

3760

0.83

2.29

2.9

3.1

0.76

0.80

ug/l

0.29

229

2556

Pathological resorption of teeth

245

2055

1.23

2.28

2.9

0.66

0.73

ug/l

0.78

161

1277

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

108

1396

0.74

2.28

2.8

2.7

0.62

0.76

ug/l

2.15

953

Symptoms and signs involving the nervous and musculoskeletal systems

4585

44018

1.05

2.27

3.0

0.71

0.78

ug/l

5.87

3011

29578

Chondrocostal junction syndrome [Tietze]

147

1160

1.30

2.26

3.0

2.9

0.53

0.75

ug/l

4.43

100

725

Postprocedural disorders of ear and mastoid process, not elsewhere classified

524

0.58

2.26

3.1

3.0

0.69

0.76

ug/l

0.42

354

Rheumatic fever incl heart disease

155

1925

0.78

2.26

3.0

3.2

0.79

0.82

ug/l

0.20

110

1328

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

202

1.86

2.26

1.9

2.3

0.48

0.67

ug/l

1.18

Paranoid personality disorder

1059

0.70

2.25

2.6

2.8

0.67

0.72

ug/l

0.20

640

Asthma, including avohilmo

10067

58118

0.97

2.25

2.9

0.68

0.78

ug/l

12.63

6408

37244

Toxic effect of carbon monoxide

1168

0.72

2.25

2.7

2.8

0.65

0.75

ug/l

0.80

722

Acute gastritis

452

5126

0.86

2.25

3.0

0.85

0.77

ug/l

0.38

316

3386

Assault by sharp object

1245

0.72

2.24

2.1

2.4

0.43

0.67

ug/l

7.55

627

Other bursitis of elbow

103

800

1.43

2.23

3.3

3.0

0.65

0.81

ug/l

1.42

533

Colitis, primary sclerosing

709

0.65

2.23

2.3

2.5

0.73

0.69

ug/l

0.06

385

Loose body in joint

235

1980

1.25

2.23

2.8

0.89

0.77

ug/l

0.35

159

1270

Other/unspecified enthesopathies of lower limb, excluding foot

370

3202

1.18

2.23

2.8

2.7

0.64

0.73

ug/l

1.53

221

1928

Other enthesopathies

1963

18458

1.07

2.22

2.9

2.8

0.66

0.77

ug/l

5.99

1257

11581

L04AX Other immunosuppressants

3607

37712

0.95

2.22

2.8

2.9

0.68

0.74

ug/l

2.59

2385

23996

Suggestive for eosinophilic asthma

775

7050

1.12

2.22

3.2

3.0

0.63

0.77

ug/l

6.61

517

4666

Other ulcerative colitis

296

3459

0.84

2.22

2.9

2.8

0.68

0.72

ug/l

0.42

205

2106

Vitamin deficiency, wide

211

2541

0.81

2.22

2.9

3.0

0.80

0.76

ug/l

0.16

149

1654

Vitamin deficiency

211

2541

0.81

2.22

2.9

3.0

0.80

0.76

ug/l

0.16

149

1654

Malignant neoplasm of testis

172

1411

1.30

2.21

2.5

2.3

0.69

ug/l

0.02

112

778

Adrenocortical insufficiency

125

1594

0.76

2.21

3.3

3.0

0.95

0.76

ug/l

0.35

1024

Acute pancreatitis (for exclusion)

1775

18865

0.93

2.21

2.8

3.0

0.70

0.77

ug/l

2.26

1201

12473

Malignant neoplasm of colon

1228

11390

1.10

2.20

3.1

2.8

0.86

0.73

ug/l

2.48

865

7954

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

257

3046

0.83

2.20

2.6

2.7

0.67

0.72

ug/l

0.34

175

1826

Acute pharyngitis

1027

9357

1.10

2.20

2.5

2.4

0.61

0.65

ug/l

1.20

570

4970

Anosmia

154

1198

1.29

2.20

3.1

2.7

0.77

0.74

ug/l

0.08

772

Primary gonarthrosis, bilateral

4222

37643

0.95

2.20

3.3

3.1

0.73

0.80

ug/l

2.73

2977

26300

Autoimmune diseases

10311

53876

0.97

2.19

2.8

2.9

0.72

0.77

ug/l

4.39

6696

34160

Desensitization to allergens

156

1241

1.27

2.19

2.4

2.2

0.62

0.64

ug/l

0.14

590

ILD, hospital admission 2, with pulmonary infections

828

9044

0.89

2.19

2.9

3.3

0.73

0.82

ug/l

1.62

593

6422

Carcinoma in situ of colon

191

1588

1.28

2.18

3.7

3.2

0.71

0.76

ug/l

0.46

143

1103

Cerebral aneurysm, nonruptured

424

4825

0.86

2.18

2.8

3.0

0.81

0.76

ug/l

0.21

273

3202

Fracture of lumbar spine and pelvis

1571

14665

1.08

2.18

2.9

3.1

0.75

0.80

ug/l

0.84

1109

10036

Fibromyalgia

124

956

1.31

2.17

2.4

2.5

0.80

0.74

ug/l

0.21

519

Hyperosmolality and hypernatraemia

876

0.68

2.17

2.4

3.1

0.78

0.80

ug/l

0.05

604

Lichen ruber planus, wide definition including periferal and oral lichen planus

1234

11429

1.09

2.17

3.0

0.74

0.75

ug/l

0.04

782

7550

Recurrent aphthous stomatitis , including avohilmo

737

6667

1.12

2.17

3.0

0.64

0.77

ug/l

3.96

482

4416

Diarrhoea and gastroenteritis of presumed infectious origin

8307

56391

0.97

2.17

2.7

2.9

0.71

0.77

ug/l

4.64

4973

36389

Left ventricular outflow tract obstruction (LVOTO), broad definition

823

8987

0.90

2.17

2.5

2.7

0.69

0.70

ug/l

0.10

522

5411

Cholangitis (primary sclerosing, PSC), with reimbursement 202

813

0.67

2.16

2.7

2.6

0.74

0.69

ug/l

0.11

456

Acute laryngitis and tracheitis

478

4140

1.15

2.16

2.3

0.71

0.66

ug/l

0.18

218

2082

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1137

12291

0.91

2.15

2.8

2.7

0.70

0.71

ug/l

0.14

715

7442

Crohn's disease NAS

296

3454

0.84

2.15

2.7

2.8

0.65

0.71

ug/l

1.30

191

2085

IBD patients in KELA-register

1461

15652

0.92

2.15

2.7

0.68

0.72

ug/l

1.10

910

9410

Reactive arthropathies

620

5574

1.13

2.15

2.9

2.8

0.71

0.79

ug/l

0.75

403

3504

Manic episode

131

1651

0.77

2.15

2.1

2.7

0.68

0.74

ug/l

0.17

947

Late syphilis

1210

0.73

2.14

2.5

2.9

0.68

0.73

ug/l

0.26

770

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

996

10821

0.91

2.14

2.8

2.7

0.70

0.72

ug/l

0.14

636

6505

Other sexually transmitted chlamydial diseases

201

1650

1.23

2.13

2.3

2.0

0.63

0.59

ug/l

0.11

111

699

Pleural effusion

1431

15281

0.92

2.13

3.2

3.3

0.74

0.83

ug/l

2.27

1063

10919

Exposure to uncontrolled fire in building or structure

584

0.61

2.13

2.2

2.8

0.63

0.71

ug/l

0.33

345

Other congenital malformations of urinary system

210

1.75

2.13

3.3

2.6

0.87

0.74

ug/l

0.12

120

Other dialysis

210

2494

0.81

2.12

2.5

2.9

0.97

0.73

ug/l

3.99

175

1577

Autoimmune diseases excluding thyroid diseases

9595

53805

0.97

2.12

2.8

2.9

0.74

0.77

ug/l

1.76

6336

34111

Bacterial intestinal infections, IBD co-morbidities

1178

12704

0.92

2.12

2.9

3.1

0.86

0.79

ug/l

0.48

807

8619

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

193

1589

1.25

2.11

2.6

2.7

0.63

0.72

ug/l

0.69

112

906

Malignant neoplasm of testis, including Hilmo

199

1666

1.27

2.11

2.6

2.3

0.68

0.70

ug/l

0.16

125

942

Bell's palsy

854

7813

1.11

2.10

2.9

0.82

0.76

ug/l

0.43

562

5099

Other disorders of adrenal gland

161

1983

0.79

2.10

3.1

3.0

0.92

0.76

ug/l

0.37

118

1273

Contact with sharp object, undetermined intent

202

1685

1.25

2.10

2.8

2.7

0.61

0.72

ug/l

1.02

127

967

Dronedarone medication

281

2422

1.22

2.10

3.5

3.2

0.70

0.80

ug/l

1.11

206

1714

Hereditary corneal dystrophies

179

1466

1.26

2.09

3.0

3.1

0.75

0.78

ug/l

0.16

138

995

Other diseases of arteries and capillaries

564

6280

0.88

2.09

3.0

3.1

0.88

0.81

ug/l

0.29

378

4364

Cholecystectomy

4910

43946

0.96

2.09

3.1

0.77

0.79

ug/l

0.78

3372

30092

Aortic valve malfunction, age under 60 years

790

8622

0.89

2.09

2.5

2.7

0.66

0.70

ug/l

0.78

503

5180

Hyperkinetic disorders

263

2169

1.20

2.08

1.8

0.43

0.54

ug/l

3.95

147

851

Short Achilles tendon (acquired)

893

0.70

2.07

2.3

2.8

0.75

ug/l

0.05

554

Ulcerative colitis (strict definition, require KELA)

1041

11272

0.91

2.07

2.8

2.7

0.70

0.72

ug/l

0.25

662

6799

Benign neoplasm: Skin of ear and external auricular canal

309

2672

1.20

2.07

3.4

3.2

0.73

0.80

ug/l

0.76

213

1855

Alzheimer’s disease (Atypical or mixed)

615

6763

0.89

2.07

2.8

3.5

0.96

0.90

ug/l

0.30

438

5024

Vestibular neuronitis

647

5851

1.13

2.07

3.0

0.77

0.75

ug/l

0.18

440

3900

Communicating hydrocephalus

1234

0.74

2.06

2.4

3.1

0.62

0.77

ug/l

1.28

817

Sudden idiopathic hearing loss

802

7336

1.12

2.06

3.2

3.0

0.83

0.78

ug/l

0.31

544

5016

Other viral hepatitis

318

3672

0.85

2.05

2.2

2.4

0.52

0.65

ug/l

3.36

214

1927

Idiopathic pulmonary fibrosis

642

7064

0.88

2.05

3.0

3.3

0.69

0.84

ug/l

3.41

465

5157

Disturbances of smell and taste

229

1924

1.22

2.05

3.0

2.9

0.72

0.75

ug/l

0.09

142

1268

Benign neoplasm: Kidney

225

1894

1.23

2.04

3.1

3.3

1.00

0.79

ug/l

0.72

156

1308

Other symptoms and signs involving cognitive functions and awareness

4191

36693

1.05

2.04

3.1

0.72

0.80

ug/l

5.26

2982

25129

Benign neoplasm: Liver/bile ducts

125

985

1.31

2.03

3.0

2.9

0.80

0.71

ug/l

0.45

648

Colorectal cancer

2113

19576

1.07

2.02

3.1

2.8

0.82

0.72

ug/l

2.44

1480

13488

Cerebrovascular diseases (FINNGEN)

2757

18568

1.06

2.02

2.6

2.7

0.74

0.73

ug/l

0.16

1819

10792

Cytomegalovirus infection, IBD co-morbidity

113

1429

0.76

2.02

2.8

2.9

0.86

0.72

ug/l

0.78

902

Other arthrosis

5203

34781

1.04

2.02

3.0

2.9

0.68

0.80

ug/l

10.54

3482

22400

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

188

1554

1.24

2.02

2.8

2.9

0.65

0.72

ug/l

0.80

124

981

Unspecified kidney failure

983

9093

1.10

2.02

2.9

3.2

0.92

0.81

ug/l

1.27

741

6413

L02BG Aromatase inhibitors

391

1.46

2.01

2.5

2.1

0.61

0.68

ug/l

0.28

164

Benign neoplasm of meninges

430

3789

1.15

2.01

3.5

3.2

0.89

0.77

ug/l

0.72

312

2630

Organ-limited amyloidosis

358

1.60

2.00

2.5

3.2

0.67

0.83

ug/l

0.77

251

Assault by bodily force

390

4435

0.86

2.00

2.3

2.4

0.64

0.66

ug/l

0.11

232

2282

Aphakia

132

1057

1.31

1.99

3.0

0.82

0.81

ug/l

0.04

713

Late syphilis

1058

0.72

1.98

2.6

2.8

0.68

0.73

ug/l

0.26

666

Acute myeloid leukaemia and myelodysplastic syndromes

101

1292

0.75

1.98

2.8

0.79

0.78

ug/l

0.05

894

Care involving dialysis

680

7447

0.89

1.98

2.4

3.0

1.05

0.75

ug/l

7.85

554

4935

Noise effects on inner ear

449

4990

0.86

1.97

2.9

0.70

0.74

ug/l

0.53

271

3223

Otitis media, unspecified

316

3368

0.86

1.97

3.0

2.8

0.76

0.71

ug/l

0.12

191

2048

Normal-pressure hydrocephalus

300

3451

0.84

1.97

2.8

3.4

0.69

0.81

ug/l

1.94

212

2515

Embolic stroke

363

4112

0.86

1.97

3.0

3.3

0.85

0.83

ug/l

0.09

242

2964

Intestinal infectious diseases

7529

58793

0.97

1.96

2.7

2.9

0.74

0.77

ug/l

0.96

4603

37657

Fungal Sepsis

255

2967

0.83

1.95

3.0

3.2

0.78

0.77

ug/l

0.02

205

2022

Other and unspecified medical devices associated with adverse incidents

342

1.59

1.95

3.0

3.1

0.62

0.80

ug/l

1.25

238

Benign neoplasm: salivary glands, exclude unknown (D119)

680

6191

1.12

1.95

3.0

3.1

0.72

0.76

ug/l

1.03

463

4189

Iron deficiency anaemia

2778

28684

0.95

1.94

3.1

3.2

0.90

0.80

ug/l

2.01

2005

19981

Other diseases of blood and blood-forming organs

536

4824

1.14

1.94

3.0

0.67

0.74

ug/l

1.96

357

3177

Neuromuscular dysfunction of bladder

745

6815

1.12

1.93

3.1

0.59

0.79

ug/l

9.13

556

4639

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

570

5155

1.14

1.93

3.0

0.75

0.73

ug/l

0.19

394

3373

Exposure to other specified electric current

1149

0.74

1.93

2.7

2.4

0.69

0.68

ug/l

0.04

619

Fall on and from ladder

921

8551

1.11

1.92

3.2

3.0

0.77

0.76

ug/l

0.08

607

5755

Sequelae of injuries of head

367

4156

0.86

1.92

2.8

0.62

0.72

ug/l

1.96

256

2565

Diplopia

970

8968

1.10

1.92

2.9

3.0

0.75

0.78

ug/l

0.26

670

6030

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

582

0.64

1.92

3.1

2.7

0.65

0.69

ug/l

0.15

330

Thyrotoxicosis with diffuse goitre

405

3559

1.15

1.92

2.8

2.9

0.74

0.73

ug/l

0.04

257

2280

Vascular dementia (other)

417

1.51

1.91

3.8

3.1

0.70

0.92

ug/l

1.45

288

Use of tolcapone

0.00

1.91

0.0

3.3

—

0.75

—

Open wound of forearm

749

6853

1.11

1.91

3.0

2.8

0.76

0.74

ug/l

0.07

502

4304

Urticaria and erythema

1774

16705

1.07

1.91

2.9

2.8

0.75

0.74

ug/l

0.11

1144

10583

Rare circulating lymphoid malignancy

379

0.56

1.91

3.6

2.7

0.68

0.84

ug/l

0.92

266

Other bursopathies

1033

9580

1.09

1.90

3.2

2.9

0.67

0.79

ug/l

6.31

714

6303

Acne

295

2532

1.17

1.90

2.5

2.3

0.56

0.64

ug/l

1.25

154

1289

Hyperkinetic disorders, excluding more controls

263

2142

1.18

1.88

1.8

0.43

0.60

ug/l

7.27

147

760

Diseases of tongue

319

2772

1.17

1.88

3.2

2.9

0.70

0.79

ug/l

0.70

228

1759

Injuries to the neck

1585

14908

1.07

1.88

2.8

0.70

0.74

ug/l

0.51

1011

9333

Other inflammatory liver diseases

353

4011

0.86

1.87

2.8

3.0

0.58

0.73

ug/l

5.78

234

2607

Sleep disorders, other/unspecified

139

1119

1.27

1.86

2.4

2.6

0.49

0.71

ug/l

6.38

629

Cytomegaloviral disease

118

1469

0.77

1.86

2.8

2.9

0.84

0.72

ug/l

0.69

915

Other abnormalities of plasma proteins

123

989

1.31

1.86

3.6

3.0

0.81

0.72

ug/l

0.60

657

Other disorders of cornea

596

5394

1.12

1.86

3.0

2.9

0.69

0.75

ug/l

0.98

414

3411

Disorder of lipoprotein metabolism, unspecified

1346

12640

1.08

1.85

3.0

3.2

0.74

0.78

ug/l

0.84

989

8864

Presbyopia

417

3703

1.15

1.85

2.8

0.65

0.72

ug/l

1.09

236

2236

Family history of malignant neoplasm

307

2655

1.17

1.84

3.0

2.8

0.77

0.70

ug/l

0.53

194

1635

Ductal carcinoma of pancreas

541

0.63

1.84

2.3

2.7

0.79

0.71

ug/l

0.18

364

Disturbance of activity and attention

238

1973

1.19

1.84

1.8

0.44

0.53

ug/l

2.84

125

754

Other coagulation defects

394

3482

1.15

1.83

2.9

3.0

0.72

0.76

ug/l

0.42

263

2271

Portal vein thrombosis

1204

0.75

1.83

2.8

3.0

0.60

0.73

ug/l

1.73

773

Carcinoma in situ of skin, other sites/unspecified

117

940

1.32

1.83

3.7

3.2

0.73

0.82

ug/l

0.79

658

Peritonsillar abscess

1494

14039

1.07

1.83

2.7

2.6

0.72

ug/l

0.11

896

8318

Other mental disorders due to brain damage and dysfunction and to physical disease

807

8758

0.91

1.82

3.1

3.2

0.69

0.83

ug/l

4.86

589

6173

Vasomotor rhinitis (mode)

412

3656

1.15

1.82

3.6

3.0

0.72

0.75

ug/l

0.19

271

2379

Abnormal findings on diagnostic imaging of other body structures

801

7355

1.10

1.82

3.3

3.1

0.80

0.77

ug/l

0.31

595

5026

Vitamin B12 deficiency anaemia

663

7264

0.90

1.82

3.1

3.2

0.82

0.83

ug/l

0.07

469

5198

Evidence of alcohol involvement determined by level of intoxication

583

0.65

1.81

2.4

2.6

0.67

0.71

ug/l

0.09

341

Moderate visual impairment, binocular

168

1391

1.24

1.81

3.2

0.88

0.83

ug/l

0.16

130

960

Transient acantholytic dermatosis [Grover]

181

1.94

1.80

3.1

3.2

0.64

0.76

ug/l

0.58

125

Other or unspecified ileus, impaction or obstruction

1483

15739

0.93

1.80

2.9

3.1

0.79

0.82

ug/l

0.37

1028

10805

Anaemia in chronic diseases classified elsewhere

162

1935

0.80

1.80

2.8

3.2

1.14

0.78

ug/l

2.00

134

1312

Gluteal tendinitis

141

1142

1.26

1.79

3.7

3.0

0.68

0.78

ug/l

1.11

763

Autoimmune diseases excluding thyroid diseases, strict definition

9460

53096

0.97

1.78

2.8

2.9

0.74

0.77

ug/l

1.78

6243

33598

Right hemicolectomy

365

4115

0.87

1.78

3.0

3.2

0.75

0.80

ug/l

0.59

251

2862

Separation of retinal layers (serosa)

407

3641

1.16

1.77

2.8

2.7

0.71

0.70

ug/l

0.08

277

2229

Pleural plaque without asbestos

395

3538

1.16

1.77

3.6

3.4

0.87

0.81

ug/l

0.36

284

2583

Impingement syndrome of shoulder

2175

20712

1.06

1.76

3.1

2.9

0.69

0.77

ug/l

2.30

1474

13635

Benign neoplasm: Cerebral meninges

380

3356

1.15

1.76

3.4

3.2

0.86

0.76

ug/l

0.60

278

2325

Multiple myeloma and malignant plasma cell neoplasms

321

3638

0.86

1.76

2.9

3.3

0.98

0.78

ug/l

1.42

233

2553

Myeloid leukaemia

150

1807

0.80

1.76

2.8

3.1

0.71

0.78

ug/l

0.63

1215

Other surgical follow-up care

198

1671

1.22

1.75

3.0

2.9

0.61

0.74

ug/l

2.70

138

1049

Other and/or unspecified nontoxic goitre

241

2057

1.18

1.75

3.3

3.2

0.85

0.78

ug/l

0.21

176

1414

Congenital malformations of trachea and bronchus

377

0.58

1.74

2.7

3.0

0.76

0.72

ug/l

0.04

246

Other and unspecified hydrocephalus

948

0.73

1.74

2.2

2.9

0.73

0.80

ug/l

0.26

621

Melanoma in situ of lower limb, including hip

221

1.63

1.74

3.4

2.8

0.75

0.73

ug/l

0.08

154

Acute renal failure

2049

21513

0.94

1.74

2.7

3.2

0.93

0.78

ug/l

3.44

1527

14912

Non-Hodgkin lymphoma, all, including Hilmo

1150

10760

1.09

1.74

2.9

2.7

0.75

0.71

ug/l

0.81

790

7376

Disorders of synovium and tendon

3843

34943

0.96

1.74

2.9

2.8

0.67

0.78

ug/l

11.19

2399

22146

Hypokalaemia

650

7119

0.90

1.74

3.0

3.1

0.79

0.77

ug/l

0.09

463

4842

Other and unspecified mental retardation

474

0.63

1.74

2.6

2.5

0.67

0.69

ug/l

0.04

254

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

396

0.58

1.74

3.4

2.9

0.80

0.69

ug/l

0.27

242

Other and unspecified injuries of head

464

4164

1.14

1.74

2.8

2.9

0.77

ug/l

0.01

322

2643

Pseudomembranous colitis

327

0.55

1.73

2.4

2.8

0.81

0.84

ug/l

—

196

Rosacea

545

4923

1.12

1.73

3.1

3.0

0.75

0.76

ug/l

0.08

358

3272

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4955

47328

1.04

1.73

3.1

0.74

0.78

ug/l

1.72

3388

32073

Mental and behavioural disorders due to opioids

141

1718

0.80

1.72

2.1

2.2

0.44

0.65

ug/l

4.54

795

Peripheral retinal degeneration

194

1640

1.22

1.72

3.1

2.9

0.73

0.77

ug/l

0.28

129

1058

Sacrococcygeal disorders, not elsewhere classified

111

880

1.29

1.71

3.4

2.7

0.53

0.76

ug/l

3.90

534

Rheumatic valve diseases

112

1389

0.78

1.70

2.8

3.2

0.81

0.83

ug/l

0.11

955

Vascular disorders of the intestines

468

5186

0.88

1.70

3.0

3.2

0.87

0.84

ug/l

0.14

336

3663

Behavioural syndromes associated with physiological disturbances and physical factors

6365

46461

0.97

1.70

2.8

0.66

0.74

ug/l

5.93

3877

28500

Pediculosis, acariasis and other infestations

947

8781

1.09

1.70

2.7

2.6

0.65

0.70

ug/l

1.32

564

5169

Lichen simplex chronicus

179

2119

0.82

1.70

2.6

3.0

0.65

0.76

ug/l

1.08

109

1363

Scleritis and episcleritis

293

2553

1.17

1.70

2.7

2.8

0.65

0.71

ug/l

0.90

197

1539

Amputation of ankle

123

0.34

1.70

2.0

3.2

0.37

0.77

ug/l

—

Helminthiases

156

1287

1.24

1.70

2.8

0.65

0.76

ug/l

1.23

775

Circumscribed brain atrophy

121

1481

0.78

1.70

2.4

3.2

1.00

0.81

ug/l

0.40

1025

Patellar tendinitis

123

997

1.28

1.70

2.3

0.57

0.71

ug/l

1.32

522

Effects of air pressure and water pressure

326

1.54

1.69

2.4

2.5

0.60

0.73

ug/l

0.42

180

Other symptoms and signs involving the digestive system and abdomen

601

5453

1.11

1.69

3.5

3.1

0.73

0.78

ug/l

0.61

423

3690

Benign neoplasm: Liver

104

822

1.30

1.69

3.2

2.8

0.84

0.72

ug/l

0.55

533

Melanoma in situ of scalp and neck

233

1.76

1.69

4.2

3.3

0.69

0.80

ug/l

0.45

166

Other and unspecified vascular occlusions

751

6922

1.11

1.69

3.3

3.2

0.79

0.83

ug/l

0.50

550

4952

Alcohol abuse counselling and surveillance

161

1352

1.26

1.69

2.8

2.6

0.77

0.69

ug/l

0.52

785

Benign neoplasm of male genital organs

295

2624

1.20

1.69

3.6

3.1

0.67

0.77

ug/l

1.78

213

1754

Hyperhidrosis

113

900

1.28

1.68

3.2

2.8

0.58

0.75

ug/l

2.60

538

Acute pancreatitis

1775

18686

0.94

1.67

2.8

3.0

0.70

0.77

ug/l

2.24

1201

12302

Spasmodic torticollis

125

1010

1.26

1.67

2.6

2.9

0.83

0.75

ug/l

0.17

644

Other and unspecified acquired haemolytic anaemias

604

0.67

1.67

2.2

2.9

0.51

0.80

ug/l

3.10

399

Other bacterial intestinal infections

1202

12820

0.93

1.67

2.9

3.1

0.84

0.80

ug/l

0.37

813

8685

Acute posthaemorrhagic anaemia

191

2245

0.83

1.67

2.8

3.2

0.86

0.79

ug/l

0.26

148

1570

Other and unspecified myopathies

638

6954

0.90

1.66

2.7

3.1

0.70

0.79

ug/l

1.99

441

4715

Somatoform disorder

792

7294

1.10

1.66

3.0

2.8

0.60

0.74

ug/l

8.14

533

4494

Cholangitis (primary sclerosing, PSC)

384

4299

0.87

1.66

2.7

3.1

0.78

ug/l

0.01

245

2870

Ulcer of lower limb, not elsewhere classified

1223

13002

0.93

1.66

2.8

3.1

0.75

0.79

ug/l

0.39

846

9043

Anaemias

1346

8236

1.07

1.66

2.5

2.2

0.72

0.68

ug/l

0.44

884

3785

therapeutic use

216

1854

1.20

1.65

3.8

3.2

0.73

0.76

ug/l

0.24

168

1299

Reactive arthropathies, FINNGEN

477

4302

1.13

1.65

2.8

0.72

0.76

ug/l

0.22

315

2649

Arthropathies in other diseases classified elsewhere

197

2307

0.83

1.65

2.7

2.8

0.61

0.79

ug/l

3.22

131

1467

Abnormal findings in nipple discharge synovial fluid wound secretions

633

1.35

1.65

3.2

2.7

0.77

0.72

ug/l

0.20

389

Implicit viral Sepsis

2440

23327

1.05

1.64

3.0

3.2

0.75

0.79

ug/l

0.73

1751

15974

Synovial cyst of popliteal space [Baker]

443

3978

1.13

1.64

3.1

3.0

0.67

0.79

ug/l

3.53

320

2663

Biomechanical lesions, not elsewhere classified

321

2832

1.16

1.64

3.2

3.0

0.77

0.76

ug/l

0.04

239

1861

Myelodysplastic syndrome

728

0.70

1.64

2.8

0.75

0.81

ug/l

0.26

504

Other viral diseases

1793

16944

1.06

1.63

2.5

2.6

0.68

0.72

ug/l

0.77

1044

9810

Superficial frostbite

483

0.64

1.63

1.9

2.8

0.66

0.79

ug/l

0.45

281

Occupant of special vehicle mainly used on industrial premises injured in transport accident

517

0.64

1.62

3.0

2.9

0.80

0.74

ug/l

0.22

328

Stomatitis and related lesions

1091

10189

1.08

1.62

2.8

2.9

0.64

0.75

ug/l

2.67

697

6520

Colon adenocarcinoma

975

9095

1.09

1.62

3.2

2.8

0.87

0.73

ug/l

1.96

689

6390

Dentofacial anomalies [including malocclusion]

3418

28536

0.96

1.62

2.9

2.6

0.64

0.70

ug/l

4.54

2018

16714

Assault

799

8640

0.91

1.62

2.3

2.4

0.57

0.66

ug/l

1.47

496

4445

Erythema multiforme

1073

0.76

1.62

3.2

3.0

0.81

0.79

ug/l

0.04

694

Follow-up examination after treatment for malignant neoplasms

736

6783

1.10

1.61

3.3

3.2

0.86

0.84

ug/l

0.09

534

4850

Other epidermal thickening

233

2689

0.85

1.61

3.1

0.68

0.77

ug/l

1.48

169

1792

Personal history of malignant neoplasm

114

911

1.26

1.61

2.9

0.75

0.74

ug/l

0.04

600

Other and unspecified diseases of blood and blood-forming organs

184

1563

1.22

1.60

2.9

3.0

0.62

0.75

ug/l

1.74

132

1042

Malignant neoplasm of digestive organs

3336

27330

0.96

1.60

2.9

2.7

0.80

0.70

ug/l

4.51

2310

18393

Respiratory tuberculosis, clinically confirmed

950

0.74

1.60

2.7

3.1

0.89

ug/l

0.00

645

Respiratory tuberculosis, confirmed

108

1328

0.78

1.59

3.3

3.1

0.76

0.81

ug/l

0.38

913

Unspecified acute lower respiratory infection

1225

13015

0.93

1.59

2.5

2.8

0.68

0.74

ug/l

0.67

739

7908

Simple and mucopurulent chronic bronchitis

263

3002

0.85

1.58

3.1

3.2

0.76

0.85

ug/l

0.61

186

2071

Benign neoplasm: Prostate

108

899

1.36

1.58

4.5

3.2

0.72

0.82

ug/l

0.73

646

Implicit fungal Sepsis

231

2657

0.84

1.58

3.0

3.2

0.77

0.76

ug/l

0.01

184

1814

356

1.43

1.58

2.3

2.7

0.79

0.68

ug/l

0.22

213

Fracture of lower leg, including ankle

3807

39027

0.96

1.57

2.8

0.72

0.75

ug/l

0.60

2489

24372

Somnolence

602

0.69

1.57

2.7

2.9

0.58

0.78

ug/l

1.40

362

Missing teeth due to accident, extraction or parodontitis

5298

48462

1.04

1.56

3.2

3.0

0.71

0.77

ug/l

5.22

3709

32843

Benign neoplasm: Pancreas

198

1699

1.21

1.56

3.4

3.3

0.76

0.75

ug/l

0.03

134

1192

Sequelae of injuries of neck and trunk

180

2108

0.83

1.56

2.6

2.8

0.61

0.71

ug/l

1.31

126

1305

Benign neoplasm: Rectosigmoid junction

333

2966

1.16

1.56

3.6

3.2

0.93

0.76

ug/l

0.63

255

2064

Acquired haemolytic anaemia

122

1481

0.80

1.56

2.9

3.1

0.90

0.78

ug/l

0.44

997

IBD (strict) with PSC

472

0.65

1.56

2.4

2.5

0.84

0.71

ug/l

0.17

242

Pustular psoriasis

161

1916

0.82

1.56

3.0

2.9

0.62

0.73

ug/l

1.97

103

1225

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

381

1.45

1.55

3.3

3.0

0.62

0.73

ug/l

0.78

252

Personal history of other diseases and conditions

254

2188

1.16

1.55

3.1

2.7

0.71

ug/l

0.00

178

1331

Pneumocystosis

114

1384

0.79

1.54

2.2

3.1

0.73

0.75

ug/l

0.09

952

Adalimumab

406

4525

0.89

1.54

2.3

2.5

0.63

0.67

ug/l

0.60

230

2511

Other and unspecified psoriasis

437

4831

0.89

1.54

2.9

3.0

0.65

0.77

ug/l

2.51

301

3190

Parkinson's disease

1322

13981

0.93

1.54

3.1

3.3

0.75

0.82

ug/l

2.00

954

10140

Diseases of arteries, arterioles and capillaries

7050

50774

1.03

1.53

3.0

3.1

0.78

ug/l

0.03

4955

34433

All influenza

2091

21878

0.95

1.52

2.7

3.0

0.74

0.76

ug/l

0.45

1352

14168

Other and unspecified degenerative diseases of nervous system

166

1948

0.82

1.52

3.4

3.3

0.67

0.81

ug/l

1.54

125

1397

Alzheimer’s disease (Late onset)

1651

14627

0.94

1.52

3.0

3.5

0.88

0.89

ug/l

0.15

1205

10876

Lesion of sciatic nerve

252

2877

0.86

1.52

2.8

3.3

0.78

0.84

ug/l

0.37

191

2061

Urethritis and urethral syndrome

117

953

1.26

1.52

3.3

2.7

0.63

0.70

ug/l

0.51

574

Injury of eye and orbit

1251

11793

1.07

1.52

2.6

2.7

0.68

0.73

ug/l

0.82

723

6930

Adhesive capsulitis of shoulder

1192

11209

1.07

1.52

3.0

0.70

0.79

ug/l

2.31

833

7419

Respiratory tuberculosis, bacteriologically and histologically confirmed

114

1386

0.79

1.52

3.2

3.1

0.75

0.82

ug/l

0.50

951

Disorders of eyelid, lacrimal system and orbit

7094

52493

1.03

1.52

3.2

3.0

0.75

0.78

ug/l

1.47

5007

34980

443

0.64

1.51

2.2

3.0

0.84

0.81

ug/l

0.09

300

Malignant neoplasm of urinary organs

925

8652

1.09

1.51

3.2

2.7

0.85

0.72

ug/l

4.08

693

5949

Intentional self-harm by sharp object

910

0.75

1.51

2.1

2.5

0.45

0.71

ug/l

4.33

468

Osteoporosis

902

9062

0.92

1.50

3.1

0.71

0.81

ug/l

2.20

642

6281

Sciatica+with lumbago

3836

36504

0.96

1.50

2.7

2.8

0.65

0.77

ug/l

10.46

2569

23139

Other injuries of lower limb, level unspecified

532

1.37

1.50

2.3

2.9

0.75

ug/l

0.02

337

L01XX Other antineoplastic agents

365

4063

0.88

1.49

2.9

3.2

0.76

0.78

ug/l

0.10

254

2856

Crohn's disease of large intestine

232

2667

0.85

1.49

2.6

2.7

0.64

0.70

ug/l

0.82

151

1568

Other and unspecified polyneuropathies, also in other diseases

1973

18865

1.06

1.49

3.2

3.1

0.68

0.79

ug/l

4.16

1475

13033

L04AA Selective immunosuppressants

1248

13247

0.93

1.49

2.5

2.8

0.72

ug/l

0.03

900

8264

Assault by unspecified means

1158

0.78

1.49

2.5

2.3

0.57

0.65

ug/l

0.68

571

Other fall from one level to another

1734

18206

0.94

1.48

2.8

2.9

0.72

0.74

ug/l

0.54

1127

11737

Dislocation, sprain and strain of joints and ligaments of thorax

233

2029

1.18

1.48

3.2

2.9

0.66

0.75

ug/l

1.19

157

1260

Superficial injury of shoulder and upper arm

774

7178

1.09

1.48

3.2

2.9

0.71

0.76

ug/l

0.62

501

4583

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

411

4556

0.89

1.48

3.2

3.1

0.71

0.74

ug/l

0.37

297

3199

Right bundle-branch block

358

3218

1.15

1.48

3.2

0.77

0.82

ug/l

0.44

250

2238

Other Crohn's disease

317

3569

0.88

1.47

2.4

2.7

0.64

0.68

ug/l

0.67

209

2089

Psoriasis (vulgaris), strict definition

215

2469

0.85

1.47

2.2

2.8

0.54

0.71

ug/l

5.86

126

1465

Tick-borne viral encephalitis

268

1.55

1.47

3.2

2.9

0.48

0.69

ug/l

2.32

176

Malignant neoplasm of endocrine gland

296

2610

1.15

1.47

3.1

2.6

0.76

0.70

ug/l

0.78

207

1647

Obstructive hydrocephalus

820

0.74

1.46

2.9

0.64

0.78

ug/l

1.08

522

Superficial injury of head

1587

15053

1.06

1.46

2.8

2.9

0.75

0.78

ug/l

0.39

1059

9548

Otalgia

306

2703

1.15

1.46

3.3

2.9

0.57

0.77

ug/l

7.37

209

1733

Hyperprolactinaemia

100

800

1.27

1.46

2.9

2.6

0.62

0.69

ug/l

0.58

472

Other zoonotic bacterial diseases, not elsewhere classified

159

1.68

1.46

2.1

3.0

0.50

0.71

ug/l

1.10

111

Osteonecrosis

441

3999

1.13

1.46

3.3

3.0

0.99

0.73

ug/l

1.68

324

2648

Synovial hypertrophy, not elsewhere classified

476

0.66

1.45

2.7

0.51

0.70

ug/l

1.67

279

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

460

0.66

1.44

2.8

2.9

1.66

0.72

ug/l

0.41

295

Hyperkalaemia

431

4742

0.89

1.44

2.8

3.2

0.88

0.83

ug/l

0.39

324

3345

Dyshidrosis [pompholyx]

606

0.71

1.44

3.2

2.8

0.86

0.71

ug/l

0.63

370

Other functional intestinal disorders

3291

29444

1.04

1.44

3.1

0.76

0.81

ug/l

1.40

2359

19945

L02BA Anti-estrogens

472

1.34

1.44

3.7

2.8

1.32

0.75

ug/l

0.47

280

Mixed conductive and sensorineural hearing loss

909

8498

1.08

1.44

3.2

3.1

0.74

0.80

ug/l

0.87

642

5973

Respiratory conditions due to other external agents

1096

0.78

1.43

3.0

3.1

0.87

0.79

ug/l

0.30

742

Myelodysplastic syndrome, including Hilmo

185

2143

0.84

1.43

3.3

2.7

0.75

0.76

ug/l

0.04

119

1518

severe traumatic brain injury, does not include concussion

2124

22156

0.95

1.43

3.1

0.78

0.80

ug/l

0.37

1508

15161

Clear cell adenocarcinoma of kidney

432

3933

1.13

1.43

3.2

2.7

0.89

0.71

ug/l

3.58

325

2630

Drug-induced hypoglycaemia without coma

1124

0.78

1.43

2.8

2.9

0.65

0.78

ug/l

1.02

715

Inflammation of lacrimal passages (chronic)

575

1.33

1.43

2.9

0.78

0.82

ug/l

0.15

375

Erythema intertrigo

114

1380

0.80

1.43

2.7

3.1

0.59

0.77

ug/l

1.71

909

Other congenital malformations of circulatory system

170

1451

1.21

1.42

3.0

2.9

0.66

0.75

ug/l

0.85

117

927

Other neurotic disorders

281

3167

0.87

1.41

2.8

2.9

0.71

0.75

ug/l

0.39

192

2030

Lichen planus, including avohilmo

1070

10051

1.07

1.40

2.9

3.0

0.77

0.75

ug/l

0.09

668

6662

Pain in joint

5160

33852

0.97

1.40

2.9

2.8

0.65

0.79

ug/l

11.68

3288

21161

Viral hepatitis

402

4446

0.89

1.40

2.4

2.5

0.54

0.67

ug/l

4.05

271

2450

Dislocation, sprain and strain of joints and ligaments at neck level

789

7329

1.09

1.40

2.9

2.7

0.72

0.71

ug/l

0.09

480

4352

Invasive ventilation

529

5759

0.90

1.40

2.6

3.1

0.73

0.76

ug/l

0.17

354

3847

STROKE

5188

34279

1.03

1.40

2.9

0.74

0.75

ug/l

0.22

3510

21381

Diseases of the myoneural junction and muscle

868

9280

0.92

1.40

2.7

3.0

0.68

0.79

ug/l

3.16

600

6248

Speech disturbances, not elsewhere classified

571

6204

0.91

1.40

3.4

3.1

0.78

0.80

ug/l

0.22

420

4277

Triptan medication for migraine, min. 3 purchases

1525

12288

0.94

1.40

2.5

2.4

0.64

0.67

ug/l

0.62

820

6689

Tick-borne viral encephalitis

296

1.50

1.40

3.1

2.9

0.45

0.73

ug/l

3.34

188

Dislocation of lens

116

960

1.26

1.39

3.3

3.2

0.61

0.79

ug/l

2.90

667

Conductive hearing loss, unspecified

517

4729

1.11

1.39

2.9

0.66

0.77

ug/l

2.48

319

3114

Visual impairment including blindness (binocular or monocular)

409

3698

1.12

1.39

3.3

3.1

0.78

0.79

ug/l

0.09

292

2531

Ulcerative ileocolitis

208

2390

0.85

1.38

2.8

2.7

0.65

0.72

ug/l

0.52

132

1396

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

160

0.46

1.38

5.0

2.5

0.94

0.85

ug/l

—

111

Foreign body in genitourinary tract

343

0.62

1.38

3.4

3.0

0.90

0.79

ug/l

0.26

228

Moderate mental retardation

256

0.56

1.38

1.7

2.5

0.92

0.63

ug/l

—

141

Other vitreous opacities

260

2295

1.16

1.38

3.5

3.2

0.68

0.76

ug/l

1.41

205

1576

Other/unspecified cytomegaloviral diseases

101

1229

0.79

1.38

2.9

2.8

0.85

0.72

ug/l

0.60

760

Congenital malformations and deformations of the musculoskeletal system

364

3241

1.13

1.38

2.9

2.6

0.73

0.69

ug/l

0.26

208

1871

Paget disease

377

1.45

1.38

4.0

3.1

0.72

0.77

ug/l

0.22

268

Injury of nerves at shoulder and upper arm level

707

0.73

1.37

2.3

2.7

0.56

0.73

ug/l

1.53

433

Ménière disease

536

4912

1.11

1.37

3.1

0.80

0.78

ug/l

0.12

354

3358

Nontoxic diffuse goitre

691

1.28

1.37

3.2

3.1

1.01

0.79

ug/l

0.29

450

Malignant neoplasm of thyroid gland, including Hilmo

303

2690

1.14

1.37

3.2

2.6

0.74

0.69

ug/l

0.72

216

1686

Injuries to the ankle and foot

4811

44001

0.97

1.37

2.6

2.7

0.65

0.73

ug/l

6.93

2861

26659

Benign neoplasm: Parotid gland

607

5608

1.10

1.36

3.0

3.1

0.72

0.76

ug/l

0.89

414

3783

Injury of muscle and tendon at forearm level

165

1417

1.21

1.36

2.8

2.6

0.71

0.73

ug/l

0.09

114

816

Other helminthiases

1.90

1.36

2.8

0.55

0.71

ug/l

—

Inflammatory bowel disease

2162

22557

0.95

1.36

2.7

2.8

0.69

0.73

ug/l

1.52

1382

13971

Mental and behavioural disorders due to use of other stimulants, including caffeine

102

1246

0.80

1.35

1.8

1.9

0.32

0.59

ug/l

10.67

494

Other disorders of nervous system

464

5070

0.90

1.34

3.0

0.66

0.75

ug/l

2.04

318

3389

Delayed puberty

2.00

1.34

1.4

1.2

0.30

0.32

ug/l

—

Graves ophthalmopathy, strict

517

1.32

1.34

2.6

2.9

0.70

0.75

ug/l

0.23

322

Parkinson's disease, including avohilmo

1392

14631

0.94

1.34

3.1

3.3

0.75

0.82

ug/l

2.61

1009

10609

Shigellosis

357

1.42

1.32

2.2

2.8

0.89

0.66

ug/l

0.62

214

Other condition

866

9249

0.93

1.32

2.6

2.8

0.69

0.74

ug/l

0.85

533

5684

Carrier of infectious disease

1066

0.79

1.32

2.8

2.9

0.83

0.73

ug/l

0.49

676

DVT of lower extremities

1553

14796

1.06

1.32

3.0

0.83

0.79

ug/l

0.56

1122

9990

Other secondary gout

291

0.58

1.31

2.6

3.3

0.79

0.77

ug/l

0.04

205

Pneumonia derived septicemia

205

2342

0.85

1.31

2.5

3.1

0.69

0.76

ug/l

0.61

134

1554

Kidney transplant status

359

3963

0.89

1.31

2.4

2.8

0.90

0.69

ug/l

4.00

297

2452

Reduction defects of lower limb

108

1.77

1.30

2.7

2.6

0.61

0.78

ug/l

—

Bipolar affective disorders

927

9886

0.93

1.30

2.6

0.57

0.71

ug/l

6.05

643

5664

Autoimmune hyperthyroidism

181

1554

1.18

1.30

2.7

2.9

0.79

0.74

ug/l

0.41

106

973

Other problems related to primary support group, including family circumstances

235

2609

0.87

1.30

2.5

2.6

0.80

0.68

ug/l

0.25

149

1445

Visual field defects

542

5879

0.91

1.30

3.0

3.1

0.78

0.80

ug/l

0.09

378

4033

Cramp and spasm

304

2720

1.14

1.30

3.0

2.9

0.59

0.75

ug/l

4.00

222

1726

Melanocytic naevi of scalp and neck

136

1147

1.22

1.30

2.9

0.69

0.76

ug/l

0.48

733

Use of entacapone

575

0.71

1.30

2.9

3.1

0.65

0.88

ug/l

1.74

400

Collapsed vertebra, not elsewhere classified

323

1.43

1.30

3.1

3.0

0.78

0.84

ug/l

0.21

229

Causalgia

673

0.74

1.30

2.1

2.6

0.67

0.71

ug/l

0.17

408

Generalized epilepsy, strict definition

821

0.76

1.29

2.0

2.5

0.80

0.72

ug/l

0.21

454

Endocarditis

321

3549

0.88

1.29

3.0

3.1

0.88

0.80

ug/l

0.34

228

2397

Renal failure

4956

42671

1.03

1.29

2.9

3.2

0.96

0.78

ug/l

11.57

3713

29605

Acute nephritic syndrome

139

1627

0.82

1.29

2.5

2.9

0.76

ug/l

0.03

1045

Lower leg

230

1.50

1.28

3.3

2.8

0.57

0.78

ug/l

1.43

141

Chronic lymphocytic leukaemia, helper endpoint

250

2224

1.16

1.28

2.8

2.7

0.78

0.74

ug/l

0.22

182

1555

Chronic lymphocytic leukaemia

250

2224

1.16

1.28

2.8

2.7

0.78

0.74

ug/l

0.22

182

1555

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

250

2224

1.16

1.28

2.8

2.7

0.78

0.74

ug/l

0.22

182

1555

Diffuse large B-cell lymphoma, helper endpoint

360

3263

1.13

1.28

2.7

0.82

0.72

ug/l

0.93

251

2217

Diffuse large B-cell lymphoma

360

3263

1.13

1.28

2.7

0.82

0.72

ug/l

0.93

251

2217

Diffuse large B-cell lymphoma, including Hilmo

360

3263

1.13

1.28

2.7

0.82

0.72

ug/l

0.93

251

2217

Epidural haemorrhage

828

0.75

1.28

2.3

2.7

0.71

0.74

ug/l

0.12

505

Leisure time condition

1204

11396

1.07

1.27

3.0

2.9

0.75

0.76

ug/l

0.21

769

7343

Unspecified nephritic syndrome

138

1616

0.83

1.27

2.8

2.9

0.72

0.74

ug/l

0.16

111

1035

Benign neoplasm: Vertebral column

151

1.69

1.27

4.7

2.8

0.80

0.82

ug/l

0.05

104

Abnormal findings on diagnostic imaging of lung

4626

45537

0.97

1.27

3.1

0.76

0.80

ug/l

0.91

3213

31642

Other infestations

113

943

1.24

1.26

2.9

0.73

0.74

ug/l

0.09

607

Primary_lymphoid and hematopoietic malignant neoplasms

2084

21684

0.95

1.26

2.9

3.2

0.78

0.79

ug/l

0.28

1444

15194

Peroneal tendinitis

595

1.29

1.26

3.0

2.6

0.65

0.73

ug/l

0.49

372

Malignant neoplasm of kidney, except renal pelvis

838

7873

1.08

1.26

3.2

2.7

0.86

0.72

ug/l

4.18

638

5398

Disorders of eyelid in diseases classified elsewhere

157

1343

1.19

1.25

3.2

2.9

0.75

0.79

ug/l

0.29

109

862

Non-allergic asthma (mode), excluding more controls

1227

12822

0.94

1.25

2.7

3.1

0.66

0.80

ug/l

4.28

807

8698

Other demyelinating diseases of the central nervous system

1205

0.81

1.25

2.9

2.5

0.67

0.69

ug/l

0.14

683

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2424

25151

0.96

1.25

2.7

2.9

0.71

0.72

ug/l

0.12

1561

15890

Glucagon-like peptide-1 (GLP-1) analogues

2424

25151

0.96

1.25

2.7

2.9

0.71

0.72

ug/l

0.12

1561

15890

Benign neoplasm of urinary organs

311

2795

1.14

1.25

3.4

3.3

0.93

0.78

ug/l

0.73

224

1978

Diseases of arteries, arterioles and capillaries (FINNGEN)

2566

17120

1.05

1.24

2.6

2.8

0.69

0.73

ug/l

1.38

1727

10322

Disorders of lacrimal system and orbit in diseases classified elsewhere

576

1.29

1.24

2.7

2.8

0.69

0.75

ug/l

0.29

353

Maltreatment syndromes

177

2046

0.85

1.24

2.2

2.3

0.52

0.66

ug/l

3.32

103

1036

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

985

0.78

1.24

3.3

2.7

0.90

0.75

ug/l

0.36

674

Pain and other conditions associated with female genital organs and menstrual cycle

2.70

1.24

1.2

1.1

—

Foreign body in respiratory tract

277

2470

1.14

1.23

2.8

3.0

0.87

0.74

ug/l

0.48

177

1568

Other viral diseases, not elsewhere classified

1122

10576

1.07

1.23

2.6

2.7

0.68

0.72

ug/l

0.96

669

6337

Viral agents as the cause of diseases classified to other chapters

146

1247

1.20

1.23

2.8

0.80

0.75

ug/l

0.18

774

Foreign body on external eye

1557

16268

0.94

1.22

2.6

2.7

0.71

0.70

ug/l

0.15

909

9685

Behavioural disorders, excluding more controls

690

0.75

1.22

1.5

2.1

0.51

0.67

ug/l

1.75

292

Pustulosis palmaris et plantaris

140

1644

0.84

1.22

3.0

2.9

0.62

0.74

ug/l

1.73

1046

Ankylosing spondylitis, ICD10

668

6225

1.09

1.22

2.8

2.7

0.66

0.71

ug/l

0.97

458

3754

Other and unspecified spinal muscular atrophies

612

0.73

1.22

3.0

3.1

0.93

0.78

ug/l

0.90

409

Inflammation of lacrimal passages (acute and unspecified)

553

1.30

1.21

2.6

2.8

0.78

0.75

ug/l

0.11

340

Sequelae of tuberculosis

1051

0.80

1.21

3.4

3.3

0.78

0.89

ug/l

0.65

750

Other congenital malformations of integument

169

1.62

1.21

2.3

2.9

1.59

0.75

ug/l

0.30

113

2763

26447

1.04

1.21

2.7

2.8

0.63

0.75

ug/l

12.61

1719

16175

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

1.21

0.0

2.3

—

0.84

—

Pterygium

274

2463

1.15

1.21

3.6

3.3

0.81

0.80

ug/l

0.06

200

1749

Benign neoplasm: Choroid

389

3544

1.12

1.21

3.6

3.1

0.72

0.76

ug/l

0.55

266

2444

Angina pectoris

5842

39848

0.97

1.21

2.9

3.0

0.73

0.78

ug/l

3.40

3982

26517

Other diseases of blood and blood-forming organs, wide

1453

15236

0.95

1.20

2.9

3.0

0.75

0.76

ug/l

0.30

987

10282

Kyphosis

618

0.74

1.20

3.0

2.8

0.71

0.82

ug/l

0.38

410

Chronic tubulo-interstitial nephritis

113

1350

0.82

1.20

2.7

3.0

0.72

0.76

ug/l

0.25

874

Mechanical strabismus

104

1.78

1.19

1.8

3.2

0.79

0.74

ug/l

0.08

Pneumothorax

623

6675

0.92

1.19

2.9

3.1

0.76

0.81

ug/l

0.57

430

4530

Other specified transport accidents

292

0.62

1.19

2.8

2.6

0.87

0.73

ug/l

—

163

Anisometropia and aniseikonia

162

1398

1.18

1.19

2.9

3.0

0.73

0.78

ug/l

0.44

106

912

Exfoliative dermatitis

928

0.78

1.18

2.9

3.1

0.52

0.80

ug/l

6.32

606

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

474

1.31

1.18

2.7

0.75

0.66

ug/l

0.36

289

Radial styloid tenosynovitis [de Quervain]

169

1457

1.17

1.18

2.8

2.7

0.65

0.73

ug/l

0.46

107

868

Other and unspecified acne

449

1.33

1.18

2.7

2.5

0.56

0.70

ug/l

0.83

245

Other and specified injuries of hip and thigh

155

1338

1.19

1.18

3.3

3.1

0.66

0.80

ug/l

1.30

896

Attention to artificial openings

381

3485

1.12

1.18

3.2

3.1

0.94

0.80

ug/l

0.70

284

2419

Episcleritis

237

2098

1.15

1.18

2.8

2.7

0.62

0.71

ug/l

1.71

159

1240

Drug-induced gout

367

0.65

1.18

3.0

3.2

0.88

ug/l

0.00

250

Cachexia

313

0.63

1.18

3.0

3.2

0.65

0.81

ug/l

0.83

211

Other crystal arthropathies

149

1286

1.20

1.18

3.5

3.0

0.65

0.86

ug/l

3.99

100

873

Iridocyclitis

1598

15278

1.05

1.17

2.9

0.69

0.75

ug/l

2.70

1075

9759

Diphtheria

106

1.81

1.17

3.9

2.7

0.67

0.83

ug/l

—

Benign neoplasm of major salivary glands

738

6914

1.08

1.17

3.0

3.1

0.72

0.77

ug/l

0.83

504

4712

Examination and encounter for administrative purposes

470

4339

1.11

1.17

3.0

3.1

0.74

0.77

ug/l

0.48

311

2887

Undescended testis, unilateral

268

1.43

1.17

2.9

2.6

0.48

0.73

ug/l

2.32

145

Other diseases of spinal cord

175

2001

0.85

1.17

3.1

3.0

0.76

0.74

ug/l

0.12

122

1324

Fibrosis of liver

473

0.70

1.17

2.6

2.9

0.86

0.75

ug/l

0.33

311

Cutaneous abscess, furuncle and carbuncle

1922

20010

0.95

1.16

2.7

2.8

0.65

0.74

ug/l

4.92

1270

12446

Crohn disease

706

7555

0.93

1.16

2.6

2.7

0.62

0.72

ug/l

3.61

450

4542

Ulcerative colitis

1669

17433

0.95

1.16

2.8

0.71

0.73

ug/l

0.56

1084

10814

Enlarged lymph nodes

1216

11553

1.06

1.16

2.8

3.0

0.68

0.76

ug/l

2.68

802

7493

Rickettsioses

147

1.68

1.16

3.1

2.8

0.66

0.69

ug/l

0.10

Lagophthalmos

743

1.26

1.16

3.6

3.1

1.09

0.79

ug/l

1.30

506

Other diseases of gallbladder

250

2228

1.14

1.15

3.1

0.68

0.77

ug/l

1.22

171

1484

Procedures for purposes other than remedying health state

449

1.31

1.15

2.8

0.67

0.72

ug/l

0.26

281

Explicit fungal Sepsis

559

0.72

1.15

3.0

3.1

0.93

0.81

ug/l

0.26

358

Low back pain

6307

44250

1.03

1.15

2.9

0.66

0.79

ug/l

15.22

4148

27930

Diphtheria

1.88

1.15

3.9

2.8

0.65

0.70

ug/l

—

Viral agents as the cause of diseases classified to other chapters

130

1108

1.21

1.15

2.8

2.9

0.79

0.76

ug/l

0.12

694

Etanercept

235

2646

0.88

1.14

2.6

2.7

0.55

0.68

ug/l

4.38

144

1546

Pyoderma

100

1193

0.81

1.14

3.2

3.0

0.64

0.79

ug/l

1.89

772

Cardiomyopathy in other diseases

452

1.37

1.14

3.0

3.3

0.73

0.77

ug/l

0.11

331

Congenital malformations of the urinary system

347

3150

1.12

1.14

3.1

2.9

1.00

0.73

ug/l

1.96

245

2024

Toxic effect of other gases, fumes and vapours

380

0.67

1.14

2.4

2.6

0.55

0.70

ug/l

0.42

221

Corneal degeneration

751

1.25

1.14

3.1

0.69

0.77

ug/l

0.69

491

Conduct disorder

695

0.76

1.14

1.5

2.1

0.55

0.62

ug/l

0.43

307

Nonsuppurative otitis media

877

8072

0.94

1.14

3.0

2.8

0.79

0.72

ug/l

0.54

561

4918

Iridocyclitis in diseases classified elsewhere

127

1083

1.21

1.14

3.2

2.9

0.70

0.77

ug/l

0.47

680

Mandibular retrognathia

233

2057

1.14

1.13

2.7

2.6

0.65

0.69

ug/l

0.30

115

1169

L04AC Interleukin inhibitors

276

3071

0.89

1.13

2.4

2.6

0.69

0.67

ug/l

0.07

153

1730

Mixed hyperlipidaemia

341

3731

0.89

1.13

3.2

3.1

0.96

0.77

ug/l

0.61

238

2515

Fracture at wrist and hand level

2889

27916

1.04

1.12

2.7

0.70

0.72

ug/l

0.51

1769

16697

Retinal vascular occlusion

1010

9575

1.07

1.12

3.2

3.3

0.78

0.81

ug/l

0.51

729

6845

Viral pneumonia (unknown virus, not influenza)

519

4811

1.10

1.12

2.7

2.9

0.72

0.73

ug/l

0.07

371

3029

Left hemicolectomy

141

1627

0.84

1.11

3.1

3.2

0.80

ug/l

0.04

103

1113

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

639

0.75

1.11

2.7

2.6

0.70

0.77

ug/l

0.29

426

Ulcerative colitis (strict definition, all Crohn cases excluded)

907

9604

0.94

1.11

2.8

2.7

0.70

0.72

ug/l

0.34

569

5786

Foreign body entering into or through eye or natural orifice

690

6471

1.08

1.10

2.8

0.65

0.73

ug/l

1.71

439

3955

Anomalies of pupillary function

687

1.25

1.10

3.2

2.8

0.71

0.78

ug/l

0.37

408

Pneumococcal septicemia

200

2256

0.87

1.10

2.5

3.1

0.70

0.76

ug/l

0.54

131

1492

Other and unspecified epidermal thickening

129

1503

0.84

1.10

3.1

0.71

0.76

ug/l

0.36

979

Other deformities of toe(s)

139

1191

1.19

1.10

3.0

2.9

0.66

0.80

ug/l

2.02

769

Assault by blunt object

991

0.80

1.10

2.5

2.4

0.64

0.68

ug/l

0.30

524

Nonalcoholic fatty liver disease

605

5638

1.09

1.10

2.8

2.7

0.68

0.70

ug/l

0.07

390

3382

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

624

6679

0.92

1.10

3.2

3.1

0.77

0.78

ug/l

0.12

425

4564

Rickettsioses

125

1.73

1.10

3.3

2.9

0.64

0.71

ug/l

0.29

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

417

0.70

1.10

2.0

2.8

0.60

0.69

ug/l

0.20

253

Burn and corrosion of shoulder and upper limb, except wrist and hand

118

1381

0.83

1.10

2.7

2.8

0.65

0.73

ug/l

0.64

836

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

457

0.71

1.09

2.4

2.6

0.69

0.73

ug/l

0.11

301

Right side

375

0.67

1.09

2.4

3.0

0.98

0.75

ug/l

1.42

264

Volume depletion

680

7253

0.93

1.09

2.9

3.2

0.89

0.82

ug/l

0.43

482

5077

Unspecific neurodegenerative disorder

3669

25780

0.97

1.09

3.2

3.5

0.82

0.85

ug/l

0.50

2647

19230

Other and unspecified effects of external causes

1483

14173

1.05

1.08

2.8

0.66

0.73

ug/l

2.59

932

8667

Other and unspecified injuries of ankle and foot

194

1707

1.15

1.08

2.7

0.70

ug/l

0.01

117

1011

Fracture of rib(s), sternum and thoracic spine

3095

30054

1.04

1.08

3.1

3.0

0.71

0.78

ug/l

3.00

2098

19904

Cerebral palsy

520

0.73

1.08

1.9

2.5

0.93

0.75

ug/l

0.18

265

Routine general health check-up of defined subpopulation

219

1.43

1.08

1.9

2.2

0.68

0.73

ug/l

0.11

105

Familial hypercholesterolemia, with ischemic heart disease

944

9937

0.93

1.08

3.0

3.4

0.77

0.82

ug/l

0.82

645

7185

Ulcerative colitis (strict) with PSC

390

0.69

1.08

2.2

2.4

0.93

0.73

ug/l

0.23

197

Necrotizing fasciitis

351

0.67

1.08

2.4

3.0

0.47

0.86

ug/l

1.92

221

Disorders of muscles

724

6797

1.08

1.07

2.8

0.67

0.77

ug/l

2.72

471

4275

Paraplegia, diplegia of upper limbs

128

1484

0.84

1.07

2.8

2.9

0.63

0.77

ug/l

1.27

971

Nausea and vomiting

1429

14650

0.95

1.07

3.0

0.82

0.80

ug/l

0.18

988

9818

Campylobacter enteritis

192

1698

1.16

1.07

2.8

0.73

0.74

ug/l

0.06

125

1079

Glaucoma suspect

2505

24220

1.04

1.07

3.2

0.76

0.79

ug/l

0.47

1748

16819

Mixed disorder of acid-base balance

0.00

1.07

0.0

2.8

—

0.69

—

Crystal arthropathies, rheuma endpoint

149

1298

1.19

1.07

3.5

3.0

0.65

0.83

ug/l

3.12

100

869

Pilonidal cyst

662

6201

1.08

1.07

2.3

2.4

0.61

0.67

ug/l

1.07

332

3264

Acute and subacute iridocyclitis

1341

12807

1.06

1.07

2.9

0.69

0.74

ug/l

1.81

900

8113

Contact with other hot metals

1073

0.81

1.06

2.6

2.8

0.70

0.74

ug/l

0.14

667

Mental and behavioural disorders due to cannabinoids

102

1213

0.83

1.06

1.7

1.9

0.43

0.60

ug/l

3.26

493

Congenital obstruction of the pelviureteric junction

265

1.41

1.06

2.9

2.5

0.80

0.65

ug/l

0.44

155

Paralytic ileus

273

3014

0.89

1.06

2.6

3.0

0.68

0.82

ug/l

1.52

191

2020

Graves ophthalmopathy

581

1.26

1.06

2.7

2.9

0.71

0.75

ug/l

0.22

358

Seminoma of testis, including Hilmo

102

868

1.24

1.06

2.5

2.2

0.70

0.67

ug/l

0.17

470

Occupant of pick-up truck or van injured in other and unspecified transport accidents

373

0.68

1.05

2.4

2.7

0.57

0.69

ug/l

0.86

209

Chondropathies

965

9139

1.06

1.05

2.9

2.7

0.62

0.72

ug/l

4.35

575

5538

Torsion of testis

128

1099

1.20

1.05

2.2

2.0

0.65

0.64

ug/l

0.05

463

Heterophoria

317

2873

1.11

1.05

2.9

0.83

0.72

ug/l

0.90

200

1762

Erectile dysfunction, exclusion

389

0.68

1.05

2.5

3.1

0.61

0.78

ug/l

1.04

256

Glomerulonephritis

717

7619

0.93

1.05

2.7

3.0

0.92

0.75

ug/l

1.56

532

4991

Acquired stenosis of external ear canal

115

993

1.23

1.05

3.1

3.0

0.71

0.73

ug/l

0.07

650

Personal history of medical treatment

533

1.29

1.04

2.7

3.0

0.90

0.76

ug/l

0.55

356

Psoriasis

2118

21947

0.96

1.04

2.8

2.9

0.64

0.74

ug/l

5.59

1391

14119

Superficial injury of lower leg

1349

12880

1.05

1.04

2.9

2.8

0.69

0.74

ug/l

0.95

885

8075

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1103

10174

1.06

1.04

2.9

2.8

0.81

0.73

ug/l

1.02

702

6281

Fasciculation

652

1.26

1.04

2.9

2.8

0.67

0.73

ug/l

0.17

402

Shoulder region

854

0.79

1.03

2.8

2.9

0.60

0.75

ug/l

1.22

535

Asthma, hospital admissions 3, pneumonia

2578

26572

0.96

1.03

2.8

3.1

0.67

0.81

ug/l

10.43

1741

18110

Asthma-related pneumonia or sepsis

2578

26572

0.96

1.03

2.8

3.1

0.67

0.81

ug/l

10.43

1741

18110

Graves disease, strict definition

247

2208

1.13

1.03

2.6

2.8

0.69

0.72

ug/l

0.34

144

1326

Undescended testicle

370

1.33

1.03

2.9

2.7

0.61

0.75

ug/l

0.82

208

Other injuries of upper limb, level unspecified

726

1.24

1.03

2.5

2.8

0.63

0.71

ug/l

0.69

438

Myositis ossificans

176

1.55

1.03

3.5

3.0

0.95

0.80

ug/l

0.23

122

Degenerative conditions of globe

349

0.68

1.03

2.8

3.0

0.83

0.80

ug/l

0.07

233

Frostbite with tissue necrosis

264

0.62

1.03

2.7

2.9

0.73

0.75

ug/l

0.04

174

Valvular operations

1587

16489

0.95

1.03

2.9

3.2

0.81

0.80

ug/l

0.12

1115

11417

Flatback syndrome

0.00

1.03

0.0

2.5

—

0.69

—

Prepatellar bursitis

514

4803

1.10

1.02

3.0

2.8

0.67

0.75

ug/l

1.78

334

3006

Polyneuropathies and other disorders of the peripheral nervous system

2214

21418

1.04

1.02

3.1

0.69

0.78

ug/l

3.14

1650

14736

Abnormal blood-pressure reading, without diagnosis

226

2018

1.14

1.02

3.5

2.9

0.71

0.75

ug/l

0.28

143

1289

241

1.42

1.02

3.0

2.5

0.67

0.70

ug/l

0.12

145

Cluster headache, wide,, including avohilmo

287

2599

1.12

1.02

2.6

0.70

ug/l

0.00

171

1514

Other disorders of amino-acid metabolism

279

0.64

1.02

3.7

3.0

0.53

0.74

ug/l

0.78

189

Amyloidosis

176

1557

1.17

1.02

3.0

3.2

0.73

0.79

ug/l

0.55

133

1111

Retinal vascular disorders

1025

9751

1.06

1.02

3.2

0.78

0.81

ug/l

0.53

739

6963

Colorectal adenocarcinoma

1784

17137

1.05

1.02

3.1

2.8

0.81

0.72

ug/l

1.76

1248

11911

Appendectomy

4443

41426

1.03

1.02

2.7

0.72

0.73

ug/l

0.06

2655

25050

Disorders of tooth development and eruption

891

6811

1.07

1.02

2.8

2.6

0.75

0.74

ug/l

0.05

571

3884

Lichen striatus

0.00

1.01

0.0

2.6

—

0.85

—

Postprocedural disorders of nervous system

223

1986

1.13

1.01

2.5

0.59

0.70

ug/l

2.04

127

1117

Primary biliary cholangitis (PBC)

571

0.76

1.01

2.8

2.9

0.83

0.73

ug/l

0.30

371

Use of levodopa decarbox-comt-inhibitor

252

2777

0.88

1.01

3.0

3.3

0.71

0.79

ug/l

0.61

181

1981

Reduction defects of unspecified limb

1.89

1.01

2.5

2.8

0.83

0.59

ug/l

—

Stenosis and insufficiency of lacrimal passages

407

3744

1.10

1.01

3.2

3.1

0.81

0.77

ug/l

0.26

278

2517

Other otitis externa (chronic)

411

3791

1.10

1.01

3.3

3.0

0.69

0.75

ug/l

0.79

254

2470

Non-allergic asthma (mode)

1227

12729

0.95

1.00

2.7

3.1

0.66

0.80

ug/l

4.43

807

8614

Asthma-related pneumonia

2576

26536

0.96

1.00

2.8

3.1

0.67

0.81

ug/l

10.42

1739

18087

Other and unspecified injuries of neck

338

1.35

1.00

2.8

2.6

0.69

0.75

ug/l

0.13

186

Other lack of coordination

1078

0.82

1.00

3.5

3.1

0.85

0.80

ug/l

0.19

718

Oesophagitis, drug-induced

144

1.62

1.00

3.1

0.54

0.77

ug/l

1.44

103

Other symptoms and signs involving the nervous and musculoskeletal systems

2692

27768

0.96

1.00

2.9

3.0

0.69

0.77

ug/l

5.22

1608

18376

Other and unspecified types of non-Hodgkin lymphoma, hilmo

276

3035

0.89

1.00

2.7

3.2

0.72

0.77

ug/l

0.49

182

2124

Periapical abscess

3670

37674

0.97

1.00

2.9

2.8

0.72

0.73

ug/l

0.21

2405

23361

Other protozoal intestinal diseases

671

1.24

1.00

3.0

2.9

0.51

0.72

ug/l

4.19

431

Other/unspecified disorders of vestibular function

224

2006

1.14

1.00

3.1

0.72

0.76

ug/l

0.26

147

1347

Dependent personality disorder

800

0.80

1.00

2.8

2.7

0.53

0.72

ug/l

1.43

486

Benign neoplasm: Brain, infratentorial

261

1.41

1.00

2.8

2.9

1.01

0.75

ug/l

0.80

165

Certain conditions originating in the perinatal period

697

0.80

0.99

2.1

0.59

0.71

ug/l

0.50

322

Labyrinthine fistula

250

0.62

0.99

3.4

3.0

0.71

0.74

ug/l

0.10

169

Other and unspecified hereditary haemolytic anaemias

0.00

0.99

0.0

2.5

—

0.67

—

Choroidal haemorrhage and rupture

212

1.49

0.99

3.0

1.90

0.80

ug/l

0.63

141

Car occupant injured in noncollision transport accident

171

1937

0.87

0.99

2.6

2.7

0.59

0.73

ug/l

2.68

111

1132

Cardiomyopathy, Hypertrophic obstructive

131

1501

0.84

0.99

3.0

0.57

0.74

ug/l

2.43

1028

Chronic suppurative otitis media, including avohilmo

411

4451

0.91

0.99

3.0

0.92

0.75

ug/l

0.94

286

2915

Other skin changes

1360

13027

1.05

0.99

3.2

0.76

0.81

ug/l

0.74

961

9089

Other and unspecified injuries of shoulder and upper arm

205

1830

1.14

0.99

2.8

0.91

0.73

ug/l

0.38

127

1151

Barrett oesophagus

512

4791

1.09

0.98

3.4

3.0

0.73

0.76

ug/l

0.13

353

3186

Toxic effect of contact with venomous animals

231

2074

1.13

0.98

2.8

2.9

0.79

0.73

ug/l

0.39

157

1316

Chronic myeloproliferative disease

943

0.81

0.98

2.5

3.2

0.83

0.78

ug/l

0.19

666

Exposure to unspecified smoke, fire and flames

638

0.77

0.98

2.8

2.7

0.72

0.75

ug/l

0.18

376

Malignant neoplasm of larynx, including Hilmo

176

1971

0.86

0.98

2.9

2.7

0.75

0.74

ug/l

0.06

127

1360

Herpesviral keratitis and keratoconjunctivitis

284

2582

1.12

0.98

2.8

3.0

0.80

0.76

ug/l

0.25

181

1677

Acute otitis externa, noninfective

861

0.80

0.98

3.0

2.8

0.66

0.75

ug/l

0.50

546

Polyarthrosis

917

8061

1.06

0.98

3.2

3.1

0.72

0.83

ug/l

1.99

642

5576

Viral infections of central nervous system, not elsewhere classified/unspecified

530

0.75

0.98

3.5

2.7

0.56

0.69

ug/l

0.97

294

Poisoning by medicine, drug-induced

652

0.77

0.97

2.4

2.5

0.38

0.68

ug/l

5.87

347

Paralytic ileus and intestinal obstruction

2057

21275

0.96

0.97

2.9

3.1

0.76

0.81

ug/l

1.17

1432

14483

Other injuries of spine and trunk, level unspecified

538

0.75

0.97

2.5

2.9

0.66

0.73

ug/l

0.28

337

Abnormal reflex

265

0.65

0.97

2.2

2.8

0.63

0.75

ug/l

—

165

Impetigo

177

2000

0.87

0.97

2.8

2.7

0.63

0.72

ug/l

0.96

101

1162

Rheumatic fever without mention of heart involvement

204

0.59

0.97

3.6

2.9

0.89

0.81

ug/l

—

135

Malignant neoplasm of nasal cavity and sinuses

435

0.72

0.96

2.6

2.5

0.80

0.70

ug/l

0.31

276

Chronic nephritic syndrome

276

3026

0.89

0.96

2.7

3.0

0.99

0.75

ug/l

2.05

217

1979

Other and unspecified rosacea

424

3920

1.09

0.96

3.2

3.0

0.73

0.75

ug/l

0.11

278

2586

Postprocedural endocrine and metabolic disorders, not elsewhere classified

368

3375

1.10

0.96

2.9

2.8

0.67

0.74

ug/l

1.41

258

2124

Ulcerative enterocolitis

162

1834

0.87

0.96

2.9

2.8

0.72

0.74

ug/l

0.14

101

1099

Scissor bite

457

1.27

0.96

2.8

2.5

0.62

0.68

ug/l

0.29

258

Contact with nonpowered hand tool

446

4158

1.10

0.95

3.1

2.8

0.77

0.71

ug/l

0.31

288

2608

Other rupture of muscle

370

1.33

0.95

3.6

2.8

0.68

0.72

ug/l

0.17

232

Lumbosacral root disorders, not elsewhere classified

703

0.78

0.95

2.1

2.9

0.61

0.74

ug/l

1.01

470

Papillary adenocarcinoma of thyroid gland

183

1620

1.14

0.95

2.9

2.5

0.71

0.69

ug/l

0.15

130

1005

Burns and corrosions of external body surface, specified by site

733

7760

0.93

0.95

2.8

2.7

0.68

0.72

ug/l

0.71

463

4732

Other necrotizing vasculopathies (FG)

388

3583

1.10

0.95

3.1

0.67

0.82

ug/l

3.80

294

2445

Nummular dermatitis

621

6597

0.93

0.94

3.0

3.1

0.81

0.79

ug/l

0.13

436

4478

Wegener granulomatosis

920

0.81

0.94

2.5

3.0

0.71

0.76

ug/l

0.29

605

Senile degeneration of the brain, not elsewhere classified

250

0.64

0.94

2.5

3.3

0.75

0.79

ug/l

0.10

170

Vitamin D deficiency

673

0.79

0.93

2.9

2.7

0.69

0.72

ug/l

0.15

416

Use of amantadine

748

0.80

0.93

3.2

2.9

0.72

0.77

ug/l

0.23

489

Parapsoriasis

126

1095

1.18

0.93

3.0

2.9

0.61

0.77

ug/l

2.05

706

Postprocedural musculoskeletal disorders, not elsewhere classified

406

4380

0.91

0.93

3.3

3.1

0.67

0.75

ug/l

1.31

270

2965

Behavioural disorders

663

0.79

0.93

1.5

2.1

0.51

0.62

ug/l

1.03

290

Tubulo-interstitial nephritis, not specified as acute or chronic

391

3611

1.09

0.93

2.9

3.2

0.84

0.78

ug/l

0.28

272

2468

Gilbert syndrome

462

1.29

0.92

2.5

2.8

0.82

0.71

ug/l

0.31

295

Spinal enthesopathy

138

1576

0.86

0.92

3.1

1.06

0.96

ug/l

0.16

1116

Deep bite that required surgery

431

1.28

0.92

2.9

2.3

0.60

0.65

ug/l

0.27

217

Carcinoma in situ of skin of lip

234

1.46

0.92

4.6

3.2

0.65

0.77

ug/l

0.37

165

Lesion of radial nerve

220

2438

0.89

0.92

2.8

2.9

0.82

0.74

ug/l

0.16

138

1504

Osteonecrosis due to drugs

113

979

1.20

0.92

4.5

3.1

1.71

0.74

ug/l

2.10

667

Other diseases of peritoneum

159

1802

0.87

0.92

3.2

3.1

0.71

0.78

ug/l

0.66

114

1221

Intermittent hydrarthrosis

121

1.62

0.92

3.3

2.6

0.59

0.73

ug/l

—

Thrombotic microangiopathy

320

0.69

0.92

1.9

3.1

0.75

0.73

ug/l

0.06

213

Pulmonary heart disease, diseases of pulmonary circulation

2504

25792

0.96

0.92

3.1

0.82

0.80

ug/l

0.30

1753

17757

Chronic conjunctivitis

122

1054

1.18

0.92

3.5

2.8

0.58

0.76

ug/l

2.73

656

Use of galantamine

535

5009

1.08

0.92

3.1

3.4

0.82

0.89

ug/l

0.55

419

3685

Other nutritional anaemias

567

0.77

0.92

3.1

3.2

0.72

0.78

ug/l

0.20

368

Secondary and unspecified malignant neoplasm of lymph nodes

654

6168

1.07

0.92

2.8

2.7

0.77

0.71

ug/l

0.99

445

4115

Other degenerative diseases of the basal ganglia

164

1463

1.17

0.92

2.9

3.3

0.62

0.79

ug/l

1.72

125

1046

Seminoma of testis

723

1.24

0.92

2.3

0.73

0.66

ug/l

0.41

386

Dermatographic urticaria

204

1822

1.13

0.91

2.9

2.8

0.83

0.73

ug/l

0.28

132

1125

Bitten or struck by other mammals

487

4535

1.08

0.91

2.9

2.7

0.74

0.71

ug/l

0.22

315

2744

Ankylosing spondylitis

700

6614

1.07

0.91

2.8

0.67

0.76

ug/l

2.47

485

4051

Contusion of ankle

165

1862

0.87

0.91

2.8

2.7

0.70

ug/l

0.02

113

1109

Burn and corrosion of ankle and foot

1000

0.82

0.91

2.8

2.9

0.68

0.75

ug/l

0.39

635

Myeloproliferative diseases

535

5704

0.93

0.90

2.7

3.1

0.75

0.78

ug/l

0.23

361

3925

Other birth injuries to central nervous system

0.00

0.90

0.0

3.3

—

0.69

—

Wilms' tumor, including Hilmo

374

0.71

0.90

2.8

2.7

0.72

0.74

ug/l

0.07

263

Benign neoplasm of bone and articular cartilage

488

4554

1.08

0.90

3.1

2.8

0.73

0.72

ug/l

0.05

313

2843

Malignant neoplasm of head and neck

706

7447

0.93

0.90

2.8

2.7

0.73

0.71

ug/l

0.40

487

5007

Other and unspecified iridocyclitis

255

2316

1.12

0.90

2.9

2.8

0.67

0.73

ug/l

0.59

173

1408

Unspecified renal colic

411

1.31

0.90

3.2

2.9

0.57

0.72

ug/l

1.41

268

Muscle strain

192

1718

1.14

0.89

2.9

2.8

0.74

ug/l

0.00

114

1065

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

476

5081

0.92

0.89

2.7

3.2

0.79

0.82

ug/l

0.20

327

3601

Postzoster neuralgia

101

867

1.20

0.89

3.4

3.1

0.80

0.84

ug/l

0.08

598

Personal history of risk-factors, not elsewhere classified

579

0.78

0.89

2.0

2.5

0.81

0.68

ug/l

0.26

332

Obesity due to excess calories

2950

30326

0.97

0.89

2.8

2.9

0.66

0.73

ug/l

3.91

1962

19277

Herpesviral [herpes simplex] infections

602

5657

1.07

0.89

2.9

3.0

0.72

0.77

ug/l

0.82

416

3646

Flatulence and related conditions

517

1.26

0.89

3.2

3.0

0.59

0.78

ug/l

2.21

339

Lactose intolerance

126

1095

1.17

0.88

3.1

2.9

0.72

0.71

ug/l

0.01

682

Malignant neoplasm of thyroid gland

258

2342

1.11

0.88

3.1

2.6

0.72

0.69

ug/l

0.37

181

1470

Other and unspecified acantholytic disorders

0.00

0.88

0.0

2.5

—

0.59

—

Use of selegiline

329

3560

0.91

0.88

2.9

3.3

0.67

0.79

ug/l

3.62

241

2510

Postprocedural disorders of digestive system, not elsewhere classified

174

1945

0.88

0.87

2.9

3.1

0.76

ug/l

0.01

114

1306

Monoamine oxidase A inhibitors

786

7457

1.06

0.87

3.1

2.9

0.62

0.76

ug/l

4.16

550

4868

Other and unspecified injuries of lower leg

345

3178

1.10

0.87

2.8

0.73

0.70

ug/l

0.21

215

1945

Other symptoms and signs involving general sensations and perceptions

164

1845

0.88

0.87

3.0

0.63

0.78

ug/l

1.84

113

1182

Other bursitis of knee

130

1145

1.18

0.87

2.8

2.7

0.73

0.76

ug/l

0.18

702

Other appendicitis

537

5038

1.08

0.86

3.1

2.8

0.72

ug/l

0.03

349

3155

Trachoma

0.00

0.86

0.0

2.5

—

0.85

—

Chronic lower respiratory diseases

10304

55677

0.98

0.86

2.8

2.9

0.69

0.78

ug/l

12.26

6549

35514

Cluster headache, strict, including avohilmo

266

2426

1.11

0.86

2.6

0.70

0.69

ug/l

0.06

159

1395

Malignant neoplasm of rectosigmoid junction, including Hilmo

196

2170

0.88

0.86

3.2

2.7

0.90

0.75

ug/l

0.48

144

1495

Injury of urinary and pelvic organs

178

1598

1.15

0.86

3.0

2.9

0.68

0.75

ug/l

0.76

112

997

Malignant neoplasm of meninges

0.00

0.86

0.0

3.2

—

0.49

—

Other contact dermatitis

366

3956

0.92

0.86

3.0

2.9

0.68

0.75

ug/l

1.24

223

2474

Intestinal adhesions without obstruction

613

5782

1.07

0.86

2.9

3.1

0.80

ug/l

0.02

423

3943

Strabismus

1513

14528

1.04

0.85

2.9

0.79

0.75

ug/l

0.39

982

9237

Drug-induced obesity

272

0.68

0.85

2.7

2.8

0.59

0.74

ug/l

0.59

170

Eustachian salpingitis and obstruction

366

3383

1.09

0.85

2.4

2.2

0.64

0.63

ug/l

0.06

174

1601

Cerebral palsy and other paralytic syndromes

651

6891

0.94

0.85

2.7

3.0

0.72

0.78

ug/l

0.51

469

4480

Esophageal diverticulum (pouch)

201

1.45

0.85

2.7

3.0

0.69

0.73

ug/l

0.16

148

Malignant neoplasm of hypopharynx

440

0.73

0.85

2.3

2.6

0.62

0.74

ug/l

0.87

296

Benign neoplasm of thyroid gland

122

1062

1.16

0.85

3.6

3.1

0.79

0.77

ug/l

0.09

698

Noninfectious colitis NAS

760

7205

1.06

0.85

2.9

0.71

0.76

ug/l

0.66

519

4599

5-aminosalicylic acid

1419

14743

0.96

0.84

2.7

0.69

0.72

ug/l

0.55

877

8915

Malignant neoplasm of hypopharynx, including Hilmo

651

0.78

0.84

2.4

2.6

0.66

0.76

ug/l

0.85

436

Non-allergic asthma

462

4938

0.93

0.84

2.8

3.0

0.65

0.76

ug/l

3.06

302

3280

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

137

1207

1.16

0.84

3.0

2.9

0.63

0.78

ug/l

2.14

780

Posteruptive colour changes of dental hard tissues

1.67

0.84

3.2

2.7

0.55

0.79

ug/l

—

Benign neoplasm of mouth and pharynx

760

7216

1.06

0.84

2.9

3.0

0.68

0.75

ug/l

1.84

492

4795

Maze procedure for atrial fibrillation

419

1.32

0.84

2.8

3.1

0.65

0.77

ug/l

0.52

273

Malignant neoplasm of floor of mouth, including Hilmo

665

0.79

0.84

3.6

2.6

0.65

0.76

ug/l

0.55

440

Benign neoplasm: Tongue

181

1625

1.14

0.84

2.7

2.9

0.67

0.74

ug/l

0.72

123

1058

Neovascular glaucoma

260

2838

0.90

0.83

3.1

0.87

0.80

ug/l

0.33

187

1927

Combinations of oral blood glucose lowering drugs

3145

32202

0.97

0.83

2.8

3.1

0.75

0.76

ug/l

0.26

2002

21724

Other symptoms and signs involving the circulatory and respiratory systems

467

4370

1.08

0.83

3.5

3.0

0.68

0.79

ug/l

1.93

342

2916

Arthropathy in Crohn disease

417

0.75

0.83

2.4

2.6

0.69

0.71

ug/l

0.04

227

Other complications of surgical and medical care, not elsewhere classified

529

4966

1.07

0.83

3.0

0.74

0.75

ug/l

0.10

370

3265

Exposure to ignition or melting of other clothing and apparel

227

0.64

0.83

1.6

2.8

0.46

0.78

ug/l

1.63

139

Traumatic subdural haemorrhage

1444

13369

1.05

0.82

3.2

3.3

0.82

0.85

ug/l

0.28

1040

9406

Moderate visual impairment, monocular

254

1.38

0.82

3.9

2.9

0.59

0.73

ug/l

1.05

172

Other and unspecified injuries of abdomen, lower back and pelvis

705

1.21

0.82

2.8

0.67

0.76

ug/l

0.51

416

Hypotension due to drugs

121

1065

1.18

0.82

2.9

3.1

0.66

0.84

ug/l

1.66

727

Drug-induced cataract

114

1303

0.86

0.82

2.9

0.71

0.73

ug/l

0.19

843

Ulcer of oesophagus, drug-induced

398

0.73

0.82

3.0

3.1

0.74

0.77

ug/l

0.06

272

Lichen simplex chronicus and prurigo

350

3774

0.92

0.82

2.8

3.0

0.66

0.75

ug/l

1.17

239

2467

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

182

0.61

0.82

3.2

2.8

0.49

0.80

ug/l

—

110

Care involving use of rehabilitation procedures

5142

48206

0.98

0.82

2.9

0.70

0.74

ug/l

1.78

3435

30967

Other erythematous conditions

171

1529

1.14

0.82

3.0

0.75

0.78

ug/l

0.12

111

1014

Cholesteatoma of external ear

573

1.25

0.82

3.5

3.0

0.69

0.74

ug/l

0.21

383

Contusion of other and unspecified parts of foot

227

2059

1.11

0.81

2.5

2.7

0.60

0.70

ug/l

1.84

124

1199

Urethral discharge

119

1.66

0.81

2.8

2.6

0.67

0.76

ug/l

0.29

Human immunodeficiency virus [HIV] disease

152

1695

0.87

0.81

2.3

2.4

0.69

0.67

ug/l

0.07

112

890

Motorcycle rider injured in noncollision transport accidents

239

2183

1.12

0.81

2.7

2.5

0.71

0.67

ug/l

0.22

129

1220

Benign neoplasm: Short bones of lower limb

496

1.25

0.81

3.2

2.9

0.75

ug/l

0.02

320

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4515

44165

1.02

0.81

3.1

0.74

0.78

ug/l

1.91

3090

30042

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.81

0.0

1.5

—

0.41

—

Molar incisor enamel hypoplasia

249

1.32

0.80

2.1

0.51

0.65

ug/l

0.91

118

Haemangioma, any site

458

4286

1.08

0.80

3.2

3.0

0.70

0.74

ug/l

0.69

308

2793

Disorders of continuity of bone

420

4502

0.93

0.80

2.8

0.75

0.72

ug/l

0.14

266

2749

Defects in the complement system

186

0.63

0.80

2.3

2.6

0.38

0.70

ug/l

—

115

Lichen sclerosus et atrophicus

195

1752

1.12

0.80

2.8

0.69

0.72

ug/l

0.13

133

1046

Malignant neoplasm of oropharynx, including Hilmo

429

0.74

0.80

2.1

2.6

0.84

0.73

ug/l

0.31

286

Pruritus

464

4340

1.08

0.80

3.1

0.71

0.79

ug/l

0.53

324

2892

Panniculitis affecting regions of neck and back

215

1951

1.12

0.80

2.8

2.9

0.61

0.75

ug/l

3.05

131

1235

Chronic suppurative otitis media

355

3822

0.92

0.80

3.0

0.96

0.76

ug/l

0.95

247

2502

Other acantholytic disorders

223

1.43

0.80

3.2

3.1

0.70

0.77

ug/l

0.25

157

Congenital malformations of the circulatory system

896

8294

1.06

0.79

2.8

0.71

0.72

ug/l

0.19

551

5113

Disorders of brain, other and unspecified

599

0.79

2.9

1.03

0.76

ug/l

0.26

387

Haemolytic anaemias

184

2038

0.89

0.79

2.7

3.0

0.81

0.77

ug/l

0.15

134

1338

Patent foramen ovale

135

1195

1.15

0.79

2.8

2.7

0.81

0.72

ug/l

0.28

695

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

1.84

0.79

2.7

3.2

0.71

0.72

ug/l

—

Unspecified event, undetermined intent

120

1364

0.86

0.79

2.7

2.8

0.60

0.72

ug/l

0.93

815

Temporal arteritis

221

2012

1.12

0.79

3.5

3.3

0.65

0.79

ug/l

3.01

164

1408

Guttate psoriasis

656

0.80

0.79

2.8

0.63

0.72

ug/l

0.36

399

Brain astrocytoma

172

0.61

0.79

2.3

2.4

0.65

0.75

ug/l

—

Brain astrocytoma, including Hilmo

172

0.61

0.79

2.3

2.4

0.65

0.75

ug/l

—

Intestinal infectious diseases

9898

57331

0.98

0.79

2.8

2.9

0.72

0.77

ug/l

3.25

6182

37164

Blepharospasm

397

1.27

0.79

2.3

3.0

0.77

0.75

ug/l

0.02

262

Small fibre neuropathy

247

2269

1.12

0.79

3.1

0.62

0.76

ug/l

2.57

169

1511

Malignant neoplasm of oral cavity, including Hilmo

324

3487

0.91

0.78

2.7

2.6

0.75

0.70

ug/l

0.41

217

2271

Viral infections of central nervous system, not elsewhere classified/unspecified

666

0.81

0.78

3.3

2.6

0.54

0.73

ug/l

1.69

378

Hypertensive encephalopathy

230

1.39

0.78

3.7

3.1

0.62

0.77

ug/l

1.13

150

Conotruncal defects

302

0.72

0.78

2.1

2.3

0.41

0.68

ug/l

2.44

157

Contact with other sharp object(s)

434

4062

1.08

0.78

2.9

2.6

0.73

0.68

ug/l

0.61

242

2351

Dislocation, sprain and strain of joint and ligaments of hip

237

2167

1.11

0.78

2.8

3.1

0.66

0.78

ug/l

1.27

155

1434

Effects of foreign body entering through natural orifice

2243

23060

0.97

0.78

2.7

0.73

0.72

ug/l

0.14

1376

14129

Contact with heat and hot substances

313

3380

0.91

0.78

2.9

2.8

0.74

0.71

ug/l

0.26

188

2098

Mandibular prognathia AND surgery (LeFortI or BSSO)

160

0.60

0.78

2.7

2.3

0.53

0.67

ug/l

—

Other hereditary haemolytic anaemias

291

1.33

0.77

2.5

2.6

0.56

0.76

ug/l

1.02

180

Benign neoplasm: Pharynx, unspecified

399

1.27

0.77

2.6

2.9

0.69

0.72

ug/l

0.15

259

Other disorders of bone

1298

12498

1.04

0.77

2.8

2.7

0.64

0.72

ug/l

2.69

773

7598

Hidradenitis suppurativa

119

1355

0.87

0.77

2.3

2.5

0.61

0.69

ug/l

0.69

760

Protozoal diseases

183

2020

0.89

0.77

2.3

3.1

0.67

0.75

ug/l

0.64

126

1343

Injury of muscle and tendon at ankle and foot level

175

1578

1.13

0.77

2.8

0.85

0.72

ug/l

0.33

112

963

Other strabismus

1061

10128

1.05

0.77

2.8

0.81

0.73

ug/l

0.55

667

6180

Giant cell arteritis with polymyalgia rheumatica

221

2015

1.12

0.77

3.5

3.3

0.65

0.79

ug/l

3.02

164

1408

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

128

1439

0.86

0.77

3.0

2.8

0.86

0.76

ug/l

0.52

1002

Congenital malformations of the urinary system

313

2894

1.09

0.77

3.1

2.9

1.04

0.74

ug/l

2.02

224

1850

Other salmonella infections

267

2454

1.10

0.77

3.1

2.9

0.74

0.75

ug/l

0.03

185

1553

Malignant neoplasm of other and ill-defined digestive organs

486

0.77

3.6

2.6

0.75

0.78

ug/l

0.08

333

Other and unspecified immunodeficiencies with predominantly antibody defects

443

1.25

0.77

2.5

2.8

0.53

0.72

ug/l

2.77

267

Foreign body in alimentary tract

341

3665

0.92

0.76

3.0

0.66

0.74

ug/l

1.58

235

2419

Allergic colitis

200

1.36

0.76

2.6

2.5

0.60

0.66

ug/l

0.24

108

Sequelae of injuries of upper limb

618

6520

0.94

0.76

2.8

2.7

0.60

0.71

ug/l

3.91

381

3913

Congenital malformations of the musculoskeletal system, not elsewhere classified

218

1.34

0.76

3.3

2.6

0.50

0.76

ug/l

1.91

119

Hypotony of eye

1.77

0.76

4.2

3.0

0.85

0.73

ug/l

0.24

Other congenital malformations of peripheral vascular system

443

1.24

0.76

2.0

2.7

0.58

0.72

ug/l

1.16

269

Abnormal results of function studies

566

5349

1.07

0.76

3.1

2.9

0.73

0.74

ug/l

0.09

385

3420

Other and unspecified abdominal hernia

219

2398

0.90

0.76

3.1

0.64

0.80

ug/l

2.78

155

1640

Unspecified misadventure during surgical and medical care

345

3704

0.92

0.76

3.2

3.1

0.64

0.76

ug/l

3.16

255

2474

Inhalation and ingestion of other objects causing obstruction of respiratory tract

301

1.31

0.76

4.1

3.0

0.67

0.77

ug/l

0.30

197

Chorioretinal scars

187

1.42

0.76

3.2

2.8

0.75

0.74

ug/l

0.02

111

Follicular lymphoma, hilmo

274

2965

0.91

0.76

2.9

3.2

0.72

0.76

ug/l

0.37

184

2037

Scabies

709

6735

1.06

0.75

2.7

2.6

0.65

0.69

ug/l

0.64

404

3875

Human immunodeficiency virus [HIV] disease resulting in other conditions

139

1549

0.87

0.75

2.2

2.4

0.69

0.67

ug/l

0.05

102

791

Ectopic testis

100

1.54

0.75

3.1

2.5

0.51

0.60

ug/l

—

Hypoplasia of dental enamel , including avohilmo

237

1.32

0.75

2.1

0.50

0.66

ug/l

0.95

111

Certain zoonotic bacterial diseases

1122

0.85

0.75

2.4

2.9

0.60

0.76

ug/l

1.87

706

Congenital malformations of oesophagus

293

1.32

0.75

2.6

2.9

0.61

0.74

ug/l

0.82

200

Spontaneous rupture of synovium and tendon

576

5450

1.07

0.75

3.1

2.9

0.70

0.79

ug/l

1.34

365

3620

Allergic urticaria

309

2855

1.09

0.75

2.9

2.8

0.67

0.72

ug/l

0.29

186

1755

Volvulus

149

1662

0.88

0.75

2.8

3.0

0.71

0.84

ug/l

0.95

108

1126

Mature T/NK-cell lymphomas, hilmo

1105

0.85

0.75

2.8

3.1

0.61

0.78

ug/l

1.95

739

Exposure to high and low air pressure and changes in air pressure

1.66

0.74

2.1

2.7

0.40

0.75

ug/l

—

Lateral epicondylitis

843

8052

1.05

0.74

2.8

2.7

0.62

0.74

ug/l

5.33

529

4826

Calcific aortic valvular stenosis, including rheumatic fever

2941

29143

0.97

0.74

3.1

3.3

0.80

0.83

ug/l

0.54

2102

21092

Giant cell arteritis

251

2308

1.10

0.74

3.5

3.3

0.64

0.78

ug/l

3.43

188

1622

Idiopathic thrombocytopenic purpura

157

1745

0.88

0.74

2.7

3.0

0.73

0.76

ug/l

0.19

108

1137

Viral haemorrhagic fevers, not elsewhere classified/unspecified

587

6187

0.94

0.74

2.8

2.9

0.82

0.72

ug/l

0.46

368

3933

Calcific aortic valvular stenosis

2932

29080

0.97

0.74

3.1

3.3

0.80

0.83

ug/l

0.52

2094

21047

Calcific aortic valvular stenosis, operated

2932

29080

0.97

0.74

3.1

3.3

0.80

0.83

ug/l

0.52

2094

21047

Congenital malformations of the musculoskeletal system, not elsewhere classified

202

1.35

0.74

3.4

2.7

0.50

0.76

ug/l

1.78

112

Sequelae of injuries, of poisoning and of other consequences of external causes

1759

18139

0.96

0.74

2.8

2.7

0.62

0.72

ug/l

7.16

1130

11074

Other specified and unspecified disorders of conjunctiva

530

1.23

0.73

2.1

2.8

0.57

0.77

ug/l

2.37

329

Other overlap syndromes

543

0.80

0.73

2.2

2.9

1.02

0.78

ug/l

0.35

359

Disorders of speech understanding and production

143

1248

1.13

0.73

2.8

2.9

0.73

0.77

ug/l

0.18

100

796

Calcific aortic valvular stenosis, diagnosis (helper)

2931

29066

0.97

0.73

3.1

3.3

0.80

0.83

ug/l

0.52

2094

21038

Operations 2 for CAVS

2931

29066

0.97

0.73

3.1

3.3

0.80

0.83

ug/l

0.52

2094

21038

Deforming dorsopathies

1596

15438

1.04

0.73

2.9

0.65

0.76

ug/l

3.07

1045

9826

Alzheimer disease, including avohilmo

2988

21541

0.97

0.73

3.1

3.5

0.86

ug/l

0.07

2178

16067

Other general symptoms and signs

215

1939

1.11

0.73

3.3

2.9

0.71

0.76

ug/l

0.34

139

1219

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1292

12473

1.04

0.73

3.4

2.7

1.06

0.70

ug/l

6.51

938

8432

Coarctation of the aorta

495

0.79

0.72

2.4

2.6

1.36

0.68

ug/l

0.60

277

Benign neoplasm: Bones of skull and face

308

0.73

0.72

2.7

2.9

0.46

0.75

ug/l

2.43

209

Preparatory care for dialysis

408

3839

1.08

0.72

2.6

3.0

1.14

0.73

ug/l

7.02

335

2521

Other disorders of urethra and urinary system

4671

34364

0.98

0.72

3.4

3.1

0.84

0.81

ug/l

0.81

3559

24030

Other/unspecified synovitis and tenosynovitis

673

6398

1.06

0.72

2.8

2.9

0.70

0.78

ug/l

1.05

412

4083

Other conjunctival vascular disorders and cysts

129

1147

1.15

0.72

3.2

3.0

0.81

0.78

ug/l

0.08

758

Gastrointestinal stromal tumor and sarcoma

738

1.19

0.72

3.4

2.7

0.88

0.76

ug/l

0.71

496

Lactose intolerance, other/unspecified

112

984

1.15

0.72

3.2

2.8

0.75

0.72

ug/l

0.12

602

Benign neoplasm: Spinal cord

839

1.18

0.72

3.2

2.9

0.63

0.72

ug/l

0.88

529

Other/unspecified reactive arthropathies

397

3719

1.08

0.72

2.8

2.9

0.74

ug/l

0.01

267

2332

Budesonide

833

7962

1.05

0.72

3.0

2.8

0.69

0.75

ug/l

0.94

533

4972

Acute suppurative otitis media

1023

9950

0.96

0.71

2.3

0.70

0.65

ug/l

0.45

538

5076

Oral leukoplakia, including avohilmo

162

1791

0.89

0.71

2.7

2.9

0.62

0.72

ug/l

1.49

1130

Injury of nerves at forearm level

100

878

1.17

0.71

2.4

2.7

0.70

0.68

ug/l

0.07

527

Gonococcal infection

117

1031

1.15

0.71

2.2

2.3

0.68

0.64

ug/l

0.10

521

Other rickettsioses

2.11

0.71

2.2

2.8

0.64

0.67

ug/l

—

Ocular pain

330

3066

1.08

0.71

3.0

2.9

0.63

0.73

ug/l

1.88

217

1904

Renal agenesis and other reduction defects of kidney

304

0.73

0.71

3.0

2.9

0.63

0.74

ug/l

0.41

188

Diseases caused by chlamydiae

221

1.33

0.71

2.5

2.4

0.62

0.72

ug/l

0.45

112

Background retinopathy and retinal vascular changes

123

1380

0.87

0.71

3.0

3.1

0.82

0.77

ug/l

0.27

907

Other specified and unspecified retinal disorders

232

2132

1.11

0.71

2.8

3.0

0.69

0.76

ug/l

0.63

159

1396

Crohn disease (strict definition, all UC cases excluded)

237

2579

0.91

0.71

2.6

2.7

0.62

0.69

ug/l

1.21

146

1505

Obsessive-compulsive disorder

217

1979

1.10

0.71

2.2

2.4

0.55

0.69

ug/l

2.07

129

1026

Other peripheral vertigo

520

4914

1.07

0.71

3.2

3.1

0.76

0.78

ug/l

0.16

382

3364

Arthropod-borne viral fevers and viral haemorrhagic fevers

756

7905

0.95

0.70

2.8

2.9

0.78

0.75

ug/l

0.16

473

5052

Asthma, unspecified (mode), excluding more controls

4273

31338

1.02

0.70

3.0

2.9

0.69

0.77

ug/l

6.25

2910

20226

Other diseases of pancreas

630

6615

0.94

0.70

3.0

3.1

0.73

0.78

ug/l

0.49

461

4457

Other orthopaedic follow-up care

347

3239

1.08

0.70

2.7

2.9

0.60

0.72

ug/l

2.45

254

2070

Disorders of parathyroid gland

841

7940

1.05

0.70

3.1

0.81

ug/l

0.04

624

5432

Coronary atherosclerosis

6838

42604

1.02

0.70

2.8

3.0

0.72

0.77

ug/l

2.14

4608

27589

Sequelae of injuries of lower limb

622

5912

1.06

0.70

2.8

2.7

0.63

0.71

ug/l

2.03

397

3572

Listeriosis

280

0.72

0.70

2.9

3.3

0.72

0.79

ug/l

0.16

194

Autism spe, excluding more controls

453

0.79

0.70

2.0

0.52

0.58

ug/l

0.25

174

Orthopaedic devices associated with adverse incidents

119

1058

1.15

0.70

4.2

3.2

0.76

0.77

ug/l

0.12

741

Psoriasis vulgaris

1445

14925

0.96

0.70

2.8

2.9

0.65

0.74

ug/l

2.83

953

9537

Migraine

1719

13495

1.03

0.69

2.7

2.6

0.68

0.72

ug/l

0.70

1048

7928

Parkinson's disease, strict definition

1256

12991

0.96

0.69

3.1

3.3

0.76

0.82

ug/l

1.68

903

9439

Demyelinating diseases of the central nervous system

270

2924

0.92

0.69

2.6

2.7

0.61

0.70

ug/l

1.59

179

1719

Fall on and from stairs and steps

1740

16884

1.04

0.69

2.9

0.66

0.76

ug/l

6.08

1185

11002

Malignant neoplasm of rectum, including Hilmo

1127

10870

1.05

0.69

3.1

2.8

0.81

0.72

ug/l

1.32

796

7512

Other metabolic disorders

434

4074

1.07

0.69

2.7

2.9

0.66

0.73

ug/l

1.64

294

2556

Other keratitis

688

6556

1.06

0.69

2.8

0.71

0.72

ug/l

0.18

449

3980

Juvenile arthritis (FINNGEN)

994

0.86

0.69

2.3

2.4

0.65

0.72

ug/l

0.49

524

Pneumonia due to Haemophilus influenzae

211

0.68

0.69

3.4

3.0

0.90

0.83

ug/l

—

122

Myeloproliferative diseases (CML excluded)

478

5057

0.93

0.69

2.8

3.1

0.76

0.77

ug/l

0.09

325

3477

Benign neoplasm: Skin of lip

701

1.19

0.69

2.8

3.0

0.73

0.75

ug/l

0.05

468

Enteropathic arthropathies

1074

0.86

0.69

2.7

2.6

0.64

0.77

ug/l

1.09

629

Pleural plaque with presence of asbestos

960

9942

0.95

0.68

3.6

3.4

0.73

0.83

ug/l

2.67

706

7397

Convalescence

220

2398

0.91

0.68

3.2

3.0

0.78

0.74

ug/l

0.19

167

1570

6-mercaptopurine

127

1424

0.88

0.68

2.8

2.5

0.68

0.69

ug/l

0.07

761

Disorder of external ear, unspecified

226

2080

1.11

0.68

2.8

2.9

0.75

ug/l

0.00

151

1324

Other benign neoplasms of connective and other soft tissue

587

5574

1.06

0.68

3.1

3.0

0.74

0.75

ug/l

0.05

368

3621

Polyarteritis nodosa

369

0.76

0.68

2.3

3.0

0.58

0.75

ug/l

1.21

239

Infective bursitis

293

2735

1.10

0.68

3.2

2.8

0.69

0.74

ug/l

0.71

192

1743

Sequelae of other external causes

346

3235

1.08

0.68

2.7

3.0

0.63

0.75

ug/l

1.65

249

2101

Traumatic amputation of wrist and hand

459

4838

0.93

0.68

3.1

2.9

0.68

0.74

ug/l

1.39

301

3154

Hyperparathyroidism

758

7153

1.05

0.68

3.1

0.81

ug/l

0.02

561

4892

Childhood asthma (age<16), excluding more controls

321

2722

0.93

0.67

1.6

1.7

0.48

0.53

ug/l

1.11

108

971

Malignant neoplasm of ureter, including Hilmo

689

1.20

0.67

2.4

2.7

0.66

0.74

ug/l

0.52

478

Malignant neoplasm of gallbladder

177

0.65

0.67

2.0

2.6

0.96

0.75

ug/l

—

114

Viral and other specified intestinal infections

910

9265

0.96

0.67

2.4

2.5

0.70

0.72

ug/l

0.10

481

5020

Benign neoplasm: Extrahepatic bile ducts

174

1.41

0.67

2.5

2.8

0.60

0.73

ug/l

0.83

115

Vertical strabismus

186

1695

1.11

0.67

3.0

2.9

0.71

0.74

ug/l

0.26

133

1096

Juvenile rheumatoid arthirtis

472

0.80

0.67

2.6

2.2

0.62

0.68

ug/l

0.25

233

Marginal zone B-cell lymphoma, including Hilmo

116

1034

1.15

0.67

3.0

2.7

0.85

0.73

ug/l

0.56

677

Complications of other internal prosthetic devices, implants and grafts

234

2156

1.10

0.67

2.8

3.1

0.63

0.79

ug/l

3.29

170

1477

Cauda equina syndrome

631

0.82

0.66

3.1

2.8

0.59

0.72

ug/l

0.98

400

Other specified/unspecified bacterial intestinal infections

415

3907

1.07

0.66

3.2

3.0

0.86

0.76

ug/l

0.49

289

2591

Nystagmus and other irregular eye movements

588

0.82

0.66

3.2

2.7

0.65

0.73

ug/l

0.34

355

Explicit bacterial Sepsis

865

9001

0.95

0.66

2.8

3.1

0.74

0.79

ug/l

0.60

594

6152

Benign neoplasm: Testis

470

1.26

0.66

3.1

3.0

0.68

0.84

ug/l

0.66

303

Melanocytic naevi, other sites/unspecified

478

4520

1.07

0.66

3.0

0.72

0.73

ug/l

0.11

311

2920

Hypertension, portal

230

0.69

0.65

2.2

2.7

0.48

0.77

ug/l

—

138

Mandibular hypoplasia

208

1.33

0.65

2.5

2.6

0.53

0.69

ug/l

1.14

118

Neuroendocrine tumor and carcinoma of small intestine

876

1.16

0.65

3.2

2.7

0.78

0.75

ug/l

0.14

592

Contact with machinery

1313

13529

0.96

0.65

2.9

0.69

0.74

ug/l

0.87

829

8726

Obesity, other/unspecified

1714

17653

0.97

0.65

2.6

2.8

0.61

0.73

ug/l

2.98

1125

10974

Scarlet fever

324

0.75

0.65

1.8

2.2

0.66

0.63

ug/l

—

152

Cutaneous lupus erythematosus

772

0.84

0.65

3.1

2.9

0.56

0.72

ug/l

1.81

491

Acute generalized exanthematous pustulosis

210

1927

1.10

0.65

3.4

3.1

0.77

0.78

ug/l

0.02

153

1281

Postdysenteric arthropathy

538

1.21

0.65

3.0

2.6

0.64

0.74

ug/l

0.62

329

Congenital malformations and deformations of the musculoskeletal system

253

2322

1.09

0.65

2.9

2.6

0.71

0.70

ug/l

0.04

151

1308

Other renal tubulo-interstitial diseases

720

1.17

0.65

3.2

3.0

1.07

0.77

ug/l

0.29

468

9508

49740

0.99

0.65

2.9

3.0

0.73

0.79

ug/l

7.01

6176

32874

Rheumatoid lung disease

308

0.74

0.65

3.4

3.3

0.58

0.82

ug/l

1.21

219

Anterior Iridocyclitis

1387

13433

1.04

0.65

2.9

0.69

0.74

ug/l

1.89

931

8559

Childhood asthma (age<16)

321

2717

0.93

0.64

1.6

1.7

0.48

0.54

ug/l

1.20

108

970

Other disorders of choroid

847

1.16

0.64

3.1

3.0

1.04

0.80

ug/l

0.43

554

Carcinoma in situ of stomach

1.75

0.64

2.3

3.1

1.31

0.72

ug/l

—

Haemangioma and lymphangioma, any site

484

4580

1.06

0.64

3.1

3.0

0.70

0.74

ug/l

0.55

321

2970

Glaucoma secondary to other eye disorders

262

2818

0.92

0.64

3.1

0.87

0.80

ug/l

0.33

188

1903

Heart failure and hypertrophic cardiomyopathy

132

1459

0.88

0.64

2.7

3.1

0.65

0.79

ug/l

1.27

987

Amoebiasis

372

1.24

0.64

3.4

2.8

0.60

0.68

ug/l

0.47

226

Other and unspecified parapsoriasis

386

1.27

0.64

3.3

3.2

0.52

0.78

ug/l

3.25

259

Autism spe

447

0.80

0.64

2.0

1.9

0.52

0.55

ug/l

0.12

174

Autoimmune hepatitis

267

0.73

0.64

2.5

3.1

0.43

0.78

ug/l

3.14

171

Congenital malformations of the respiratory system

629

0.83

0.64

2.6

2.8

0.65

0.73

ug/l

0.29

395

Aortic aneurysm

3249

31273

1.03

0.64

3.2

3.3

0.81

0.82

ug/l

0.14

2324

22191

Other congenital malformations of face and neck

142

1280

1.12

0.63

2.5

2.7

0.66

0.72

ug/l

0.46

752

Parkinson's disease, excluding more controls

1322

12845

0.96

0.63

3.1

3.3

0.75

0.86

ug/l

4.49

954

9251

Myositis

179

1637

1.11

0.63

2.9

0.69

0.76

ug/l

0.71

126

1075

Nail disorders

459

4340

1.07

0.63

2.8

0.65

0.73

ug/l

1.72

290

2615

Malignant neoplasm of nasopharynx, including Hilmo

351

0.76

0.63

2.4

2.5

0.61

0.74

ug/l

0.66

223

Hyperchylomicronaemia

192

0.66

0.63

2.5

3.0

0.64

0.69

ug/l

0.22

125

Complications of genitourinary prosthetic devices, implants and grafts

119

1063

1.14

0.63

3.0

3.1

0.93

0.78

ug/l

0.47

723

Benign neoplasm: Pelvic bones, sacrum and coccyx

184

1.36

0.62

2.8

2.7

0.59

0.76

ug/l

0.89

101

Oral lichen planus

817

1.15

0.62

3.1

3.0

0.62

0.74

ug/l

1.15

546

Familial hypercholesterolemia

1506

14634

1.04

0.62

3.0

3.2

0.76

0.79

ug/l

0.38

1042

10349

Impacted maxillary molar

103

908

1.14

0.62

2.2

0.54

0.66

ug/l

1.53

444

Special screening examination for other diseases and disorders

751

7831

0.95

0.62

3.0

0.84

0.79

ug/l

0.40

410

5168

Residual foreign body in soft tissue

407

3844

1.07

0.62

2.9

2.6

0.59

0.73

ug/l

5.01

264

2330

Intracranial injury

5005

46561

1.02

0.62

2.9

3.0

0.73

0.78

ug/l

1.98

3362

30255

Bicuspidal aortic valve syndrome

327

3073

1.08

0.62

2.8

0.70

ug/l

0.01

194

1868

Acute myeloid leukaemia, helper endpoint

560

0.82

0.62

2.9

2.7

0.84

0.79

ug/l

0.14

380

Acute myeloid leukaemia, including Hilmo

560

0.82

0.62

2.9

2.7

0.84

0.79

ug/l

0.14

380

Acute myeloid leukaemia

560

0.82

0.62

2.9

2.7

0.84

0.79

ug/l

0.14

380

Hyperkinetic disorders (excl. ADHD)

367

1.23

0.62

1.6

1.7

0.41

0.59

ug/l

2.58

129

Chronic hepatitis, not elsewhere classified

142

1569

0.89

0.61

2.5

2.9

0.68

0.75

ug/l

0.39

986

Other mycoses, not elsewhere classified/unspecified

250

0.72

0.61

2.3

3.1

0.81

0.80

ug/l

0.02

174

Pedestrian injured in collision with pedal cycle

194

1783

1.10

0.61

2.4

2.8

0.73

0.75

ug/l

0.07

126

1079

Viral Sepsis

1591

16366

0.97

0.61

2.9

3.1

0.77

0.79

ug/l

0.18

1132

11237

Malignant neoplasm of adrenal gland

221

1.33

0.61

3.4

2.6

1.09

0.75

ug/l

0.57

138

Streptococcal septicaemia

748

7788

0.95

0.61

2.8

3.2

0.77

0.78

ug/l

0.11

515

5347

Pervasive developmental disorders excl. Autism + Asperger

129

1.39

0.61

1.7

1.9

0.35

0.60

ug/l

—

Other articular cartilage disorders

184

1691

1.11

0.61

3.1

2.8

0.64

0.80

ug/l

1.57

115

1063

Vascular dementia (subcortical)

224

2074

1.10

0.61

2.9

3.5

0.74

0.90

ug/l

1.91

178

1495

Malignant neoplasm of ureter

169

1.40

0.61

2.2

2.6

0.66

0.67

ug/l

0.03

121

Congenital malformations of larynx

1.62

0.61

1.7

2.5

0.56

0.70

ug/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.57

0.60

2.7

3.0

1.25

0.80

ug/l

—

Granulomatous disorders of skin and subcutaneous tissue

820

0.86

0.60

3.1

2.9

0.77

0.75

ug/l

0.08

511

Oesophageal obstruction

270

2888

0.92

0.60

2.9

3.1

0.81

0.77

ug/l

0.13

189

1991

Bruxism

372

1.22

0.60

2.2

2.5

0.69

0.73

ug/l

0.10

214

Sequelae of other and unspecified infectious and parasitic diseases

352

3311

1.07

0.60

2.7

2.6

0.66

0.70

ug/l

0.36

208

1867

Secondary thrombocytopenia

803

0.85

0.60

2.5

3.0

0.80

0.74

ug/l

0.27

523

Dislocation, sprain and strain of joints and ligaments of elbow

277

2580

1.08

0.60

2.5

2.7

0.68

0.69

ug/l

0.08

154

1479

Helminthiases

784

1.16

0.60

2.9

0.65

0.78

ug/l

1.00

503

Contact with blunt object, undetermined intent

367

1.24

0.60

3.1

2.8

0.77

0.75

ug/l

0.04

219

Recurrent dislocation of patella

102

902

1.14

0.60

1.9

2.1

0.82

0.70

ug/l

0.21

433

Open bite

104

921

1.14

0.60

3.2

2.4

0.70

0.69

ug/l

0.05

492

Scabies

301

3211

0.93

0.60

2.7

0.65

0.71

ug/l

0.60

181

1915

Other autoimmune haemolytic anaemias

718

0.84

0.60

3.0

3.1

1.23

0.81

ug/l

0.93

486

Traumatic amputation of ankle and foot

246

0.71

0.60

1.5

2.9

0.48

0.71

ug/l

—

157

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

333

1.27

0.60

2.8

2.7

0.57

0.80

ug/l

2.29

230

Secondary hypertension

624

6441

0.95

0.60

2.7

3.1

0.91

0.76

ug/l

1.75

456

4153

Malignant neoplasm of oropharynx, including Hilmo

176

1908

0.90

0.59

2.9

2.6

0.71

0.69

ug/l

0.14

119

1211

Congenital malformations of eye, ear, face and neck

260

2416

1.08

0.59

2.8

0.72

ug/l

0.01

152

1444

Thiazolidinediones

1081

11163

0.96

0.59

3.0

3.2

0.85

0.77

ug/l

1.13

766

7821

Toxic effect of organic solvents

271

0.74

0.59

3.0

2.9

0.55

0.66

ug/l

0.60

167

Corneal ulcer

1259

12199

1.04

0.59

2.8

0.71

0.73

ug/l

0.43

769

7513

Spondylopathies (FG)

900

8668

1.04

0.59

2.8

2.7

0.66

0.75

ug/l

3.11

589

5187

Syndrome of inappropriate secretion of antidiuretic hormone

316

0.76

0.59

2.3

2.9

0.61

0.74

ug/l

0.75

211

Short stature, not elsewhere classified

1.58

0.59

1.4

1.2

0.54

0.45

ug/l

—

Asymptomatic human immunodeficiency virus [HIV] infection status

530

0.81

0.59

2.4

2.3

0.97

0.62

ug/l

0.50

265

Drug-induced osteoporosis

515

0.82

0.59

2.7

2.9

0.51

0.73

ug/l

2.14

336

Congenital malformations of the respiratory system

677

0.84

0.59

2.7

2.8

0.64

0.73

ug/l

0.41

416

Membranous nephropathy

306

1.28

0.58

2.6

2.9

1.07

0.76

ug/l

0.76

188

Toxic effect of other and unspecified substances

558

0.83

0.58

2.2

2.4

0.58

0.65

ug/l

0.34

295

Disorders of porphyrin and bilirubin metabolism

761

1.16

0.58

2.8

2.9

0.90

0.73

ug/l

0.66

484

Exposure to ignition of highly flammable material

389

0.78

0.58

3.6

2.7

0.75

0.78

ug/l

0.11

226

Implicit viral Sepsis

1590

16337

0.97

0.58

2.9

3.1

0.77

0.79

ug/l

0.18

1131

11221

Defect, injury or illness of neck

222

1.30

0.57

2.9

2.8

1.20

0.75

ug/l

0.52

136

Restrictive cardiomyopathy

247

0.73

0.57

3.3

3.0

0.88

0.76

ug/l

0.23

155

Acquired pure red cell aplasia [erythroblastopenia]

223

1.31

0.57

3.1

2.9

1.21

0.78

ug/l

0.33

153

Other primary thrombocytopenia

169

1.36

0.57

2.9

3.1

0.72

0.71

ug/l

0.02

117

Secondary polycythaemia

212

1970

1.10

0.57

3.0

2.8

0.72

0.73

ug/l

0.12

139

1215

Mixed disorders of conduct and emotions, excluding more controls

158

1.34

0.57

1.3

1.4

0.32

0.58

ug/l

—

Disorders of orbit

185

1700

1.10

0.57

2.8

0.61

0.74

ug/l

2.06

119

1050

Other and unspecified erythematous conditions

151

1376

1.11

0.57

3.0

0.77

0.76

ug/l

0.03

910

Intentional self-harm by jumping from a high place

216

0.72

0.57

1.6

2.2

0.59

0.65

ug/l

—

Mesial bite

206

0.72

0.57

2.7

2.5

0.62

0.75

ug/l

—

114

Discharge from other and unspecified firearms

290

0.75

0.57

2.3

2.4

0.73

ug/l

0.02

159

Anxious personality disorder

633

0.84

0.57

2.2

2.3

0.51

0.64

ug/l

0.43

309

Nail dystrophy

314

1.25

0.57

4.1

2.8

0.63

0.77

ug/l

0.86

196

Superficial injury of neck

101

901

1.14

0.56

2.7

2.6

0.62

0.73

ug/l

1.07

499

Other haemoglobinopathies

127

1.45

0.56

2.2

2.6

0.49

0.71

ug/l

1.46

Perforation of oesophagus

410

0.79

0.56

3.0

3.1

0.69

0.72

ug/l

0.07

277

Coeliac disease

547

5734

0.95

0.56

2.8

3.0

0.76

0.75

ug/l

0.05

366

3761

Non-seminoma of testis, including Hilmo

389

1.23

0.56

2.8

2.0

0.58

0.63

ug/l

0.21

183

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1013

9482

1.04

0.56

2.9

2.8

0.82

0.72

ug/l

1.32

650

5870

Aortic stenosis

109

1.47

0.56

3.6

3.1

0.74

0.78

ug/l

—

Congenital malformations of genital organs

826

1.13

0.56

2.7

0.62

0.77

ug/l

1.08

476

Chondromalacia

172

1582

1.10

0.56

3.4

2.8

0.67

0.72

ug/l

0.69

103

975

Disorders of synovium and tendon in diseases classified elsewhere

164

1508

1.11

0.56

3.0

2.8

0.60

0.74

ug/l

2.01

107

952

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

402

0.80

0.56

2.6

2.4

0.42

0.76

ug/l

5.57

251

Melanoma of uvea

711

0.85

0.55

3.5

3.0

0.74

0.81

ug/l

0.35

471

Other (seronegative) rheumatoid arthritis, wide

916

9494

0.96

0.55

3.0

3.1

0.72

0.78

ug/l

0.93

651

6494

Leukaemia of unspecified cell type

573

0.83

0.55

3.0

2.9

0.58

0.81

ug/l

1.76

362

Keratoconus

139

1523

0.90

0.55

2.6

0.71

0.69

ug/l

0.05

856

Secondary uncertain malignant neoplasm

994

10273

0.96

0.55

2.9

2.7

0.85

0.72

ug/l

3.37

699

7027

Suppurative otitis media, unspecified

1096

0.88

0.55

3.1

3.0

0.73

0.75

ug/l

0.15

703

Deaf mutism, not elsewhere classified

280

0.76

0.55

2.4

2.8

0.83

0.86

ug/l

0.06

182

Acute bronchiolitis

925

0.88

0.55

2.7

2.8

0.72

0.74

ug/l

0.10

556

Sleep disorders

6030

44166

0.98

0.55

2.8

0.66

0.74

ug/l

5.13

3656

26881

Atypical mycobacterium lung infection

606

0.84

0.54

3.3

3.1

0.96

0.83

ug/l

0.15

408

Any reimbursement code in KELA

4073

20771

0.98

0.54

2.6

2.5

0.69

ug/l

0.00

2431

11206

Thyrotoxicosis with toxic single thyroid nodule

223

1.28

0.54

2.1

3.0

0.65

0.71

ug/l

0.15

147

Arthropathy in ulcerative colitis

564

0.83

0.54

2.9

2.6

0.67

0.70

ug/l

0.10

339

Diabetic retinopathy

2589

16469

0.98

0.54

3.0

2.9

0.79

0.76

ug/l

0.42

1857

11213

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.48

0.54

2.8

2.4

0.62

0.64

ug/l

—

Asthma

6716

35672

0.98

0.54

2.8

2.9

0.67

0.77

ug/l

10.46

4312

22473

Liposarcoma

551

1.19

0.54

3.0

2.5

0.61

0.72

ug/l

0.79

359

Other bacterial agents as the cause of diseases classified to other chapters

595

0.84

0.54

2.9

3.2

1.23

0.74

ug/l

0.30

403

Malaria

308

1.25

0.54

2.6

3.0

0.68

0.73

ug/l

0.28

192

Acute drug-induced interstitial lung disorder

485

0.82

0.54

3.3

3.2

0.90

0.78

ug/l

0.31

338

Retinoschisis and retinal cysts

184

1705

1.10

0.53

3.2

0.66

0.78

ug/l

1.60

124

1170

Disorder of the sleep-wake schedule

801

1.14

0.53

2.6

2.7

0.62

0.73

ug/l

0.89

480

Other specified/unspecified nutritional deficiencies

313

0.78

0.53

2.4

2.8

0.55

0.85

ug/l

1.61

200

Cellulitis

1750

17930

0.97

0.53

2.8

2.9

0.69

0.75

ug/l

1.37

1142

11464

Previous suicide attempt

412

0.81

0.53

1.8

2.5

0.80

0.71

ug/l

0.12

227

Small plaque parapsoriasis

191

1.34

0.53

3.2

3.1

0.67

0.69

ug/l

0.04

119

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

524

0.82

0.53

2.1

2.6

0.50

0.68

ug/l

2.66

299

Biological medicines for asthma

811

1.14

0.53

2.5

0.52

0.66

ug/l

2.17

457

Use of ropinirole

264

2807

0.92

0.53

3.0

3.2

0.65

0.75

ug/l

2.24

176

1946

Muscle wasting and atrophy, not elsewhere classified

408

0.80

0.52

2.4

2.9

0.76

0.82

ug/l

0.17

268

Nonalcoholic steatohepatitis

447

1.20

0.52

2.5

2.7

0.52

0.70

ug/l

1.79

275

Early syphilis

113

1026

1.13

0.52

2.5

2.4

0.58

0.70

ug/l

1.12

553

Benign neoplasm: Connective and other soft tissue, unspecified

587

1.17

0.52

3.1

3.0

0.82

0.76

ug/l

0.13

383

Chorioretinal inflammation

139

1519

0.90

0.52

2.5

2.9

0.76

0.73

ug/l

0.10

958

Other bacterial agents as the cause of diseases classified to other chapters

496

0.83

0.52

3.0

3.1

1.38

0.76

ug/l

0.31

338

Primary adrenocortical insufficiency

400

0.81

0.52

3.0

2.8

0.99

0.77

ug/l

0.49

240

Post-traumatic wound infection, not elsewhere classified

203

1890

1.09

0.52

2.8

0.63

0.75

ug/l

2.01

135

1154

Coagulation defects, purpura and other haemorrhagic conditions

1307

12708

1.03

0.52

2.9

3.0

0.79

0.77

ug/l

0.16

891

8533

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

124

1356

0.89

0.52

2.5

2.6

0.75

0.69

ug/l

0.39

754

Other psoriatic arthropathies

635

6610

0.95

0.52

2.8

0.58

0.73

ug/l

8.12

390

4129

Tibial collateral bursitis [Pellegrini-Stieda]

418

1.19

0.52

2.7

0.61

0.73

ug/l

0.59

261

Liver disorders in diseases classified elsewhere

108

0.62

0.52

2.7

2.6

0.50

0.69

ug/l

—

Other and unspecified heterotropia

137

1.38

0.51

2.6

3.0

1.21

0.73

ug/l

0.36

Other immunodeficiencies

367

0.80

0.51

2.5

2.7

0.61

0.73

ug/l

0.25

228

Acute mastoiditis

504

1.18

0.51

2.2

2.5

0.76

0.71

ug/l

0.18

275

Other factor of the environment

708

0.86

0.51

3.1

2.9

0.80

0.74

ug/l

0.19

441

Bullous pemphigoid

155

1429

1.11

0.51

2.7

3.3

1.09

0.81

ug/l

0.52

107

985

Congenital malformations of aortic and mitral valves

339

3213

1.07

0.51

2.8

0.70

ug/l

0.02

200

1960

Exposure to controlled fire, not in building or structure

209

0.73

0.51

2.8

2.5

0.94

0.76

ug/l

—

127

Injury of cranial nerves

375

0.80

0.51

3.0

2.7

0.67

0.73

ug/l

0.22

220

Malignant neoplasm of other and unspecified parts of mouth

331

0.79

0.51

2.2

2.6

1.00

0.77

ug/l

0.21

231

Injury of nerves and spinal cord at neck level

159

1719

0.91

0.51

2.5

3.0

0.57

0.73

ug/l

2.71

111

1098

Panniculitis, unspecified

457

1.18

0.50

2.5

3.0

0.59

0.77

ug/l

1.54

296

Disorders of male genital organs in diseases classified elsewhere

623

1.18

0.50

3.1

2.3

0.58

0.69

ug/l

1.14

337

Drug-induced adrenocortical insufficiency

751

0.87

0.50

3.5

3.0

1.05

0.79

ug/l

0.24

479

Cardiomyopathy, other and unspecified

685

7104

0.95

0.50

2.7

3.1

0.84

0.78

ug/l

0.41

487

4799

Injury of blood vessels at lower leg level

308

0.78

0.50

2.3

2.8

0.75

0.80

ug/l

0.11

185

Acute appendicitis, with complications

1569

16078

0.97

0.50

2.9

0.77

0.76

ug/l

0.12

1019

10352

Ingrowing nail

297

2800

1.07

0.50

2.7

2.6

0.61

0.71

ug/l

1.60

174

1585

Burn and corrosion confined to eye and adnexa

168

1555

1.10

0.50

2.5

2.6

0.55

0.70

ug/l

3.55

100

863

Other degenerative diseases of the nervous system

2269

17297

0.98

0.50

2.9

3.2

0.80

0.84

ug/l

0.68

1634

12188

Other congenital malformations of male genital organs

272

1.24

0.50

2.9

2.6

0.50

0.74

ug/l

1.66

148

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

612

1.17

0.50

2.8

2.7

0.62

0.77

ug/l

1.43

420

Osteitis due to dental implant

375

1.21

0.50

2.8

3.0

0.83

0.77

ug/l

0.21

247

Additional codes for the location of defect, injury or illness

299

3168

0.94

0.50

2.9

3.0

0.72

0.75

ug/l

0.29

205

2061

Candidiasis

608

6333

0.96

0.50

2.9

3.0

0.77

0.76

ug/l

0.04

444

4173

Benign neoplasm: Connective and other soft tissue of thorax

265

1.26

0.49

3.1

2.9

0.57

0.70

ug/l

0.45

178

Hyperfunction of pituitary gland

162

1492

1.09

0.49

2.7

2.8

0.60

0.73

ug/l

2.20

106

879

Systemic disorders of connective tissue in diseases classified elsewhere

201

1.29

0.49

2.4

2.7

0.67

0.75

ug/l

0.30

127

Benign neoplasm: Nasopharynx

535

1.17

0.49

3.2

2.9

0.76

0.81

ug/l

0.16

336

Congenital malformations of oesophagus

265

1.25

0.49

2.7

3.0

0.62

0.74

ug/l

0.61

179

Embolic stroke with flimmer

195

2088

0.92

0.49

2.9

3.3

0.83

0.81

ug/l

0.06

128

1505

Benign neoplasm: Orbit, unspecified

292

1.23

0.49

2.7

3.1

0.99

0.78

ug/l

0.45

192

Other mosquito-borne viral fevers

130

1.39

0.49

2.4

2.7

0.63

0.71

ug/l

—

Dermatitis due to substances taken internally

266

2500

1.07

0.49

3.3

3.0

0.74

0.77

ug/l

0.21

189

1608

Disorders of other and unspecified cranial nerves

302

1.23

0.49

2.8

3.0

0.93

0.85

ug/l

0.17

196

Personal history of allergy to analgesic agent

255

1.25

0.49

3.4

2.6

0.46

0.75

ug/l

2.82

148

Myopia

484

4622

1.05

0.48

2.7

0.65

0.69

ug/l

0.71

294

2693

Exclusion endpoint for supernumerary teeth

318

1.21

0.48

2.3

2.4

0.53

0.75

ug/l

1.67

163

Superficial injury of forearm

516

4939

1.05

0.48

2.9

2.8

0.69

0.72

ug/l

0.41

341

3074

Other superficial mycoses

137

1258

1.11

0.48

2.9

2.7

0.59

0.73

ug/l

1.83

763

Pedestrian injured in other and unspecified transport accidents

546

0.84

0.48

2.9

0.75

0.80

ug/l

0.14

337

Combined immunodeficiencies

492

0.84

0.48

2.7

3.0

1.22

0.73

ug/l

0.31

311

Generalized skin eruption due to drugs and medicaments

180

1670

1.09

0.48

3.4

3.1

0.77

0.78

ug/l

0.07

131

1115

Urticaria due to cold and heat

200

1.27

0.48

2.8

2.3

0.63

0.67

ug/l

0.09

114

Hereditary spherocytosis

112

1.40

0.48

2.8

2.3

0.85

0.66

ug/l

—

Delirium, not induced by alcohol and other psychoactive substances

956

9832

0.96

0.48

3.0

3.3

0.79

0.83

ug/l

0.42

668

6924

Spondylopathies in diseases classified elsewhere

870

0.87

0.48

3.7

3.1

0.84

0.83

ug/l

0.05

628

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

0.48

0.0

2.3

—

0.66

—

Complications following infusion, transfusion and therapeutic injection

799

0.87

0.48

3.1

3.0

0.82

0.78

ug/l

0.12

514

Intentional self-harm by unspecified means

407

0.82

0.47

2.4

2.3

1.09

0.73

ug/l

0.36

213

Subacute thyroiditis

107

968

1.11

0.47

3.2

2.9

0.66

0.74

ug/l

0.75

629

Injuries to the thorax

4533

44686

1.02

0.47

3.0

2.9

0.70

0.77

ug/l

3.73

3032

29100

Other disorders of iris and ciliary body

181

1684

1.09

0.47

2.7

2.9

0.70

0.77

ug/l

0.65

108

1083

Burn and corrosion of other internal organs

174

0.72

0.47

2.6

0.71

0.77

ug/l

—

Rheumatism, unspecified

256

2401

1.07

0.47

3.2

2.8

0.79

0.74

ug/l

0.14

167

1548

Overjet

298

1.21

0.47

3.1

2.5

0.65

0.72

ug/l

0.32

161

Drug-induced myopathy

206

0.74

0.47

1.9

2.9

1.00

0.91

ug/l

—

134

Scleritis

497

1.17

0.47

2.6

2.7

0.78

0.72

ug/l

0.27

295

Dislocation, sprain and strain of joints and ligaments of head

136

1482

0.91

0.47

2.4

2.7

0.57

0.73

ug/l

2.38

844

Other congenital malformations of skin

157

1449

1.09

0.47

2.4

2.8

0.62

0.73

ug/l

1.02

892

Iron deficiency

439

1.17

0.47

3.1

2.7

0.76

0.73

ug/l

0.08

270

Familial erythrocytosis

332

1.22

0.47

2.7

2.8

0.73

0.75

ug/l

0.08

197

Abnormality of white blood cells, not elsewhere classified

447

0.83

0.47

3.7

2.8

0.58

0.67

ug/l

0.66

286

Other congenital malformations of intestine

498

1.17

0.47

2.6

2.9

0.57

0.81

ug/l

2.12

319

Intracranial and intraspinal abscess and granuloma

852

1.13

0.47

2.9

0.61

0.72

ug/l

1.24

545

Burn and corrosion of wrist and hand

213

2274

0.93

0.47

2.5

2.7

0.66

0.70

ug/l

0.35

130

1330

Psoriatic arthropathies, ICD10

652

6764

0.96

0.47

2.8

0.58

0.73

ug/l

8.52

402

4231

Perioral dermatitis

282

1.21

0.47

2.6

0.41

0.75

ug/l

3.34

169

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

606

1.16

0.47

2.8

1.08

0.78

ug/l

0.32

428

Disorders of optic nerve and visual pathways

464

4436

1.05

0.47

3.1

3.0

0.74

ug/l

0.01

301

2846

Medial epicondylitis

198

1847

1.08

0.47

2.8

2.7

0.73

0.72

ug/l

0.09

127

1134

Cluster headache, wide

222

2080

1.08

0.47

2.5

2.6

0.69

0.72

ug/l

0.18

132

1249

Hypersomnia

783

1.13

0.46

2.9

2.8

0.82

0.73

ug/l

0.20

499

Fracture of foot, except ankle

1475

14391

1.03

0.46

2.6

2.7

0.64

0.72

ug/l

3.92

905

8737

Pemphigus

424

0.82

0.46

3.4

3.1

0.81

0.75

ug/l

0.08

266

Dacryoadenitis

284

1.22

0.46

3.1

2.8

0.64

0.86

ug/l

0.97

189

Other chondrocalcinosis

100

910

1.13

0.46

3.1

3.2

0.64

0.83

ug/l

2.59

619

Other and unspecified corneal deformities and disorders

183

1704

1.09

0.46

3.2

2.8

0.67

0.73

ug/l

0.58

131

1018

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

224

2387

0.93

0.46

3.1

2.9

0.77

0.75

ug/l

0.12

134

1488

Fourth [trochlear] nerve palsy

165

1534

1.09

0.46

2.9

3.2

0.72

0.77

ug/l

0.48

117

1046

Melanocytic naevi of eyelid, including canthus

404

0.82

0.46

2.3

2.9

1.03

0.72

ug/l

0.34

261

Gonococcal infection

123

1124

1.10

0.46

2.2

2.3

0.67

0.65

ug/l

0.06

567

Benign neoplasm: Hypopharynx

381

1.21

0.46

2.5

3.1

0.80

0.79

ug/l

0.03

250

Viral pneumonia

995

10242

0.97

0.46

2.8

3.0

0.71

0.77

ug/l

1.26

698

6736

Benign neoplasm: Skin of trunk

240

2257

1.07

0.46

3.0

0.71

0.75

ug/l

0.39

166

1458

Follicular cysts of skin and subcutaneous tissue

1387

13534

1.03

0.46

2.9

0.75

0.74

ug/l

0.11

912

8687

Seronegative juvenile rheumatoid arthritis

198

0.75

0.45

2.2

2.3

0.73

ug/l

—

107

Other obstructive and reflux uropathy

245

2305

1.07

0.45

3.0

1.01

0.76

ug/l

1.75

172

1543

Hemiplegia

271

2868

0.94

0.45

2.7

3.1

0.73

0.79

ug/l

0.27

199

1920

Disorders of puberty

103

1.37

0.45

1.9

1.5

0.31

0.46

ug/l

—

Superficial injury of abdomen, lower back and pelvis

948

9199

1.04

0.45

3.0

2.9

0.70

0.76

ug/l

0.52

615

5876

Other gastritis (incl. Duodenitis)

1879

18405

1.03

0.45

3.1

0.72

0.79

ug/l

1.61

1394

12495

Unspecified human immunodeficiency virus [HIV] disease

926

0.88

0.45

2.2

2.5

0.71

0.66

ug/l

0.09

485

Mixed disorders of conduct and emotions

165

1.28

0.45

1.3

1.4

0.32

0.52

ug/l

—

Malignant neoplasm of eye and adnexa

508

0.84

0.45

2.9

2.6

0.96

0.78

ug/l

0.53

336

Hyphaema and other vascular disorders of iris and ciliary body

147

1362

1.10

0.45

2.7

3.0

0.75

0.79

ug/l

0.25

870

Other interstitial pulmonary diseases

1360

13925

0.97

0.45

3.0

3.2

0.72

0.82

ug/l

3.27

978

9962

Absence of one kidney

172

0.72

0.45

2.2

2.8

0.69

0.80

ug/l

—

115

MS-disease / Multiple Sclerosis

213

2275

0.93

0.45

2.4

2.6

0.57

0.70

ug/l

2.64

143

1295

Esophageal diverticulum (pouch)

178

1.32

0.45

3.0

3.1

0.73

0.72

ug/l

0.00

132

Xerosis cutis

1013

0.89

0.44

2.9

3.2

0.54

0.79

ug/l

5.25

686

Congenital malformation of vitreous humour

0.00

0.44

0.0

2.9

—

0.75

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

0.44

0.0

2.8

—

0.71

—

Localized scleroderma [morphea]

312

1.20

0.44

3.1

2.7

0.95

0.72

ug/l

0.27

187

Specific development disorders of scholastic skills

789

1.12

0.44

1.9

2.0

0.40

0.59

ug/l

2.92

328

Seronegative rheumatoid arthritis

573

5511

1.04

0.44

3.0

3.1

0.70

0.80

ug/l

2.13

414

3725

Convergent concomitant strabismus

199

2129

0.93

0.44

2.4

2.5

0.52

0.70

ug/l

3.40

102

1156

Injury of muscle and tendon at wrist and hand level

1245

12145

1.03

0.44

2.8

0.69

0.72

ug/l

0.22

786

7488

Cholecystitis

1106

11357

0.97

0.44

3.0

3.2

0.79

0.82

ug/l

0.37

774

7939

Horner syndrome

710

1.14

0.44

2.5

2.8

0.69

0.76

ug/l

0.32

457

Other encephalitis

156

1447

1.09

0.44

2.8

2.9

0.76

0.77

ug/l

0.01

106

899

Dissection of aorta

291

3061

0.94

0.44

2.9

3.2

0.88

0.81

ug/l

0.18

206

2107

Typhus fever

0.00

0.44

0.0

3.0

—

0.74

—

Use of interferon beta-1a

522

0.85

0.44

1.7

2.3

0.55

0.63

ug/l

0.52

248

Malignant neoplasm of oral cavity

251

2652

0.93

0.44

2.7

2.6

0.81

0.70

ug/l

0.86

168

1716

Malignant neoplasm of accessory sinuses, including Hilmo

292

0.79

0.44

2.9

2.6

0.67

0.76

ug/l

0.31

192

Nezelof syndrome

227

0.77

0.44

2.2

3.0

0.57

0.72

ug/l

0.78

154

Use of cabergoline

681

1.14

0.44

2.6

2.8

0.70

0.79

ug/l

0.48

419

Acute poliomyelitis

541

0.85

0.44

2.6

2.8

0.56

0.79

ug/l

1.47

318

Other abnormal immunological findings in serum

651

1.13

0.44

3.3

2.8

0.60

0.65

ug/l

0.32

401

281

0.79

0.43

3.1

3.2

0.64

0.77

ug/l

0.58

189

Paralytic strabismus

522

5022

1.05

0.43

2.9

3.1

0.74

0.76

ug/l

0.12

362

3420

Other meningitis

699

0.87

0.43

2.9

2.8

0.72

0.73

ug/l

0.07

426

Marginal zone B-cell lymphoma

560

1.16

0.43

3.1

2.6

0.74

0.73

ug/l

0.04

376

Hypertensive Heart Disease

2476

19728

0.98

0.43

3.1

3.2

0.80

0.78

ug/l

0.31

1771

13852

Contusion of toe(s) without damage to nail

899

1.11

0.43

2.9

2.7

0.66

0.73

ug/l

0.30

534

Malignant neoplasm of larynx

144

1546

0.91

0.43

3.1

2.7

0.72

0.74

ug/l

0.13

105

1081

Scoliosis

226

2121

1.07

0.43

3.2

2.9

0.71

0.77

ug/l

0.40

156

1373

Other disorders of Eustachian tube

149

1381

1.09

0.43

3.1

2.9

0.65

0.72

ug/l

0.94

111

877

Benign neoplasm: Connective and other soft tissue of head, face and neck

101

921

1.11

0.43

3.2

3.0

0.83

0.75

ug/l

0.34

579

Speech and linguistic disorders

244

2203

1.07

0.43

2.4

2.5

0.62

0.71

ug/l

0.76

158

1212

Trigeminal neuralgia

253

2387

1.07

0.43

3.3

3.0

0.71

0.77

ug/l

0.43

178

1581

Benign neoplasm: Spinal meninges

389

1.18

0.43

2.8

3.1

1.12

0.73

ug/l

0.42

259

Burns and corrosions

998

10259

0.97

0.43

2.8

2.7

0.67

0.72

ug/l

1.35

632

6232

Other bursitis, not elsewhere classified

612

0.86

0.43

2.9

0.64

0.81

ug/l

1.13

392

Other bursal cyst

845

1.12

0.43

3.8

3.0

0.66

0.75

ug/l

0.56

574

Syphilis

198

2105

0.93

0.43

2.6

2.7

0.64

0.71

ug/l

0.68

138

1261

Syphilis

198

2105

0.93

0.43

2.6

2.7

0.64

0.71

ug/l

0.68

138

1261

Mandibular prognathia

551

0.86

0.43

2.6

2.7

0.73

0.72

ug/l

0.03

318

Chronic mastoiditis

190

1782

1.08

0.43

3.2

0.97

0.79

ug/l

0.81

121

1207

Amyloidosis, other/unspecified

141

1309

1.10

0.42

3.3

3.2

0.72

0.78

ug/l

0.53

106

948

Drug-induced tremor

388

0.83

0.42

2.3

3.0

0.76

0.75

ug/l

0.04

266

Retinoblastoma

0.00

0.42

0.0

1.6

—

0.73

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

441

4102

0.95

0.42

1.9

2.0

0.47

0.60

ug/l

5.72

243

1747

Bus occupant injured in other and unspecified transport accidents

195

1.26

0.42

2.7

2.9

0.74

0.70

ug/l

0.10

126

Acute nasopharyngitis (common cold)

1207

11701

1.03

0.42

2.2

2.3

0.66

0.63

ug/l

0.44

574

5936

Traumatic ischaemia of muscle

884

0.89

0.42

2.4

2.6

0.57

0.70

ug/l

1.23

535

Acute lymphadenitis

267

2821

0.94

0.42

2.5

2.7

0.67

0.72

ug/l

0.29

140

1647

Injury of nerves at wrist and hand level

296

2815

1.06

0.42

2.7

0.73

0.71

ug/l

0.06

188

1691

Iliotibial band syndrome

324

1.19

0.42

2.8

2.5

0.77

0.74

ug/l

0.09

194

Interstitial lung disease endpoints

1360

13908

0.97

0.42

3.0

3.2

0.72

0.82

ug/l

3.22

978

9947

Interstitial lung disease

1360

13908

0.97

0.42

3.0

3.2

0.72

0.82

ug/l

3.22

978

9947

Benign neoplasm: Carotid body

133

1.33

0.42

1.9

3.0

0.79

0.71

ug/l

—

Contact with other specified venomous animals

335

1.19

0.42

2.8

0.66

0.71

ug/l

0.20

211

Lichen planus

670

6477

1.04

0.41

2.9

3.0

0.76

ug/l

0.00

428

4302

Psoas tendinitis

187

1.26

0.41

3.8

2.8

0.93

0.74

ug/l

0.24

124

Severe visual impairment, monocular

476

1.16

0.41

3.2

3.0

1.16

0.84

ug/l

0.35

315

Motor- or nonmotor-vehicle accident in traffic area

345

0.82

0.41

2.6

2.5

0.85

0.73

ug/l

0.29

201

Pedestrian injured in collision with car, pick-up truck or van

107

1167

0.91

0.41

3.0

2.8

0.79

0.74

ug/l

0.17

718

Central retinal artery occlusion

166

1772

0.92

0.41

2.9

3.3

0.69

0.83

ug/l

1.35

116

1263

Chloasma

1.39

0.41

3.0

0.73

0.69

ug/l

—

Atrophic disorders of skin

348

3314

1.05

0.41

2.9

2.8

0.76

0.72

ug/l

0.16

236

2032

ILD medications: nintedanib

583

0.85

0.41

2.4

3.2

0.58

0.79

ug/l

1.96

414

Iodine-deficiency-related thyroid disorders and allied conditions

0.00

0.41

0.0

3.3

—

0.86

—

Disorders of puberty, all

114

1.32

0.41

1.8

1.5

0.30

0.47

ug/l

—

Excluding asthma or asthma-COPD overlap

7114

36006

0.99

0.41

2.8

2.9

0.73

0.77

ug/l

1.51

4468

22641

Atopic dermatitis

3008

25038

0.98

0.41

2.8

2.6

0.67

0.72

ug/l

1.73

1830

14556

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

147

1576

0.92

0.41

2.8

2.6

0.71

ug/l

0.02

1038

Distal bite

564

1.13

0.41

2.5

2.6

0.74

0.68

ug/l

0.28

327

Artificial opening status

434

4170

1.05

0.41

3.0

0.81

0.78

ug/l

0.19

299

2855

Magnesium deficiency

223

0.77

0.41

2.5

2.8

0.40

0.76

ug/l

4.15

143

Neuroendocrine tumor and carcinoma of lung

355

0.83

0.40

2.5

2.6

0.50

0.75

ug/l

3.09

225

LSIL lesion of the cervix uteri

0.00

0.40

0.0

1.1

—

Other salmonella infections

229

2163

1.07

0.40

3.2

2.9

0.73

0.76

ug/l

0.10

162

1384

Childhood allergy (age < 16)

109

820

1.10

0.40

1.3

0.40

ug/l

0.05

239

Superficial injury of ankle and foot

593

5723

1.04

0.40

2.7

0.64

0.72

ug/l

1.65

360

3394

Valgus deformity, not elsewhere classified

261

1.21

0.40

2.7

2.5

0.75

0.78

ug/l

0.05

158

Hypertrophy of bone

152

1.30

0.40

2.9

2.8

0.62

0.67

ug/l

0.25

Pemphigoid

182

1709

1.08

0.40

2.8

3.3

1.02

0.80

ug/l

0.46

125

1193

Psoriatic and enteropathic arthropathies

752

7753

0.97

0.40

2.8

0.59

0.75

ug/l

9.17

460

4796

Other disorders of optic [2nd] nerve and visual pathways

363

3471

1.05

0.40

3.2

3.0

0.75

ug/l

0.04

242

2291

Thyroiditis

200

1877

1.07

0.40

3.3

2.9

0.67

0.75

ug/l

1.21

138

1190

Burn and corrosion, body region unspecified

375

1.18

0.40

2.7

0.79

0.73

ug/l

0.20

229

Actinomycosis

245

0.79

0.40

2.7

2.8

0.45

0.75

ug/l

3.05

153

Selective serotonin reuptake inhibitors

9561

50342

0.99

0.40

2.9

0.66

0.79

ug/l

27.26

6296

32029

Certain disorders involving the immune mechanism

1322

12924

1.03

0.39

2.8

2.9

0.77

0.74

ug/l

0.46

857

8222

Use of other anti-dementia drugs

2142

18059

0.98

0.39

3.1

3.5

0.87

ug/l

0.01

1528

13463

Use of memantine

2142

18059

0.98

0.39

3.1

3.5

0.87

ug/l

0.01

1528

13463

Sarcoidosis

917

8924

1.03

0.39

2.8

2.9

0.76

0.74

ug/l

0.22

570

5671

Other embolism and thrombosis

925

9003

1.03

0.39

3.1

3.0

0.72

0.78

ug/l

0.90

642

6011

Mycoses

1892

19278

0.98

0.39

2.8

3.0

0.72

0.76

ug/l

0.67

1310

12826

Juvenile cataract

180

0.76

0.39

3.3

2.3

2.24

0.67

ug/l

—

103

Hordeolum and other deep inflammation of eyelid

309

2944

1.06

0.39

2.9

2.8

0.71

0.72

ug/l

0.09

214

1819

Endometriosis of pelvic peritoneum

0.00

0.39

0.0

1.1

—

Other specified and unspecified disorders of eyelid

822

1.11

0.39

2.7

2.9

0.59

0.80

ug/l

1.73

522

Alopecia areata

637

1.12

0.39

2.6

2.7

0.59

0.71

ug/l

1.26

372

Acquired absence of organs, not elsewhere classified

837

0.89

0.39

2.2

3.0

0.99

0.75

ug/l

0.57

550

Blindness, monocular

502

0.86

0.39

3.0

0.73

0.82

ug/l

0.33

323

Other and unspecified aplastic anaemias

698

1.13

0.39

2.8

3.1

0.86

0.81

ug/l

0.10

466

Tetraplegia

511

0.86

0.39

2.7

3.0

0.66

0.80

ug/l

0.74

332

Other infiltrative disorders of skin and subcutaneous tissue

245

0.79

0.39

3.4

2.9

0.57

0.71

ug/l

0.50

145

Lesion of lateral popliteal nerve

400

3842

1.05

0.39

2.7

3.0

0.68

0.74

ug/l

0.85

260

2485

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.39

0.0

1.1

—

Blindness or visual impairment, binocular

234

0.79

0.39

2.8

2.9

1.08

0.76

ug/l

—

155

Other dermatomyositis

169

0.75

0.39

2.4

2.8

0.72

0.75

ug/l

—

111

Spondylolisthesis/Spondylolysis

1132

11046

1.03

0.39

2.8

2.9

0.66

0.76

ug/l

1.71

743

7086

Follicular adenocarcinoma of thyroid gland

272

1.20

0.39

3.8

2.5

0.84

0.77

ug/l

0.16

180

Use of rivastigmine

1030

10014

1.03

0.39

3.1

3.4

0.73

0.87

ug/l

6.20

756

7405

Ankylosis of joint

320

0.82

0.38

3.6

2.8

0.96

0.97

ug/l

0.01

207

Chronic myeloid leukaemia [CML], BCR/ABL-positive

637

0.87

0.38

2.4

3.0

0.70

0.80

ug/l

0.48

423

Non-Hodgkin lymphoma, all

331

3458

0.95

0.38

2.8

2.7

0.77

0.75

ug/l

0.14

223

2420

Vitiligo

513

0.86

0.38

2.7

2.6

0.67

0.70

ug/l

0.18

306

Malignant neoplasm of base of tongue

550

1.15

0.38

2.6

2.5

0.78

0.71

ug/l

0.29

337

Other localized connective tissue disorders

515

1.14

0.38

2.9

2.7

0.88

0.72

ug/l

0.30

307

Unspecified urinary incontinence

226

2133

1.06

0.38

3.0

3.1

0.75

0.76

ug/l

0.04

168

1435

Striae atrophicae

234

1.21

0.38

2.9

2.7

0.62

0.81

ug/l

0.79

125

Monoplegia

842

1.11

0.38

2.6

2.9

0.66

0.78

ug/l

0.81

542

300

0.82

0.38

2.3

2.5

0.80

0.71

ug/l

0.14

170

Other disorders of binocular movement

756

0.89

0.38

2.8

2.9

0.57

0.73

ug/l

1.63

475

Dermatitis

4660

45882

1.01

0.38

2.9

3.0

0.72

0.77

ug/l

1.90

3149

30264

Other and unspecified injuries of wrist and hand

176

1651

1.07

0.38

3.2

2.8

0.63

0.73

ug/l

1.07

114

980

Hereditary motor and sensory neuropathy

480

1.15

0.38

2.8

2.9

0.76

0.74

ug/l

0.08

294

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

220

0.77

0.38

3.2

2.6

0.74

ug/l

0.00

136

Other proliferative retinopathy

276

0.81

0.38

2.6

2.7

1.13

0.79

ug/l

0.78

172

Malignant neoplasm of rectum

811

8329

0.97

0.37

3.0

2.7

0.71

ug/l

0.01

559

5755

Hypermobility syndrome

344

0.84

0.37

2.1

2.3

0.90

0.67

ug/l

0.22

168

Livedoid vasculitis

181

1.26

0.37

2.5

2.7

0.52

0.74

ug/l

1.53

106

Benign neoplasm: Penis

222

1.28

0.37

2.5

2.9

0.43

0.72

ug/l

3.44

150

Perforation of tympanic membrane

572

5914

0.96

0.37

3.0

0.88

0.77

ug/l

0.63

400

3904

Artificial joint re-operation

406

3902

1.05

0.37

3.3

3.2

0.64

0.76

ug/l

3.15

294

2730

Otosclerosis

426

4097

1.05

0.37

3.2

3.1

0.78

0.75

ug/l

0.27

275

2763

Viral and other specified intestinal infections

1329

12534

1.02

0.37

2.5

0.69

0.73

ug/l

0.31

718

6924

Other acute viral hepatitis

719

1.12

0.37

2.4

2.6

0.66

0.71

ug/l

0.32

396

Other/unspecified mastoiditis and related conditions

293

1.20

0.37

2.7

2.8

0.67

0.71

ug/l

0.24

185

Contact with other and unspecified heat and hot substances

435

0.85

0.37

3.1

2.8

0.68

0.79

ug/l

0.47

252

Disorders of optic nerve, not elsewhere classified

144

1347

1.09

0.37

3.3

3.0

0.77

0.78

ug/l

0.07

906

Early syphilis

106

982

1.10

0.37

2.5

0.58

0.69

ug/l

0.93

525

Hypermetropia

315

3005

1.05

0.37

3.1

2.9

0.69

0.73

ug/l

0.50

205

1921

Pedal cyclist injured in noncollision transport accidents

733

7120

1.03

0.37

2.8

2.7

0.66

0.72

ug/l

1.58

482

4311

Operations for atrial fibrillation

162

1529

1.09

0.36

2.7

3.1

0.70

0.75

ug/l

0.31

100

1033

Dystonia

225

2130

1.06

0.36

2.7

2.9

0.72

0.74

ug/l

0.07

155

1349

Other and unspecified mononeuropathies of lower limb

130

1209

1.09

0.36

2.9

0.63

0.75

ug/l

1.13

783

Varus deformity, not elsewhere classified

277

0.82

0.36

2.3

2.6

0.55

0.95

ug/l

1.73

167

Abnormal findings on diagnostic imaging of central nervous system

253

2405

1.06

0.36

2.9

0.71

0.74

ug/l

0.26

159

1546

Hereditary deficiency of other clotting factors

320

1.17

0.36

2.9

2.8

0.66

0.76

ug/l

0.28

209

Autism

449

0.86

0.36

1.9

0.49

0.55

ug/l

0.28

173

Vitreous haemorrhage

744

7650

0.97

0.36

3.0

0.85

0.78

ug/l

0.60

520

5143

Gangrene, not elsewhere classified

612

0.87

0.36

2.1

3.1

0.87

0.80

ug/l

0.08

427

Benign lipomatous neoplasm of other sites/unspecified

561

5429

1.04

0.36

2.9

3.1

0.75

0.79

ug/l

0.35

397

3666

Other abnormal auditory perceptions

367

1.16

0.36

3.5

2.7

1.31

0.74

ug/l

0.41

225

Inflammatory disorders of male genital organs, not elsewhere classified

148

1392

1.09

0.36

3.0

2.5

0.94

0.72

ug/l

0.55

813

Papulosquamous disorders

2868

29091

0.98

0.36

2.9

0.67

0.75

ug/l

3.50

1874

18884

Enterobiasis

291

1.18

0.36

2.7

2.3

0.72

0.66

ug/l

0.17

130

Heart failure and antihypertensive medication

2190

14085

1.02

0.36

2.7

2.8

0.72

0.74

ug/l

0.27

1545

8653

Kela reimbursement Agammaglobulinemia (D80-84)

330

1.17

0.36

2.7

2.6

0.71

0.69

ug/l

0.04

182

Nonspecific lymphadenitis

292

2786

1.05

0.36

2.4

2.6

0.81

0.70

ug/l

0.33

155

1612

Other endocrine disorders

158

1615

0.93

0.36

3.3

2.8

0.72

0.75

ug/l

0.26

109

1007

Infection due to other mycobacteria

896

0.90

0.36

3.4

3.2

0.84

0.79

ug/l

0.10

600

Family history of certain disabilities and chronic diseases leading to disablement

163

1528

1.07

0.36

2.7

2.5

0.67

0.68

ug/l

0.13

858

Phobic anxiety disorders

458

4748

0.96

0.36

2.5

2.4

0.54

0.67

ug/l

4.46

292

2450

Mixed and other personality disorders

377

3926

0.96

0.35

2.3

2.5

0.50

0.67

ug/l

4.78

280

2152

Injury of blood vessels at shoulder and upper arm level

147

1.31

0.35

3.2

2.9

1.29

0.73

ug/l

0.53

D07AA Corticosteroids, weak (group I)

694

6724

1.03

0.35

2.7

2.8

0.63

0.74

ug/l

3.22

432

4183

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

276

0.82

0.35

2.1

2.5

0.56

0.68

ug/l

—

148

Findings of drugs and other substances, not normally found in blood

276

1.20

0.35

3.8

2.7

0.68

0.70

ug/l

0.08

167

Onycholysis

228

1.21

0.35

2.9

3.0

0.89

0.76

ug/l

0.41

132

Ankylosing spondylitis, strict definition

286

2733

1.06

0.35

2.6

2.5

0.70

0.67

ug/l

0.29

184

1501

Mixed connective tissue disease

165

1757

0.93

0.35

2.7

3.0

0.69

0.75

ug/l

0.32

108

1145

Other disorders of binocular vision

308

0.84

0.35

2.6

0.72

0.70

ug/l

—

183

Osteopathy in diseases classified elsewhere

433

0.86

0.35

2.9

3.1

1.15

0.83

ug/l

0.71

289

Other disorders of the musculoskeletal system and connective tissue

1000

9766

1.03

0.35

3.2

3.0

0.75

0.76

ug/l

0.07

686

6452

Discitis, unspecified

143

1343

1.08

0.35

2.9

3.0

0.68

0.80

ug/l

1.06

104

924

Malignant neoplasm of tonsil, including Hilmo

152

1612

0.92

0.35

3.0

2.6

0.70

ug/l

0.01

105

1033

Benign neoplasm: Scrotum

489

1.16

0.35

2.7

2.9

0.55

0.74

ug/l

1.98

322

Multiple myeloma

159

1689

0.93

0.35

2.8

2.7

0.86

0.75

ug/l

0.56

122

1178

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

159

1689

0.93

0.35

2.8

2.7

0.86

0.75

ug/l

0.56

122

1178

Arthropathic psoriasis

726

7464

0.97

0.35

2.8

2.9

0.59

0.74

ug/l

8.25

455

4714

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2191

22261

0.98

0.35

2.8

0.73

0.75

ug/l

0.29

1383

14074

Other bacterial intestinal infections

1613

15833

1.02

0.35

3.0

0.79

0.78

ug/l

0.09

1096

10595

Asthma, excluding more controls

6405

33719

0.99

0.34

2.8

2.9

0.66

0.76

ug/l

10.60

4095

21092

Peptic ulcer

622

0.88

0.34

2.8

2.9

0.63

0.82

ug/l

1.35

404

Other and unspecified disorders of binocular movement

210

1.22

0.34

3.4

2.6

0.58

0.70

ug/l

0.65

134

Congenital stenosis of pulmonary valve

199

0.79

0.34

2.3

2.2

0.54

0.63

ug/l

—

100

Hypocalcemia

115

1236

0.92

0.34

3.3

3.0

1.13

0.76

ug/l

0.56

827

Other specified and unspecified disorders of lens

322

1.17

0.34

4.4

3.2

0.99

0.87

ug/l

0.34

229

Renal agenesis and other reduction defects of kidney

273

0.82

0.34

3.0

2.8

0.63

0.73

ug/l

0.35

169

Fall involving bed

181

1915

0.94

0.34

3.0

3.3

0.82

0.81

ug/l

0.02

136

1346

Pedal cyclist injured in collision with motor vehicle

150

1598

0.93

0.34

3.2

2.8

0.68

0.74

ug/l

0.56

943

Other congenital malformations of intestine

398

1.15

0.34

2.6

2.8

0.59

0.82

ug/l

1.43

253

Open wound of abdomen, lower back and pelvis

214

2032

1.06

0.34

2.5

2.7

0.57

0.72

ug/l

3.36

138

1182

Oher contracture of tendon (sheath)

221

1.22

0.34

3.4

2.9

0.63

0.93

ug/l

1.18

148

Caught, crushed, jammed or pinched in or between objects

379

3649

1.05

0.34

2.7

0.65

0.70

ug/l

0.84

215

2186

Scarlet fever

295

0.83

0.34

1.8

2.2

0.66

0.62

ug/l

—

136

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

238

0.80

0.34

2.8

2.6

0.52

0.70

ug/l

0.77

121

Neuroendocrine tumor and carcinoma of stomach

277

1.19

0.34

2.3

2.8

0.90

0.75

ug/l

0.20

181

Melanoma in situ, other sites/unspecified

212

1.23

0.34

4.4

3.1

0.98

0.77

ug/l

0.42

134

Open bite that required surgery (Lefort1 or BSSO)

155

0.77

0.34

2.2

2.3

0.50

0.70

ug/l

—

Other and unspecified myoneural disorders

193

1.23

0.33

2.3

2.9

0.69

0.77

ug/l

0.27

124

Benign neoplasm: Eye, unspecified

202

1.22

0.33

3.1

3.0

0.79

0.71

ug/l

0.14

139

Sequelae of intentional self-harm, assault and events of undetermined intent

305

0.84

0.33

2.8

2.4

0.44

0.69

ug/l

3.20

160

Labyrinthitis

110

1.31

0.33

2.9

2.5

0.61

0.78

ug/l

—

Motorcycle rider injured in other and unspecified transport accidents

443

4280

1.04

0.33

2.6

2.5

0.60

0.67

ug/l

1.74

250

2406

Chronic hepatitis NAS

559

0.88

0.33

2.7

2.9

0.73

0.74

ug/l

0.01

351

Atopic dermatitis, strict definition

1051

10054

1.03

0.33

2.5

0.64

0.68

ug/l

0.81

604

5547

Other disorders of bone density and structure

102

1101

0.92

0.33

3.2

2.9

0.68

0.74

ug/l

0.26

673

Other acute disseminated demyelination

285

1.17

0.33

2.3

2.7

0.71

0.72

ug/l

0.01

157

Meretoja disease

203

1.23

0.33

3.4

2.8

0.87

0.77

ug/l

0.30

128

Anankastic personality disorder

137

1463

0.93

0.33

2.8

2.6

0.49

0.70

ug/l

5.55

834

Other melanin hyperpigmentation

1017

0.91

0.33

3.5

3.1

0.84

0.78

ug/l

0.26

692

Persistent mood disorders

1042

10659

0.97

0.33

2.6

2.8

0.59

0.76

ug/l

11.30

748

6635

Other specified disorders of kidney and ureter

191

2014

0.94

0.33

2.7

3.0

0.76

0.74

ug/l

0.14

134

1317

Nephropathy induced by other drugs, medicaments and biological substances

130

1.31

0.33

2.7

0.75

0.76

ug/l

—

Melanocytic naevi of lip

220

1.20

0.33

3.1

2.9

0.74

0.77

ug/l

0.10

135

Benign neoplasm: Mediastinum

196

0.79

0.33

2.4

2.8

1.10

0.78

ug/l

0.25

127

Benign neoplasm of other and unspecified intrathoracic organs

630

0.89

0.32

3.1

3.0

1.35

0.80

ug/l

0.91

412

Benign neoplasm: Lip

127

1355

0.93

0.32

3.3

3.0

0.79

0.78

ug/l

0.08

900

Villonodular synovitis (pigmented)

381

1.15

0.32

2.6

2.5

0.54

0.74

ug/l

1.65

219

Wide developmental disorders, excluding more controls

572

0.89

0.32

1.9

2.0

0.47

0.60

ug/l

0.77

231

Other congenital malformations, not elsewhere classified

211

1.20

0.32

2.9

2.7

0.69

0.75

ug/l

0.17

120

Ulcerative rectosigmoiditis

526

5426

0.96

0.32

2.7

2.8

0.77

0.72

ug/l

0.41

328

3278

Other misadventures during surgical and medical care

154

1452

1.07

0.32

3.4

3.0

0.75

ug/l

0.00

111

965

Hypertensive Renal Disease

334

3215

1.05

0.32

2.9

3.3

0.90

0.84

ug/l

0.54

254

2265

Lumbosacral plexus disorders

166

1.25

0.32

3.5

3.0

0.66

0.73

ug/l

0.22

122

Brachial plexus disorders

391

3766

1.04

0.32

2.7

0.61

0.68

ug/l

1.66

248

2208

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

451

0.87

0.32

2.2

2.6

0.71

0.73

ug/l

0.07

287

Pulmonary embolism

2309

23416

0.98

0.32

3.1

0.80

0.79

ug/l

0.19

1624

16091

Corneal scars and opacities

174

1647

1.07

0.32

3.2

3.0

0.66

0.75

ug/l

1.24

127

1069

Chronic iridocyclitis

234

2454

0.95

0.32

3.0

2.9

0.74

0.76

ug/l

0.19

162

1517

Xanthelasma of eyelid

372

1.15

0.32

2.7

2.8

0.66

0.77

ug/l

0.44

241

Deficiency of other B group vitamins

105

1128

0.92

0.32

2.9

3.1

0.82

ug/l

0.00

770

Other mosquito-borne viral fevers

344

1.16

0.32

2.9

2.7

0.69

0.72

ug/l

0.08

206

Other intracranial haemorrhages

293

2816

1.05

0.32

3.5

3.3

1.27

0.80

ug/l

1.33

204

2032

Lesion of plantar nerve

188

1780

1.06

0.32

3.5

3.1

0.70

0.77

ug/l

0.46

123

1176

Meralgia paraesthetica

205

1950

1.06

0.31

2.9

0.58

0.72

ug/l

3.15

137

1233

Polyarteritis nodosa and related conditions

640

0.89

0.31

2.5

2.9

0.65

0.74

ug/l

0.63

415

Other congenital malformations

287

2746

1.05

0.31

2.5

2.7

0.64

0.71

ug/l

0.87

177

1663

Contact with lifting and transmission devices, not elsewhere classified

183

1742

1.07

0.31

3.0

2.8

0.69

0.72

ug/l

0.29

129

1071

Mucosal proctocolitis

807

8269

0.97

0.31

2.6

2.7

0.69

0.72

ug/l

0.30

515

4905

Cardiac murmurs and other cardiac sounds

340

3230

1.04

0.31

3.1

3.0

0.80

0.78

ug/l

0.05

236

2149

Toxic liver disease

816

0.91

0.31

2.7

2.9

0.68

0.73

ug/l

0.23

506

Benign neoplasm: Endocrine pancreas

480

1.14

0.31

3.8

3.2

0.85

0.78

ug/l

0.28

324

Glaucoma secondary to eye trauma

499

1.13

0.31

3.3

3.0

0.79

ug/l

0.00

325

Other juvenile arthritis

736

0.91

0.31

2.0

2.4

0.63

0.73

ug/l

0.72

388

Cluster headache, strict

201

1911

1.06

0.31

2.5

2.6

0.68

0.70

ug/l

0.09

120

1143

Benign neoplasm: Other and unspecified parts of small intestine

814

1.10

0.31

2.8

3.1

0.78

0.79

ug/l

0.03

553

Speech therapy

1745

17167

1.02

0.31

2.9

3.1

0.70

0.78

ug/l

2.44

1351

11602

Encephalitis

163

1541

1.07

0.31

2.8

2.9

0.76

ug/l

0.01

112

955

Donors of organs and tissues

681

0.90

0.31

2.7

2.6

0.76

0.71

ug/l

0.25

396

Follicular adenocarcinoma of thyroid gland, including Hilmo

411

1.14

0.30

3.8

2.6

0.77

0.73

ug/l

0.13

261

Actinomycosis

248

0.82

0.30

2.6

2.9

0.66

0.75

ug/l

0.14

155

Microscopic polyangiitis

346

1.16

0.30

2.5

3.2

0.76

0.79

ug/l

0.15

235

Cerebral atherosclerosis

863

0.91

0.30

2.9

3.2

0.88

0.84

ug/l

0.07

604

KRA_PSY_EATING, excluding more controls

732

0.91

0.30

2.4

2.5

0.48

0.71

ug/l

2.97

387

Benign neoplasm: Oesophagus

741

0.90

0.30

2.7

2.9

0.54

0.76

ug/l

2.52

490

ILD and respiratory illness in diseases classified elsewhere

301

0.84

0.30

3.0

3.1

0.64

0.76

ug/l

0.54

197

Unspecified visual impairment (binocular)

718

1.10

0.30

3.4

2.9

0.70

0.81

ug/l

0.77

457

Golimumab

125

1333

0.93

0.30

2.1

2.4

0.60

0.65

ug/l

0.55

695

Congenital malformations of the nervous system

525

0.89

0.30

2.3

2.5

0.51

0.68

ug/l

2.31

280

Postviral fatigue syndrome

102

1.29

0.30

2.5

1.9

0.60

0.59

ug/l

—

Other specified/unspecified soft tissue disorders

202

1921

1.06

0.30

3.1

3.0

0.81

0.80

ug/l

0.03

135

1291

Benign neoplasm: Skin of scalp and neck

153

1446

1.07

0.30

3.4

3.1

0.73

0.77

ug/l

0.26

110

961

Other necrotizing vasculopathies

434

4201

1.04

0.30

3.0

3.2

0.68

0.77

ug/l

1.58

330

2877

Crohn disease (strict definition, require KELA)

297

3092

0.96

0.30

2.5

2.7

0.57

0.69

ug/l

3.47

183

1798

Malignant neoplasm of gallbladder, including Hilmo

291

0.84

0.30

2.2

2.6

0.94

0.75

ug/l

0.56

192

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

576

0.89

0.30

2.8

2.6

0.60

0.77

ug/l

1.49

374

Sicca syndrome [Sjögren]

184

1744

1.06

0.30

2.9

3.0

0.69

0.74

ug/l

0.49

124

1143

Infections of the skin and subcutaneous tissue

4979

49757

0.99

0.30

2.7

2.8

0.68

0.75

ug/l

5.82

3134

30910

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

347

1.16

0.30

2.5

2.4

0.99

0.72

ug/l

0.47

223

Amblyopia ex anopsia

145

1538

0.94

0.30

2.6

2.9

0.84

0.75

ug/l

0.25

966

Use of donepezil

1436

13983

0.98

0.30

3.1

3.4

0.85

0.87

ug/l

0.22

995

10388

Benign neoplasm: Duodenum

164

1728

0.94

0.30

3.1

3.2

0.62

0.77

ug/l

2.03

126

1191

Contact with hot air and gases

452

1.13

0.30

2.7

2.8

0.91

0.73

ug/l

0.38

282

Malignant neoplasm of bone and articular cartilage

576

1.11

0.30

2.4

2.6

0.98

0.73

ug/l

0.76

370

Sequelae of poliomyelitis

531

0.88

0.29

2.6

3.2

0.96

0.81

ug/l

0.64

386

Benign neoplasm: Epididymis

418

1.16

0.29

3.5

2.8

0.73

0.70

ug/l

0.09

265

Bacterial, viral and other infectious agents

664

6473

1.03

0.29

2.6

2.5

0.77

0.69

ug/l

0.42

374

3540

Other noninfective disorders of lymphatic vessels and lymph nodes

168

1592

1.06

0.29

3.0

2.8

0.76

0.74

ug/l

0.06

103

997

Other diseases of stomach and duodenum

435

4214

1.04

0.29

3.1

0.71

0.77

ug/l

1.08

315

2868

Arteriovenous malformation of peripheral vessels

186

1.21

0.29

2.1

2.7

0.61

0.77

ug/l

0.79

117

Multiple congenital exostoses

131

1.26

0.29

4.8

2.5

0.99

0.74

ug/l

0.33

Epiphora

825

1.09

0.29

3.3

3.0

0.72

0.80

ug/l

0.39

558

Isolated proteinuria

213

2036

1.06

0.29

3.0

0.92

0.76

ug/l

0.83

161

1332

Ulcerative proctitis

361

3485

1.04

0.29

2.8

0.66

0.71

ug/l

0.58

239

2140

Mental disorders, not otherwise specified

293

3050

0.96

0.29

2.5

2.6

0.55

0.68

ug/l

2.44

202

1707

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

149

1408

1.07

0.29

3.1

2.7

0.66

0.73

ug/l

0.62

819

Other and unspecified injuries of forearm

343

0.86

0.29

3.3

2.6

0.79

0.69

ug/l

0.28

198

Benign neoplasm: Larynx

264

2745

0.95

0.29

2.9

3.1

0.70

0.76

ug/l

0.82

171

1815

Malignant neoplasm of other connective and soft tissue

168

1596

1.06

0.29

3.1

2.7

0.72

0.74

ug/l

0.14

127

1061

Crohn disease (strict definition, require KELA, min 2 HDR)

292

3037

0.96

0.29

2.5

2.7

0.57

0.69

ug/l

3.37

181

1764

Asthma mixed form (mode)

276

2873

0.96

0.29

2.9

3.1

0.74

0.84

ug/l

1.16

166

1922

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

489

0.88

0.29

2.7

3.2

0.77

ug/l

0.00

331

Pulmonary heart disease

2309

23388

0.98

0.29

3.1

0.80

0.79

ug/l

0.16

1624

16059

Dental caries

2164

21085

0.98

0.29

2.6

2.7

0.80

0.78

ug/l

0.17

1528

12775

Primary angle-closure glaucoma

249

2387

1.05

0.29

3.3

3.2

0.75

0.79

ug/l

0.26

186

1655

Allergic asthma (mode)

1156

11094

1.02

0.29

2.6

2.7

0.64

0.74

ug/l

1.92

675

6563

Unspecified threat to breathing

343

0.86

0.28

2.9

2.8

0.51

0.74

ug/l

2.86

205

Drug-induced thyroiditis

198

1.22

0.28

2.5

2.6

0.74

0.72

ug/l

0.05

129

Emotional disorders and disorders of social functioning with onset specific to childhood

401

0.88

0.28

1.6

1.7

0.36

0.54

ug/l

2.48

132

Benign neoplasm: Bronchus and lung

104

975

1.09

0.28

2.6

3.1

0.61

0.78

ug/l

2.14

645

Other specified/unspecified deforming dorsopathies

643

1.10

0.28

3.2

2.6

0.62

0.81

ug/l

1.73

380

Open wound of hip and thigh

239

2292

1.05

0.28

2.9

2.7

0.61

0.70

ug/l

1.54

150

1351

Other nonthrombocytopenic purpura

491

1.12

0.28

3.0

3.1

0.85

0.72

ug/l

0.25

330

Ankylosis of teeth

112

1.27

0.28

3.0

2.5

0.99

0.71

ug/l

—

Arteriovenous malformation of cerebral vessels

665

0.90

0.28

3.1

2.8

0.65

0.70

ug/l

0.23

426

Varicella [chickenpox]

391

4034

0.96

0.28

2.5

2.4

0.66

0.67

ug/l

0.12

194

2185

Other drug-induced secondary parkinsonism

602

0.90

0.28

2.9

0.68

0.76

ug/l

0.35

397

ILD differential diagnosis

7105

35861

0.99

0.28

2.8

2.9

0.73

0.77

ug/l

1.16

4459

22605

Post-traumatic stress disorder

174

1651

1.06

0.28

2.7

2.5

0.54

0.68

ug/l

3.08

116

863

Asthma, unspecified (mode)

4404

32842

1.01

0.28

3.0

2.9

0.69

0.78

ug/l

7.86

2997

21353

Effects of other external causes

151

1593

0.94

0.28

2.6

2.5

0.59

0.68

ug/l

1.11

862

Hereditary retinal dystrophy

761

1.09

0.28

2.7

2.8

0.59

0.72

ug/l

1.41

459

Tularaemia

830

0.91

0.28

2.2

2.9

0.60

0.78

ug/l

1.75

534

Malignant neoplasm of oropharynx

144

1515

0.93

0.27

2.9

2.6

0.70

0.69

ug/l

0.02

971

Spinal osteochondrosis

636

1.10

0.27

3.1

2.5

0.46

0.76

ug/l

4.64

365

Hepatomegaly and splenomegaly, not elsewhere classified

674

0.90

0.27

3.1

2.9

0.83

0.76

ug/l

0.26

438

Misadventures to patients during surgical and medical care

903

9219

0.98

0.27

3.1

0.73

0.78

ug/l

1.09

648

6311

Other and unspecified disorders of adult personality and behaviour

182

0.81

0.27

2.9

2.3

0.59

0.74

ug/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

961

0.93

0.27

2.0

0.50

0.63

ug/l

1.43

407

Follow-up care involving plastic surgery

106

1132

0.93

0.27

3.5

3.1

0.70

0.75

ug/l

0.45

760

Other and unspecified nail disorders

986

0.92

0.27

2.7

2.9

0.66

0.77

ug/l

0.69

634

Mandibular retrognathia AND surgery (BSSO)

818

1.08

0.27

2.8

2.4

0.65

ug/l

0.01

448

Hypertension, Pulmonary Arterial

362

0.87

0.27

2.4

3.0

0.61

0.80

ug/l

0.95

236

Foreign body or object entering through skin

487

4737

1.03

0.27

2.9

2.7

0.65

0.71

ug/l

1.02

311

2867

Other and unspecified disorders of pigmentation

267

0.85

0.27

3.5

2.7

0.58

0.74

ug/l

0.83

156

Astigmatism

308

2965

1.04

0.27

2.8

2.9

0.76

0.74

ug/l

0.04

199

1874

Benign neoplasm: Long bones of lower limb

184

1755

1.06

0.27

2.9

2.7

0.68

0.72

ug/l

0.40

109

1039

Pyogenic granuloma

102

956

1.08

0.27

3.0

2.9

0.71

0.75

ug/l

0.22

614

COPD differential diagnosis

7107

35864

0.99

0.27

2.8

2.9

0.73

0.77

ug/l

1.14

4462

22606

Procreative management

1498

12693

0.98

0.27

2.4

2.3

0.62

0.65

ug/l

0.50

796

6388

Other disorders of central nervous system

550

0.90

0.27

3.2

2.8

0.87

0.78

ug/l

0.34

358

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

631

0.90

0.27

2.9

0.73

0.80

ug/l

0.26

394

Disorders of pituitary gland, other and/or unspecified

254

1.16

0.27

3.1

2.6

0.91

0.64

ug/l

0.54

149

Bursitis of shoulder

135

1277

1.07

0.27

3.4

2.8

0.71

0.73

ug/l

0.10

806

All influenza (not pneumonia)

1203

12237

0.98

0.27

2.7

2.8

0.75

0.74

ug/l

0.08

738

7543

Secondary malignant neoplasm of other and unspecified sites

122

1290

0.93

0.27

3.8

2.7

1.46

0.74

ug/l

4.13

901

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

185

1734

1.05

0.27

2.7

2.5

0.57

0.69

ug/l

1.76

907

Other specified/unspecified disorders of bone/cartilage

223

2141

1.05

0.26

2.9

2.7

0.68

0.70

ug/l

0.10

133

1306

Disorder of pancreatic internal secretion, other and/or unspecified

298

0.86

0.26

2.7

0.59

0.72

ug/l

0.50

180

Injury of blood vessels at abdomen, lower back and pelvis level

265

0.84

0.26

2.1

2.9

0.51

0.72

ug/l

1.54

170

Malignant neoplasm of penis, including Hilmo

720

1.11

0.26

3.5

2.6

1.07

0.78

ug/l

0.55

474

Asthma mixed form (mode), excluding more controls

276

2865

0.96

0.26

2.9

3.1

0.74

0.84

ug/l

1.11

166

1910

Fenamates

806

5347

1.03

0.26

3.0

2.8

0.71

0.86

ug/l

4.18

539

3679

Other facial nerve disorders

136

1287

1.06

0.26

3.0

2.9

0.75

0.74

ug/l

0.01

825

Anomalies of dental arch relationship, including avohilmo

787

6937

1.02

0.26

2.9

2.7

0.64

0.70

ug/l

1.41

447

4121

Optic atrophy

983

0.93

0.26

2.8

2.9

0.71

0.74

ug/l

0.11

628

Other osteochondrodysplasias

368

1.13

0.26

3.7

2.8

0.81

0.69

ug/l

0.29

219

Vitreous prolapse

126

0.77

0.26

3.0

3.4

1.19

0.71

ug/l

—

Abscess of anal and rectal regions

733

7173

1.03

0.26

2.7

0.70

0.74

ug/l

0.40

447

4294

Migraine without aura, drug-induced

192

0.83

0.26

2.1

2.2

0.68

0.66

ug/l

—

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

182

1.23

0.26

2.8

2.5

1.27

0.81

ug/l

0.24

122

Other aneurysm

500

5129

0.97

0.26

2.9

3.2

0.79

0.82

ug/l

0.27

328

3615

Hodgkin lymphoma, hilmo

174

1822

0.95

0.26

2.8

3.0

0.73

0.74

ug/l

0.07

118

1149

Renal cell carcinoma of kidney

229

2382

0.95

0.26

3.2

2.7

0.85

0.76

ug/l

0.57

175

1647

Other diseases of oesophagus

780

7638

1.03

0.26

3.0

3.1

0.84

0.81

ug/l

0.17

576

5202

Sixth [abducent] nerve palsy

242

2329

1.05

0.26

3.0

3.1

0.80

0.76

ug/l

0.19

168

1598

Benign neoplasm: other/unspecified salivary gland

165

1573

1.06

0.26

2.9

3.1

0.77

0.80

ug/l

0.10

109

1078

Malignant neoplasm of base of tongue, including Hilmo

787

1.09

0.26

2.5

0.77

0.69

ug/l

0.46

495

Burn and corrosion of trunk

198

2066

0.95

0.26

2.9

0.65

0.73

ug/l

0.94

138

1304

Benign neoplasm: Skin of other and unspecified parts of face

669

6538

1.03

0.26

3.2

3.1

0.78

0.80

ug/l

0.18

465

4503

Calcific tendinitis of shoulder

284

2738

1.04

0.26

2.7

2.8

0.55

0.74

ug/l

7.21

187

1759

Unspecified protein-energy malnutrition

244

0.85

0.25

2.1

3.1

2.01

0.87

ug/l

0.54

160

Malnutrition

931

0.93

0.25

2.4

3.0

1.30

0.79

ug/l

0.81

614

Whooping cough

159

0.81

0.25

2.5

2.3

0.40

0.72

ug/l

—

Alzheimer disease, excluding more controls

1594

10657

0.98

0.25

3.0

3.5

0.84

0.88

ug/l

0.51

1145

7949

Cerebrovascular diseases

7256

51311

0.99

0.25

3.0

0.80

0.77

ug/l

1.25

5152

34329

Assault by other specified means

454

0.89

0.25

2.5

2.3

0.52

0.72

ug/l

2.10

228

Idiopathic urticaria

570

1.09

0.25

2.4

2.7

0.75

0.72

ug/l

0.05

339

Mesothelioma, including Hilmo

108

1142

0.93

0.25

3.2

2.8

0.82

0.78

ug/l

0.24

816

Benign neoplasm: Scapula and long bones of upper limb

572

1.10

0.25

3.2

2.8

0.77

0.72

ug/l

0.18

345

Immunodeficiencies

200

2088

0.95

0.25

2.9

0.77

0.76

ug/l

0.03

143

1299

Other congenital malformations of the digestive system

215

2046

1.05

0.25

2.7

3.0

0.64

0.75

ug/l

1.15

154

1317

Benign neoplasm: Skin, unspecified

230

2211

1.05

0.25

3.3

3.0

0.82

0.76

ug/l

0.45

157

1442

Immunodeficiency associated with other specified major defects, or unspecified

1.39

0.25

2.8

0.83

0.74

ug/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

882

1.08

0.25

3.4

2.9

0.74

ug/l

0.03

559

IgA nephropathy (IgA glomerulonephritis)

195

1871

1.05

0.25

2.5

2.8

0.96

0.73

ug/l

2.20

143

1159

Congenital malformations of gallbladder, bile ducts and liver

341

1.13

0.25

2.9

0.69

0.77

ug/l

0.23

224

Lifestyle-related condition

650

0.91

0.25

3.1

2.9

0.78

0.74

ug/l

0.13

400

Cystic kidney disease

223

2144

1.05

0.25

3.2

3.0

1.11

0.74

ug/l

1.87

165

1351

Raynaud syndrome

367

3557

1.04

0.25

2.9

0.78

0.73

ug/l

0.24

241

2275

Convergence insufficiency and excess

297

0.87

0.25

2.5

2.8

0.41

0.71

ug/l

3.37

177

Use of levodopa decarboxylase inhibitor

1209

12281

0.98

0.24

3.1

3.3

0.74

0.82

ug/l

2.79

886

8969

Congenital musculoskeletal deformities of head, face, spine and chest

427

1.11

0.24

2.6

0.78

0.67

ug/l

0.32

247

Other congenital malformations of digestive system

106

1.26

0.24

3.6

2.6

0.81

0.69

ug/l

—

Hypothyroidism due to medicaments and other exogenous substances

466

1.11

0.24

2.4

3.2

0.59

0.81

ug/l

1.25

306

Anorexia

318

0.87

0.24

2.3

2.9

0.53

0.76

ug/l

1.88

197

Implicit parasitic Sepsis

304

1.14

0.24

2.3

3.0

0.55

0.70

ug/l

0.81

196

Anuria and oliguria

462

0.89

0.24

3.7

3.0

0.78

0.75

ug/l

0.10

303

Dietary selenium deficiency

0.00

0.24

0.0

3.1

—

0.81

—

Malignant neoplasm of renal pelvis

420

1.12

0.24

3.3

2.7

0.82

0.78

ug/l

0.13

293

Ehlers-Danlos syndrome

1.27

0.24

3.5

2.7

0.65

0.72

ug/l

—

Osteomyelitis of vertebra

262

0.85

0.24

2.2

3.0

0.66

0.86

ug/l

0.85

178

Mental and behavioural disorders due to hallucinogens

211

0.84

0.24

1.5

2.1

0.41

0.59

ug/l

0.78

Exposure to other and unspecified animate mechanical forces

118

1115

1.06

0.24

2.6

0.72

0.69

ug/l

0.08

633

Viral hepatitis, IBD co-morbidity

331

3417

0.96

0.24

2.3

0.53

0.81

ug/l

7.71

221

1727

Open wound of shoulder and upper arm

132

1254

1.06

0.24

2.2

2.7

0.58

0.73

ug/l

1.93

734

Benign neoplasm: Ill-defined sites within the digestive system

314

1.14

0.24

2.7

3.0

0.76

0.74

ug/l

0.03

212

Cicatricial alopecia [scarring hair loss]

237

1.15

0.24

2.0

3.0

1.11

0.73

ug/l

0.36

153

Burns classified according to extent of body surface involved

681

1.09

0.24

2.5

2.8

0.66

0.71

ug/l

0.29

421

Viral conjunctivitis

795

1.08

0.24

2.8

2.7

0.71

0.70

ug/l

0.06

461

Marfan's syndrome

284

0.86

0.24

1.6

2.6

0.56

0.69

ug/l

0.96

163

Congenital malformations of posterior segment of eye

257

1.15

0.24

3.7

3.0

0.67

0.78

ug/l

0.34

165

Carcinoma in situ of lip, oral cavity and pharynx

211

1.19

0.24

1.9

2.9

0.50

0.77

ug/l

1.27

141

Bronchiectasis

528

5154

1.03

0.24

3.4

3.2

0.67

0.81

ug/l

3.90

377

3657

Thromboangiitis obliterans

262

0.85

0.24

2.7

3.1

0.74

0.81

ug/l

0.14

185

Optic atrophy

927

0.93

0.24

2.8

2.9

0.70

0.73

ug/l

0.13

596

Conjunctivitis

4066

33644

1.01

0.24

2.9

2.7

0.70

0.73

ug/l

0.62

2491

20390

Monoarthritis, not elsewhere classified

250

2411

1.04

0.23

2.8

0.74

0.78

ug/l

0.43

169

1494

Spinal instabilities

137

1440

0.94

0.23

2.6

2.7

0.59

0.73

ug/l

2.61

880

Malignant neoplasm of other connective and soft tissue, including Hilmo

283

2738

1.04

0.23

3.2

2.7

0.72

ug/l

0.02

204

1833

Maxillary retrognathism

573

1.09

0.23

2.6

2.5

0.88

0.72

ug/l

0.39

312

Pneumoconiosis due to asbestos and other mineral fibres

230

2380

0.95

0.23

3.2

3.4

0.85

ug/l

0.04

170

1731

Congenital deformities of feet

835

0.93

0.23

2.7

2.6

0.70

0.67

ug/l

0.06

465

Chronic myringitis

283

0.86

0.23

3.1

3.0

1.17

0.70

ug/l

0.74

182

Speech and linguistic disorders, excluding more controls

244

2211

1.04

0.23

2.4

2.6

0.62

0.75

ug/l

1.36

158

1197

Seborrhoeic dermatitis

816

8012

1.02

0.23

2.9

3.0

0.75

0.77

ug/l

0.16

552

5308

Polycythaemia vera

212

2201

0.96

0.23

2.8

2.7

0.77

0.72

ug/l

0.14

147

1475

Pediculosis and phthiriasis

271

0.86

0.23

1.7

2.5

0.61

0.70

ug/l

0.25

150

Other/unspecified crystal arthropathies

383

1.12

0.23

3.9

3.1

0.61

0.85

ug/l

1.51

261

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

304

0.87

0.23

3.3

3.0

0.80

ug/l

0.01

197

Congenital varicose veins

116

1.23

0.23

1.9

2.4

0.60

0.69

ug/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

290

2810

1.04

0.23

3.0

0.82

0.75

ug/l

0.52

195

1848

Congenital malformations, deformations and chromosomal abnormalities

4039

36889

1.01

0.22

2.7

0.73

0.72

ug/l

0.16

2478

21952

Burn and corrosion of head and neck

150

1568

0.95

0.22

3.2

2.7

0.73

ug/l

0.02

947

Hypertrophy of (infrapatellar) fat pad

533

0.91

0.22

2.7

2.6

0.57

0.74

ug/l

1.31

315

Thyroiditis, ILD-related definition

311

3011

1.03

0.22

3.0

2.9

0.69

0.75

ug/l

0.73

206

1874

Contact with other hot fluids

154

1611

0.95

0.22

3.0

2.7

0.70

0.71

ug/l

0.04

967

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

260

0.85

0.22

2.6

0.58

0.70

ug/l

0.55

132

Chronic Coagulation defects

661

1.08

0.22

2.9

2.7

0.67

0.76

ug/l

0.38

405

Hypothyroidism, drug reimbursement

685

4939

0.98

0.22

2.9

2.4

0.67

0.72

ug/l

1.01

472

2755

Leiomyosarcoma, including Hilmo

363

1.12

0.22

3.5

2.7

0.71

0.73

ug/l

0.11

236

Benign neoplasm: Parathyroid gland

469

1.10

0.22

3.6

3.1

0.73

0.76

ug/l

0.11

317

Acquired clawhand, clubhand, clawfoot and clubfoot

272

0.87

0.22

3.0

2.4

0.80

0.79

ug/l

0.02

159

Sequelae of other and unspecified effects of external causes

316

1.13

0.22

2.6

3.0

0.77

0.78

ug/l

0.02

191

Erysipeloid

198

0.84

0.22

4.6

3.1

0.75

0.73

ug/l

0.08

139

Migraine, unspecified, drug-induced

163

1.18

0.22

2.2

2.5

0.65

0.73

ug/l

—

Viral meningitis

143

1364

1.05

0.22

2.4

2.5

0.63

0.71

ug/l

0.65

724

Hypercalcemia

225

2332

0.96

0.22

3.0

3.2

0.97

0.75

ug/l

1.67

170

1594

Pedal cyclist injured in collision with pedestrian or animal

461

1.10

0.22

2.8

0.60

0.70

ug/l

0.65

283

DVT of lower extremities and pulmonary embolism

3536

34908

1.01

0.22

3.0

3.1

0.82

0.79

ug/l

0.64

2501

23768

Polyarthritis, unspecified

209

2013

1.04

0.22

3.2

2.9

0.72

0.80

ug/l

0.99

141

1307

Chondrolysis

0.00

0.22

0.0

2.6

—

0.75

—

Divergent concomitant strabismus

341

3511

0.97

0.22

2.8

0.84

0.70

ug/l

0.50

215

2100

Hypertrophy of breast in women and men

416

4048

1.03

0.22

3.3

3.0

0.68

0.74

ug/l

0.94

272

2596

Dermatopolymyositis, unspecified

313

0.88

0.22

2.8

3.0

0.68

0.76

ug/l

0.42

214

Other and unspecified mononeuropathies, also in other diseases

167

1741

0.95

0.22

2.9

3.0

1.04

0.77

ug/l

0.51

105

1158

Traumatic subarachnoid haemorrhage

308

3171

0.96

0.22

2.8

3.0

0.68

0.80

ug/l

2.13

217

2128

Scar conditions and fibrosis of skin

113

1192

0.94

0.22

3.3

2.8

0.91

0.76

ug/l

0.22

736

Injury of nerves at ankle and foot level

376

0.89

0.22

3.5

2.7

0.67

0.68

ug/l

0.02

232

Other secondary coxarthrosis

204

1965

1.05

0.22

2.9

0.71

0.78

ug/l

0.69

138

1256

Pneumoconiosis due to dust containing silica

373

0.88

0.21

3.6

3.2

0.66

0.78

ug/l

0.54

247

Atypical virus infections of central nervous system

490

0.91

0.21

2.7

2.8

0.60

0.74

ug/l

0.81

281

Other and unspecified disorders of white blood cells

247

2553

0.96

0.21

3.0

3.1

0.74

0.76

ug/l

0.14

168

1693

Benign neoplasm: Rectum/anal canal icd-9

428

0.90

0.21

3.8

3.2

0.86

0.88

ug/l

0.03

303

Selective deficiency of immunoglobulin A [IgA]y

164

1.18

0.21

2.7

0.64

0.72

ug/l

0.25

Multiple myeloma, including Hilmo

311

3201

0.97

0.21

2.9

2.7

0.98

0.73

ug/l

2.06

230

2220

Accessory breast

0.00

0.21

0.0

2.4

—

0.53

—

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

1.1

—

Inflammatory disorders of breast

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.0

—

Other puerperal infections

0.00

0.21

0.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.1

—

Other disorders of thyroid

287

1.12

0.21

3.6

3.1

0.60

0.71

ug/l

0.48

201

Otorrhoea

113

0.78

0.21

3.1

0.52

0.68

ug/l

—

Other specified/unspecified systemic involvement of connective tissue

156

1630

0.95

0.21

2.8

3.0

0.66

0.76

ug/l

0.54

106

1055

Tongue abnormality

288

2792

1.04

0.21

3.4

3.1

0.71

0.74

ug/l

0.23

212

1847

Elevated blood glucose level

545

5569

0.97

0.21

2.8

0.67

0.70

ug/l

0.27

381

3576

Amoebiasis

269

1.13

0.21

3.5

2.8

0.65

0.69

ug/l

0.15

167

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.21

0.0

1.1

—

Crushing injury of ankle and foot

311

0.87

0.21

2.8

2.9

0.55

0.73

ug/l

0.82

195

Drug-induced polyneuropathy

520

1.09

0.21

3.1

3.0

0.93

0.74

ug/l

0.27

331

Benign neoplasm: Lower jaw bone

176

0.84

0.21

2.3

2.7

0.83

0.79

ug/l

—

115

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

176

1691

1.05

0.21

3.2

3.0

0.68

0.78

ug/l

1.23

125

1085

Septal defects

264

2501

1.04

0.21

2.9

2.8

0.78

0.71

ug/l

0.27

160

1493

Oral lichen planus and hypothyroidism or thyroxine medication

211

1.14

0.21

4.9

3.1

0.59

0.77

ug/l

0.70

150

Dermatophytosis

1105

11210

0.98

0.21

2.7

3.0

0.71

0.76

ug/l

0.55

738

7502

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

115

0.77

0.21

3.4

2.9

0.87

0.67

ug/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.1

—

Bullous keratopathy

433

1.10

0.21

3.2

3.0

0.53

0.86

ug/l

3.32

284

Prurigo nodularis

136

1300

1.05

0.21

2.9

3.1

0.71

0.76

ug/l

0.26

103

855

Drug-induced interstitial lung disorders, unspecified

1.26

0.20

2.2

2.9

0.38

0.71

ug/l

—

Open wound of neck

591

0.92

0.20

2.5

2.6

0.47

0.70

ug/l

4.14

331

Unspecified parasitic disease

599

1.09

0.20

2.6

3.1

0.60

0.81

ug/l

1.83

404

Single delivery by forceps and vacuum extractor

0.00

0.20

0.0

1.0

—

Car occupant injured in other and unspecified transport accidents

1012

10280

0.98

0.20

2.9

2.7

0.69

0.74

ug/l

1.24

633

6243

Injury of blood vessels at hip and thigh level

248

0.86

0.20

3.5

3.0

0.53

0.72

ug/l

1.12

169

Radiculopathy

1153

11696

0.98

0.20

3.1

3.0

0.70

0.83

ug/l

5.50

797

7920

Allergic asthma (mode), excluding more controls

1156

11145

1.02

0.20

2.6

2.7

0.64

0.74

ug/l

2.05

675

6605

Polymyositis

414

1.10

0.20

2.8

3.0

0.69

0.75

ug/l

0.34

273

Left ventricular outflow tract obstruction, narrow definition

375

3656

1.03

0.20

2.8

0.76

0.71

ug/l

0.36

221

2241

Contact with venomous snakes and lizards

540

0.92

0.20

2.6

3.0

0.76

0.78

ug/l

0.03

352

Traction detachment of retina

529

0.91

0.20

2.9

2.8

0.67

0.74

ug/l

0.41

321

Congenital malformations of spine and bony thorax

174

1.16

0.20

2.9

2.4

0.50

0.77

ug/l

1.85

Drug-induced acute pancreatitis

1.28

0.20

3.8

2.3

0.65

0.79

ug/l

—

Crowding of teeth, including avohilmo

153

1210

1.05

0.20

2.3

2.4

0.59

0.66

ug/l

0.59

634

Need for immunization against other single viral diseases

147

1411

1.05

0.20

2.4

2.7

0.79

0.69

ug/l

0.28

109

826

Pedal cyclist injured in other and unspecified transport accidents

720

7071

1.02

0.20

2.7

2.8

0.67

0.72

ug/l

0.68

439

4344

ILD medications: pirfenidone

105

1099

0.94

0.20

2.8

3.4

0.60

0.75

ug/l

1.22

788

Eating disorder

716

0.93

0.20

2.4

0.48

0.66

ug/l

2.12

382

Thyrotropin deficiency

385

1.10

0.20

3.3

2.7

0.60

0.72

ug/l

0.81

235

Other disorders of peripheral nervous system

396

1.11

0.20

2.6

2.9

0.63

0.76

ug/l

0.48

251

Unequal limb length (acquired)

165

0.84

0.20

3.0

2.4

0.80

0.69

ug/l

—

Pulmonary eosinophilia, not elsewhere classified

642

0.92

0.20

3.0

0.69

0.80

ug/l

0.56

419

Idiopathic peripheral autonomic neuropathy

206

0.85

0.20

3.8

3.0

0.84

0.93

ug/l

0.15

124

Benign neoplasm: Bladder

732

0.93

0.19

4.2

3.2

0.76

0.81

ug/l

0.17

523

Foreign body granuloma of skin and subcutaneous tissue

164

0.84

0.19

3.0

2.8

0.50

0.71

ug/l

—

108

Burns and corrosions confined to eye and internal organs

188

1814

1.04

0.19

2.5

2.6

0.56

0.70

ug/l

3.40

110

1007

Immunodeficiency with predominantly antibody defects

109

1037

1.06

0.19

3.0

2.8

0.63

0.71

ug/l

0.54

629

ILD, hospital admissions

1347

13636

0.98

0.19

3.0

3.2

0.72

0.82

ug/l

3.28

969

9757

Sacroiliitis, not elsewhere classified

148

1418

1.05

0.19

1.9

2.3

0.53

0.69

ug/l

2.67

723

Abscess of tendon sheath

338

1.11

0.19

2.3

3.0

0.48

0.76

ug/l

3.40

209

Congenital lactase deficiency

1.16

0.19

3.5

2.9

0.63

0.65

ug/l

—

Parkinson's disease, strict definition, excluding more controls

1256

12110

0.98

0.19

3.1

3.3

0.76

0.86

ug/l

3.81

903

8756

Malignant neoplasm of thymus

214

1.15

0.19

3.7

2.4

0.93

0.74

ug/l

0.47

130

Impacted maxillary canine

154

0.84

0.19

2.8

3.1

0.81

0.84

ug/l

—

105

Burn and corrosion of hip and lower limb, except ankle and foot

145

1510

0.95

0.19

2.7

2.8

0.67

0.75

ug/l

0.51

925

Pedestrian injured in transport accident

385

3757

1.03

0.19

2.6

2.9

0.71

0.73

ug/l

0.14

250

2333

Chromosomal abnormalities, not elsewhere classified

500

1.08

0.19

1.9

2.4

0.52

0.65

ug/l

0.98

262

Poisoning by narcotics and psychodysleptics [hallucinogens]

642

0.93

0.19

2.0

2.2

0.36

0.67

ug/l

5.97

280

Specific development disorders of speech and language

176

1631

1.04

0.19

2.6

2.7

0.70

0.75

ug/l

0.24

116

968

Diabetes insipidus

404

0.91

0.19

3.5

2.7

1.14

0.76

ug/l

0.34

248

Sequelae of external causes of morbidity and mortality

1834

18535

0.99

0.19

3.0

0.71

0.78

ug/l

2.09

1291

12573

Respiratory disorders in diseases classified elsewhere

723

0.93

0.19

2.9

3.1

0.65

0.77

ug/l

0.88

478

Intestinal helminthiases, other/unspecified

157

1.18

0.19

2.5

3.4

0.60

0.76

ug/l

0.71

115

Transplanted organ and tissue status

785

7974

0.98

0.19

2.4

2.8

0.76

0.72

ug/l

0.68

603

4998

Other pulmonary diagnosis

7149

36006

0.99

0.19

2.8

2.9

0.73

0.77

ug/l

1.56

4492

22641

Inflammatory diseases of the central nervous system

521

5105

1.02

0.19

2.8

2.9

0.67

0.73

ug/l

0.64

341

3234

Malignant neoplasm of tongue, including Hilmo

204

2106

0.96

0.18

2.8

2.6

0.73

0.71

ug/l

0.20

136

1361

Vascular dementia (undefined)

258

2479

1.03

0.18

2.8

3.4

0.82

0.92

ug/l

1.25

176

1808

Isolated proteinuria with specified morphological lesion

738

1.07

0.18

3.3

3.0

1.25

0.79

ug/l

1.01

484

Other acquired deformities of musculoskeletal system and connective tissue

288

2959

0.97

0.18

3.0

2.8

0.84

0.71

ug/l

0.49

190

1812

Disorders of phosphorus metabolism and phosphatases

278

0.88

0.18

3.0

2.9

0.80

0.72

ug/l

0.18

189

Dermatitis herpetiformis

1018

0.94

0.18

3.1

2.9

0.62

0.77

ug/l

0.93

662

Viral pneumonia (known virus, not influenza)

167

1730

0.96

0.18

2.9

3.1

0.71

0.77

ug/l

0.55

120

1168

Other specified and unspecified disorders of choroid

215

1.14

0.18

3.1

2.7

0.59

0.70

ug/l

0.36

130

Venous thromboembolism

4597

44671

0.99

0.18

3.1

0.81

0.79

ug/l

0.38

3229

30335

Hypertrophic disorders of skin

190

1835

1.04

0.18

3.1

2.8

0.66

0.74

ug/l

0.95

126

1083

Malignant neoplasm of rectosigmoid junction

115

1200

0.95

0.18

2.9

2.7

1.06

0.77

ug/l

0.61

811

Disorders of iron metabolism

118

1131

1.05

0.18

2.7

2.9

0.67

0.71

ug/l

0.17

722

Disorder of thyroid, unspecified

281

1.11

0.18

3.6

3.1

0.59

0.73

ug/l

0.61

195

Calcification and ossification of muscle

162

0.84

0.18

2.9

3.0

0.49

0.78

ug/l

—

108

Disorders of adrenal gland, other and/or unspecified

236

0.88

0.18

2.7

2.9

2.33

0.68

ug/l

0.54

150

Common variable immunodeficiency

253

1.12

0.18

2.6

2.7

0.57

0.73

ug/l

0.86

143

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

864

0.94

0.18

2.9

2.6

0.70

0.73

ug/l

0.11

491

Other eating disorders

454

1.08

0.18

2.4

0.50

0.67

ug/l

1.48

256

Other and unspecified disorders of autonomic nervous system

173

0.85

0.18

3.3

2.8

0.78

0.71

ug/l

—

120

Malignant neoplasm of small intestine

156

1505

1.05

0.17

2.9

2.7

0.86

0.73

ug/l

0.61

113

1030

Hyperprolactinaemia, drug-induced

110

1.19

0.17

2.2

2.9

0.44

0.72

ug/l

—

Other and unspecified water transport accidents

264

1.13

0.17

2.7

2.8

0.68

0.76

ug/l

0.29

159

Tooth agenesis EXCLUDE clefts and syndromes

581

1.07

0.17

2.3

2.4

0.70

0.68

ug/l

0.05

298

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

535

0.92

0.17

2.3

2.6

0.77

0.73

ug/l

0.06

357

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

307

0.89

0.17

3.0

3.3

0.65

0.83

ug/l

0.78

212

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.75

0.17

3.3

2.7

1.11

0.82

ug/l

—

Fracture of skull and facial bones

1749

17665

0.99

0.17

2.7

0.67

0.73

ug/l

2.38

1140

10621

Myasthenia gravis

118

1132

1.05

0.17

2.7

3.1

0.61

0.75

ug/l

2.08

771

conjunctival degenerations and deposits

106

1013

1.05

0.17

2.8

3.0

0.63

0.77

ug/l

1.94

682

Pedestrian injured in collision with two- or three-wheeled motor vehicle

158

1.16

0.17

1.7

2.6

0.57

0.69

ug/l

—

Retinal haemorrhage

150

1446

1.04

0.17

3.4

3.1

0.76

0.80

ug/l

0.32

105

966

Viral encephalitis, not elsewhere classified/unspecified

112

1169

0.95

0.17

3.6

2.9

0.68

0.76

ug/l

0.59

748

Toxic effect of other noxious substances eaten as food

158

1.16

0.17

2.4

2.8

0.38

0.67

ug/l

—

101

Cervical root disorders

452

0.92

0.17

2.2

2.8

0.66

0.79

ug/l

0.65

294

Guillain-Barre syndrome

116

1113

1.05

0.17

3.4

2.9

0.70

0.77

ug/l

0.43

724

Neuralgia and neuritis, unspecified

251

2581

0.97

0.17

3.0

2.8

0.78

0.74

ug/l

0.13

165

1635

Mononeuritis multiplex

203

0.86

0.17

3.1

2.9

0.53

0.74

ug/l

1.08

140

Other specified/unspecified necrotizing vasculopathies

789

1.06

0.17

2.6

3.0

0.69

0.78

ug/l

0.47

517

Frontotemporal dementia, wide, incl. Pick's disease

472

0.92

0.17

2.4

3.1

0.96

0.82

ug/l

0.15

320

Ankylosing hyperostosis [Forestier]

120

1154

1.05

0.17

3.2

2.9

0.58

0.77

ug/l

3.49

788

Phantom limb syndrome

182

0.86

0.17

2.5

3.2

0.41

0.74

ug/l

3.65

126

Burns and corrosions of multiple and unspecified body regions

167

1615

1.04

0.17

2.8

0.72

0.74

ug/l

0.17

118

979

Systemic lupus erythematosus, unspecified

641

1.06

0.17

2.5

2.8

0.79

0.74

ug/l

0.08

411

Neuralgic amyotrophy

169

1.17

0.17

3.5

2.8

0.49

0.73

ug/l

1.23

118

Intussusception

546

0.93

0.17

2.7

0.66

0.83

ug/l

0.83

340

Contact with sharp glass

202

2083

0.97

0.16

2.6

0.75

0.69

ug/l

0.29

113

1150

Right ventricular outflow tract obstruction

141

0.84

0.16

2.2

2.4

0.31

0.83

ug/l

—

Abnormal weight loss

611

6009

1.02

0.16

3.2

3.1

0.73

0.80

ug/l

0.90

441

4139

Use of rasagiline

194

1998

0.96

0.16

3.2

0.64

0.76

ug/l

2.59

143

1401

Vitamin A deficiency

172

0.86

0.16

3.1

2.9

0.81

0.95

ug/l

—

123

Chronic inflammatory disorders of orbit

159

1.16

0.16

1.9

2.8

0.66

0.69

ug/l

0.07

104

Autonomic disorders

137

1320

1.04

0.16

2.8

2.9

0.68

0.75

ug/l

0.42

855

Lesion of femoral nerve

266

0.89

0.16

3.3

2.9

0.63

0.68

ug/l

0.16

181

Emotional disorders starting during childhood or adolecense, excluding more controls

432

0.92

0.16

1.6

1.8

0.33

0.58

ug/l

4.68

146

Other reaction to severe stress, and adjustment disorders

1606

16227

0.99

0.16

2.6

2.5

0.63

0.70

ug/l

2.34

1013

8804

Tuberculosis of other organs, strict

120

1249

0.96

0.16

3.0

3.2

0.62

0.83

ug/l

2.56

862

Other/unspecified enthesopathies, not elsewhere classified

544

5345

1.02

0.16

3.0

2.9

0.70

0.80

ug/l

1.10

337

3508

Other acquired deformities of ankle and foot

293

1.10

0.16

3.2

2.5

0.78

0.93

ug/l

0.35

182

Benign neoplasm: Brain, supratentorial

790

1.06

0.16

2.7

2.9

0.80

0.75

ug/l

0.17

499

Bradycardia, unspecified, drug-induced

140

1.17

0.16

2.6

3.0

1.25

0.89

ug/l

—

100

Benign neoplasm: Connective and other soft tissue of pelvis

0.74

0.16

5.3

2.9

0.68

0.84

ug/l

—

Neurofibromatosis, type 1

216

1.12

0.16

2.7

2.5

0.82

0.64

ug/l

0.61

122

Rhinophyma

706

1.07

0.16

3.3

3.1

0.99

0.84

ug/l

0.51

483

Habit and impulse disorders

800

0.94

0.16

1.8

2.3

0.47

0.64

ug/l

2.19

400

Folate deficiency anaemia

686

0.94

0.16

3.0

3.1

0.86

0.78

ug/l

0.39

463

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

296

0.90

0.16

2.0

2.6

0.66

0.74

ug/l

0.21

180

SLE, strict definition

789

1.06

0.16

2.6

2.8

0.77

0.73

ug/l

0.08

499

SLE, ICD10

789

1.06

0.16

2.6

2.8

0.77

0.73

ug/l

0.08

499

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

326

3336

0.97

0.16

2.5

2.7

0.58

0.68

ug/l

3.01

194

1953

Personal history of certain other diseases

349

0.91

0.16

2.6

0.60

0.75

ug/l

0.58

199

Pediculosis and phthiriasis

327

0.91

0.16

1.8

2.5

0.62

0.68

ug/l

0.20

174

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

387

3951

0.98

0.16

2.8

3.1

0.77

ug/l

0.00

271

2694

Other diseases caused by chlamydiae

293

1.10

0.16

2.5

0.59

0.88

ug/l

1.42

167

Other and unspecified disorders of orbit

275

0.89

0.16

2.6

0.49

0.74

ug/l

2.00

170

Malignant neoplasm of tonsil

132

1366

0.96

0.15

3.0

2.6

0.71

0.70

ug/l

0.07

864

Kaposi sarcoma, including Hilmo

122

1.19

0.15

3.1

2.7

0.69

0.77

ug/l

—

Infection of intervertebral disc (pyogenic)

122

1177

1.05

0.15

3.1

3.0

0.72

0.81

ug/l

0.49

809

Alzheimer’s disease (Late onset), excluding more controls

1317

8539

1.01

0.15

3.1

3.6

0.85

0.90

ug/l

0.82

969

6486

Congenital lens malformations

150

0.86

0.15

2.6

2.5

0.86

0.71

ug/l

—

Fibrosarcoma

431

1.08

0.15

2.6

0.58

0.76

ug/l

1.61

281

Other and unspecified papulosquamous disorders

285

1.10

0.15

2.5

3.0

0.77

0.76

ug/l

0.02

185

Diving or jumping into water causing injury other than drowning or submersion

334

1.10

0.15

2.4

2.5

0.50

0.73

ug/l

1.99

190

Congenital ptosis

131

1.16

0.15

1.8

2.9

0.81

0.68

ug/l

—

Endocrine disorders, other/unspecified

788

0.95

0.15

3.9

2.8

0.73

0.72

ug/l

0.09

481

Multiple system atrophy (rare forms of Parkinsonism)

201

0.87

0.15

2.2

3.1

0.56

0.85

ug/l

0.56

145

Other operation for atrial fibrillation

531

1.08

0.15

2.9

3.2

0.72

0.79

ug/l

0.21

365

Atopic conjunctivitis

135

1302

1.04

0.15

2.2

2.6

0.63

0.73

ug/l

0.98

735

Acute inflammation of orbit

324

1.09

0.15

2.9

2.6

0.48

0.74

ug/l

2.87

208

Unspecified hairloss

1.23

0.15

2.4

2.5

0.51

0.68

ug/l

—

Essential (haemorrhagic) thrombocythaemia

207

2014

1.03

0.15

2.7

0.71

0.72

ug/l

0.09

141

1342

Other and unspecified primary disorders of muscles

363

1.09

0.15

2.8

0.69

0.74

ug/l

0.12

225

Burns and corrosions of multiple body regions

704

0.94

0.15

3.3

2.9

0.75

0.77

ug/l

0.08

445

Other superficial injuries of ankle and foot

305

0.91

0.14

2.2

2.6

0.67

0.70

ug/l

0.06

177

Cleft palate

202

0.89

0.14

1.9

0.48

0.67

ug/l

—

Adenocarcinoma of small intestine

180

1.14

0.14

2.3

2.6

0.87

0.82

ug/l

0.12

120

Rare circulating lymphoid malignancy, including Hilmo

201

2064

0.97

0.14

3.3

2.7

0.70

0.73

ug/l

0.16

138

1375

Lower back pain or/and sciatica

8936

58561

1.00

0.14

2.9

0.67

0.77

ug/l

15.13

5903

37355

Acute hepatitis A

263

0.90

0.14

2.7

2.9

0.74

0.78

ug/l

0.06

153

Injuries involving multiple body regions

207

2015

1.03

0.14

2.9

2.8

0.63

0.74

ug/l

1.87

138

1223

Other diseases of liver

1156

11683

0.99

0.14

2.9

0.73

0.75

ug/l

0.10

764

7476

Congenital retinoschisis

190

1.13

0.14

3.5

3.1

0.58

0.82

ug/l

—

127

Other osteochondropathies

477

4850

0.98

0.14

2.8

2.7

0.64

0.70

ug/l

0.98

284

2924

Malignant neoplasm of small intestine, including Hilmo

207

2124

0.97

0.14

2.8

2.7

0.84

0.72

ug/l

0.77

149

1450

Superficial injury of thorax

1122

11339

0.99

0.14

3.0

2.9

0.68

0.77

ug/l

1.61

760

7271

Cervical disc disorders

3192

31725

1.01

0.14

3.0

2.9

0.68

0.79

ug/l

5.49

2154

20607

Adhesive middle ear disease

725

1.05

0.14

3.1

2.8

0.81

0.77

ug/l

0.18

452

Idiopathic hypercalciuria

335

1.09

0.14

2.7

2.8

0.68

0.73

ug/l

0.37

204

Bacterial, viral and other infectious agents

631

6221

1.02

0.14

2.5

0.77

0.69

ug/l

0.41

354

3396

Colorectal neuroendocrine tumor and carcinoma

588

1.06

0.14

2.5

0.68

0.70

ug/l

0.07

378

Failure and rejection of transplanted organs and tissues

907

0.95

0.14

2.4

2.7

0.87

0.70

ug/l

1.06

558

Hypospadias

209

1.12

0.14

2.5

2.7

0.76

0.77

ug/l

0.00

127

Nonpyogenic thrombosis of intracranial venous system

393

1.08

0.14

3.4

2.8

0.76

0.72

ug/l

0.06

248

Meningococcal infection

366

0.92

0.14

2.6

0.65

0.66

ug/l

0.03

201

Granuloma annulare

418

0.93

0.14

3.4

2.9

0.74

0.79

ug/l

0.22

274

Viral infections of the central nervous system

346

3529

0.98

0.14

2.9

2.8

0.64

0.72

ug/l

1.28

215

2118

Certolizumab pegol

412

1.07

0.14

2.1

2.4

0.55

0.68

ug/l

0.67

221

Shigellosis

190

1.13

0.14

2.0

2.8

0.73

0.70

ug/l

0.04

118

Other prurigo

499

0.93

0.13

2.9

3.0

0.50

0.85

ug/l

3.90

315

Carcinoma in situ of middle ear and respiratory system

395

0.92

0.13

3.4

3.2

0.92

0.77

ug/l

0.65

280

Use of rotigotine

682

0.94

0.13

3.4

2.9

0.67

0.74

ug/l

0.48

460

Acute epiglottitis

106

1022

1.05

0.13

2.5

2.7

0.70

0.76

ug/l

0.46

614

Other specified and unspecified disorders of iris and ciliary body

169

0.87

0.13

3.8

2.5

0.51

0.61

ug/l

—

Malignant neoplasm of lip

559

0.94

0.13

3.0

2.8

0.75

0.81

ug/l

0.32

394

Toxic colitis

210

0.89

0.13

2.5

2.9

0.84

0.74

ug/l

0.19

139

Congenital musculoskeletal deformities of head, face, spine and chest

374

1.08

0.13

2.8

2.6

0.70

0.67

ug/l

0.10

209

Acute hepatitis B

268

1.10

0.13

2.2

2.8

0.55

0.72

ug/l

0.57

156

Tooth eruption problems

316

3146

0.98

0.13

2.5

2.4

0.64

0.66

ug/l

0.07

170

1670

Cleft lip and cleft lip and palate

277

1.09

0.13

3.0

2.4

0.60

0.68

ug/l

0.38

143

Disorders of calcium metabolism

374

3808

0.98

0.13

3.0

3.1

0.99

0.77

ug/l

1.18

276

2594

Congenital malformations of eyelid, lacrimal apparatus and orbit

138

0.86

0.13

2.3

2.6

0.67

0.63

ug/l

—

Drug-induced osteoporosis with pathological fracture

611

0.94

0.13

2.6

3.0

0.49

0.76

ug/l

3.42

400

Other congenital malformations of brain

142

1.14

0.13

1.8

2.3

0.49

0.61

ug/l

0.75

Congenital malformations, deformations and chromosomal abnormalities

3547

33576

1.01

0.13

2.7

0.73

0.72

ug/l

0.18

2168

19863

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

1.20

0.13

1.6

2.6

0.65

ug/l

—

Adult-onset Still disease

179

0.88

0.13

3.3

2.5

0.53

0.71

ug/l

—

102

Acute myringitis

262

0.91

0.13

2.8

2.7

0.70

0.75

ug/l

0.06

160

Cerebral amyloid angiopathy

394

0.92

0.13

2.9

3.3

0.75

0.78

ug/l

0.08

284

Family history of other conditions

355

0.93

0.13

3.3

2.3

0.67

ug/l

0.01

186

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

793

0.95

0.13

3.9

3.2

0.96

0.83

ug/l

0.21

555

Muscular dystrophy

385

0.93

0.13

3.4

2.8

0.67

0.74

ug/l

0.26

250

Asthma and opportunity respiratory infection

256

2505

1.03

0.13

3.1

3.3

0.58

0.79

ug/l

6.75

170

1765

Haemorrhage, not elsewhere classified

289

2833

1.02

0.13

3.2

0.73

0.81

ug/l

1.11

206

1949

Benign neoplasm: Floor of mouth

220

1.11

0.13

3.4

2.7

0.74

0.73

ug/l

0.03

142

Crushing injury of wrist and hand

159

1549

1.04

0.13

2.8

2.9

0.55

0.73

ug/l

5.39

101

979

Personal history of allergy to drugs, medicaments and biological substances

414

1.07

0.12

3.1

2.6

0.54

0.74

ug/l

1.71

250

Diseases of the respiratory system

5450

27182

1.01

0.12

2.9

3.0

0.76

0.79

ug/l

0.74

3543

17889

Protein-energy malnutrition of moderate and mild degree

385

1.07

0.12

2.5

3.2

0.88

0.80

ug/l

0.21

267

Rubella [German measles]

491

4847

1.02

0.12

2.4

0.61

0.66

ug/l

0.99

263

2641

Intestinal malabsorption

267

2615

1.02

0.12

2.8

2.9

0.65

0.72

ug/l

0.93

194

1645

Contracture of joint

758

1.05

0.12

2.5

2.8

0.58

0.82

ug/l

2.04

467

Pityriasis rosea

239

1.10

0.12

2.7

2.6

0.56

0.75

ug/l

0.96

141

Malignant neoplasm of meninges, including Hilmo

162

1.13

0.12

4.3

2.6

0.80

0.78

ug/l

0.05

103

Aggressive periodontitis

139

1350

1.04

0.12

3.1

0.77

0.76

ug/l

0.08

107

886

Pyogenic arthritis

542

5346

1.02

0.12

2.8

2.9

0.70

0.80

ug/l

2.22

365

3500

Maxillary prognathism

133

1.14

0.12

2.7

2.3

0.62

0.73

ug/l

—

Other specific arthropathies, wide

105

1087

0.96

0.12

3.2

2.7

0.69

0.77

ug/l

0.41

671

Implicit parasitic Sepsis

269

1.09

0.12

2.3

2.9

0.55

0.71

ug/l

0.73

171

Impacted teeth

489

4417

0.98

0.12

2.2

2.3

0.59

0.63

ug/l

0.65

256

2234

LeFortI or BSSO operation

127

1311

0.97

0.12

2.6

2.4

0.76

0.67

ug/l

0.43

704

Other disorders starting during childhood or adolescence

526

1.06

0.12

2.3

2.0

0.53

0.65

ug/l

0.86

220

Hand

269

1.09

0.12

3.2

2.7

0.68

0.70

ug/l

0.07

162

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

189

0.89

0.12

3.2

2.5

0.68

0.72

ug/l

—

106

Other and unspecified local infections of skin and subcutaneous tissue

655

6631

0.99

0.12

3.0

0.71

0.75

ug/l

0.71

440

4342

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

133

1.13

0.12

2.5

2.8

0.64

0.70

ug/l

—

Malignant cancer of tonsil and base of tongue, including Hilmo

225

2297

0.97

0.12

2.9

2.6

0.71

0.69

ug/l

0.19

156

1460

Malignant neoplasm of adrenal gland, including Hilmo

347

1.08

0.12

2.9

2.5

0.94

0.74

ug/l

0.37

216

Malignant neoplasm of mesothelium and soft tissue

277

2717

1.02

0.12

3.0

2.7

0.74

0.73

ug/l

0.13

211

1867

Mild or no visual impairment, binocular

172

1.12

0.12

3.3

2.8

0.67

0.77

ug/l

0.15

118

Benign neoplasm: Tonsil

659

0.95

0.12

2.6

2.9

0.65

0.72

ug/l

0.60

432

Sequelae of inflammatory diseases of the central nervous system

157

0.88

0.12

2.5

2.7

0.39

0.75

ug/l

—

Papilloedema, unspecified

103

995

1.04

0.12

3.2

2.9

0.83

0.77

ug/l

0.36

637

Polycystic kidney disease

166

1618

1.03

0.12

2.7

2.9

1.21

0.76

ug/l

1.79

126

1011

Periodontal disease, other/unspecified

119

1228

0.97

0.12

3.3

3.0

0.61

0.74

ug/l

2.56

775

Other and unspecified trigeminal disorders

578

0.95

0.12

2.7

2.8

0.67

0.75

ug/l

0.44

373

Crohn's disease of small intestine

356

3621

0.98

0.12

2.7

0.61

0.71

ug/l

2.36

228

2172

Pedal cyclist injured in transport accident

1497

14853

1.01

0.12

2.8

2.7

0.67

0.72

ug/l

1.81

951

9092

Lesion of ulnar nerve

1186

11962

0.99

0.11

2.9

2.8

0.67

0.75

ug/l

1.13

820

7580

Abnormality of red blood cells

299

1.08

0.11

2.8

0.66

0.81

ug/l

0.49

181

Abnormal findings on examination of urine, without diagnosis

321

3155

1.02

0.11

3.1

0.90

0.77

ug/l

1.01

230

2134

Malignant neoplasm of lip, including Hilmo

790

0.95

0.11

3.3

2.8

0.71

0.80

ug/l

0.79

556

Other congenital malformations of male genital organs

211

1.10

0.11

2.7

2.6

0.52

0.74

ug/l

—

117

Purulent endophthalmitis

403

0.93

0.11

3.1

1.00

0.77

ug/l

0.56

268

Myocarditis

407

4007

1.02

0.11

2.4

2.8

0.65

0.72

ug/l

1.14

232

2410

Use of teriflunomide

240

1.09

0.11

1.8

1.9

0.57

0.63

ug/l

0.24

103

Otorrhagia

454

0.94

0.11

2.7

2.8

0.66

0.82

ug/l

0.65

289

Other specified/unspecified dorsopathies

169

1648

1.03

0.11

2.9

0.71

0.77

ug/l

0.28

114

1042

Postprocedural disorders of eye and adnexa, not elsewhere classified

177

0.89

0.11

3.8

3.0

0.42

0.78

ug/l

—

113

Other bursitis of hip

740

1.04

0.11

3.2

2.9

0.76

0.82

ug/l

0.30

501

Meningitis, viral

134

1.13

0.11

2.0

2.8

0.83

0.73

ug/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1003

0.96

0.11

3.2

2.9

0.76

0.79

ug/l

0.08

655

Folliculitis decalvans

125

1.15

0.11

2.5

3.0

0.81

0.77

ug/l

—

Other and unspecified mononeuropathies of upper limb

188

1838

1.03

0.11

2.7

2.8

0.60

0.72

ug/l

1.67

124

1140

Cysts of oral region, not elsewhere classified

428

4220

1.02

0.11

2.9

0.88

0.74

ug/l

0.75

266

2706

Pediculosis, acariasis and other infestations

436

4421

0.98

0.11

2.7

0.63

0.71

ug/l

1.59

274

2690

Cystic disease of liver

280

1.08

0.11

3.1

3.0

0.75

0.79

ug/l

0.07

188

Viral warts

502

5087

0.99

0.11

2.6

2.8

0.63

0.73

ug/l

2.74

307

3177

CR(E)ST syndrome

260

1.08

0.11

2.5

2.8

0.44

0.77

ug/l

2.46

165

Nerve, nerve root and plexus disorders

9457

58071

1.00

0.11

2.9

0.70

0.77

ug/l

7.00

6243

37201

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

125

0.87

0.11

2.6

3.0

0.78

0.99

ug/l

—

Lymphoid leukaemia

447

4410

1.02

0.11

3.0

3.2

0.77

0.78

ug/l

0.02

320

3092

Thyroiditis, unspecified

348

1.07

0.11

3.2

2.8

0.67

0.74

ug/l

0.41

226

Meningitis

272

2769

0.98

0.11

2.9

2.8

0.64

0.71

ug/l

1.21

174

1687

Disorders of purine and pyrimidine metabolism, other/unspecified

1.19

0.10

5.0

3.3

0.66

0.57

ug/l

—

Disorders resulting from impaired renal tubular function

261

2657

0.98

0.10

2.4

3.0

0.89

0.72

ug/l

3.05

211

1725

Benign neoplasm of middle ear and respiratory system

651

6440

1.01

0.10

2.9

3.0

0.75

0.78

ug/l

0.32

432

4298

Spondyloarthritis

1257

12666

0.99

0.10

2.8

0.72

0.77

ug/l

0.91

835

8029

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

223

2187

1.02

0.10

2.5

2.8

0.92

0.72

ug/l

1.98

159

1350

Injury of blood vessels at wrist and hand level

546

1.06

0.10

2.7

2.9

0.78

0.75

ug/l

0.04

344

Hypertrophic scar

165

1610

1.03

0.10

3.1

2.7

0.65

0.73

ug/l

0.88

109

946

Purpura and other haemorrhagic conditions

914

9224

0.99

0.10

2.9

3.1

0.82

0.77

ug/l

0.39

628

6236

Congenital malformations of ear causing impairment of hearing

125

1.13

0.10

3.9

2.6

0.79

0.67

ug/l

—

Benign neoplasm: Ribs, sternum and clavicle

135

1.14

0.10

3.1

2.8

0.54

0.77

ug/l

—

Other secondary gonarthrosis

365

3596

1.02

0.10

3.2

3.0

0.61

0.76

ug/l

4.59

254

2373

Hypertrophic cardiomyopathy

329

3341

0.98

0.10

2.7

3.0

0.66

0.76

ug/l

1.80

223

2218

Disorders of mineral metabolism

558

5514

1.01

0.10

3.0

0.90

0.75

ug/l

1.06

388

3693

Symptoms and signs involving emotional state

111

1144

0.97

0.10

3.0

2.6

0.66

0.76

ug/l

0.74

664

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

8989

57378

1.00

0.10

3.1

2.9

0.77

ug/l

0.08

6152

36993

Palindromic rheumatism

514

0.95

0.10

3.7

2.8

0.79

0.86

ug/l

0.19

324

Aplastic and other anaemias

4129

38632

1.00

0.10

3.2

0.86

0.80

ug/l

1.63

3000

27186

Glaucoma secondary to eye inflammation

473

0.94

0.10

3.4

3.0

0.66

0.78

ug/l

0.66

297

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

526

1.05

0.10

2.5

0.78

0.71

ug/l

0.21

331

Tic and related disorders

300

0.93

0.10

3.1

2.3

0.62

0.76

ug/l

0.42

142

Cleft lip and palate

232

1.09

0.10

3.1

2.4

0.58

0.70

ug/l

0.51

121

Carcinoma in situ of larynx

175

0.88

0.10

3.2

0.98

0.71

ug/l

—

132

Other and unspecified thalassaemias

1.12

0.10

2.2

2.7

0.72

0.63

ug/l

—

Other lesions of median nerve

121

1177

1.03

0.10

2.9

3.0

0.71

0.78

ug/l

0.37

793

Other hammer toe(s) (acquired)

665

6067

1.01

0.10

3.0

3.1

0.70

0.82

ug/l

1.61

445

4156

Carcinoid syndrome

675

0.95

0.10

3.1

0.73

0.76

ug/l

0.19

455

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

487

1.05

0.10

2.7

0.69

0.67

ug/l

0.06

300

Schistosomiasis [bilharziasis]

184

1.10

0.10

3.0

2.9

0.79

0.78

ug/l

0.01

117

Benign neoplasm: Cornea

1.17

0.10

4.8

3.1

1.39

0.69

ug/l

—

Melanocytic naevi of ear and external auricular canal

252

1.08

0.10

3.0

3.1

0.66

0.77

ug/l

0.29

174

Haemorrhagic disorder due to circulating anticoagulants

999

0.96

0.10

3.1

3.2

0.72

0.82

ug/l

0.55

702

Chronic myeloid leukaemia, including Hilmo

604

0.95

0.10

2.4

2.5

0.70

0.74

ug/l

0.15

387

Benign neoplasm of other and unspecified sites

175

1788

0.98

0.10

3.2

2.9

0.71

0.76

ug/l

0.36

119

1143

Ventral hernia

1767

17564

1.01

0.09

3.1

3.0

0.74

0.79

ug/l

1.97

1234

11867

Other specified acquired deformities of limbs

186

0.91

0.09

2.4

2.5

0.40

0.83

ug/l

—

108

Benign neoplasm: Other/unspecified site

817

0.96

0.09

3.1

2.9

0.68

0.76

ug/l

0.37

527

Insomnia

5679

41498

1.00

0.09

2.8

2.7

0.64

0.73

ug/l

5.89

3423

24963

Other and unspecified bullous disorders

478

1.05

0.09

2.7

3.1

0.81

0.79

ug/l

0.03

305

Other and unspecified diseases of spleen

247

0.92

0.09

3.6

3.0

0.71

0.85

ug/l

0.37

159

Other disorders of electrolyte and fluid balance, not elsewhere classified

431

0.94

0.09

2.9

3.1

0.66

0.74

ug/l

0.31

286

Social phobias

303

2982

1.02

0.09

2.6

2.3

0.53

0.67

ug/l

3.48

197

1496

Cellulitis of external ear

634

0.96

0.09

2.7

2.8

0.61

0.73

ug/l

0.94

395

Other acute skin changes due to ultraviolet radiation

202

1982

1.02

0.09

3.3

3.0

0.63

0.79

ug/l

2.81

132

1310

Noninfective enteritis and colitis

3289

32705

1.00

0.09

2.9

0.70

0.75

ug/l

2.02

2141

20708

Other papulosquamous disorders

573

0.95

0.09

3.3

3.0

0.66

0.76

ug/l

0.48

375

Erythema nodosum

807

0.96

0.09

2.9

0.95

0.70

ug/l

1.00

510

Viral conjunctivitis

128

1248

1.03

0.09

2.9

2.7

0.63

0.71

ug/l

0.84

734

Ependymoma

1.10

0.09

3.5

2.1

0.67

0.99

ug/l

—

Thrombocytopenia, unspecified

520

5256

0.99

0.09

3.0

3.1

0.88

0.76

ug/l

0.68

362

3589

Malignant neoplasm of palate

195

1.10

0.09

2.1

2.6

1.02

0.71

ug/l

0.76

131

Fracture of neck

525

5196

1.01

0.09

2.8

3.1

0.66

0.77

ug/l

1.97

355

3453

Malignant neoplasm of heart, mediastinum and pleura

101

1037

0.97

0.09

3.1

2.8

0.90

0.76

ug/l

0.62

725

Eosinophilia

101

983

1.03

0.09

2.8

3.0

0.80

0.75

ug/l

0.17

665

Open wound of ankle and foot

797

7904

1.01

0.09

2.7

2.9

0.68

0.74

ug/l

1.46

500

5012

Disorders of plasma-protein metabolism, not elsewhere classified

460

0.95

0.09

1.9

3.0

0.75

0.71

ug/l

0.12

289

Embedded teeth, including avohilmo

251

2552

0.98

0.08

2.5

0.68

0.67

ug/l

0.04

139

1375

Allergic bronchopulmonary aspergillosis (ABPA)

378

0.94

0.08

3.4

3.0

0.65

0.75

ug/l

0.56

262

Other bullous disorders

145

1482

0.97

0.08

3.0

0.63

0.76

ug/l

1.01

103

966

Asymmetry of jaw

351

1.06

0.08

2.2

2.6

0.76

0.67

ug/l

0.22

202

Type of accident

2038

20277

1.01

0.08

2.8

2.9

0.73

0.74

ug/l

0.45

1286

12885

Systemic sclerosis (FG)

538

1.04

0.08

2.9

2.7

0.60

0.80

ug/l

1.18

336

Contusion of toe(s) with damage to nail

588

1.04

0.08

2.7

2.8

0.60

0.76

ug/l

1.39

340

Other and unspecified injuries of thorax

115

1122

1.03

0.08

2.2

2.8

0.51

0.74

ug/l

5.94

684

Benign neoplasm: Urethra

1.09

0.08

4.3

3.3

0.60

0.71

ug/l

—

Other disorders of white blood cells

347

3515

0.98

0.08

2.9

3.1

0.74

0.76

ug/l

0.13

237

2343

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

105

1022

1.03

0.08

2.6

2.4

0.60

0.71

ug/l

0.76

529

Disorders of vagus nerve

1.07

0.08

1.6

2.9

0.49

0.75

ug/l

—

Malignant neoplasm of other and unspecified major salivary glands

205

1.09

0.08

2.2

2.6

0.63

0.72

ug/l

0.38

122

Corticotropin deficiency

401

1.06

0.08

2.9

0.63

0.78

ug/l

1.19

251

Enteritis due to Yersinia enterocolitica

244

1.08

0.08

2.5

2.7

0.78

0.69

ug/l

0.15

138

Choroidal detachment

127

1.12

0.08

2.8

3.0

0.54

0.88

ug/l

—

Phantom limb syndrome with pain

174

0.90

0.08

2.5

3.0

0.41

0.74

ug/l

3.77

118

Juvenile osteochondrosis

140

1431

0.98

0.08

2.4

2.6

0.57

0.72

ug/l

1.76

807

Leiomyosarcoma

293

1.07

0.08

3.3

2.6

0.74

0.75

ug/l

0.02

190

Scleritis and episcleritis in diseases classified elsewhere

0.79

0.08

2.3

3.0

1.04

0.71

ug/l

—

Caries of dentine

1929

18856

0.99

0.08

2.6

2.8

0.81

0.78

ug/l

0.29

1366

11425

Explosion of other materials

294

1.07

0.08

2.1

2.8

0.47

0.78

ug/l

1.93

175

Frontotemporal dementia

402

1.06

0.08

2.5

3.1

0.96

0.83

ug/l

0.14

279

Assault by drugs, medicaments and biological substances

0.80

0.08

4.0

2.1

0.60

0.67

ug/l

—

Wide developmental disorders

540

0.96

0.08

1.9

2.0

0.47

0.55

ug/l

0.40

228

Failure of sterile precautions during surgical operation

184

0.91

0.08

2.4

3.1

0.63

0.71

ug/l

0.40

116

Gingival hyperplasia

214

2175

0.98

0.08

2.9

3.0

0.74

0.73

ug/l

0.07

169

1423

Myotonic disorders

372

1.06

0.08

2.6

0.50

0.72

ug/l

2.04

223

Congenital malformations of great arteries

620

0.96

0.08

3.0

2.6

1.15

0.69

ug/l

0.77

365

Osteomalacia

378

0.95

0.08

2.6

2.9

0.80

0.72

ug/l

0.19

231

Multifocal fibrosclerosis

264

1.07

0.08

3.0

3.2

0.84

0.78

ug/l

0.18

175

Achalasia of cardia

122

1193

1.03

0.08

3.3

3.0

0.66

0.75

ug/l

0.62

795

Osteoporosis with pathological fracture (FG)

602

0.96

0.08

2.6

2.9

0.49

0.82

ug/l

3.95

392

Inguinal hernia, unilateral

157

1540

1.02

0.08

3.1

0.86

0.78

ug/l

0.14

109

1058

Inguinal of femoral hernia, unilateral

157

1540

1.02

0.08

3.1

0.86

0.78

ug/l

0.14

109

1058

Femoral hernia, unilateral

157

1540

1.02

0.08

3.1

0.86

0.78

ug/l

0.14

109

1058

Hypertensive heart and/or renal disease

2800

20975

1.00

0.08

3.1

3.2

0.81

0.78

ug/l

0.79

2021

14641

Non-follicular lymphoma

807

8129

0.99

0.08

2.9

3.2

0.77

0.79

ug/l

0.32

566

5703

Varicella [chickenpox]

415

4191

0.99

0.08

2.5

2.4

0.67

0.66

ug/l

0.02

210

2264

Weight loss

631

6256

1.01

0.08

3.1

0.72

0.80

ug/l

1.09

457

4310

Recurrent cholesteatoma of postmastoidectomy cavity

204

0.92

0.07

3.2

3.0

0.66

0.80

ug/l

—

130

245

0.93

0.07

2.6

2.5

0.61

0.68

ug/l

0.23

130

Congenital cataract

143

0.90

0.07

2.6

2.5

0.86

0.71

ug/l

—

Systemic lupus erythematosus

856

1.03

0.07

2.5

2.8

0.75

0.73

ug/l

0.06

544

Other specified/unspecified inflammatory spondylopathies

180

1832

0.98

0.07

2.7

2.6

0.66

0.73

ug/l

0.61

1045

Malignant neoplasm of other and unspecified urinary organs

216

1.08

0.07

3.0

2.6

0.75

0.79

ug/l

0.10

154

Complex cardiac defects

108

1.12

0.07

1.8

2.2

0.33

0.70

ug/l

—

Chondrosarcoma, including Hilmo

265

0.93

0.07

2.4

1.03

0.72

ug/l

0.76

165

Other diseases of appendix

511

1.04

0.07

3.6

2.9

0.77

0.71

ug/l

0.30

315

Perichondritis of external ear

102

1044

0.97

0.07

3.3

3.0

0.71

0.80

ug/l

0.59

694

Other specified and unspecified strabismus

442

1.05

0.07

3.0

2.8

0.59

0.70

ug/l

0.49

267

Generalized pustular psoriasis

224

0.93

0.07

2.6

3.0

0.65

0.81

ug/l

0.50

144

Atopic dermatitis, strict definition with reimbursement

1164

11304

0.99

0.07

2.5

0.64

0.70

ug/l

1.91

666

6279

Chronic myeloid leukaemia

295

0.94

0.07

2.5

2.6

0.70

0.73

ug/l

0.06

184

Other specified congenital malformation syndromes affecting multiple systems

488

0.96

0.07

2.1

2.5

0.69

0.65

ug/l

0.10

263

L04AD Calcineurin inhibitors

753

7476

1.01

0.07

2.2

2.8

0.77

0.70

ug/l

1.15

576

4580

Atrial septal defect, secundum type

789

0.97

0.07

2.6

2.7

0.84

0.69

ug/l

0.25

451

Lesion of medial popliteal nerve

183

0.92

0.07

1.8

2.7

0.59

0.69

ug/l

—

115

Other follicular disorders

406

4101

0.99

0.07

2.7

2.8

0.64

0.71

ug/l

1.38

254

2511

Chondrosarcoma

197

1.08

0.07

2.6

1.16

0.75

ug/l

0.91

120

Dermatopolymyositis (FG)

690

1.03

0.07

2.7

2.9

0.73

0.77

ug/l

0.26

451

Colectomy operation

1340

13333

1.01

0.07

3.1

0.77

0.78

ug/l

0.25

950

9224

Abnormal findings in cerebrospinal fluid

142

0.90

0.07

3.8

2.4

1.15

0.73

ug/l

—

Disorders in reading

275

1.06

0.07

1.8

1.9

0.48

0.60

ug/l

0.51

101

Pericarditis

306

3026

1.01

0.07

2.7

3.0

0.81

0.78

ug/l

0.12

207

1978

Other local infections of skin and subcutaneous tissue

718

7230

0.99

0.06

3.0

0.70

0.76

ug/l

1.27

479

4732

Other specified/unspecified spondylopathies

155

1524

1.02

0.06

3.2

3.1

0.75

0.82

ug/l

0.19

111

1050

Injury of nerves and spinal cord at thorax level

335

1.05

0.06

3.3

2.8

0.58

0.76

ug/l

1.12

197

Fracture of shoulder and upper arm

2345

23333

1.00

0.06

2.9

0.74

0.76

ug/l

0.22

1539

14874

Diseases of thymus

109

1.12

0.06

2.4

2.9

0.41

0.66

ug/l

—

Allergic contact dermatitis due to drugs in contact with skin

859

1.03

0.06

2.6

3.1

0.75

0.74

ug/l

0.04

578

Other and unspecified anaemias

3845

36535

1.00

0.06

3.2

0.84

0.81

ug/l

0.90

2773

25782

Use of glatiramer acetate

315

0.95

0.06

1.7

2.3

0.61

0.65

ug/l

0.16

150

Viral infections of the central nervous system

374

3777

0.99

0.06

2.9

2.8

0.63

0.72

ug/l

1.72

233

2272

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

168

1.08

0.06

2.6

2.5

0.84

0.68

ug/l

—

113

Renal tubulo-interstitial disorders in diseases classified elsewhere

678

0.97

0.06

2.6

3.0

0.97

0.70

ug/l

1.03

441

Sequelae of burns, corrosions and frostbite

304

0.95

0.06

2.0

2.7

0.67

0.74

ug/l

0.20

182

Intercostal neuropathy

464

1.04

0.06

3.0

3.1

0.56

0.75

ug/l

1.69

315

!Aliquae complicationes praecoces traumatis

315

3118

1.01

0.06

2.7

2.9

0.64

0.73

ug/l

1.74

212

1959

Early complications of trauma

315

3118

1.01

0.06

2.7

2.9

0.64

0.73

ug/l

1.74

212

1959

Whooping cough

355

0.95

0.06

2.6

0.59

0.68

ug/l

0.42

197

Erysipelas

5869

51804

1.00

0.06

2.9

3.0

0.73

0.76

ug/l

0.87

4024

33621

Tic and related disorders

294

0.95

0.06

3.1

2.2

0.62

0.69

ug/l

0.18

144

Other infestations

141

0.91

0.06

3.0

2.9

0.53

0.76

ug/l

—

Used for control exclusion in common control thyroid runs

10265

51770

1.00

0.06

2.9

0.73

0.77

ug/l

3.20

6667

32727

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

758

0.97

0.06

2.6

0.92

0.73

ug/l

0.55

502

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

114

1162

0.98

0.06

3.4

3.0

0.58

0.76

ug/l

2.79

773

Impaction of intestines

336

1.05

0.05

3.0

2.9

0.60

0.95

ug/l

2.30

205

Tarsal tunnel syndrome

324

0.95

0.05

2.4

2.7

0.67

0.75

ug/l

0.31

207

Superficial injury of hip and thigh

960

9545

1.01

0.05

3.1

0.77

0.82

ug/l

0.45

656

6547

Exclusion endpoint for clefts

606

0.97

0.05

2.3

2.6

0.71

0.66

ug/l

0.16

333

Allergic purpura

146

1437

1.02

0.05

2.7

2.8

0.70

0.74

ug/l

0.24

877

Hereditary nephropathy, not elsewhere classified

151

0.92

0.05

3.1

2.9

0.52

0.66

ug/l

—

105

Chylothorax

161

0.92

0.05

2.9

3.0

0.62

0.69

ug/l

—

119

Effects of heat and light

455

0.96

0.05

3.8

2.9

0.59

0.74

ug/l

0.76

281

Injury of other and unspecified intrathoracic organs

595

5912

1.01

0.05

2.7

3.0

0.73

0.76

ug/l

0.40

387

3857

Vascular dementia

656

6285

1.01

0.05

2.9

3.4

0.80

0.91

ug/l

2.67

480

4631

Dissection of cerebral arteries, nonruptured

475

0.96

0.05

2.5

2.8

0.61

0.71

ug/l

0.45

296

Other retinal disorders in diseases classified elsewhere

171

0.92

0.05

3.4

3.1

0.35

0.69

ug/l

—

118

Other disorders involving the immune mechanism, not elsewhere classified

234

2314

1.01

0.05

2.5

2.9

0.93

0.72

ug/l

2.01

165

1431

Traumatic amputation of hip and thigh

120

1.11

0.05

1.9

3.1

4.75

0.73

ug/l

—

Ankle and foot

374

0.96

0.05

2.7

3.0

0.67

0.73

ug/l

0.26

247

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

867

8711

0.99

0.05

3.0

2.8

0.75

0.71

ug/l

0.28

600

6033

Juvenile Open Angle Glaucoma

313

0.95

0.05

2.8

2.7

0.61

0.80

ug/l

1.15

169

Emotional disorders starting during childhood or adolescence

421

0.96

0.05

1.6

1.7

0.33

0.56

ug/l

3.96

149

Clubfoot

394

0.96

0.05

3.0

2.5

0.80

0.67

ug/l

0.18

210

Malignant neoplasm of anus and anal canal, including Hilmo

634

1.03

0.05

2.7

0.88

0.77

ug/l

0.15

426

Autoimmune thyroiditis

303

0.96

0.05

4.1

2.9

0.64

0.79

ug/l

0.80

196

Atypical facial pain

175

1727

1.01

0.05

2.8

2.9

0.55

0.75

ug/l

3.99

117

1104

Event of undetermined intent

409

4059

1.01

0.05

2.8

2.7

0.72

0.71

ug/l

0.05

269

2438

Malignant neoplasm of eye and adnexa, including Hilmo

106

1042

1.02

0.05

3.3

2.7

0.79

0.78

ug/l

0.08

691

Benign neoplasm: Other and unspecified parts of mouth

205

2027

1.01

0.05

2.8

3.0

0.58

0.76

ug/l

3.33

143

1326

Surgical ablation of atrial fibrillation

594

0.97

0.05

2.5

3.0

0.71

0.72

ug/l

0.05

404

Benign neoplasm: Retina

278

1.05

0.05

2.9

3.1

0.73

0.77

ug/l

0.20

187

Systemic sclerosis, icd10

545

1.03

0.05

2.9

2.8

0.60

0.71

ug/l

0.65

335

Bronchitis, not specified as acute or chronic

641

6445

0.99

0.05

2.7

2.8

0.76

ug/l

0.00

383

4020

Neuroendocrine tumor and carcinoma of pancreas

413

0.96

0.05

2.9

2.5

0.85

0.73

ug/l

0.40

255

Other anaemias

3872

36725

1.00

0.04

3.2

0.84

0.80

ug/l

0.91

2793

25917

Enduring personality changes

231

0.94

0.04

2.1

2.4

0.45

0.69

ug/l

1.70

125

Optic neuritis

127

1289

0.98

0.04

2.7

2.8

0.70

0.74

ug/l

0.21

767

Pigmented purpuric dermatosis

564

0.97

0.04

2.8

3.0

1.03

0.80

ug/l

0.58

360

Bullous disorders

367

3643

1.01

0.04

3.0

3.2

0.84

0.77

ug/l

0.21

248

2513

Other abnormal findings in urine

106

1077

0.98

0.04

3.4

3.2

0.86

0.80

ug/l

0.29

747

Cholesteatoma of middle ear

379

3817

0.99

0.04

3.3

3.1

0.90

0.77

ug/l

0.64

259

2612

Mucinous and mucinous cystic tumor of rectum

372

0.96

0.04

2.5

2.8

0.73

0.71

ug/l

0.04

254

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

107

1087

0.98

0.04

3.3

3.2

0.78

0.80

ug/l

0.11

759

Reiter disease

517

1.03

0.04

2.8

2.7

0.52

0.71

ug/l

2.62

313

Phakomatoses, not elsewhere classified

443

0.97

0.04

2.5

2.7

0.72

0.74

ug/l

0.06

264

Malignant neoplasm of thymus, including Hilmo

259

1.05

0.04

3.5

2.4

0.90

0.71

ug/l

0.53

156

Tuberculosis of other organs

108

1097

0.98

0.04

2.9

3.1

0.62

0.84

ug/l

2.43

757

Agoraphobia

864

1.02

0.04

2.3

2.2

0.49

0.67

ug/l

1.88

397

Benign lipomatous neoplasm of of intra-abdominal organs

180

0.93

0.04

3.2

3.0

0.93

0.74

ug/l

—

113

Disorders of globe

137

1352

1.02

0.04

3.1

3.0

0.78

0.81

ug/l

0.14

105

894

Gender identity disorders

241

0.95

0.04

1.8

2.2

0.37

0.65

ug/l

2.44

117

Meckel's diverticulum

402

0.96

0.04

2.5

2.8

0.79

0.74

ug/l

0.13

249

Early lumbar disc prolapse operation

564

5670

0.99

0.04

2.2

2.1

0.55

0.60

ug/l

1.24

248

2555

Bacterial meningitis

208

2100

0.99

0.04

2.9

0.61

0.72

ug/l

2.05

133

1269

Torticollis

704

0.98

0.04

2.4

0.50

0.75

ug/l

2.66

395

Symptoms and signs concerning food and fluid intake

707

7090

0.99

0.04

3.0

3.1

0.72

0.79

ug/l

1.05

509

4818

Congenital malformations of heart and great arteries

767

7400

1.00

0.04

2.8

0.74

0.72

ug/l

0.22

466

4516

Benign neoplasm: Skin of lower limb, including hip

140

1383

1.01

0.04

2.9

3.0

0.71

0.75

ug/l

0.16

907

Absence of one kidney

139

0.93

0.03

2.2

2.8

0.69

0.79

ug/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

232

2300

1.01

0.03

2.8

2.6

0.61

0.70

ug/l

1.47

138

1361

Pleural plaque

1260

12635

1.00

0.03

3.6

3.4

0.77

0.84

ug/l

1.39

924

9387

Cleft lip, lip and palate or palate

472

0.97

0.03

2.7

2.2

0.59

0.62

ug/l

0.12

222

Deformity of finger(s)

371

0.96

0.03

3.3

2.9

0.61

0.83

ug/l

1.49

243

Other congenital malformations of nervous system

131

1.07

0.03

2.9

2.5

0.54

0.71

ug/l

—

Struck by thrown, projected or falling objec

395

3927

1.01

0.03

2.6

2.8

0.69

0.71

ug/l

0.21

233

2397

Liposarcoma, including Hilmo

757

1.02

0.03

2.8

2.6

0.62

0.72

ug/l

0.68

492

Typhoid and paratyphoid fevers

250

1.05

0.03

2.5

2.7

0.54

0.87

ug/l

1.42

143

Other congenital malformations of the digestive system

179

1760

1.01

0.03

2.7

3.0

0.67

0.76

ug/l

0.69

128

1130

Disorders of psychological development

320

2987

0.99

0.03

2.3

2.4

0.59

0.68

ug/l

1.09

202

1545

Abscess of external ear

743

0.98

0.03

2.7

0.76

0.70

ug/l

0.22

443

Benign neoplasm: Short bones of upper limb

733

0.98

0.03

2.8

0.58

0.72

ug/l

1.82

451

Eosinophilic disease (BM)

101

996

1.02

0.03

2.8

3.1

0.80

0.78

ug/l

0.05

662

Injury of intra-abdominal organs

152

1536

0.99

0.03

2.6

0.72

ug/l

0.03

107

903

Mesothelioma

913

0.98

0.03

3.0

2.9

0.82

0.78

ug/l

0.20

652

Flat foot [pes planus] (acquired)

317

3191

0.99

0.03

3.0

2.8

0.77

ug/l

0.01

211

2007

Glaucoma

4699

40364

1.00

0.03

3.2

0.79

0.80

ug/l

0.32

3340

28272

Lymphangioma, anys site

280

0.96

0.03

2.4

2.5

0.62

0.75

ug/l

0.57

159

Oesophagitis

428

4302

0.99

0.03

3.1

3.0

0.66

0.78

ug/l

2.30

301

2854

Congenital malformations of eyelid, lacrimal apparatus and orbit

169

0.94

0.03

2.0

2.7

0.76

0.65

ug/l

—

104

Implicit fungal Sepsis

409

4112

0.99

0.03

3.3

3.2

0.71

0.76

ug/l

0.37

320

2829

Other retinal artery occlusion

182

1804

1.01

0.03

3.1

3.3

0.85

0.82

ug/l

0.19

126

1246

Typhoid and paratyphoid fevers

300

1.04

0.03

2.5

2.8

0.84

0.83

ug/l

0.02

178

Tularaemia

117

1156

1.01

0.03

2.3

2.9

0.86

0.77

ug/l

0.17

721

Mental and behavioural disorders due to sedatives or hypnotics

381

3831

0.99

0.03

2.4

2.6

0.48

0.68

ug/l

10.14

272

2147

Bilateral sagittal split ramus osteotomy operation

111

1096

1.01

0.03

2.7

2.5

0.79

0.68

ug/l

0.52

585

Femoral hernia

261

2628

0.99

0.03

3.3

3.1

0.88

0.77

ug/l

0.29

187

1818

Degenerative myopia

211

1.05

0.03

2.8

3.0

0.60

0.76

ug/l

0.76

137

Congenital iodine-deficiency syndrome/hypothyroidism

718

1.02

0.03

2.8

3.0

0.58

0.83

ug/l

2.75

471

Other and unspecified vasculitis limited to skin

135

1364

0.99

0.03

2.5

3.0

0.63

0.77

ug/l

1.28

878

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

611

0.98

0.03

2.9

3.1

0.58

0.80

ug/l

2.45

412

Mantle cell lymphoma, including Hilmo

126

1247

1.01

0.03

3.2

2.7

0.71

0.72

ug/l

0.05

852

Other or unspecified paralytic strabismus

400

1.03

0.03

3.1

3.0

0.55

0.72

ug/l

1.44

257

Congenital deformities of feet

134

1326

1.01

0.03

2.7

2.6

0.71

0.69

ug/l

0.06

753

Other and unspecified syphilis

269

0.96

0.03

2.5

2.4

0.71

0.69

ug/l

0.07

134

Malignant neoplasm of other and unspecified parts of tongue

942

0.98

0.03

3.1

2.6

0.80

0.71

ug/l

0.44

622

Injury of blood vessels at neck level

279

0.96

0.03

2.8

2.6

0.84

0.75

ug/l

0.11

170

Other and unspecified neuropathies

281

1.04

0.02

3.3

3.1

0.63

0.74

ug/l

0.42

183

Other and unspecified iron deficiency

2164

21586

1.00

0.02

3.1

3.2

0.92

0.79

ug/l

2.36

1577

15163

Congenital deformities of hip

221

1.04

0.02

3.0

2.2

0.89

0.68

ug/l

0.41

119

Narcolepsy and cataplexy

261

1.04

0.02

3.4

3.0

0.50

0.81

ug/l

1.96

162

Other and unspecified pemphigoid

480

0.98

0.02

2.8

3.1

1.45

0.82

ug/l

0.36

335

Superficial injuries involving multiple body regions

132

1333

0.99

0.02

3.2

2.8

0.60

0.73

ug/l

2.03

804

Fractures involving multiple body regions

162

1.06

0.02

2.1

2.4

0.71

0.68

ug/l

—

Other congenital malformations of tongue, mouth and pharynx

289

1.03

0.02

3.2

2.6

0.65

0.73

ug/l

0.28

176

Tic disorders

279

0.97

0.02

3.3

2.2

0.64

0.66

ug/l

0.05

139

Discontinuity and dislocation of ear ossicles

311

1.03

0.02

3.2

2.7

0.67

0.75

ug/l

0.17

197

Sequelae of infectious and parasitic diseases

485

4869

1.00

0.02

2.8

0.72

0.75

ug/l

0.38

303

2995

Psoriatic arthropathies

673

6709

1.00

0.02

2.8

2.7

0.58

0.77

ug/l

10.67

414

4199

Exposure to other and unspecified man-made environmental factors

851

0.99

0.02

3.0

2.7

0.62

0.71

ug/l

0.49

501

Foreign body in ear

839

1.01

0.02

3.3

2.9

0.83

0.77

ug/l

0.22

521

Malignant cancer of tonsil and base of tongue

192

1933

0.99

0.02

2.9

2.6

0.72

0.68

ug/l

0.31

132

1219

Other and unspecified follicular disorders

277

2755

1.01

0.02

2.8

2.9

0.65

0.72

ug/l

1.18

183

1733

Polymorphous light eruption

172

1.05

0.02

2.2

2.8

0.55

0.89

ug/l

—

108

Other disorders of optic disc

610

1.02

0.02

3.3

2.9

0.72

0.76

ug/l

0.15

386

Ischaemic heart disease, wide definition

7626

47187

1.00

0.02

2.8

2.9

0.72

0.77

ug/l

2.46

5081

30127

Congenital malformations of cardiac septa

284

2734

1.01

0.02

2.8

0.77

0.71

ug/l

0.30

175

1636

Open wounds involving multiple body regions

208

0.96

0.02

2.6

0.74

0.76

ug/l

0.03

115

Ventricular septal defect, a heart condition

478

0.98

0.02

2.4

2.7

0.59

0.74

ug/l

0.94

285

Other and unspecified drugs and medicaments

440

4383

1.00

0.02

3.0

0.70

0.75

ug/l

0.57

298

2875

Other and unspecified paralytic syndromes

740

1.02

0.02

2.6

2.7

0.95

0.79

ug/l

0.26

449

Malignant neoplasm of parotid gland

471

1.02

0.02

2.8

2.6

0.72

ug/l

0.00

300

Injury of blood vessels at forearm level

268

0.96

0.02

2.5

2.8

0.74

0.70

ug/l

0.07

168

Heberden's nodes [with arthropathy]

228

0.96

0.02

4.1

3.0

0.66

0.75

ug/l

0.31

150

Benign neoplasm: Small intestine

251

2523

0.99

0.02

2.9

3.2

0.68

0.77

ug/l

0.87

194

1715

Adenocarcinoma and papilloma adenocarcinoma of rectum

831

8326

1.00

0.02

3.0

2.8

0.75

0.71

ug/l

0.28

576

5754

Crossbite

201

1869

0.99

0.02

2.8

2.6

0.64

0.70

ug/l

0.63

101

1081

Other and unspecified disorders of skin and subcutaneous tissue

343

3416

1.00

0.02

3.6

3.1

0.73

0.76

ug/l

0.42

244

2295

Other disorders of pigmentation

203

2018

1.01

0.02

3.1

3.0

0.82

0.78

ug/l

0.27

134

1331

Measles

609

0.98

0.02

2.2

0.62

0.61

ug/l

0.06

275

Nosocomial condition (hospital)

322

1.03

0.02

3.4

2.9

0.79

0.84

ug/l

0.13

212

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

467

4655

1.00

0.02

3.0

0.70

0.74

ug/l

0.62

318

3066

Unspecified fall

3897

38358

1.00

0.02

3.0

0.71

0.77

ug/l

3.33

2604

25049

Malignant neoplasm of penis

438

0.97

0.02

2.9

2.5

0.80

0.78

ug/l

0.03

274

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

671

1.02

0.02

3.5

2.9

0.68

0.74

ug/l

0.36

443

Congenital malformations of pulmonary and tricuspid valves

113

1.06

0.02

2.1

2.5

0.37

0.79

ug/l

—

Other specified disorders of muscle

179

1801

0.99

0.01

2.3

2.7

0.54

0.73

ug/l

4.11

112

1083

Asthma, hospital admission 2, infections

4134

40438

1.00

0.01

2.8

2.9

0.66

0.79

ug/l

15.67

2655

25963

Asthma-related infections

4134

40438

1.00

0.01

2.8

2.9

0.66

0.79

ug/l

15.67

2655

25963

Nephrotic syndrome

217

2159

1.01

0.01

2.6

3.0

0.96

0.75

ug/l

1.26

159

1374

Nonhereditary hypogammaglobulinemia

432

1.02

0.01

2.8

0.74

0.70

ug/l

0.08

264

Cervicobrachial syndrome

1229

12271

1.00

0.01

2.7

2.8

0.66

0.75

ug/l

2.72

799

7719

Benign neoplasm: Ciliary body

183

1.05

0.01

2.8

2.9

0.70

0.74

ug/l

—

127

Certain zoonotic bacterial diseases

172

1710

1.01

0.01

2.6

2.9

0.76

0.78

ug/l

0.07

109

1089

Yaws

193

1.04

0.01

2.6

2.9

0.95

0.74

ug/l

0.26

119

Abnormal findings in peritoneal fluid saliva

203

1.04

0.01

2.5

2.7

0.70

0.73

ug/l

0.10

133

Other sideroblastic anaemias

217

0.96

0.01

3.1

3.0

0.57

0.78

ug/l

0.98

154

Vascular dementia (mixed)

124

1231

1.01

0.01

3.0

3.5

0.81

0.87

ug/l

0.41

901

Atrial septal defect

143

1411

1.01

0.01

2.6

2.7

0.79

0.72

ug/l

0.21

833

Hypertrophy of tongue papillae

658

0.99

0.01

3.0

2.9

0.59

0.74

ug/l

1.43

425

Severe visual impairment, binocular

257

0.97

0.01

3.8

2.9

0.75

0.87

ug/l

0.28

170

Vasculitis limited to skin, not elsewhere classified

148

1471

1.01

0.01

2.6

3.0

0.61

0.78

ug/l

1.88

107

944

Other and unspecified haemorrhagic conditions

798

0.99

0.01

3.0

0.69

0.80

ug/l

0.87

516

Other osteochondrodysplasias

293

1.03

0.01

3.6

2.8

0.83

0.68

ug/l

0.26

174

Hypersensitivity pneumonitis due to organic dust

982

1.01

0.01

3.1

3.0

0.83

0.78

ug/l

0.12

651

Disorders of purine and pyrimidine metabolism

447

0.98

0.01

3.3

3.1

0.74

0.72

ug/l

0.07

312

Other disorders starting during childhood or adolecense, excluding more controls

543

0.99

0.01

2.3

2.0

0.53

0.74

ug/l

1.21

226

Cushing syndrome

447

0.98

0.01

3.5

3.0

0.84

0.72

ug/l

0.33

293

Allergic contact dermatitis

442

4430

1.00

0.01

2.7

2.9

0.82

0.73

ug/l

0.32

272

2764

Disorders of magnesium metabolism

637

0.99

0.01

2.6

3.2

1.38

0.73

ug/l

0.45

457

Localized skin eruption due to drugs and medicaments

563

1.01

0.01

3.3

3.0

0.73

ug/l

0.02

364

Other and unspecified acute skin changes due to ultraviolet radiation

171

1718

0.99

0.01

3.5

3.0

0.65

0.79

ug/l

1.93

115

1147

Deep bite

425

3717

1.00

0.01

2.9

2.8

0.62

0.70

ug/l

1.97

248

2252

ILD, hospital admissions 1, main diag only

1205

12039

1.00

0.01

3.0

3.3

0.72

0.81

ug/l

2.50

868

8624

Other and unspecified disorders of globe

106

0.93

0.01

2.6

2.8

0.60

0.73

ug/l

—

SLE (Finngen)

873

1.01

0.01

2.5

2.8

0.75

0.71

ug/l

0.11

546

Hypoparathyroidism

913

1.01

0.01

3.0

0.75

0.73

ug/l

0.07

578

Other congenital malformations of heart

186

0.96

0.01

1.9

2.6

0.47

0.78

ug/l

2.89

109

Osteosarcoma, including Hilmo

194

1.04

0.00

1.8

2.5

0.70

0.74

ug/l

0.07

116

Other congenital malformations of tongue, mouth and pharynx

195

0.97

0.00

3.2

2.3

0.71

0.72

ug/l

0.03

111

Malignant neoplasm of anus and anal canal

246

0.97

0.00

1.5

2.6

0.46

0.75

ug/l

2.08

167

Toxic effect of corrosive substances

246

0.97

0.00

2.7

2.4

0.76

0.63

ug/l

0.37

120

Caries in Clefts patients

274

1.02

0.00

2.6

2.2

0.55

0.66

ug/l

0.56

131

Malignant neoplasm of palate, including Hilmo

364

1.02

0.00

1.9

2.6

0.84

0.72

ug/l

0.38

229

Carcinoma in situ of oral cavity, oesophagus and stomach

474

1.02

0.00

2.1

3.1

0.63

0.76

ug/l

0.38

316

Calcific tendinitis

516

0.99

0.00

2.4

2.9

0.70

0.74

ug/l

0.21

347

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

484

1.01

0.00

3.2

2.9

0.65

0.78

ug/l

1.17

299

Recurrent and persistent haematuria

544

1.01

0.00

3.5

3.1

1.59

0.83

ug/l

0.47

360

Sequelae with surgical and medical care as external cause

1433

14322

1.00

0.00

3.1

0.74

0.77

ug/l

0.67

1008

9828

Early lumbar disc prolapse, operated

542

5413

1.00

0.00

2.2

2.0

0.55

0.62

ug/l

1.70

238

2365

Crystalline deposits in vitreous body

686

0.99

0.00

2.8

3.2

0.82

0.79

ug/l

0.11

483

Gout due to impairment of renal function

102

1026

0.99

0.00

3.0

3.1

1.00

0.79

ug/l

0.89

703

Other and unspecified mood [affective] disorders

240

2406

1.00

0.00

2.3

2.5

0.50

0.70

ug/l

7.17

164

1270

Calcaneal spur

455

0.99

0.00

3.0

2.8

0.88

0.75

ug/l

0.27

302

Family history of other specific disorders

327

1.01

0.00

2.5

2.6

0.78

0.70

ug/l

0.19

208

Dermatopolymyositis

706

1.01

0.00

2.7

3.0

0.73

0.75

ug/l

0.14

460

Von Willebrand disease

198

1.01

0.00

2.9

2.4

0.48

0.69

ug/l

1.58

104

Disorders of myoneural junction and muscle in diseases classified elsewhere

252

0.99

0.00

3.5

2.9

0.75

0.69

ug/l

0.12

157

Beningn neoplasm: Meninges, unspecified

547

1.01

0.00

3.9

3.1

0.79

0.83

ug/l

0.18

378

Increased muscle tone

282

0.99

0.00

3.0

2.8

0.74

ug/l

0.00

182

Diseases of spleen

115

1146

1.00

0.00

2.7

2.9

0.75

0.77

ug/l

0.09

756

Algoneurodystrophy

103

1034

1.00

0.00

2.3

2.6

0.48

0.69

ug/l

4.45

590

Pyoderma gangrenosum

322

0.99

0.00

2.9

0.57

0.74

ug/l

1.19

203

Malignant neoplasm of tongue

152

1524

1.00

0.00

2.9

2.6

0.79

0.71

ug/l

0.67

103

985

Vertigo of central origin

803

1.00

0.00

3.6

3.1

0.96

0.76

ug/l

0.46

549

Benign neoplasm: Bone and articular cartilage, unspecified

402

0.99

0.00

3.0

2.8

1.25

0.75

ug/l

0.35

240

Disorders of sphingolipid metabolism and other lipid storage disorders

176

1.03

0.00

2.3

3.2

0.89

0.74

ug/l

0.27

125

Benign neoplasm: Other parts of oropharynx

488

1.00

0.00

2.7

2.8

0.69

0.74

ug/l

0.25

307

Other, unspecified and serous retinal detachments

233

2326

1.00

0.00

3.4

3.0

0.71

0.77

ug/l

0.74

158

1553

Exophthalmic conditions

482

1.00

0.00

3.3

2.6

0.55

0.76

ug/l

2.09

301

Acute thyroiditis

131

0.99

0.00

3.5

2.8

0.62

0.73

ug/l

—

Malignant neoplasm of parotid gland, including Hilmo

608

1.00

0.00

3.0

2.6

0.70

0.73

ug/l

0.18

398

Toxoplasmosis

244

0.98

0.00

2.2

2.7

0.44

0.76

ug/l

1.73

145

Other disorders of carbohydrate metabolism

274

0.98

0.00

1.7

2.8

0.52

0.69

ug/l

1.08

167

Systemic sclerosis

558

1.00

0.00

2.9

0.60

0.72

ug/l

0.70

347

Henoch-Schönlein purpura nephritis (HSPN)

201

0.99

0.00

2.4

2.8

0.67

0.73

ug/l

0.14

122

Corneal pigmentations and deposits

231

0.99

0.00

2.7

2.8

0.71

0.78

ug/l

0.24

145

Third [oculomotor] nerve palsy

114

1138

1.00

0.00

2.8

3.0

0.69

0.79

ug/l

0.89

771

Malignant neoplasm of gum

279

1.00

0.00

2.5

0.62

0.75

ug/l

0.67

188

Hypersplenism

281

1.00

0.00

3.0

2.8

0.72

ug/l

0.01

184

Congenital retinoschisis

148

1.02

0.00

3.3

3.1

0.52

0.84

ug/l

—

Infarction of spleen

441

1.00

0.00

2.3

3.1

0.64

0.82

ug/l

0.76

300

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

942

0.99

0.00

2.4

2.5

0.68

0.67

ug/l

0.01

505

Fibrosarcoma, including Hilmo

499

1.00

0.00

2.6

0.60

0.73

ug/l

1.04

320

Malignant neoplasm of gum, including Hilmo

559

1.00

0.00

2.6

0.74

0.75

ug/l

0.01

372

Major anomalies of jaw size

130

1301

1.00

0.00

2.6

2.5

0.71

0.68

ug/l

0.15

749

Cystic kidney disease

196

1961

1.00

0.00

3.1

2.9

1.17

0.74

ug/l

2.00

148

1235

Amiodarone users

1006

10063

1.00

0.00

2.8

3.2

0.72

0.79

ug/l

0.68

708

7058

Mumps

190

1897

1.00

0.00

2.5

0.65

0.68

ug/l

0.16

105

1034

Dermatitis due to ingested food

217

1.02

0.00

1.2

2.1

0.64

0.77

ug/l

—

Benign intracranial hypertension

143

0.98

0.00

2.1

2.6

0.63

ug/l

—

Use of dimethyl fumarate

163

0.98

0.00

1.8

2.0

0.60

0.57

ug/l

—

153

0.98

0.00

1.1

2.2

1.02

0.72

ug/l

—

Apocrine sweat disorders, other sweat gland disorders

167

1.02

0.00

2.5

2.8

0.63

0.73

ug/l

0.33

113

Other degenerative disorders of eyelid and periocular area

167

1.02

0.00

2.0

3.0

0.87

0.75

ug/l

0.10

111

Other corneal oedema

433

0.99

0.00

3.1

3.0

0.73

0.86

ug/l

0.35

279

Superficial injury of ankle and foot, unspecified

187

1.02

0.00

2.6

2.7

0.56

0.69

ug/l

—

Benign neoplasm: Heart

183

0.98

0.00

3.0

2.09

0.73

ug/l

0.71

125

Adrenomedullary hyperfunction

183

0.98

0.00

3.2

2.8

1.08

0.70

ug/l

0.60

117

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

213

0.98

0.00

3.6

2.5

0.71

0.75

ug/l

0.08

143

Mastocytosis

233

0.99

0.00

2.4

2.8

0.58

0.76

ug/l

0.86

142

Pityriasis lichenoides chronica

213

0.98

0.00

2.5

2.9

0.42

0.79

ug/l

2.64

140

Sequelae of poliomyelitis

633

0.99

0.00

2.8

3.3

1.08

0.80

ug/l

0.99

458

Benign neoplasm: Central nervous system, other parts/unspecified

213

0.98

0.00

3.0

2.7

0.83

0.94

ug/l

0.14

124

Other specified/unspecified disorders of tympanic membrane

243

0.98

0.00

3.7

3.0

0.79

0.76

ug/l

0.07

159

Malignant immunoproliferative diseases

807

1.00

0.00

2.8

3.2

0.67

0.76

ug/l

0.66

562

Benign neoplasm: Brain, unspecified

283

0.99

0.00

3.4

2.8

0.73

0.78

ug/l

0.14

172

Systemic sclerosis,strict definition

175

0.97

0.00

1.7

2.7

0.44

0.79

ug/l

—

108

Other endophthalmitis

275

1.02

0.00

3.0

3.1

0.55

0.77

ug/l

1.11

178

Other and unspecified hypertrophic disorders of skin

266

1.02

0.00

3.2

2.8

0.62

0.67

ug/l

0.19

162

Aspergillosis

696

1.01

0.00

3.0

3.1

0.63

0.80

ug/l

1.60

467

Acromegaly and pituitary gigantism

334

0.99

0.00

2.2

2.7

0.51

0.72

ug/l

1.89

197

Congenital malformations of anterior segment of eye

286

1.02

0.00

2.7

2.9

0.70

0.79

ug/l

0.25

191

Diastasis of muscle

395

1.01

0.00

3.2

2.9

0.58

0.76

ug/l

1.16

259

Transient synovitis

234

0.98

0.00

2.3

2.7

0.74

0.76

ug/l

0.04

151

Symptoms and signs involving appearance and behaviour

344

0.99

0.00

2.7

2.8

0.44

0.78

ug/l

5.69

211

Migraine with aura, drug-induced

234

0.98

0.00

1.8

2.7

0.62

0.70

ug/l

0.41

144

Injury of nerves at lower leg level

586

1.01

0.00

2.7

0.75

0.78

ug/l

0.11

357

Mantle cell lymphoma

835

0.99

0.00

3.5

2.6

0.73

0.74

ug/l

0.03

569

Congenital ptosis

112

0.98

0.00

2.0

2.7

0.71

0.68

ug/l

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

488

1.01

0.00

2.9

3.2

0.84

0.86

ug/l

0.03

340

Other fibroblastic disorders

228

1.01

0.00

3.0

2.7

0.67

0.79

ug/l

0.35

143

Colour vision deficiencies

185

1.03

0.00

2.7

2.5

0.93

0.70

ug/l

0.80

108

Other hyperalimentation

145

1.04

0.00

2.9

0.69

0.70

ug/l

—

Exposure to other and unspecified forces of nature

338

1.01

0.00

3.0

2.9

0.54

0.75

ug/l

1.53

226

Localized adiposity

145

0.96

0.00

1.9

2.5

0.66

0.72

ug/l

—

Malignant neoplasm of bone and articular cartilage of limbs

242

0.99

0.00

2.2

2.7

0.97

0.79

ug/l

0.37

155

Tracheo-bronchomalasia

155

1.04

0.00

2.9

2.4

0.44

0.65

ug/l

—

Unspecified transport accident

268

1.01

0.00

2.0

2.5

0.67

0.69

ug/l

0.05

151

Other and unspecified pemphigus

225

0.97

0.00

3.3

2.9

0.76

0.69

ug/l

0.08

146

Unspecified multiple injuries

175

1.03

0.00

3.0

2.4

0.77

0.65

ug/l

0.44

Exposure to sunlight

125

1.05

0.00

2.4

2.7

0.55

0.68

ug/l

—

Injury of nerves at hip and thigh level

215

0.97

0.00

2.7

3.3

1.34

0.84

ug/l

0.40

150

Other specified/unspecified disorders of ear

105

1.05

0.00

2.0

2.7

0.44

0.74

ug/l

—

Enteropathogenic Escherichia coli infection

194

0.98

0.00

2.2

2.9

0.90

0.70

ug/l

0.29

129

Erythrasma

159

1.01

0.00

3.1

2.7

0.46

0.71

ug/l

1.53

112

Malignant neoplasm of nasopharynx

221

0.99

0.00

2.4

2.5

0.64

0.71

ug/l

0.28

134

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

236

1.02

0.00

4.2

3.0

0.99

0.75

ug/l

0.72

150

Traumatic subcutaneous emphysema

108

1.02

0.00

2.7

2.8

0.56

0.77

ug/l

—

Porphyria cutanea tarda

0.98

0.00

3.4

3.3

0.72

0.76

ug/l

—

Cyst of Bartholin Gland

0.00

0.0

1.0

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.0

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.0

—

Infections of breast associated with childbirth

0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

1.0

—

Polyhydramnios

0.00

-0.00

0.0

1.1

—

Secondary lactase deficiency

0.86

-0.00

2.4

3.3

0.39

0.77

ug/l

—

Toxic effect of other inorganic substances

0.85

-0.00

5.8

3.0

0.56

0.80

ug/l

—

Polycystic ovarian syndrome

0.00

-0.00

0.0

1.0

—

Failed induction of labour

0.00

-0.00

0.0

1.1

—

Acne conglobata

190

1.00

-0.00

2.5

2.4

0.71

0.67

ug/l

0.08

Use of apomorphine

0.91

-0.00

3.0

0.51

0.76

ug/l

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.0

—

Disorders of glycoprotein metabolism

0.90

-0.00

4.8

3.0

1.81

0.61

ug/l

—

Hirsutism in women

0.00

-0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.0

—

Amenorrhoea

0.00

-0.00

0.0

1.0

—

Disorder of carbohydrate metabolism, other/unspecified

210

1.00

-0.00

1.9

2.7

0.45

0.69

ug/l

1.69

123

Nutritional and metabolic disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.5

—

1.28

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.0

—

Other and unspecified syphilis

220

1.00

-0.00

2.7

2.5

0.79

0.70

ug/l

0.26

116

Unspecified/other endometriosis

0.00

-0.00

0.0

1.1

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.1

—

Postpartum care and examination

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the vulva

0.00

-0.00

0.0

1.0

—

Oligomenorrhoea

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS